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Background: Decisions regarding the management of Type 2 Diabetes Mellitus 
(T2DM) are complex as the management of this chronic illness requires a 
multifaceted approach. Shared decision-making is a patient-centred care approach in 
which the patients and their healthcare professionals (HCPs) collaboratively make a 
health decision, not only using the best available evidence, but also reflecting 
patients‘ needs, preferences and values. While there is growing evidence of the 
effectiveness of shared decision-making in supporting T2DM patients‘ involvement 
in the decisions across the world, potentially contributing to the improvement of their 
overall well-being, little is actually known about patient involvement in the decisions 
and particularly about shared decision-making in the Malaysian context.  
Aims: This study explores the experiences and perspectives of patients and HCPs on 
patient involvement in decision-making in the management of T2DM in Malaysia.   
Methods: A qualitative research design is employed in this study. Data were 
collected in the outpatient setting of three health facilities in the urban area of 
Malaysia. Face-to-face in-depth interviews were conducted, over a period of six 
months, with 19 HCPs (including three specialists, five medical officers, five 
diabetes educators/nurses, four dietitians/nutritionist and two pharmacists) and 24 
T2DM patients. Thematic analysis and constant comparative method were used to 
analyse the data.  
Findings: The data highlighted a range of interpretations of shared decision-
making. While patients described shared decision-making as a way for their concerns, 
preferences and values to be heard and addressed by their HCPs, the HCPs 
emphasised their patients‘ agreement and compliance with their recommendations. 
The types of decisions made, despite professed patient involvement would seem to 
remain largely in the hands of the HCPs. The extent to which patients are generally 
involved is subtle, whereby the decision is not necessarily shared and the decision-
making for T2DM extends outside the face-to-face clinical encounter. 
This study also highlights that patient involvement in their decision is mainly 
influenced by patients and HCPs characteristics, values, beliefs, culture and past 
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experience; their interpersonal relationship and communication; and role 
expectations in the healthcare field. Using Bourdieu‘s work to shape analysis showed 
that these factors intersect with each other and create a multifaceted patient-HCP 
power dynamic in making the decision. By including different groups of HCPs, this 
study also has provided valuable insight into the struggle among the non-physicians, 
who perceived to have limited decision-making power in managing patients with 
T2DM despite being the HCPs who were found to be more encouraging of patient 
involvement in the decisions. This is an addition to the struggles that are generally 
faced by all groups of HCPs, including their dilemma to balance their ethical 
foundation of beneficence and respecting patients‘ autonomy; their limited 
opportunity for involving patients due to constraints on the resources available at 
their facilities; and the language barrier. 
Conclusion:  In conclusion, this study highlights the benefit of integrating the 
shared decision-making approach with some additional emphases on facilitating 
patient involvement in the decisions. These emphases include (1) inclusion of 
problem identification as one of the element of shared decision-making; (2) reducing 
the power gap and struggle by explicitly addressing the power issue and improving 
patients‘ cultural health capital; (3) strengthening of patient-HCP interpersonal 
relationship and communication skills; (4) allowing experimentation of different 
options that suit patients‘ condition; (5) integration of other approaches including 
motivational interviewing, support for self-management and interprofessional 
collaboration.  
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Shared decision-making has been spreading throughout the world as a patient-
centred care approach to help patients to be involved in the decisions during the 
clinical encounter. In this approach, patients‘ needs, preferences and values are 
important in making a decision apart from healthcare professionals‘ (HCPs‘) medical 
expertise, In Malaysia, despite the integration of patient-centred care particularly in 
Type 2 Diabetes Mellitus (T2DM) as a long-standing illness, little is known about 
patient involvement in decision-making particularly shared decision-making.  
The research aimed to understand the experiences and views of T2DM patients and 
HCPs regarding patient involvement in decision-making in the management of 
T2DM in Malaysia. In the course of six months, 19 HCPs (including three specialists, 
five medical officers, five diabetes educators/nurses, four dietitians/nutritionist and 
two pharmacists) and 24 T2DM patients from three different clinics in Malaysian 
urban area were interviewed.  
Shared decision-making was interpreted differently between patients and HCPs. 
While some patients described shared decision-making as a way for their concerns, 
preferences and values to be heard and addressed by their HCPs, the HCPs 
emphasised their patients‘ agreement and compliance with their recommendations. 
Even though the participants generally claimed that the decisions are shared among 
patients and HCPs, it seemed to remain largely in the hands of the HCPs. The extent 
to which patients are generally involved is subtle, whereby the decision is not 
necessarily shared and the decision-making for T2DM extends outside the face-to-
face clinical encounter. 
This study also highlights that patient involvement in their decision is mainly 
influenced by patients and HCPs characteristics, including their values, beliefs, 
culture and past experience; their interpersonal relationship and communication, and 
the roles that they are expected to play when they meet each other. These factors 
found to be interlinked with each other and contribute to a complex patient-HCP 
power dynamic in making the decisions. By including different groups of HCPs, this 
study also has found the struggle among the non-physicians, who perceived to have 
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limited decision-making power in managing patient with T2DM. This is an addition 
to the struggles that are generally faced by all groups of HCPs, including their 
dilemma to balance their ethical foundation of doing good for patients and respecting 
patients‘ right; their limited opportunity for involving patients due to constraints on 
the resources available at their facilities; and the language barrier. 
In conclusion, this study highlights the benefit of integrating shared decision-making 
approach with some additional emphases in encouraging patient involvement in the 
decisions. These emphases include (1) inclusion of problem identification as one of 
the element of shared decision-making; (2) reducing the power gap and struggle by 
explicitly addressing the power issue and improving patients‘ ability to be involved; 
(3) strengthening the patient-HCP interpersonal relationship and communication 
skills; (4) allowing the patients to try different options that suit patients‘ condition; (5) 
integration of other approaches including motivational interviewing, support for self- 
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Outline of the thesis 
 
This thesis consists of seven chapters. Chapter 1 has outlined the background 
information about T2DM, shared decision-making, together with Malaysian cultural 
background and document review regarding patient involvement in decision-making 
Malaysia, to set the context for this study. Chapter 2 presents an overview of the 
theoretical context surrounding patient involvement in decision-making and a review 
of the related empirical studies. These highlight the gap in knowledge and practice to 
further justified the relevant of this study. Chapter 3 provides details on the study 
design and methodological approach used in this study. Chapters 4 and 5 present and 
discuss the findings of the study from the perspective of both patients and HCPs, 
while Chapter 6 further explores and discusses the key findings of this study. Finally, 
Chapter 7 summarises the thesis in addition to presenting the implications and 









CHAPTER 1: INTRODUCTION 
 
1.1 Introduction 
This chapter introduces the study context in the form of an overview of the Type 2 
Diabetes Mellitus (T2DM) epidemic occurring both globally and in Malaysia. This is 
followed by a discussion of patient empowerment and autonomy as the foundation of 
patient-centred care in the management of T2DM. Next, there is an overview of 
shared decision-making as one of the approaches to patient involvement in decision-
making. Setting the context for the study, the following section presents an overview 
of the Malaysian background, including the cultural background and the integration 
of patient involvement in decision-making in the current Malaysian government 
documentation.  
 
1.2 Type 2 Diabetes Mellitus (T2DM) 
Diabetes is defined as “… a serious, chronic disease that occurs either when the 
pancreas does not produce enough insulin (a hormone that regulates body glucose), 
or when the body cannot effectively use the insulin it produces” (World Health 
Organization (WHO), 2016: p. 6). T2DM is the most common form of diabetes, 
occurring among 90% of the diabetic population, and is a major health issue 
affecting people worldwide. In 2012, WHO (2014) estimated that a total of 1.5 
million deaths could be directly attributed to this non-communicable disease. By 
2017, this figure had almost tripled, to 4 million deaths (International Diabetes 
Federation (IDF), 2017a). The International Diabetes Federation (IDF) (2017a) has 
also estimated that 80% of the 425 million T2DM cases worldwide occur in low- and 
middle-income countries. It is considered to be a lifestyle disease despite also being 
partly affected by genetic disposition (Holman, Young & Gadsby, 2015). In Asia, 
there were estimated to be 110 million individuals with diabetes in 2007, with this 
number continuing to rise due mainly to the impacts of economic development, the 
modification of nutritional intake and the adoption of a sedentary lifestyle (Chan et 




As an Asian country, Malaysia is currently grappling with this type of health 
situation. A series of National Health Morbidity Surveys conducted by the Ministry 
of Health (MOH) Malaysia revealed a shocking escalation in the prevalence of 
T2DM among individuals aged 30 years and over, with the number showing an 
almost twofold increase over a period 15 years, rising from a rate of 8.3% in 1996 to 
14.9% in 2006 and, finally, to 20.8% in 2011 (Institute for Public Health, 2011). The 
same national surveys also reported that the prevalence of T2DM among adults aged 
18 and over rose from 11.6% in 2006 to 17.5% in 2015, which is double the 
estimated prevalence of 8.5% for the South East Asia region in 2017 (Institute for 
Public Health, 2015; IDF, 2017b). This demonstrates not only the alarming trend of 
the increase in T2DM in Malaysia but also a phenomenon similar to the surge in 
early-onset T2DM as seen in the United Kingdom (UK) and United States of 
America (USA) (Mokdad et al., 2000; Gonzalez, Johansson, Wallander, & 
Rodriguez, 2009). 
 
Currently, while a large number of T2DM patients are able to endure acute 
complications of the disease owing to the development of new technologies in the 
healthcare system, there remains no cure for T2DM, except for the replacement of 
pancreatic cells (Buse et al., 2009). Thus, the main objective of T2DM management 
is remission, as opposed to treatment of the disease being curative in nature. T2DM 
is managed through a combination of lifestyle modifications and pharmacological 
modalities in the effort to mitigate its symptoms and either prevent or delay chronic 
complications, which may be macrovascular (amputation, cardiovascular diseases) 
and/or microvascular (retinopathy, nephropathy) in nature and potentially lead to 
premature disability and death (Klein, 1995; Stratton, 2000).  
 
T2DM as a chronic illness also demands the long-term active engagement of patients 
as it requires continuous adjustment, decision-making and self-management. In 
facilitating its management, the Chronic Care Model (Bodenheimer, Lorig, Holman, 
& Grumbach, 2002) has been globally accepted. This model advocates the active 
involvement of patients who must be kept well informed as to their current condition 
owing to the important role that they themselves play in the management of their 
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T2DM (Coleman, Austin, Brach & Wagner, 2009). Nonetheless, advances in 
medical technology and strategy have also provided an array of T2DM management 
options. It is thus becoming ever more complicated to select the ideal 
pharmacological therapy and lifestyle modification for patients (Cohen & Shaw, 
2007; Nathan, 2015).  
 
Globally, the common aim of T2DM management is to reduce patients‘ glycaemic 
level to an optimum level, with the glycated haemoglobin (HbA1c) test being one of 
the most popular ways of measuring this (National Institute for Health and Care 
Excellence (NICE), 2015; Malaysian Endocrine & Metabolic Society (MEMS), 2016; 
American Diabetes Association (ADA), 2017). This is due to its strong association 
with a reduction in the risk of T2DM complications despite it being incapable of 
providing glycaemic variability or occurrences of hypoglycaemia, with the latter 
being one of the dangerous acute complications of T2DM (Duckworth et al., 2009; 
ADA, 2017). HbA1c is a blood test that reveals the average measures of plasma 
glucose concentration, with the optimum level varying among countries and patients. 
According to the ADA (2017), the target HbA1c level should in the range of less 
than 6.5% to less than 8.0%, dependent on the individual case, while guidelines 
issued by the UK‘s NICE (2015) stipulate a target of less than 6.5% to less than 7.0%, 
with the recommendation to be less stringent in some cases in order to minimise the 
risk of hypoglycaemia. The Malaysian Clinical Practice Guidelines (MEMS, 2016) 
resolve with a target optimum range of less than 6.0% to less than 8.0%, depending 
on the patient‘s condition. 
 
As a chronic progressive illness, T2DM is considered to be a major health concern 
due to its negative implications in terms of both the quality of life of the sufferer and 
also with respect to its impact on national economies (Ibrahim et al., 2010). Patients 
with T2DM require prolonged and frequent health follow-ups to ensure the delivery 
of consistent pharmacological and non-pharmacological management. This is crucial 
for the prevention of acute and chronic multiple-organ T2DM complications. The 
IDF (2017b) has estimated that global healthcare expenditure on patients with 
diabetes aged 20–79 rose from 232 billion US dollars (US$) in 2007 to US$ 727 
4 
 
billion in 2017, in parallel with the aforementioned steep rise in the prevalence of 
T2DM worldwide. Similarly, in response to the massive increase in the prevalence of 
diabetes in Malaysia, the Malaysian government has allocated a significant 
proportion of its health budget to improving management of the condition. It is 
estimated that a total of 2.04 billion Malaysia ringgits (RM) (approx. US$ 521 
million) was spent in 2011, while approximately 78% of cases are still considered to 
be of uncontrolled diabetes (Mafauzy, Hussein, & Chan, 2011; Feisul et al., 2017). 
Furthermore, T2DM is a chronic disease that requires long-term management, with 
the majority of this management being carried out in the primary care setting. It is 
estimated that 60.2% of the total budget is allocated to this setting (Sharifa Ezat, 
Azimatun, Amrizal Rohaizan, Saperi, 2009). 
 
Overall, T2DM imposes an economic burden not only in terms of direct medical 
expenditures globally, nationally and personally, but also indirectly due to the 
frequent disability and early mortality of T2DM patients arising from its increasingly 
early onset (WHO, 2016). Thus, an exploration of new low-cost approaches to 
managing patients suffering from this disease, especially in the primary care setting, 
is needed to facilitate the better achievement of optimal outcomes and to prevent 
further devastating complications. Globally, the management of T2DM is being 
strengthened by the integration of patient-centred care. Despite the debate with 
regard to its cost-effectiveness, this approach is found to contribute positively to 
patients‘ experience in managing their health, which then improves their quality of 
life (Inzucchi, et al., 2012; Slingerland, et al., 2013; Ahmad, Ellins, Krelle & Lawrie, 
2014; Zanariah, Sri Wahyu, Singh, 2015). The care required to manage patients‘ 
long-term illness is tailored to their personal needs, abilities and values since both 
patients and healthcare professionals (HCPs) work together to improve patients‘ 
health outcomes and quality of life. In doing so, two major components of the 
concept are emphasised – patient involvement in decision-making and patients‘ self-





1.3 Patients’ empowerment and autonomy in T2DM  
As mentioned in the previous section 1.2, there is great scope for the involvement of 
T2DM patients in decision-making and self-management, arising from the need for 
them to continuously adapt to their uncertain health condition as a way of managing 
the chronic illness. Hence, Anderson and Funnell (2010) emphasised the importance 
of strengthening patients‘ autonomy and empowerment so that they are able to play 
an active role during discussions of their T2DM management and to enable them to 
effectively carry out their own self-management. Peek and colleagues (2012) 
demonstrated that a lack of adherence to treatment is often associated with patients‘ 
lack of autonomy as it provides a means by which they can express their preferences, 
especially if they consider their treatment to be not flexible, too limiting or as 
something that has been chosen for them by a physician. On the other hand, Ahmad 
and colleagues (2014) found that many patients were keen to become more involved 
in their healthcare and that patient-centred care in T2DM management has a hugely 
positive impact on patients‘ self-efficacy. This then has the effect of further 
facilitating patients‘ involvement in decision-making and self-management. 
 
The process of empowering T2DM patients is defined as “… the discovery and 
development of one‟s inherent capacity to be responsible for one‟s own life” 
(Funnell et al., 1991: p. 37). This definition was further elaborated by Funnell and 
Anderson (2004: p. 124) as “…a patient-centered, collaborative approach tailored 
to match the fundamental realities of diabetes care”. While autonomy “… 
encompasses self-rule that is free from both controlling interference by others and 
limitations that present meaningful choice (such as inadequate understanding)” 
(Beauchamp & Childress, 2013, p. 101). The notion of autonomy supports the 
involvement of patients in their own healthcare management, while HCPs are 
responsible for explaining in detail the treatment options available. Strengthening 
patients‘ autonomy and empowering them to self-manage their health is also pivotal 
within policymakers‘ attempts to achieve value for money and may also help in 
tackling the problem of health inequalities between socio-economic groups 




Patient involvement in the making of health- and medical-related decisions has also 
been widely encouraged due to the growing recognition of the need for patient 
autonomy in respect of biomedical ethics. Over the past decade, interest in this 
ethical principle has surpassed beneficence in the health and medical field due to the 
strong arguments made by lawyers, judges and medical ethicists regarding patients‘ 
right to decide what will be done to their bodies (Moulton & King, 2010). Patient 
autonomy has gained increasing levels of attention in line with the rise of 
consumerism, liberalism and individualism, all of which are interrelated within the 
current broader global socio-economic framework (Macfarlane, 1978; Mohd Darbi, 
2006). Autonomy means that T2DM patients have the right to be fully informed 
regarding their medical or health condition and involved in their own disease 
management, thus ultimately improving their overall outcomes and reducing medical 
costs (Flierler, Nübling, Kasper, & Heidegger, 2013; Miller & Jawad, 2014).  
 
Moreover, it is important that the management and treatment options selected are 
those that are best suited to T2DM patients. This is because treatment modalities will 
mostly be carried out by the patients themselves, outside of the healthcare system. 
Certain types of management also require an element of deliberation with patients as 
they will usually be required to attend a medical appointment to receive them. 
Patients are supported in becoming involved via the concept of autonomy. It is 
essential that a patient is both mentally and medically capable of making an 
autonomous decision since decision-making is an intentional act that needs to be 
accompanied by a substantial understanding of the existing options and free of any 
influence from external or internal sources (Beauchamp & Childress, 2013). 
Autonomous decisions made by patients should not be overridden by HCPs, with the 
latter being responsible for carrying out the treatment as requested by their patients 
(Kumarasamy et al., 2014).  
 
However, there is always the potential for an autonomous request or decision made 
by a patient to contradict the treatment or management option that an HCP believes 
will be best for him or her. This HCP‘s recommendation of the option which he or 
she believes to be the best is reflecting the concept of beneficence. Beneficence is 
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described by Beauchamp and Childress (2013: p. 203) as “… a statement of moral 
obligation to act for the benefit of others”. Beneficence has commonly been used as 
the basis of the traditional paternalistic approach, together with the concept of 
nonmaleficence, which is defined as “… obligations not to harm others” 
(Beauchamp & Childress, 2013: p. 151). The contribution of HCPs to the decision-
making process remains crucial as they possess the medical knowledge and skills to 
help patients better manage their T2DM. Thus, the HCP team require some common 
ground in order to ensure they are in the best position to respect patients‘ autonomy 
while still adhering to the principle of beneficence in relation to their patients‘ care 
and striving to improve patient-centred care. Shared decision-making is considered 
to be the most applicable approach in terms of striking a balance between these two 
important components of biomedical ethics (Charles, Gafni, & Whelan, 1997) and 
has been found to have a positive relationship with patient empowerment (Zoffmann, 
Harder, & Kirkevold, 2008; Varming et al., 2015). Elwyn et al. (2012) further 
emphasise the relevance of shared decision-making in current health practice due to 
it being based on the two tenets of self-determination and relational autonomy. They 
interpret the latter as “… the term used to describe the view that we are always 
related to interpersonal relationships and mutual dependencies” (p. 1362).  
 
1.4 Shared decision-making and T2DM 
Patient involvement in decision-making is often referred to as shared decision-
making in the existing literature as it describes the optimum balance of combined 
patient/HCP effort in making decisions (Charles et al., 1997; Lewis-Barned, 2016). 
Similar to the support given to self-management, shared decision-making has 
attracted a lot of attention over this 20 years since Charles and colleagues introduced 
one of the first models in 1997. However, it can also be sensed that the research on 
shared decision-making in T2DM is not as extensive as that related to support for the 
self-management of T2DM. This may be due to the common conceptualisation of 
shared decision-making that it occurs at a specific time, in a certain context and in 
one-off dyadic encounters, which is in contrast to self-management that is more 
concerned with the management of a long-term health problem (Charles et al., 1997; 
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Ahmad et al., 2014;). This therefore adds to the lack of clarity with regard to the 
shared decision-making approach itself (Clayman & Makoul, 2009).  
 
Nevertheless, since shared decision-making encourages a collaborative patient–HCP 
effort, it is believed that this approach will enable the team to reach the most suitable 
decision that has a significant impact in the long run (Montori, Gafni, & Charles, 
2006). Shared decision-making also appears to be particularly relevant in the case of 
T2DM as it may enhance patient empowerment and self-efficacy, enabling them to 
have better control of their glycaemic level and prevent the development of any 
complications (Zoffmann et al., 2008; Clark et al., 2009). It may also provide a range 
of benefits, such as improving patients‘ knowledge of the disease, reducing their 
anxiety and stress, improving various health outcomes and reducing the associated 
range of treatment and cost (Olsson, Jakobsson Ung, Swedberg, & Ekman, 2012; E. 
O. Lee & Emanuel, 2013; Veroff et al., 2013). Since patients share their initial 
treatment plan with their HCPs, they also have the opportunity to modify it, notably 
should they encounter any barriers to or consequences of carrying it out (Montori et 
al., 2006). For these reasons, shared decision-making has become the current central 
paradigm in the concept of patient participation and has developed into a 
contemporary evidence-based approach to managing chronic illness (Deegan & 
Drake, 2006; Zikmund-Fisher et al., 2010).  
 
1.4.1 Shared decision-making vs self-management in T2DM 
Aside from shared decision-making, self-management is another common area of 
patient-centred care in the management of patients with T2DM. Whether the practice 
and research of these two important areas of patient-centred care are carried out 
separately or together, it is undeniable that they are closely related (Ahmad et al., 
2014). Ahmad and colleagues (2014: p. 12) define self-management as “… the 
behaviours that individuals engage in outside of the health context”, while self-
management support refers to “… how individuals are supported in their self-
management goals and activities by health care professionals (and others)”. These 
definitions highlight the difference between shared decision-making and self-
management, with shared decision-making relating to how the management decision 
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(including self-management decision) is reached and requiring an ongoing 
partnership between patients and HCPs (Montori et al., 2006). Correspondingly, 
Ahmad and colleagues (2014) suggest that shared decision-making is a component of 
self-management support.  
 
1.5 Malaysian contextual background 
To reiterate, Malaysia, as the setting of this current study, is facing a rapidly growing 
T2DM epidemic. This section presents the contextual and cultural background in 
order to set the scene of the study. This is followed by the findings of an analysis of 
the existing government documentation related to patient involvement in decisions. 
 
Malaysia is a country in South East Asia with an equatorial and tropical climate, 
being hot and humid throughout the year. It consists of Peninsular Malaysia and East 
Malaysia and has a total land area of 329,847 km
2
. Malaysia became an independent 
country on 31
st
 August 1957. Prior to gaining its independence from the British 
Empire, it attracted traders and colonial powers due to its strategic location on the 
Malay Peninsula straddling East and West, in addition to its natural resources. This 
contributed to the diversity of ethnicities, cultures and religions currently seen in the 
country. In 2017, the total population of Malaysia was estimated at 32 million, 
spread across 14 states. Malays account for 68.8% of the population, Chinese make 
up 23.2%, Indians 7.0%, while 1% are classed as others (Department of Statistics 
Malaysia, 2017). The country‘s official religion is Islam, while other religions, 
including Buddhism, Hinduism, Christianity and others, are also represented. Malay 
is the official language and the mother tongue of the Malays, the country‘s majority 
ethnic group. Despite this, English is spoken by the majority and is the preferred 
language, especially in the realm of intercultural interaction.  
      
Since its independence, Malaysia has functioned as a democratic country and adopts 
a British-style parliamentary system with a prime minister as the head of the 
government. The government of Malaysia holds federal legislative powers covering 
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areas including finance, health, defence, education, external affairs, internal security, 
civil and criminal law, and citizenship. In comparison to the era before the 1970s, 
when Malaysia‘s economy was mostly dependent on its raw natural resources, the 
country nowadays has a diversified economy that ranges from its natural resources to 
its industrial and manufacturing commodities (The World Bank, 2017). Due to the 
growth of its economy, Malaysia is today one of the most urbanised developing 
countries. Its remarkable development has also attracted workers from other 
countries, contributing to a non-citizen population of 3.3 million (10.3%) 
(Department of Statistics Malaysia, 2017). This rapid growth is exerting pressure not 
only on the provision of physical infrastructure in Malaysia but also on the country‘s 
health services.  
    
1.5.1 The cultural background of Malaysia 
Culture has been defined differently across various fields and throughout time, yet 
the various definitions share a common basis. One of the earliest and clearest 
definitions of culture was by Sir Edward Tylor, who described culture as “… that 
complex whole which includes knowledge, belief, art, morals, law, custom, and any 
other capabilities and habits acquired by man as a member of society” (1870: p. 1; 
cited by Avruch, 1998: p. 6). Hofstede (1993: p. 89) defined it more recently as “… 
the collective programming of the mind which distinguishes one group or category of 
people from another”. Thus, it can be concluded that different societies have 
different cultures that are composed of distinct norms and values, and these will 
manifest in different attitudes, behaviours and practices.   
 
As an Asian country, Malaysia is a collectivist society, characterised by high power 
distance, a high-context culture and low uncertainty avoidance (Hall, 1976; Hofstede, 
1980). Although Hofstede‘s cultural dimensions are not typically used when 
discussing culture in medicine and health (Verma, Griffin, Dacre, & Elder, 2016), 
these dimensions were found to be related to the views and practices of the 
participants in this current study. This is presented and discussed further in the 
Findings and Discussion chapters. 
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Collectivism refers to “… societies in which people from birth onward are integrated 
into strong, cohesive in-groups, which throughout people‟s lifetime continue to 
protect them in exchange for unquestioning loyalty” (Hofstede & Hofstede, 2005: p. 
76). As a collective society, Malaysia is situated at the opposite end of the spectrum 
from UK and US, which known as individualist society (Hofstede, 1980).  In a 
collectivist society, and thus including Malaysia, an individual‘s main concern when 
making a decision is to ensure that neither the decision nor the process of making it 
harms their relationship with others (Guess, 2004). This is because they believe that 
the success of any decision-making depends on them fulfilling their social and 
cultural expectation. This element is important since they are more dependent on and 
loyal to their group, in comparison to the individualist (Darwish & Huber, 2003). 
Consequently, the collectivist tends to compromise with others and is motivated by a 
desire to maintain social harmony (LeFebvre & Franke, 2013). In contrast, the 
individualist‘s primary orientations are to achieve personal justice and autonomy and 
to uphold the right of the individual, with relatively less in the way of concern for 
others (Guess, 2004; Darwish & Huber, 2003). As a result, in comparison to the 
collectivist, the individualist tends to be more confident in their decision-making 
ability, in addition to being more rational and focused on the task of making the 
decision itself (Guess, 2004; LeFebvre & Franke, 2013). Despite this, Chen and Li 
(2005) revealed that the individualism–collectivism cultural spectrum is not at all 
simple. They investigated the cultural differences in decision-making between 
collectivists and individualists. They found the collectivists in their study to be less 
cooperative with other groups of people when making decisions compared to the 
individualists, which contradicts the values commonly associated with collectivism. 
However, they also discovered that the collectivists were more cooperative with 
other groups when they were in a foreign territory. Compared to previous studies, 
Chen and Li also found that the collectivists were more confident in their judgements, 
which is parallel to individualism. This is further discussed at the end of this section.  
 
The power distance index is described by Hofstede and Hofstede (2005) as “… the 
extent to which the less powerful members of institutions and organizations within a 
country expect and accept that power is distributed unequally” (p. 46). Based on a 
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study by Hofstede (1980), Malaysia has one of the highest power distance values. 
Power itself is defined as “… the potential to determine or direct (to a certain extent) 
the behaviour of another person/other persons more so than the other way round” 
(Mulder, 1977: p. 90). Correspondingly, as a country with a high power distance, it is 
common in Malaysia for hierarchical boundaries to be obvious and for there to be 
top-down decision-making with little to no discussion as a result of the society‘s high 
respect for both hierarchy and the people occupying the upper levels of the hierarchy, 
who are usually the experts (Abdullah, Hassan, Ali, & Karim, 2014). For the same 
reason, there is a lack of interest in becoming involved in arguments with the experts, 
thereby leading to a reluctance to question, refuse or disagree with them (Jung & 
Kellaris, 2006). This contrasts with people in societies where there is low power 
distance who typically view everyone as being somewhat equal. In terms of 
communicating information, Pornpitakpan and Francis (2000) found that, in contrast 
to a society with lower power distance, which focuses on the evidence provided, a 
society with high power distance places a high value on the credibility of the source 
of such evidence. In combining this with threatening messages, De Meulenaer, De 
Pelsmacker and Dens (2017) proved that adherence can be improved among people 
from high power distance cultures. Mulder (1977) found that due to the advantages 
associated with occupying the higher levels of the hierarchy, it is common for people 
in such positions to strive to maintain the power distance that exists between 
themselves and those with less power. 
 
In discussing communication from the cultural aspect, Hall (1976) divided the 
context into two: Eastern countries (including Malaysia), which have a high-context 
culture, and Western countries, which generally have a low-context culture. As a 
society with a high-context culture, the Malaysian “… communication or message is 
one in which most of the information is either in the physical context or internalized 
in person, while very little is in the coded, explicit, transmitted part of the message” 
(Hall, 1976: p. 91). To further clarify, non-verbal communication and sociocultural 
values in high-context cultures carry higher-value messages in comparison to 
messages that are communicated either verbally or in writing. As such, verbal or 
written communication in a high-context culture does not require too much detail or 
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contain explicit information in the message as the remainder is conveyed via mutual 
understanding and trust (Hallenbeck, 2006; Hooker, 2012). Besides, since non-verbal 
communication, including facial expressions, eye contact, body gestures and tone of 
voice, carries greater meaning than verbal communication, it is common in a high-
context culture for the words uttered to not convey the actual meaning of the 
message (Hooker, 2012). Thus, communication in a high-context culture tends to be 
more indirect or ambiguous compared to communication in a low-context culture 
where speech is more direct and precise (Hooker, 2012). Hooker (2012) further 
explained that in this type of culture ‗yes‘ may not necessarily indicate agreement as 
it can also be used to signal understanding or acknowledgement. Similarly, when an 
individual in a high-context culture does not agree with something they will tend to 
use ‗maybe‘ or ‗I will think about it‘ as opposed to stating ‗no‘.  
 
Communication in a high-context culture also does not depend simply on verbal and 
non-verbal speech but is heavily dependent on the other cultural dimensions 
mentioned in this section. Due to the fact that societies with a high-context culture 
are also collectivist, with a high value placed on relationships with others, 
individuals generally use indirect speech or non-verbal cues in order to save face or 
avoid causing offence to their counterparts (Hooker, 2012). This contrasts with 
individualist Westerners, who tend to be franker and express themselves more openly, 
as their main concern is the upholding of justice and their own rights. Thus, decision-
making in such low-context societies tends to be carried out more immediately, 
during the meeting or encounter, whereas in a high-context culture, deliberation and 
decisions generally take place behind the scenes (Hooker, 2012).  
 
Hooker (2012) also mentions that it is becoming more common nowadays for low-
context communication to be found in a high-context culture as a result of Western 
influences and technological advancement. This is in parallel to the assertion by 
Helman (2007: p. 3) in his book Culture, Health and Illness, where he described 
culture as “… an increasingly fluid concept, which in most societies is undergoing a 
constant process of change and adaptation”. Globalisation and Malaysia‘s 
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modernisation and rapid economic development have led to social change and 
mobility (Mohd Darbi, 2006; Noordin & Jusoff, 2010). Therefore, individualism is 
further permeating Malaysian society and, as asserted by Mohd Darbi (2006), is 
becoming common within affluent societies that are financially, emotionally and 
socially independent. Data from a study by Noordin and Jusoff (2010) also indicate a 
slight shift in the Malaysian collectivist society, reflecting the fact that members of 
the society are becoming more competitive in spite of the enduring value they place 
on social relations, family integrity and the concept of self-sacrifice. A similar 
change was also detected by Ken and Ying (2013), who found a lower value for the 
power distance index compared to that found in Hofstede‘s study in 1980.  
 
Similarly, the culture of uncertainty avoidance among Malaysians is changing. 
Hofstede (1980) employed an uncertainty avoidance index to measure the ambiguity 
tolerance level when describing different cultures in different countries. Malaysia 
was found to be among the lowest in this dimension, together with Great Britain and 
Ireland (Hofstede, 1980). This indicates that Malaysians have a more relaxed attitude 
to dealing with uncertainty compared to countries that scored higher, including 
Greece and Portugal. However, a more recent study by Ken and Ying (2013) 
indicated that uncertainties are no longer well accepted among Malaysians, who are 
becoming more concerned with regard to their future. As such, more in the way of 
written rules and guidelines are required to reduce this uncertainty (Hofstede, 1984). 
Ken and Ying (2013) further suggested that this change is due to several factors, 
including political uncertainty, high economic growth and increased levels of 
competitiveness, which can also be cited as the underlying factors of the 
transformation of the other Malaysian cultural dimensions mentioned above.  
 
Overall, discussion of the Malaysian cultural background indicates how Malaysians 
live in significantly different social and cultural contexts from those found in 
Western countries. However, more recent studies have served to demonstrate its 
transformation. Consequently, there is a greater possibility that the values and 
demands of the society are also evolving. This further complicates the Malaysian 
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cultural condition, and caution is recommended when attempting to understand 
Malaysian behaviours and practices.  
 
1.5.2 Document review and analysis in Malaysia regarding patient 
involvement in decision-making  
A review of government documents on patient involvement in decision-making was 
conducted in order to obtain a better overview of its implementation in Malaysia. A 
search of the internet resulted in a few of MOH Malaysia official documents 
mentioning this notion.  
  
The Malaysian Medical Council, as the governmental body that regulates medical 
practitioners and physicians in Malaysia, makes no specific mention in their Code of 
Professional Conduct for Medical Practitioners of any requirement for patient 
involvement in deliberation about their treatment decisions (Malaysian Medical 
Council, 1986). Nonetheless, it is something that is highlighted in their 
supplementary document of Good Medical Practice, which delineates the duties of 
physicians in Malaysia (Malaysian Medical Council, 2001). Physicians are required 
to establish a good and reciprocal relationship with their patients as an aspect of 
ensuring patients‘ well-being. Several of the points made in relation to facilitating 
physicians to achieve the recommended partnership and collaborative relationship 
were found to be in accordance with elements of shared decision-making. These 
include the following: “frank discussion in which the patient‟s needs and 
preferences and the doctors‟ clinical expertise are shared to select the best treatment 
option” (p. 8), and “give the relevant options when discussing treatment, and the 
limitation and possible complications” (p. 9).  
 
For nurses in Malaysia, patient involvement in decision-making is mentioned by the 
Nursing Board Malaysia, as the regulatory body of nursing practice in Malaysia, in 
their Code of Professional Conduct for Nurses (Nursing Board Malaysia, 1998). 
Their guidelines encourage nurses to work “… cooperatively with the patient and his 
family and respect their decisions about his care” (p. 1). Emphasis is also placed in 
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this document on the need for nurses to “… give correct information and education 
to each patient according to the needs” (p. 2), and to “maintain informed consent in 
the provision of nursing care to all patients” (p. 1). Nurses‘ responsibility as the 
advocators of patient involvement in decision-making is further described as they are 
responsible “to promote and protect the interest of the patient when he is incapable 
of communicating his needs and protecting himself” (p. 2). Similar recommendations 
are made by the Pharmacy Board Malaysia, as the Malaysian governmental body that 
controls pharmaceutical activities, in their Code of Conduct for Pharmacists and 
Bodies Corporate (2009), in which descriptions pertaining to pharmacists‘ 
professional relationship with patients are outlined (Pharmacy Board Malaysia, 
2009). Pharmacists should “… determine the patient needs, values and desired 
outcome” (p. 5) in order “… to involve their patients or clients in the decisions 
regarding their health” (p. 5). However, no description was found with respect to 
allied HCPs in Malaysia.  
Some descriptions related to patient involvement in decision-making were also found 
in the current Malaysian T2DM Clinical Practice Guidelines (CPG) (MEMS, 2016) 
and Diabetes Education Manual 2016 (Malaysian Diabetes Educators Society, 2016). 
These are produced to promote standardised guidance and are for use by HCPs 
dealing with patients with diabetes in Malaysia. In the CPG, the recommendation is 
for patients‘ educational strategies, including dietary counselling, to be 
individualised based on their personal characteristics, including their health, beliefs, 
information needs, personalised goals, cultural preferences and individual lifestyle. 
Consistent with this, an analogous emphasis is apparent in the Diabetes Education 
Manual 2016 as it also recognises a change of approach in encouraging the self-
management of T2DM, with a shift from an instructional style to patient 
empowerment and improved self-efficacy. However, it also focuses only on the 
involvement of diabetes patients in decisions relating to non-pharmacological 
modalities, including diet therapy and physical activity. In both documents, there was 
a lack of description pertaining to the individualised pharmacological modalities that 




The other Malaysian document mentioned patient involvement in decision-making is 
the Malaysian Medical Council Guideline: Consent for Treatment of Patients by 
Registered Medical Practitioners (Malaysian Medical Council, 2016). This document 
by the Malaysian Medical Council is aimed at guiding physicians regarding the 
concept of consent to care. Within this guideline, consent is defined as “… the 
voluntary acquiescence by a person to the proposal of another; the act or result of 
reaching an accord; a concurrence of minds; actual willingness that an act or an 
infringement of an interest shall occur” (p. 1). Similar to most parts of the world, 
there is a legal requirement for consent to be obtained from the patient, his or her 
family or legal guardian in respect of every examination, procedure and treatment, 
following HCPs‘ sharing of related information. Nonetheless, unlike in shared 
decision-making, patient involvement in informed consent is restricted only to 
whether they agree or disagree with the recommended examination or modalities, 
with no mention of patients‘ contribution to the selection of the recommended option 
in the first place.  
 
1.6 Chapter summary 
The global and Malaysian trends of T2DM are alarming. These include its 
prevalence, patients‘ adherence to their T2DM management and also the high 
incidence of T2DM-related complications. As such, shared decision-making, as a 
model of involving the patient in decisions, has been introduced and encouraged as 
part of a continuous and persistent effort to improve the service provided to patients. 
This is being carried out with the ultimate goal of improving the health outcomes of 
patients. Nonetheless, despite the shared decision-making approach having been in 
place for more than 20 years the review of the Malaysian government documentation 
on patient involvement in decision-making and shared decision-making uncovered 
only superficial explanation of these matters, despite them being recognised as 
important and having a distinct contextual background. Thus, a comprehensive 
literature review was performed to further explore this area, the results of which are 







 CHAPTER 2: LITERATURE REVIEW 
 
2.1 Introduction 
This chapter is divided into three main parts. Part 1 provides an overview of patient-
centred care, which is the foundation of shared decision-making. The first part of this 
chapter also discusses the theoretical perspective of patient involvement in making 
health decisions, including the shared decision-making model. Part 2 begins with the 
search strategy used for the existing literature on patient involvement in decision-
making and shared decision-making. The second part also presents the findings from 
the review, covering the preferences of patients and HCPs and the factors related to 
patient involvement, its implementation and outcomes. Part 3 contains an overview 
of Malaysia, which is the setting for this study, along with descriptions of its 
healthcare system, including its T2DM management. This section also includes an 
analysis of empirical studies around the studied area in the Malaysian context. 
Finally, the chapter summarises how this study fills the gaps in the current 
knowledge in the area before presenting the statement of problems of this study 
together with my personal reflections. 
 
2.2 Part 1: Patient-centred care and healthcare decision-making 
A healthcare system is an environment in which providers are bound to a certain 
level of professionalism. Eliot Freidson (1971), in his book Profession of Medicine, 
highlighted the authority held by HCPs stemming from their altruism (they work in 
the best interests of their patients), expertise (they possess technical knowledge not 
readily accessible to others) and self-regulation (they superintend their own 
profession without interference from others). Due to these factors, patients‘ medical 
and health management has traditionally been planned and determined by HCPs with 
little or no consideration given to the preferences, values and needs of patients. 
However, the transformation of the contemporary healthcare landscape following the 
rise in patient autonomy and the consumerism that has triggered patient activation 
and empowerment has increased the demands on this paternalistic practice, which is 
based on the traditional biomedical model to change. This need for change has been 
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illuminated by the upsurge in the concept of patient-centred care within the 
healthcare system. 
2.2.1 Patient-centred care  
Patient-centred care is a concept that has been interchangeably termed ‗person-
centred‘, ‗people-centred‘, ‗client-centred‘, ‗resident-centred‘ and ‗relationship-
centred‘ (Nolan, Davies, & Brown, 2006; McCormack, Karlsson, Dewing, & Lerdal, 
2010; Morgan & Yoder, 2012). In this thesis, the term patient-centred care is used 
when referring to the concept, unless one of the other terms is more suited to the 
context being discussed or if the existing frameworks being mentioned use these 
other terms.  
 
Patient-centred care has been defined differently from various perspectives and in 
different contexts (Morgan & Yoder, 2012; Lusk & Fater, 2013). Generally, the 
Picker Institute and the Institute of Medicine (IOM) are among the renowned bodies 
in the healthcare system to have pioneered this concept in a bid to shift the focus of 
the healthcare service onto the individual instead of focusing solely on disease. IOM 
(2001) described patient-centred care as care that is respectful and responsive to 
patients‘ individual needs, preferences and values, with this definition proceeding to 
inform all clinical guidelines. As mentioned in Chapter 1, Malaysia is witnessing an 
increasing demand for healthcare services, yet it has limited resources with which to 
provide them. By placing the patient at the centre of their care, it is anticipated that 
the healthcare service can be improved as the patient obtains the care they need, 
when they need it, at the same time as being encouraged to participate more in their 
health management (Coulter & Collins, 2011). Consequently, patient-centred care 
may facilitate the improvement of patients‘ health at the same time as reducing the 
burden and cost of healthcare services (de Silva, 2012). 
 
The involvement of patients in their own care plans and disease management is a key 
element within the concept of patient-centred care. It has become established as a 
priority in the healthcare system over the past few decades due mainly to it having 
been proven to improve patient outcomes as a result of them being more actively 
21 
 
engaged (Michie, Miles, & Weinman, 2003; Longtin et al., 2010). Nonetheless, 
patient involvement in healthcare is a complex and multi-layered concept as it also 
covers other terms such as ‗partnership‘ (Sahlsten et al., 2008), ‗concordance‘ and 
‗patient empowerment‘ (Mead & Bower, 2000). Furthermore, the concept of patient 
involvement in decision-making refers to a form of practice in which patients and 
HCPs address the importance of a good mutual affiliation within which relevant but 
sufficient information is exchanged in an effort to encourage patients to become 
actively involved in the decision-making process (Sahlsten et al., 2008; 
Thorarinsdottir & Kristjansson, 2014).  
 
The Picker Institute identifies the following eight characteristics of patient-centred 
care: (1) respect for patients‘ values, preferences and expressed needs; (2) the 
coordination and integration of care; (3) information, communication and education; 
(4) physical comfort; (5) emotional support and alleviation of fear and anxiety; (6) 
involvement of family and friends; (7) transition and continuity; and (8) access to 
care (Gerteis, Edgman-Levitan, & Delbanco, 1993). The same eight characteristics 
have also been recommended by the IOM in explaining this concept so that the needs 
of each patient can be met (IOM, 2001).  
 
Mead and Bower (2000) also put forward a number of propositions with regard to the 
concept that they developed based on a review of the conceptual and empirical 
literature. Theirs is one of the most prominent works on patient-centred care, with 
their propositions including (1) the biopsychosocial perspective; (2) the „patient-as-
person‟; (3) sharing power and responsibility; (4) the therapeutic alliance, and (5) the 
„doctor-as-person‟. Yet it has been argued that Mead and Bower's (2000) 
propositions regarding the patient-centred approach are not applicable to non-
physician HCPs as nursing literature was excluded from their concept of patient-
centred care. Additionally, Gillespie, Florin and Gillam (2004) outlined that different 
HCPs have a different focus when describing this concept based on their own 
professional roles and interests. However, Kitson, Marshall, Bassett, and Zeitz 
(2013), in a further narrative review and synthesis of the existing literature on 
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patient-centred care in different medical and healthcare practices, found an 
overlapping of the described elements.  
 
In this section, the discussion on patient-centred care is based on the description of 
the person-centred framework developed by McCormack and McCance (2017) 
which focuses on this concept in a broader context and covers a wider range of 
healthcare viewpoints. In 2006, McCormack and McCance took their first framework, 
which focused only on the concept in nursing practice, and developed it into this 
current concept that covers not only nursing but also overall healthcare practice, thus 
reflecting the contemporary inclusiveness of healthcare philosophy (McCormack & 
McCance, 2017). In combining the existing conceptual frameworks on patient-
centred care with their empirical work, the conceptual framework was developed and 
updated accordingly. Their framework comprises four constructs, as follows: 1. 
prerequisites (HCPs‘ attributes); 2. the care environment; 3. person-centred processes; 
and 4. expected outcomes. 
 
McCormack and McCance (2017) acknowledge both the imperative role played by 
HCPs and their strong influence in shaping the level of patient involvement in their 
own management. This is because, as previously mentioned, even though healthcare 
systems around the globe are continuously changing, HCPs remain to be the 
gatekeepers to these systems and continue to play a major role in delivering care to 
patients. McCormack and McCance stipulate this as a prerequisite in their person-
centred care framework, and it is the first construct within it. The construct outlines 
the attributes of HCPs that are considered important, including HCPs‘ professional 
competence, their interpersonal skills and commitment, personal characteristics, 
including their beliefs and values, and their sense of knowing.  
 
The framework‘s second construct describes the environment in which care is 
provided. In this construct, emphasis is given to the importance of an environment 
that is both conducive to and supportive of person-centred care, including the sharing 
of power and responsibility and the therapeutic alliance that exists not only between 
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patients and HCPs but also between different groups of HCPs. This is combined with 
other characteristics that include an appropriate mix of skills (including the 
communication skills of patients and HCPs), supportive organisational systems that 
facilitate shared decision-making and the physical environment. It is also important 
that there is the latitude for innovation and risk-taking. In having these characteristics, 
it can be said that McCormack and McCance‘s framework addresses the involvement 
of other HCPs and the importance of the environment in managing a patient‘s health 
condition, which is something that is lacking in the patient-centred medical 
framework by Mead and Bower (2000).  
 
In facilitating the involvement of patients in their management, including in 
decisions, McCormack and McCance (2017) suggested different healthcare activities 
to enable HCPs to assess and take into consideration each patient‘s beliefs and values 
when formulating an individualised care plan for them. Patients‘ personal 
interpretation, meaning, socio-economic and cultural background, and motivation 
and experience of illness should all be considered. The aim is to provide a holistic 
and effective form of management to each individual patient. Besides, it is also 
important that HCPs are sympathetic towards their patients so that they can engage 
with them and work together in making decisions at the same time as providing a 
holistic level of care (McCormack & McCance, 2017). Also in this construct, 
McCormack and McCance (2017) place further emphasis on shared decision-making 
by identifying the approach as one of the methods for delivering person-centred care. 
 
The framework by McCormack and McCance (2017) went further and described the 
outcomes of the person-centred care concept. In this construct, they emphasised the 
importance of including measurable outcomes to serve as reliable indicators of the 
effectiveness of the concept. These outcomes include patients‘ satisfaction, a good 
experience and involvement in their care, patients‘ feeling of well-being and the 
creation of a healthy culture or therapeutic environment. They recommend a number 
of methods by which to measure the outcomes, including a person-centred practice 
inventory, observations of practice, narrative and story, and routine data. The 
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recognition of these measurable outcomes may also be one of the reasons for the 
adoption of the concept of patient-centred care by the global healthcare system 
(Kitson et al., 2013). Consequently, the adoption of patient-centred care in the 
healthcare system adds another dimension due to the fact that the target of the service 
provided no longer revolves solely around clinical outcomes.  
The following Figure 1 is a visual representation of the latest person-centred practice 
framework. This framework includes McCormack and McCance's latest addition to 
the concept in the form of the macro context of healthcare. In this construct, they 
emphasise the importance of both health and social policy, the strategic framework, 
workforce development and strategic leadership. This supports the integration of 
patient-centred practice in a broader sense within the healthcare system.  
 
  





Nonetheless, as attractive as patient-centred care may appear, Fredericks and 
colleagues (2012) highlight some of the challenges that may be faced in terms of 
integrating patient-centred care into the healthcare system, including the initial cost 
of training HCPs, the inherent medical power and knowledge, and a lack of resources. 
These challenges sit alongside evidence that the outcomes of any patient-centred care 
initiatives may not be sustained over time and that some patients feel more 
comfortable leaving the responsibility for managing their health condition to their 
HCPs, which has notably been observed among the elderly and less educated groups 
(Levinson, Kao, Kuby, & Thisted, 2005; McMillan et al., 2013). Furthermore, the 
discussion around this concept by Dubbin, Chang and Shim (2013) also highlights 
the lack of consensus with regard to how the concept is conceptualised, 
institutionalised and implemented across practices, different groups of HCPs and 
patients.  
 
However, due to its relevance and benefits, the adoption of patient-centred care 
across a wide range of T2DM management measures has been endorsed by bodies 
around the world, including by the ADA (2015), NICE (2015) and MEMS (2016). 
Besides, among the research on the management of illness, patient education and 
participation, Longtin and colleagues (2010) suggest that patient involvement in 
decision-making is considered to be the most fundamental right of the patient in the 
field of biomedical ethics 
 
2.2.1.1 Patient involvement in decision-making 
The continuum of patient involvement in decision-making ranges from paternalistic 
models, through advocate models or informed non-dissent, shared decision-making 
or equal partners, to models of informed choice or clinicians‘ recommendations for 
increased patient control and, ultimately, patient-driven decision-making (Gafni, 
Charles & Whelan, 1998; Kon, 2010). As mentioned earlier, the patient–HCP 
relationship has evolved from being paternalistic to patient-centred in nature. Hence, 
it is important for HCPs to identify, facilitate and support patients‘ preferences with 
regard to their participation in decision-making. However, a thorough analysis of this 
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matter is suggested due to the potential for misinterpretation of patients‘ ability to be 
involved in the decision-making process and their ability to perform self-
management (Florin et al., 2006).  
 
Similar to patients‘ involvement in managing their health, various different terms 
have been used by different parties to describe patients‘ involvement in making 
decisions concerning their management, with these including ‗shared decision-
making‘, ‗participatory decision-making‘, ‗informed decision-making‘, ‗evidence-
informed patient choice‘ and ‗informed choice‘ (Parchman et al., 2010; McCaffery, 
Smith & Wolf, 2015). Each term is defined differently, but the important point is that 
each conveys a sharing of information and involvement in the decision-making 
process on the part of patients and HCPs.  
 
2.2.2 Models of decision-making 
Owing to its importance, decision-making in health and medicine has been discussed 
and studied from many different angles. Consequently, large numbers of models and 
theories have been developed and have emerged in different fields to explain 
decision-making in relation to those fields, including in medicine and health, 
psychology and economics. These include expected utility theories, information 
processing theories, social judgement theory, the theory of reasoned action (Fishbein 
& Ajzen, 1975; Ajzen & Fishbein, 1980), and normative, prescriptive and descriptive 
models (Bell, Raiffa, & Tversky, 1995). However, for this study, the focus is on 
patient involvement in decision-making, with the discussion around this based more 
on models that explain not only patients‘ sociocultural factors and their access to 
resources but also on the patient–HCP relationship. As such, patient–HCP decision-
making models are used as the main models in this study. These models include 
paternalism, shared decision-making, interpretative decision-making and informed 
decision-making, as illustrated in the following Figure 2, which is modified from 
Wirtz, Cribb, and Barber (2006). The explanation of shared decision-making and 
interpretive decision-making is presented last despite these appearing in the middle 
of the continuum since explanations of paternalism and informed decision-making 
are essential to an understanding of the former two types of decision-making. 
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Additionally, some of the other aforementioned models and theories are used when 




2.2.2.1 Paternalistic decision-making 
The paternalistic model was widely adopted by healthcare systems in the past due to 
its alignment with the central element of the Hippocratic oath and the traditional 
concept of the professionalism of HCPs, especially that of physicians. An earlier 
definition of paternalism in the Oxford English Dictionary (1989) was “… the 
principle and practice of paternal administration; government as by a father; the 
claim or attempt to supply the needs or to regulate the life of a nation or community 
in the same way as a father does those of his children”. From this standpoint, HCPs 
were considered to be the best decision makers to act on the patients‘ behalf as they 
had the requisite knowledge and understanding of the patients‘ medical needs and 
interests. However, in the current edition of the dictionary, this positive-sounding 
definition has shifted to one with a more negative tone, as “… the policy or practice 
of restricting the freedoms and responsibilities of subordinates or dependants in 
Paternalism 
Shared decision-making & Interpretive decision-
making 
Informed decision-making 
Figure 2: Decision-making models (modified from Wirtz, Cribb and Barber, 2006) 
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what is considered or claimed to be their best interests” (Oxford English Dictionary, 
2005). This aligns with the shift in the medical and health landscape that is currently 
more supportive of patient autonomy and involvement in decision-making 
(Hafemeister & Gulbrandsen, 2009). Nonetheless, Beauchamp and Childress (2013: 
p. 215), in their book Principle of Biomedical Ethics, further define paternalism in a 
more neutral tone as “… the intentional overriding of one person‟s preferences or 
actions by appeal to the goal of benefiting or of preventing or mitigating harm to the 
person whose preference or actions are overridden”. This describes how, in this 
model, HCPs uphold the values of beneficence and nonmaleficence, along with the 
justification that patients‘ autonomy may potentially bring harm and would not 
benefit them in terms of some of the decisions that need to be made (Hafemeister & 
Gulbrandsen, 2009; Pelto-Piri, Engström, & Engström, 2013). Sjöstrand, Eriksson, 
Juth, and Helgesson (2013) further argue that paternalism and autonomy are not 
necessarily entirely antithetical, as, in some conditions, patients‘ decisions can be 
overruled as part of an HCP‘s effort to protect the autonomy of patients.  
 
Nonetheless, in this model, patient involvement in decision-making is generally 
denied as decisions are made solely based on HCPs‘ expertise in determining the 
best course of treatment and management for restoring their patients‘ health 
(Emanuel & Emanuel, 1992). This is because patients are assumed to have limited to 
no medical and health knowledge, thus rendering them unqualified to determine what 
is best for them from a medical perspective. Consequently, the role of the patient in 
this model is to tacitly agree and comply with their HCPs‘ orders (Laine & Davidoff, 
1996; Sagoff, 2013). Sagoff (2013) further argues that a patient‘s preferences will 
not matter if a patient trusts that their HCPs are doing what is best for them; that is, 
they are acting in the patient‘s best interests. Furthermore, Emanuel and Emanuel 
(1992) argue that paternalism is supported by the more recently introduced informed 
consent despite the fact that it is aligned with the Bolam principle, which was 
established in an effort to prevent medical negligence. This is because it is common 
for the information provided as part of the consent-obtaining process to be shaped by 
HCPs in order that patients will accept and agree with the HCPs‘ decisions (Emanuel 
& Emanuel, 1992). For the same reason, informed consent is described as a product 
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of soft paternalism by Cohen (2013) and is also referred to as paternalism justified by 
consent by Beauchamp and Childress (2013). Wirtz and colleagues (2006), on the 
other hand, argue that in doing this, the patient does actually become involved in the 
decision-making.  
 
Nevertheless, this one-directional model can be considered as a therapeutically 
superficial model in terms of decision-making, especially when it comes to chronic 
medical problems. This is because a decision is made based only on an objective 
judgement by the HCPs based on a patient‘s medical complaints, the HCP‘s 
assessment of the patient‘s medical needs and the patient‘s biomedical test results. 
This runs contrary to the Chronic Care Model (Bodenheimer et al., 2002) in which 
the management of patients with chronic medical conditions requires them to be fully 
informed and actively involved in their overall health management (Coleman et al., 
2009). Thus, patients‘ subjectivity and experiential knowledge are also fundamental 
in deciding what is best for them.   
 
2.2.2.2 Informed decision-making 
The informed decision-making model is also known as the informative model 
(Emanuel & Emanuel, 1992). In this model, patients have full accountability for the 
deliberation and decision based on all of the relevant information that is provided by 
their HCP (Emanuel & Emanuel, 1992). When compared to shared decision-making, 
the HCPs‘ personal values and understanding of the patients‘ values are less 
important since their role is to act only as information providers and executors of the 
treatments or interventions selected by the patients. Nonetheless, it is fundamental 
that the information provided is sufficiently comprehensive to enable the patients to 
make a decision that aligns with their values (Emanuel & Emanuel, 1992).  
 
2.2.2.3 Shared decision-making and interpretive decision-making  
Sitting in the middle of the continuum of decision-making models are interpretive 
decision-making and shared decision-making (Wirtz et al., 2006). Emanuel and 
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Emanuel (1992: p. 2221) outline that the main aim of interpretive decision-making 
“… is to elucidate the patient‟s values and what he or she actually wants, and to 
help the patient select the available medical interventions that realize these values”. 
In terms of the final decision, similar to the informed decision-making model, it is 
the patient who will decide. 
 
The shared decision-making model, on the other hand, is considered to contain an 
optimal and ideal balance of patient and HCP interaction (President‘s Commission 
for the Study of Ethical Problems in Medicine and Biomedical and Behavioral 
Research, 1982). This is because, according to Sandman and Munthe (2010), the 
shared decision-making model differs from the interpretive model in that the latter is 
a model in which HCPs help patients to interpret and understand their preferences 
and values in relation to the situations and it is then up to the patients to make a 
decision based on this. The former, in addition to considering patients‘ personal 
values and preferences, takes into account the HCPs‘ technical expertise and, on 
some occasions, compromise and negotiation are needed between the two parties. 
This serves to make collaborative, shared decision-making more relevant to the 
management of chronic diseases, including diabetes. Decisions under the shared 
decision-making model are made based on both the HCPs‘ medical and health 
knowledge and the patients‘ personal values and preferences, in order to achieve the 
most effective therapeutic management for improving patients‘ behaviours and 
outcomes (Montori et al., 2006; Drewelow et al., 2012). 
 
Patient involvement in decision-making has been researched and written about 
internationally for more than three decades. One of the earliest mentions of the 
approach was by the President‘s Commissioner for the Study of Ethical Problems in 
Medicine and Biomedical and Behavioural Research in 1982, in promoting the 
balance between patients‘ autonomy and HCPs‘ ethical sense of beneficence and 
nonmaleficence. It is an approach in which HCPs and patients collaboratively select 
tests, treatments, management or support packages (Coulter & Collins, 2011). Due to 
the fact that the current medical and health environment limits the ability of HCPs to 
function as patient advocates and have total control of the required resources, 
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patients‘ trust in their HCPs may be reduced (Mechanic, 1998), with paternalism no 
longer accepted unquestioningly by patients (Chin, 2002). This phenomenon is 
currently spreading due mainly to patients‘ growing access to medical-related 
information (Diaz et al., 2002) and increased societal demands for HCPs to adopt a 
more encouraging attitude when providing care for their patients, in contrast to them 
delivering only their medical knowledge and skills (Gelhaus, 2013). This points to 
the need for a better way for patients to have control over their care. Thus, as a 
concept that encourages patient involvement in the decision-making process, shared 
decision-making fulfils this particular purpose (Weston, 2001).  
 
However, as mentioned earlier in the introduction chapter and paternalistic decision-
making section, this is not the only reason why the shared decision-making model is 
important in determining patients‘ management of their care. Patients with a chronic 
condition have to perform the self-management regimen within their own homes, 
thus elevating the value of patient autonomy in the management of chronic illnesses, 
including T2DM. Furthermore, previous studies have proved that a lack of adherence 
to a treatment regimen is often associated with autonomy as it serves as a means by 
which patients are able to express their preferences, especially if they consider the 
regimen in question to be insufficiently flexible, too limiting or that the choice of 
treatment was made by the physician (Peek et al., 2008; Sandman, Granger, Ekman 
& Munthe, 2012). 
 
Additionally, a growing body of literature has highlighted that patients with unbiased 
information about their treatment options end up receiving less invasive and lower-
cost services which are better aligned with their preferences, beliefs and values 
compared to patients who have not had access to the same kind of information, 
thereby leading to more cost-effective care (Veroff et al., 2013; Stacey et al., 2014). 
This is because patients tend to make more conservative judgements which have the 
effect of reducing unwarranted management variation and cost (Stacey et al., 2014). 
Studies have also revealed that both patients and HCPs described shared decision-
making as the paramount approach when it comes to patient and public involvement 
in healthcare, which will therefore increase patient knowledge, in addition to their 
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confidence in decisions, satisfaction and adherence (Peek et al., 2008; Rise et al., 
2013; Stacey et al., 2014). These become the reasons why many countries around the 
world, including the UK, USA, Canada and Germany, are endorsing or at least 
encouraging the integration of shared decision-making in their healthcare systems 
(General Medical Council, 2008; Härter, Van Der Weijden & Elwyn, 2011). 
 
Models and definition of shared decision-making 
One of the first theoretical models of shared decision-making was introduced 20 
years ago by Charles and colleagues (1997) as a way of embracing patient-centred 
care in the healthcare system, and it has since become one of the most cited models 
(Makoul & Clayman, 2006). In this model, Charles and her colleagues stated that in 
order for shared decision-making to occur, the decision-making process must include 
each of the following four important elements: 1) the involvement of both parties 
(HCP and patient) in all phases of the process; 2) the sharing of information 
possessed by both parties regarding all of the treatment choices; 3) the articulation 
and sharing of each preferred treatment choice; and 4) the reaching of an agreement 
on the type of treatment to implement. 
 
Despite this model being the most acceptable basis for shared decision-making, 
several basic problems and questions have nevertheless arisen. The initial 
development of the model was very much based on decisions related to acute or life-
threatening medical conditions (Charles et al., 1997). Over the years, other 
researchers have worked to continuously improve and broaden the model in order for 
it to be applied to other medical conditions, including chronic diseases (Towle & 
Godolphin, 1999; Montori et al., 2006; Murray, Charles & Gafni, 2006; Elwyn et al., 
2012; Entwistle, Cribb & Watt. 2012). Currently, shared decision-making has been 
recommended to encourage the participation of patients in self-management or 
psychological interventions, and to initiate long-term medications and lifestyle 





The concept of shared decision-making is also defined differently and inconsistently 
within the literature, thus leading to a degree of perplexity with regard to the 
implementation and measurement of the concept (Clayman & Makoul, 2009). A 
systematic review was conducted to determine the range of conceptual definitions 
and the most frequently invoked elements of shared decision-making (Makoul & 
Clayman, 2006), with the finding that the definitions varied across the literature. This 
is aligned with a paper by Charles and colleagues (2006) in which the authors 
recommended a preliminary exploration of the meaning, preferences and 
applicability of shared decision-making across different groups of people due to the 
potential for cultural variations between them. As such, it is not impossible for 
policymakers and HCPs to make trade-offs between the elements of different shared 
decision-making models based on their respective ethical advantages and 
disadvantages (Cribb & Entwistle, 2011). Furthermore, a review by Makoul and 
Clayman (2006) identified that only elements of patient values or preferences and the 
present options were included in more than half of the conceptual definitions. This 
paper also listed the essential elements, ideal elements and general qualities of the 
shared decision-making model based on the existing models. These elements are 
given in Table 1 and have been used as the main tool in conducting this study in 
conjunction with the original model by Charles and colleagues (1997) and other 
existing models. 
 
Table 1: The essential, ideal elements and general qualities of shared decision-
making as emphasised in prominently cited models (modified from Makoul and 
Clayman, 2006) 












Define roles (desire for 
involvement) 
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The review by Makoul and Clayman (2006) suggests that shared decision-making 
begins with a definition and/or an explanation of the problem to be addressed. This is 
followed by a presentation of the options, which may be provided not only by the 
HCPs but also by the patients. According to Charles and colleagues (1997), and 
supported by Branda and colleagues (2013), shared decision-making is most useful 
when there is more than one sensible choice of treatment. However, a review by 
Stacey and colleagues (2014: p. 3) found that shared decision-making is also useful 
in various situations, including “… when there is more than one reasonable option, 
when no option has a clear advantage in term of health outcomes, and when each 
option has benefits and harms”. In addition, not choosing any treatment options and 
maintaining the status quo are also considered to be options available to patients, for 
whatever reason they may have for this to be their preferred course of action (Elwyn, 
Edwards, Kinnersley, & Grol, 2000; Towle, Godolphin, Grams, & Lamarre, 2006). 
The review also found that the existing models emphasise how the benefits and 
downsides of each presented option should be equally shared and discussed so that 
patients may have a sense of equipoise and choose their preference without bias 
(Makoul & Clayman, 2006). This can be achieved through HCPs‘ use of decision 
aids, decision support tools or verbal explanations (Stiggelbout et al., 2012; Stacey et 
al., 2014). Stiggelbout and colleagues (2012) also argue that decision aids are more 
useful for use independently, outside the clinical encounter. Next, patients‘ views, 
preferences, concerns, values and ability to follow or carry out the management must 
be explored so that they can be compared with HCPs‘ recommendations and further 
deliberated upon according to HCPs‘ knowledge.  
 
After all of the options and important information have been presented and obtained 
from the patients, the patients‘ preferred role should be identified (Makoul & 
Clayman, 2006; Stiggelbout et al., 2012). It is important to note that not all patients 
are willing to be involved in their own healthcare decision-making and prefer for the 
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HCPs to decide on their behalf, or else they prefer to simply agree with the 
recommendation provided (van den Brink-Muinen et al., 2006; Lewin and Piper, 
2007; S.N. Whitney et al., 2008; Shay & Lafata, 2014). This group should not be 
abandoned, as this course of action may merely reflect differences in their 
understanding and the dominant conceptualisation of a patient‘s involvement in 
decision-making (Hoffmann et al., 2014). Their involvement in shared decision-
making could be encouraged through the development of custom-made interventions 
which are grounded to the patients‘ meaning and needs from this process in order to 
help them participate (Hibbard & Greene, 2009; Légaré & Thompson-Leduc, 2014). 
According to Légaré and colleagues (2011), patients‘ hesitance to be involved in 
decision-making is not merely due to a lack of desire but rather due to a lack of self-
efficacy to make their own decision.  
 
Nonetheless, in some cases, patients are left alone to make their own decision after 
being informed about the available choices, without any professional 
recommendation and support from their HCPs, especially when they want to make 
an autonomous decision (Laine & Davidoff, 1996). Yet even competent patients may 
come to feel abandoned and depressed in the absence of good support and help from 
their HCPs (Davies & Elwyn, 2008). Although patients may express a preference to 
be more involved in making health- or medical-related decisions for themselves, they 
also still highly value their HCPs‘ suggestions and recommendations regarding the 
best treatment option for their health condition (Mazur, Hickam, Mazur & Mazur, 
2005). This is where shared decision-making displays a further strength as it serves 
as a platform from which to strike a balance between two of the major principles in 
biomedical ethics, autonomy and beneficence, thus resulting in shared responsibility 
between the patients and their HCPs for the decision that is made collaboratively.  
 
Scholars have emphasised that the role of the patient–HCP partnership and 
deliberation, which differentiates this model from any other decision-making model, 
including interpretive decision-making, should be maintained throughout the process, 
in order to ensure the effectiveness of shared decision-making (Makoul & Clayman, 
2006; Elwyn et al., 2012; Stiggelbout et al., 2012). However, when compared to 
36 
 
other elements such as offering options and eliciting patients‘ preferences and values, 
the description and exploration of this element of shared decision-making is found to 
be lacking (Charles et al., 1997; Sandman, 2009; Wirtz et al., 2006; Elwyn et al., 
2012). This may be indicative of the complexity of this element and also point to the 
high possibility of its absence in current practice. According to O‘Connor, Stacey, 
and Légaré (2008), together with Tinsel and colleagues (2013), this is something that 
could be resolved through educational opportunities or by having a decision coach. 
 
2.2.3 Shared decision-making model in T2DM 
To reiterate, shared decision-making is beneficial to T2DM patients as it can 
empower the patient to take better care of themselves. Supporting this, Montori and 
colleagues (2006) together with Entwistle and Watt (2006) also emphasise the 
applicability of the shared decision-making model in the management of T2DM as a 
chronic illness and where patients‘ active involvement is more likely to be required 
as they need to carry out the decisions on their T2DM management without the 
presence of their HCPs as compared to patients with an acute condition, which is the 
focus of the work by Charles and colleagues (1997) on this approach. They 
suggested a few modifications to the shared decision-making model by Charles and 
colleagues (1997) as one of the most popular models of this approach, including 
ongoing patient–HCP partnerships as another element of shared decision-making. 
This addition is deemed to be important due to the chronic nature of T2DM, which 
involves long-term and lifelong management. Due to this, there are more 
opportunities to make decisions and to revise them based on the effects and patients‘ 
experience of the decisions that have previously been made. For this to be successful, 
it is crucial that the elements of trust and respect which are commonly fostered by an 
ongoing partnership continue to exist (Montori et al., 2006).             
 
Other than the suggestion for the additional element of an ongoing partnership, 
Montori and colleagues (2006) also highlight the difference between shared decision-
making in chronic illness compared to acute conditions, whereby consideration needs 
to be given to the adjustment of a few existing elements. These include information 
exchange, deliberation on options and deciding and acting on the decision. Besides 
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‗technical‘ information about the options available to patients, they emphasise that 
information exchange should also include both the values and preferences of both 
sides based on their social, cultural and personal backgrounds. On the other hand, 
since T2DM is a chronic health condition, patients often make their own decisions 
concerning any problems that arise outside consultation time. Thus, the presentation 
of different options by HCPs also requires them to provide information related to 
each option so that a discussion about the best decision can be entered into, while at 
the same time information can be included that may prove helpful for patients when 
they encounter any difficulties outside of the patient–HCP encounter.   
 
Montori and colleagues (2006) further raise a concern regarding the lack of attention 
to and exploration of the deliberation and negotiation phase. Here, the pros and cons 
of each option for treating a chronic illness are considered. As compared to the 
deliberation on acute illness, where any patient–HCP disagreements will most 
probably lead to disruption of their partnership and to the need for the patient to be 
referred to other HCPs, any disagreement in the management of T2DM provides the 
opportunity for further information exchange and partnership. HCPs are considered 
to be responsible for supporting a patient if they opt for a suboptimal yet acceptable 
option since this can always be revisited at the next follow-up (Montori et al., 2006). 
Finally, Montori and colleagues (2006) highlight the importance of HCPs‘ 
responsibility in promoting self-efficacy among their T2DM patients in carrying out 
the management that has been decided, in addition to the early identification of any 
barriers to implementation and the promotion of patients‘ own problem-solving skills.   
  
2.2.3.1 Implementation of shared decision-making in the management of T2DM 
In recent years, due to the benefits of shared decision-making, a growing body of 
research has investigated its implementation in the management of T2DM. From the 
review of the literature, most of the studies concerned focused on the implementation 
of shared decision-making in the outpatient setting, which is where most of the 
decisions relating to the long-term care of these patients are made. Similarly, these 
studies were concentrated in Western countries, with the exception of one, by Y.Y. 
Lee & Lin (2010), that was conducted in Taiwan, and another, by Wang and 
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colleagues (2017), that was carried out in China. Nevertheless, reflecting the fact that 
the implementation of shared decision-making is contextual, recent studies on its 
implementation have been more focused on patients‘ sociodemographic and cultural 
backgrounds as part of an effort to develop more tailored and contextual 
interventions (Peek et al., 2008; Beverly, Wray, Lacoe & Gabbay, 2014; Baig et al., 
2016). 
 
Besides, almost all of the interventions focused on the importance of patients‘ 
preference and contribution to the decisions that needed to be made. These 
interventions were also primarily aimed at encouraging patient involvement in 
decision-making, whether by using decision aids and/or by eliciting verbal responses 
from patients during their encounters with their HCPs in identifying the most suitable 
management based on the patients‘ contribution and HCPs‘ medical expertise. In 
doing this, the programmes were focused on both patient education and skill 
development. For several studies, training was provided for the HCPs, not only to 
introduce and encourage the adoption of newly introduced interventions but also to 
develop their skill to include their patients in making decisions (Corser, Holmes-
Rovner, Lein, & Gossain, 2007; Mathers et al., 2012; Peek et al., 2012; Branda et al., 
2013; Griffith, Siminerio, Payne, & Krall, 2016; Den Ouden, Vos, & Rutten, 2017). 
 
The shared decision-making interventions in T2DM were found to focus mainly on 
the management of T2DM, comprising pharmacological therapies and lifestyle 
modification. Beside antihyperglycemic medications (Mullan et al., 2009; Mathers et 
al., 2012; R.A. Bailey et al., 2016; Den Ouden et al., 2017; Wang et al., 2017), 
statins were also targeted as a preventive measure for diabetes complications 
(Weymiller et al., 2007; Nannenga et al., 2009; Mann, Ponieman, Montori, Arciniega, 
& McGinn, 2010; Branda et al., 2013; Perestelo-Perez et al., 2016). For lifestyle 
modification, the interventions were not only focused on personalised goal setting 
but also extended coverage and support to the decisions needing to be made by 
patients outside the patient–HCP encounter. In order to do this, in some interventions 
shared decision-making models were integrated with other concepts or models, 
including motivational interviewing (Long & Gambling, 2012; Elwyn et al., 2014; 
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Varming et al., 2015; Swoboda, Miller, & Wills, 2017) and self-management and 
empowerment (Corser et al., 2007; Peek et al., 2012; Karagiannis et al., 2014; E. 
Whitney et al., 2017). This revealed that the implementation of shared decision-
making in the management of T2DM is challenging and varied due to the chronic 
nature of T2DM itself. 
 
The decision aid was found to be one of the most popular tools when implementing 
shared decision-making, whether used by itself or in combination with other shared 
decision-making methods. It was used to improve patients‘ understanding of their 
illness and the shared decision-making interventions, to facilitate HCPs in conveying 
important information during their encounters with patients and encourage shared 
decision-making behaviour among HCPs (Corser et al., 2007; Mullan et al., 2009; 
Mathers et al., 2012; Denig, Schuling, Haaijer-Ruskamp, & Voorham, 2014; Gillani 
& Singh, 2014; Karagiannis et al., 2014; Buhse et al., 2015; McBride et al., 2016; 
Perestelo-Perez et al., 2016; R. A. Bailey et al., 2016; Den Ouden et al., 2017; Wang 
et al., 2017). Other methods were also employed by these existing interventional 
studies, varying from the conventional methods of one-to-one consultation (McBride 
et al., 2016; Peek et al., 2012) or peer/group support (Peek et al., 2012) to 
unconventional methods that used information technology (IT) software (Ma, 
Warren, Phillips, & Stanek, 2006; Klonoff, 2013) and electronic health record data 
(Wang et al., 2017). Similar to decision aids, these methods were used either on their 
own or were integrated with each other.  
 
With regard to the outcomes of the programmes, discussions were held not only on 
their effects on patients but also on the feasibility of the programmes. Based on a 
systematic review by Saheb Kashaf and colleagues (2017) on the outcomes of shared 
decision-making programmes in the management of T2DM, which also included 
most of the previously mentioned interventions in this section, positive outcomes 
were more visible in patients‘ knowledge despite the question of the validity of the 
measuring tools. Significant improvement was also detected in patients‘ decision 
quality and risk perception. Nevertheless, the same significant improvement was not 
noticeable in patients‘ clinical outcomes, including their HbA1c level, as only a 
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study by Parchman et al. (2010) showed a significant improvement in this clinical 
outcome. Saheb Kashaf et al. (2017) argued that this may be due to measurement 
bias or the fact that the shared decision-making model itself may not serve the 
purpose of improving patients‘ biomedical status. Similarly, the review also 
identified a lack of improvement in adherence, satisfaction, trust in physicians and 
quality of life, despite these aspects not being used as indicators of shared decision-
making interventions as compared to clinical outcomes. However, this minimal 
impact may be due to the fact that these programmes were short-term in nature and 
the outcomes were mostly measured shortly after the interventions, thereby 
highlighting the need for long-term shared decision-making interventions and 
outcome studies. This may also indicate the importance of integrating shared 
decision-making models with other concepts, which was lacking in the studies 
included in the review paper, in addition to a re-investigation of the shared decision-
making concept and its implementation (Saheb Kashaf et al., 2017). 
 
2.2.4 Section summary                                                                                                                                                                                                                                                                                                                                                                                                                                                       
Patient-centred care, including shared decision-making, has been greatly accentuated 
in the current healthcare system. Compared to other decision-making models, shared 
decision-making may serve as a better model for patients with T2DM, who are often 
required to actively manage their illness on their own. This is because, in this 
collaborative approach, patients‘ preferences, needs and values are greatly respected 
and taken into consideration in decisions while also retaining the expertise of HCPs. 
Nonetheless, the review of interventions based on the shared decision-making model 
revealed this to be a challenging task, mostly due to the chronic nature of T2DM and 
its complex management arising from its classification as a human biological 
dysfunction that is closely related to human physiology, psychology and behavioural 
aspects. In addition, patient self-management is considered to be the biggest 
component of T2DM management, and this needs to be taken into consideration 
when planning any interventions related to the illness. These have contributed to a 
complicated process of providing comprehensive care for patients, at the same time 
as having to consider patients‘ concerns and preferences. These challenges can be 
clearly seen in the studies on the effectiveness of the interventions that have adopted 
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this model. Despite including a variety of methods, very few of these interventions 
have been shown to effectively improve the condition of patients, particularly with 
regard to their clinical outcomes. Nonetheless, clinical outcomes may not be the best 
way to measure effectiveness owing to the fact that the shared decision-making 
model is a tool to help identify the best-suited decision versus the ideal decision. 
Thus, the minimal effects of shared decision-making programmes on clinical 
outcomes should not act as a barrier to its future implementation in managing T2DM, 
but rather they should serve as a catalyst for improving both its implementation and 
the model itself. 
 
2.3 Part 2: Research into patient involvement in decision-making and shared 
decision-making in T2DM 
2.3.1 Overview of reviewing the literature 
The main aim of this review was to explore and identify the relevant literature on 
patient involvement in decision-making and shared decision-making in the 
management of T2DM patients. This section presents a critical analysis of the most 
prevalent areas that are discussed in the reviewed literature. These include the 
preferences for patient involvement in making decisions, factors related to patients‘ 
involvement, HCPs‘ inter-professional collaboration and the outcomes of 
involvement.   
 
2.3.2 Searching and reviewing the literature  
The search for journal articles was conducted on Cinahl, Cochrane, Embase, 
MEDLINE, PubMed and PsycINFO. The initial searches were conducted in October 
2014 and were regularly updated as the thesis was developed. The search was limited 
to a period from 2000 to 2017 as studies from this time were most likely to reflect 
the current discussion around patient involvement in decision-making. Studies that 
had not been peer-reviewed and published in English or Malay were excluded. The 
keywords used included ‗Type 2 diabetes‘, ‗non-insulin dependent diabetes‘, 
‗chronic illness‘ linked to ‗shared decision-making‘, ‗patient involvement‘, ‗patient 
participation‘, ‗partnership‘, collaboration‘ and ‗decision‘. The search terms were 
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combined using the Boolean terms ‗AND‘ and ‗OR‘ to produce more specific search 
findings. Chronic illness was included as a keyword during the initial phase of the 
review so that those papers that defined T2DM as a chronic illness could also be 
included. As such, a huge volume of papers was returned in the first stage. The 
outcomes of the search are presented in the following flow diagram (Figure 3) that 
was adapted from the PRISMA Group and used for a systematic review and meta-
analysis by Moher et al. (2009). The search terms used resulted in a handful of 
studies which discussed patient involvement in decisions and shared decision-
making from different angles. Therefore, the final results of the review were 
categorised into the following two main areas: 1) Patients‘ and HCPs‘ views and 
experiences of patient involvement in T2DM decision-making (section 2.3.3), and 2) 















































Figure 3: Literature on patient involvement in decision-making (Adapted PRISMA 
2009 diagram) 
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2.3.3 The perspective of the patients and HCPs on patient involvement in 
decision-making and shared decision-making 
The analysis of the literature on the views and experiences of patients and HCPs with 
regard to patient involvement in decision-making is presented in this section in a 
narrative form. A narrative overview enables the existing studies to be summarised at 
the same time as identifying areas that may need to be further addressed (Ferrari, 
2015). As presented in Figure 3, a total of 35 articles were reviewed presenting 
patients‘ and HCPs‘ views and experiences concerning patient involvement in 
decision-making. The research activities surrounding patient involvement in T2DM 
decision-making were concentrated in the USA, with almost half of the reviewed 
studies conducted in that region, with only one study found from Asia, which was 
conducted among Iranian T2DM patients (Rahimian Boogar, Mohajeri-Tehrani, 
Besharat, & Talepasand, 2013). Two studies were also found that compared 
participants from different countries, including one by Hajos, Polonsky, Twisk, 
Marie-Paule, & Snoek (2011) involving patients and HCPs from seven European 
countries (France, Germany, the UK, Italy, the Netherlands, Spain and Sweden) and 
the USA. On the other hand, patients were found to be the main focus of most of the 
identified studies. In those studies that included HCPs, greater attention was paid to 
physicians and nurses, compared to other HCPs. Only nine studies were found that 
included both patients and HCPs.   
 
The identified studies explored and investigated different aspects of patient 
involvement in decision-making among the participants, including their 
understanding and expectations, perceived preferences, actual current associated 
factors, and their outcomes, while some also included model or theory development 
and validation. The findings of such exploration resulted in a discussion of the main 
concerns among the key individuals involved in the management of T2DM. This will 
further help researchers to develop and shape interventions that are based on shared 
decision-making models so that they fit with the study context in terms of ensuring 




2.3.3.1 Patients’ and HCPs’ preferences in and perception of shared decision-
making 
Preference is one of the most popular aspects to have been examined within the 
reviewed studies on patient involvement in decision-making. The study of 
preferences was mostly conducted among patients on a quantitative basis, with a 
greater focus on a reporting of the percentages of participants who prefer each 
decision-making approach. Shared decision-making was found to be generally 
preferred by both patients (Corser, Lein, Holmes-Rovner, & Gossain, 2010; Hajos et 
al., 2011; Peek, Tang, Cargill, & Chin, 2011; Stenner et al., 2011; Beverly et al., 
2014; Marahrens et al., 2017; Tinelli et al., 2017) and HCPs (Shortus, Kemp, 
Mckenzie, & Harris, 2011) when it comes to determining a treatment and 
management option for patients with diabetes. However, it has also been strongly 
suggested that the preferences for shared decision-making among patients and HCPs 
are multifaceted.  
 
Tinelli and colleagues (2017) conducted a quantitative study among diabetes patients 
in Cyprus who had never experienced shared decision-making and diabetes patients 
in England who had experienced shared decision-making. Despite this difference, the 
patients in both groups were found to prefer shared decision-making as they believed 
it would ensure they received compassionate and personalised care from their HCPs, 
increased accessibility to their preferred options and result in reduced waiting time. 
This study provided a good indication that shared decision-making is valued by 
patients with experience of involvement in decision-making from different 
sociocultural backgrounds. The finding was consistent with that of another 
quantitative study, by Peek and colleagues (2011), conducted among patients in the 
US. They found there to be no difference among different races in terms of patients‘ 
preferences regarding the attributes of shared decision-making.  
 
On the other hand, despite the fact that the different groups of patients valued several 
of the same attributes of shared decision-making (i.e. involvement in choosing their 
own management and treatment, shorter waiting times, the opportunity to meet the 
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physician and being treated compassionately), Tinelli and colleagues (2017) also 
highlighted various differences between the two groups. The Cypriot patients were 
found to be more appreciative in comparison to their English counterparts with 
regard to the fact that shared decision-making would provide them with the 
opportunity to access detailed and accurate information about their diabetes 
condition and the options available to them, aside from having greater access to 
continuous care. Although not directly comparable, it is worth noting that 
preferences and perceptions with regard to the shared decision-making approach 
were not shared among patients with a similar sociocultural background as they had 
different health backgrounds or experiences, as shown in the study by Searle and 
colleagues (2008). This UK-based qualitative study included the following two 
different groups of patients: patients with foot ulcerations and patients without foot 
ulcerations. The study indicated that those patients with foot ulcerations preferred 
and indeed played a more passive role in discussions with their HCPs in comparison 
to those patients without foot problems. Thus, both Searle et al. (2008) and Tinelli et 
al. (2017) emphasised that the existing shared decision-making model should be 
modified to ensure it is suited to both the specific context of the country in which it 
is being applied and the patients‘ personal experience. Other than variations 
according to the patients‘ sociocultural and medical backgrounds, preferences among 
patients were also found to vary between different age groups and levels of education 
(Marahrens et al., 2017).  
 
Another quantitative study, by Cvengros, Christensen, Cunningham, Hillis, & Kaboli, 
(2009), investigated the association between the preference for decision-making 
approach and the outcome of patients‘ diabetes management. In this US study, which 
was conducted quantitatively, preference by itself was not found to be associated 
with any outcome, but if the patients perceived that their preference was fulfilled, 
especially when it came to information sharing, they were more satisfied with the 
decision and significant improvements in their HbA1c levels were also detected. It 
was common for patients‘ preferences with regard to the shared decision-making 
approach to not actually be met in practice. A study by Hajos and colleagues in 2011 
found that relatively few HCPs believed that their patients needed more information 
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and discussion concerning their diabetes management and that they often 
underestimated their patients‘ worries regarding the severity of their diabetes 
condition. This was contrary to the findings that the authors gathered from the 
patients involved in their study. The mixed-methods study involving patients, general 
practitioners and diabetes specialists across seven European countries (France, 
Germany, the UK, the Netherlands, Spain, Sweden and Italy) and the USA 
demonstrated that the patients preferred to have both more and the latest information 
about their health problems and treatment options. They also wanted to be more 
involved in the discussion so that their treatment plans would suit their individual 
needs. Thus, Cvengros and colleagues (2009) suggested that HCPs conduct a brief 
assessment regarding their patients‘ main concern that they wanted to see addressed 
in each consultation in order that agreement on the aim of the discussion might be 
reached, with the study showing that the patients believed this could lead to more 
successful self-management.  
 
The topic of preference has not only been investigated among patients. Shortus and 
colleagues (2011) investigated preference among HCPs. A total of 29 HCPs, 
including general practitioners, allied HCPs and endocrinologists, were interviewed 
as part of their qualitative study. It was found that preferences were complex even 
among HCPs as they faced a dilemma in determining the right thing to do when it 
came to the involvement of patients in deciding their treatment modalities, which 
may also have resulted from the qualitative nature of the study. It was found that, 
despite their common belief that patient involvement would be beneficial among 
patients with T2DM, which is a condition requiring self-management by patients, 
there were discrepancies with regard to how this could be achieved and the measures 
that should be taken to determine the overall effectiveness of such management. 
Besides those HCPs who preferred and encouraged patient involvement, there were 
also HCPs who treated their patients by focusing mainly on their biomedical 
characteristics. These HCPs preferred to take a paternalistic approach based mainly 




2.3.3.2 Factors related to patient involvement in decision-making and shared 
decision-making 
HCPs’ characteristics 
As mentioned in the previous section, the preferences of HCPs concerning how 
decisions are made affects the actual practice (Shortus et al., 2011). Based on the 
review, this is not exclusive to this study, as it was found that HCPs‘ characteristics 
were one of the most common factors that facilitated or limited patient involvement 
in decision-making. Patients found it easier to become involved in decision-making 
when the HCPs treated them in an approachable, respectful and compassionate 
manner (Entwistle, Prior, Skea, & Francis, 2008; Courtenay et al., 2009; Corser et al., 
2010; Stenner et al., 2011; Detz et al., 2014; Grohmann, Espin, & Gucciardi, 2017; 
Tinelli et al., 2017). 
 
Approachability was described by diabetes patients in a study by Stenner et al. (2011) 
as being closely related to the ways in which their HCPs treated them during their 
encounter. These include the willingness of HCPs to spend more time providing 
detailed information to patients and on establishing a good relationship with them. 
The qualitative study among 41 diabetes patients in the UK being prescribed 
medication by their nurse prescribers further explained that the patients felt 
encouraged to be actively involved in making decisions as they considered their 
nurses to be really interested in their concern and the information that they shared. 
This was due to their belief that they were being listened to as the nurses addressed it 
accordingly.  
 
This finding is comparable to that of a study by Courtenay and colleagues (2009) that 
was conducted to explore the practices of nurse prescribers in managing T2DM 
patients in several areas of England. Comparable to the findings by Stenner and 
colleagues (2011) and a few other studies (Entwistle et al., 2008; Searle et al., 2008; 
Beverly et al., 2014; Grohmann et al., 2017), the patients who participated in this 
study expressed their appreciation of their nurses‘ positive communication 
behaviours, which included active listening, the provision of detailed and 
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understandable explanations and asking questions of patients that encouraged them 
to enquire about and share their problems and concerns. These empathetic 
behaviours led to the patients becoming further involved in planning their T2DM 
management when compared to their encounters with physicians. As this study 
involved nurses, it also contained an exploration from their perspective and found 
that they believed they had to use their communication skills and the perception of 
being more approachable in comparison to physicians in terms of helping patients to 
feel more at ease in disclosing important and useful information during discussions 
regarding their T2DM management. This showed that HCPs‘ facilitative behaviours 
were related to their realisation of the importance of the information given by their 
patients. Combining this with their capacity to prescribe and their expertise, patient 
satisfaction levels were higher compared to the care that they received from their 
physicians as they believed that the care and modalities chosen were those that were 
best suited to their preferences and values (Courtenay et al., 2009).  
 
Entwistle and colleagues (2008) also found HCP characteristics to be an important 
factor in patient involvement in decision-making. In this Scottish study, 18 patients 
with diabetes were qualitatively interviewed and it was found that the patients‘ 
perception of their HCPs‘ attitude and behaviours influenced their involvement in the 
decision-making process. In contrast to the aforementioned studies by Courtenay and 
colleagues (2009) and Stenner and colleagues (2011), Entwistle and colleagues 
(2008) did not focus on patient–nurse encounters but rather focused more on a 
general sense of the patient–HCP encounter. Besides the HCP characteristics 
discussed earlier, the patients in the study by Entwistle and colleagues (2008) also 
tended to withhold their involvement if they felt they were being judged and/or 
blamed for their lack of adherence or achievement in relation to the optimal or ideal 
biomedical outcomes. The patients also expressed an interest in being involved in 
discussions regarding decisions with HCPs who were honest, who would treat them 
as an equal partner and who would respect them as both an expert and an individual 
with unique experience of dealing with their own T2DM on a day-to-day basis, 
which has also been put forward by other studies (Corser et al., 2010; Detz et al., 
2014). These studies showed that besides HCPs‘ medical expertise, their 
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communication skills and attitude were found to be important factors in terms of 
creating a reciprocal relationship in which patients feel comfortable and safe to be 
actively involved in discussing their concerns, healthcare practices and preferences.  
  
Trust  
Trust was another aspect that routinely emerged from the reviewed studies in 
discussions on the interaction between patients and HCPs in decision-making. 
However, similar to the other issues related to shared decision-making, trust is also a 
multifaceted matter. The placing of an excessive amount of trust, or a lack of it, was 
found to lead to patients being actively involved in a discussion about the decisions 
that needed to be made (Saba et al., 2006; Searle et al., 2008; Peek et al., 2009). The 
HCPs in the study by Searle and colleagues (2008) outlined some of the difficulties 
involved, especially in the context of dealing with patients with foot ulcers. It was 
reported that the HCPs‘ efforts to engage with these patients went unreciprocated, 
leading to frustration among them. This was not merely due to the patients‘ 
indifference regarding their health problems and their inability to make a decision, 
but was also due to the fact that the issue extended beyond the patients‘ encounters 
with their HCPs. It was also due to them placing immense trust in their HCPs, with 
some patients believing their HCPs to be the ones responsible for managing their 
foot ulcer problem, in addition to them feeling they were not sufficiently empowered 
to manage their foot problem themselves (Searle et al., 2008). In contrast, other 
studies suggested that some patients did not share their concerns as their trust in their 
HCPs made them feel grateful and satisfied with the service that they received and 
the way in which decisions were made (Saba et al., 2006; Searle et al., 2008). 
 
Peek and colleagues (2013) also reported similar findings and emphasised the 
advantages and disadvantages of patients‘ full trust in their HCPs. This study, which 
was part of a larger shared decision-making intervention project, extensively 
explored the issue of trust in this approach. Additionally, since the study was based 
on the experiences of African American patients in an American healthcare setting 
dominated by white HCPs, elements of racial and sociocultural discordance added an 
51 
 
extra dimension to the issue. These elements were found to negatively impact 
patients‘ trust in their HCPs and prevented them from taking an active role in 
decision-making. Bauer and colleagues (2014) suggested that this would harm 
patients further as the practice of non-adherence would become common among 
these patients. Nonetheless, Peek and colleagues (2013) accentuated the potential of 
shared decision-making to guide HCPs to properly address their patients‘ concerns 
and provide sufficient information to improve their level of trust. By doing this, the 
patients in this study felt encouraged to become further involved in making decisions 




It is typical within the existing patient-centred care guidelines and models of shared 
decision-making to include patient–HCP information exchange as one of the 
important elements. In describing the meaning and experience with regard to patient 
involvement in decision-making, this issue also emerges as one of the important 
themes in the reviewed literature. For instance, a study by Corser and colleagues 
(2010) reported on the difficulties experienced by patients in accessing important 
information that might enable them to have a better understanding of their T2DM 
conditions and management. In this US study involving interviews with 44 T2DM 
patients, concerns relating to both a lack of and the provision of ambiguous 
information by HCPs were raised by the patients. This was especially the case 
concerning their biomedical status and medications. Concern was also raised in 
relation to the patients‘ reported action of requesting more and clearer information, 
with the HCPs having failed to address this appropriately. It can also be seen from 
this study that this lack of information negatively impacted the patients‘ perception 
and most probably their self-management practice as they perceived there to be a 
lack of connection between their self-management and the decision made during 




The findings of Corser and colleagues (2010) were found to support the request that 
was raised by the patients in a study by Hajos and colleagues (2011), in which the 
patients wanted their HCPs to share more information, including information about 
the available options for their medical problem and the latest information concerning 
their diabetes and treatment. On the other hand, despite being an indication that the 
patients were ready to play an active role in discussions about their decision, it was 
found that the patients perceived the actual length of their medical consultation to be 
adequate and that no additional consultation time was needed to address their need 
for more information (Hajos et al., 2011). This finding is aligned with the study by 
Stenner and colleagues (2011) in which they asserted that consultation time is not 
necessarily related to the quality of information shared. 
 
A study by Peek and colleagues (2009) further explained the nature of the 
information that patients wanted from their HCPs. Aside from requiring more 
information about the biomedical results, similar to the request of the patients in the 
above-mentioned study by Corser and colleagues (2010), it was also crucial that 
information was shared using terms that patients could understand. However, it is 
important for HCPs to not underestimate patients‘ ability to understand complex 
concepts related to their diabetes condition and treatment as they have also been 
shown to desire detailed and accurate information, not merely superficial information 
concerning their condition and care (Tinelli et al., 2017).  
 
In a study by Searle and colleagues (2008), the patients involved described 
information sharing from their side and not merely from the perspective of their 
HCPs. On some occasions, these patients believed that their concerns about their 
health problems and the information that they shared with HCPs were not being paid 
sufficient attention or being adequately addressed. As such, they felt it was difficult 
to engage with their HCPs. The importance of information exchange from the very 
beginning of the patient–HCP encounter was emphasised by Zoffmann and 
colleagues (2008) in terms of ensuring that further communication is focused on 
patients‘ individual health problems and challenges. This finding was supported by 
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Searle and colleagues (2008) as patients tend to refrain from asking further questions 
and raising concerns or sharing information due to a perception that these types of 
behaviours do not form part of their expected role as a patient.  
 
The importance of information exchange between patients and HCPs was further 
accentuated by Peek and colleagues (2008), whereby the patients involved perceived 
it to be more beneficial compared to making the final decision, regardless of any 
preference concerning the decision-making approach. Even those patients who 
preferred the HCPs to make the decision about them also stressed the need for a two-
way exchange of information between themselves and their HCPs. This is because 
the patients had a desire to be heard by their HCP. This was found to be comparable 
with two other studies, Saba and colleagues (2006) and Courtenay and colleagues 
(2009), wherein the same emphasis was highlighted by the patients. Courtenay and 
colleagues (2009) further emphasised that information shared by the HCPs increased 
patients‘ understanding of their illness and care, which was found by Marahrens and 
colleagues (2017) to be one of the facilitators of shared decision-making. 
 
In contrast to the findings of the previous studies, where the patients expressed their 
desire for more information on decision-making, Stenner and colleagues (2011) 
found that the patients in their study were satisfied with the information provided to 
them by the nurses. They described the information that they received as being 
sufficiently detailed, clear and understandable. The patients in this study also 
perceived that the information provided by their nurses was more tailored to them 
compared to the information offered by the physicians, since the nurses also took 
account of the information that had been shared in their current and previous 
encounters.  
 
Nonetheless, a previous quantitative study by Heisler and colleagues (2003) found 
there to be a lack of concordance between patients and their HCPs with regard to the 
treatment plans and strategies in real practices, which led to decisional conflict 
between them. Furthermore, patients who doubted the effectiveness of the treatment 
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plans also tended to express their dissent with their prescribed health management 
through non-adherence. It can also be said that there was an association between 
discordance and information sharing as this study also revealed discordance to be 
more apparent among patients with a lower level of involvement in decision-making 
and who had limited discussion about the decisions, in addition to among patients 
with a lower level of education. Nonetheless, this study found no association 
between the concordance and the length of the patient–HCP relationship. As long as 
the HCPs conducted a substantial discussion with their patients that included 
elements of information exchange and negotiation, there would be higher levels of 
concordance with regard to the planned management strategies. 
 
2.3.3.3 Outcome of patient involvement in decision-making 
Another area of shared decision-making or patient involvement in decision-making 
that was commonly studied in the reviewed literature was the outcomes of these 
approaches. Collectively, the studied outcomes of patient involvement in decision-
making are related to patients‘ satisfaction, adherence and biomedical status (Golin, 
DiMatteo, Duan, Leake, & Gelberg, 2002; Franciosi et al., 2004; Jahng et al., 2005; 
Saba et al., 2006; Searle et al., 2008; Cvengros et al., 2009; Rahimian Boogar et al., 
2013). A study by Golin and colleagues (2002) is one of the earliest of the included 
studies to have investigated the outcome of patients‘ active involvement in deciding 
their T2DM management. A total of 198 T2DM patients in the US were interviewed 
and their satisfaction was assessed quantitatively using an adapted version of the 
RAND-developed Patient Satisfaction Questionnaire (PSQ)-18. This study 
concluded that patients‘ perception of their physicians‘ facilitative behaviour with 
regard to their involvement in decision-making and their desired level of 
involvement was able to predict their level of satisfaction with their encounters with 
physicians. 
 
A quite different finding from that by Golin et al. (2002) featured in an Italian study 
by Franciosi and colleagues in 2004. This study was conducted among 2,515 
diabetes patients and looked at different aspects of the illness using a variety of 
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assessment tools, including patient involvement in the decision-making process 
(measured using four items assessing the patients‘ perception of the frequency of 
involvement), level of satisfaction (measured using the American Board of Internal 
Medicine satisfaction questionnaire) and quality of life (measured using the SF-36 
Health Survey and the Centres for Epidemiologic Studies-Depression (CES-D)). 
Compared to the findings by Golin and colleagues (2002), satisfaction was found to 
not merely depend on the patients‘ desire to be involved. Rather, they proved that 
patients‘ satisfaction was dependent on the congruency of their expectation and their 
perceived involvement in decision-making. With no congruence between their 
perceived involvement and expectation, the result tended to be lower patient 
satisfaction with regard to their relationship with their physicians. Similar to the 
finding by Franciosi and colleagues (2004) is a finding from the study mentioned in 
section 2.3.3.1 by Cvengros and colleagues (2009), who also reported an increase in 
patients‘ satisfaction level when they perceived that their preferred level of 
involvement in decision-making was being attained. 
 
A study by Jahng and colleagues (2005) also emphasised the importance of the 
patient and physician sharing similar preferences in terms of patient involvement in 
order to ensure the realisation of benefits from their collaboration in determining the 
most suitable treatment option for the patients. Another study with findings 
comparable to those of the study by Franciosi and colleagues (2004) was a grounded 
theory study by Saba and colleagues (2006). This study, which employed 
observation and interview as its methods of data collection, found that patients‘ 
satisfaction with their relationship with their physicians did not merely depend on 
their actual level of involvement in decision-making. There were also other factors 
involved, including good communication skills and a good interpersonal relationship 
with their physicians, as previously discussed in section 2.3.3.1.  
 
In a study by Schoenthaler, Schwartz, Wood, and Stewart (2012), patients‘ 
satisfaction with their encounter with physicians was found to improve their 
adherence to the prescribed medication. Adherence is another important outcome of 
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patient involvement in decision-making that was studied in the reviewed literature 
due to the fact that T2DM involves lifelong self-management by patients away from 
the healthcare setting. Besides satisfaction and other factors, Schoenthaler et al.‘s 
quantitative study involving 608 T2DM patients and 41 physicians also investigated 
the effect on patients‘ adherence of the patient–physician decision-making approach. 
Similar to patient satisfaction, shared decision-making or collaborative decision-
making was found to significantly improve patient adherence to their diabetes 
medication. A similar finding was also presented by Bauer and colleagues (2014) in 
their survey of 1,523 diabetes patients. Bauer and colleagues (2014) found that 
diabetes patients who perceived themselves as not being actively involved in making 
a decision had lower adherence to their medication. However, both of these US 
studies, together with studies by Heisler, Bouknight, Hayward, Smith, and Kerr 
(2002) and Peek and colleagues (2008), also emphasised that T2DM patients‘ 
adherence is complex due to the fact that other factors such as social support, 
disease- and patient-related factors and other elements of the relationship with 
physicians, such as information exchange, the presence of a trusting relationship and 
good communication, also play an important role when it comes to adherence. 
Nonetheless, Schoenthaler and colleagues (2012) underlined that action should be 
taken to improve patient–physician interaction in order to increase the level of 
adherence among T2DM patients.  
 
Based on the study by Grohmann and colleagues (2017), by being involved in the 
discussion about their management decision, patients expressed an increase in their 
levels of motivation and confidence as they felt they had the requisite knowledge and 
skill to perform their T2DM self-management. Furthermore, involvement in 
decision-making was considered to be very important among African American 
T2DM patients in Peek and colleagues‘ (2008) study. The patients in this qualitative 
study dealt with the different approaches to decision-making by using adherence or 
non-adherence. Some of the patients resorted to non-adherence as a means of 
regaining control over their body, while non-adherence was particularly common 
when their preference was not assessed and taken into consideration by the HCP in 
planning their T2DM management.  
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Cvengros and colleagues (2009) was found to be the only study that demonstrated a 
positive outcome of patient involvement in decision-making on their HbA1c levels, 
which was considered to be the main indicator of the effectiveness of T2DM 
management. This was especially the case when patients felt that sufficient 
information was being shared by their HCPs. Other studies, on the other hand, were 
unable to prove this, including Heisler and colleagues (2009), in which no 
improvement was found for any biomedical readings despite there being active 
patient involvement in decision-making. However, Heisler and colleagues (2009) 
also indicated that the preference of HCPs and self-reported practices of shared 
decision-making positively impacted the patients as they were more likely to provide 
the patients with risk factor screening tests and motivate the patients, which may 
have prevented them from developing diabetes complications. On the other hand, 
since this study involved both HCPs and patients, a comparison was possible of the 
preference of HCPs with regard to the decision-making approach and self-reported 
practices against the patients‘ self-reported quality of care and biomedical outcomes.  
 
2.3.3.4 Inter-professional collaboration 
Some studies have suggested that inter-professional collaboration in the management 
of T2DM adds another layer of intricacy to the involvement of patients in decision-
making (Shortus, McKenzie, Kemp, Proudfoot & Harris, 2007; Courtenay et al., 
2009; McDowell et al., 2009; Corser et al., 2010; Snyder et al., 2010; J. McDonald et 
al., 2012). A  2007 study by Shortus and colleagues conducted in Australia revealed 
a lack of information sharing between different groups of HCPs involved in the 
management of T2DM patients despite the Australian government‘s encouragement 
of multidisciplinary care planning in primary care. In this study, nineteen general 
practitioners, eight non-medical HCPs and two endocrinologists were interviewed, 
along with nine T2DM patients. The study indicated that care plans for T2DM 
patients were developed and coordinated by the general practitioners with little to no 
involvement from not only the patients but also other HCPs. The care plans 
developed by the general practitioners were usually shared with other HCPs based on 
their level of expertise in a particular area or type of management, typically when the 
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plans concerned an area with which the general practitioners were not familiar, 
notably when dealing with complex cases. It was also common for the general 
practitioners to cease sharing or referring patients‘ care plans with other HCPs once 
they had gained an understanding of those areas with which they were unfamiliar. 
General practitioners holding of the ultimate power to strategise T2DM patients‘ care 
plans were found to be due to their sense of responsibility to ensure the achievement 
of an optimal level of their patients‘ biomedical status, which they considered to be 
the most important element as it could prevent the development of complications. It 
can also be sensed from this study that the other HCPs, including the 
endocrinologists, had no issues with the fact that the patients‘ care plans were 
developed without their active involvement. Instead, similar to the patients who were 
indifferent with regard to their lack of involvement in the planning of their 
management, the non-medical HCPs seemed to be comfortable with their role as 
executors of the plans, while the endocrinologists worked as advisors.  
 
Nonetheless, inter-professional collaboration was further investigated in other studies 
due to the importance of multidisciplinary participation in the management of T2DM. 
In discussing the other studies in relation to this approach to making decisions for 
patients, one important issue raised was that of role specification (McDowell et al., 
2009; Snyder et al., 2010; J. McDonald et al., 2012). These studies emphasised the 
transparent and clear description of the roles for each group of HCPs in terms of both 
managing patients‘ T2DM and in making decisions regarding their treatment and 
management. This reflects the expanding roles of non-medical HCPs in the current 
management of T2DM, especially in primary care. In the study by Snyder and 
colleagues (2010), which explored collaboration between physicians and pharmacists 
in the US, it was found that to ensure the success of the collaboration, it is important 
that both groups mutually acknowledge the physicians‘ role as the main decision 
maker and the pharmacists as the supportive personnel or persons who are referred to 
with regard to patients‘ drug therapy. This finding is similar to the findings of the 
prior quantitative study by McDowell and colleagues (2009), in which there was a 
recognition of the different roles played by physicians and nurses despite nurses in 
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the UK increasingly expanding their role as HCPs who also make decisions on 
insulin initiation.   
 
In discussing the role specification of each discipline in managing T2DM, however, 
a study by J. McDonald and colleagues (2012) reported that a lack of clarity around 
the roles of each discipline affected the level of trust and power dynamic in terms of 
sharing responsibility for the management of patients between the different HCP 
groups. In this Australian qualitative study, interviews were conducted with T2DM 
patients and various groups of HCPs involved in the management and/or prevention 
of T2DM, including general practitioners, medical specialists, nurses (diabetes 
educators, community nurses), a pharmacist, allied HCPs (dietitians, optometrists, 
physiotherapist, podiatrists) and other practitioners (an Aboriginal health education 
officer, fitness instructor and an Aboriginal community worker). It was also found 
that the HCPs tended to implicitly minimise their dependency on other HCPs in 
order to maintain their autonomy and that some of the general practitioners also 
limited the referral of patients to non-medical HCPs in a low-level collaboration. The 
study by Snyder and colleagues (2010) also reported an interweaving of the elements 
of trust, respect, confidence and communication when describing the practice of 
inter-professional collaboration. The pharmacists were reported as needing to 
consistently make explicit to the physicians their own contributions to improving 
patients‘ T2DM condition, in order for them to gain the physicians‘ trust and respect 
and be allowed to actively contribute their expertise to the patients‘ management. 
This reflected the physicians‘ role as the gatekeepers to other healthcare services for 
the patients. 
 
Despite the challenges identified in the area of inter-professional collaboration, it 
seems that the patients perceived that they were receiving multidisciplinary care 
based on a considerable degree of coordination, most probably due to the established 
guidelines or protocols in managing T2DM (J. McDonald et al., 2012). Conversely, 
another study by Corser and colleagues (2010) conducted among 44 American 
T2DM patients discovered that the patients encountered difficulty in managing their 
60 
 
T2DM due to the inconsistency of the information they received and the fact that 
they received advice from different physicians, which was described by some 
patients as inadequate and fragmented. This led to patients‘ lack of trust in and 
frustration with the service that they received (Corser et al., 2010). 
  
2.3.4 Section summary  
In this part, the review has focused not only on shared decision-making but has also 
considered the literature on patient involvement in decision-making as a whole in 
order to provide a more comprehensive overview of the topic. The review of the 
existing literature indicates that patients have not been given sufficient opportunity to 
become actively involved in the making of decisions despite them displaying 
increased preferences to the contrary. The review has also acknowledged the 
importance of patient involvement in decision-making, especially in relation to 
chronic illnesses such as T2DM. From the discussion around patients‘ and HCPs‘ 
preferences on patient involvement, it can be concluded that the level varies 
depending on the meaning and value that a person attaches to the involvement of the 
patient in discussing the decision that needs to be made in order to improve their 
T2DM status. However, patient involvement in making the management decision 
and in planning their T2DM care does not depend solely on patients‘ preferences 
since it is also related to other factors, as discussed earlier. 
 
The findings from the existing literature also support the conclusion drawn in the 
first part of this chapter, which described the challenge and complexity of managing 
T2DM, a large element of which comprises the patient‘s self-management. 
Nonetheless, in T2DM, which requires patients to self-manage and make their own 
decisions without the presence of their HCPs, it is important that patients become 
involved from the start of the management process, which is the decision-making 
phase, and to have comprehensive knowledge about T2DM and their health 
condition. It can be said that in chronic health conditions such as T2DM, patients are 
making two types of decision – a treatment decision in the presence of their HCP, 
and a management decision without their HCPs. This strengthens the need for a 
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mechanism that can integrate patients‘ needs and values with their T2DM 
management, which is consistent with the shared decision-making model. 
 
In discussing the groups of participants involved in the studies, it was found that 
insufficient attention has tended to be paid to HCPs, despite their important role in 
decision-making in the healthcare system. This was evident from the number of 
studies conducted among HCPs being far lower than the number of studies 
conducted among patients. The studies that did involve HCPs focused only on 
certain groups, including HCPs and nurses. None of the studies was found to involve 
dietitians and only one included pharmacists. As the current management of T2DM 
is multidisciplinary, the inclusion of these HCPs may shed some light and provide a 
new perspective on the shared decision-making approach. There was also a lack of 
involvement of both patients and different groups of HCPs in discussing similar 
issues on the concept. In terms of the methodology and methods used, qualitative 
methods were employed more widely when conducting deeper exploration, 
especially in the Asian context where patient involvement in decision-making 
remains uncommon. On the other hand, despite the fact that observation may be a 
good additional method of collecting information when investigating the current 
practice of the studied topic, based on the existing literature, interviews were also 
found to be a good way of exploring the topic and generating a substantial and 
comprehensive explanation of the perspectives and experiences of the participants 
related to patient involvement in decision-making.   
 
2.4 Part 3: Malaysian T2DM contextual background 
2.4.1 The healthcare system in Malaysia 
The healthcare system in Malaysia is a dual system involving both the public and 
private sectors (Jaafar et al., 2013). The public healthcare sector falls under federal 
government legislation and is governed by MOH Malaysia. This serves as the main 
provider of health services in Malaysia since it caters for majority of the country‘s 
total population, although the private healthcare sector has experienced tremendous 
growth over recent years. The public healthcare system in Malaysia provides a 
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world-class service and is equipped with the latest advances in medical equipment. 
Nonetheless, Malaysians pay only nominal fees for access to these high-quality 
services as the government subsidises them through the general taxation of income. 
Correspondingly, Malaysia‘s public health sector is characterised by limited 
resources, overcrowding and long waiting times, especially for specialised services. 
Thus, the private healthcare sector in Malaysia provides an alternative option, 
especially for those who can afford to pay for faster services (WHO, 2017). Apart 
from this, however, there is not much difference between the quality of services 
provided by the public and private healthcare sectors in Malaysia. 
 
The MOH encompasses three levels of healthcare: primary, secondary and tertiary. 
Primary care sits at the core of the Malaysian healthcare system and serves as the 
first point of contact for users of the healthcare service. It provides the broadest 
scope of healthcare services to members of the local community regardless of their 
socio-economic and demographic backgrounds. The types of services offered at the 
primary care level in Malaysia vary from antenatal check-ups to the well-being of the 
elderly, and from health surveillance and school healthcare to home nursing and 
rehabilitation. Currently, there are 1,060 public healthcare clinics providing primary 
healthcare services across Malaysia (MOH 2017), with primary care physicians 
referred to as general practitioners, which as a category also includes medical 
officers and Family Medicine Specialists (FMS). Referrals to secondary and tertiary 
healthcare services may be made for patients depending on their needs. Secondary 
healthcare in Malaysia refers to the services provided in hospitals by medical officers 
and specialists, including general medicine, general surgery, orthopaedics, 
paediatrics, obstetrics and gynaecology, anaesthesiology, imaging, geriatrics and 
others. Tertiary healthcare covers highly specialised care across the areas of 
endocrinology, cardiology, cardiothoracic surgery, neurosurgery, respiratory 
medicine and plastic surgery, among others. To date, 144 hospitals and special 
medical institutions have a total of 41,995 beds for the provision of secondary and 
tertiary healthcare services in Malaysia (MOH Malaysia, 2017). These types of 
services, despite being curative and illness-focused, are expensive, fragmented and 
institution-based, which may be inappropriate for the majority of the public (Amar, 
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2004). Nonetheless, the demand for tertiary healthcare services in Malaysia has 
increased over the past decade due to the lack of understanding among the public and 
some HCPs of the importance of health assessment and prevention services (Amar, 
2004). 
 
In achieving better health services for its population and in order to meet the current 
trends for demand in healthcare services, there has been a remarkable increase in 
health expenditure, from 2.94% of the country‘s GDP (RM 8.2 billion) in 1997 to 
4.49% of GDP (RM 49.7 billion) in 2014 (Malaysia National Health Accounts, 
2014). Despite the increased budgetary allocation by the government, the MOH is 
challenged by the fact that the cost of providing medical and health services 
continues to increase year on year. In sustaining and maintaining the highest quality 
of care, MOH Malaysia is continuously seeking to implement cost-containment 
measures without adversely affecting citizens‘ access to healthcare. Furthermore, 
despite struggling to reduce communicable diseases such as dengue and tuberculosis, 
Malaysia has successfully reduced the prevalence of other communicable diseases, 
including HIV and malaria. As a result, there has been a recent shift in focus towards 
non-communicable diseases as its main burden. In doing this, the MOH has set its 
focus on preventing and controlling non-communicable diseases and their risk 
factors, alongside promoting lifestyle modification among the country‘s population 
in an effort to reduce the demand for costly medical interventions among the 
sufferers of chronic non-communicable diseases (WHO, 2017). The privatisation of 
the healthcare system has also reduced the government‘s financial burden, as 
consumers now cover the cost within the private sector. Additionally, with rising 
levels of education and awareness of patient rights, the healthcare system in 
Malaysia also faces increased demands and expectations from the population it 
serves (MOH Malaysia, 2011).  
 
2.4.2 T2DM management in Malaysia  
As a developing upper-middle-income country, Malaysia is facing economic, 
epidemiological, demographic and social changes which are reflected in its citizens‘ 
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way of living. Consequently, the prevalence of chronic, non-communicable diseases, 
including T2DM, continues to rise.  
 
Similar to the situation seen in European and other developing countries, this 
alarming trend has become a major health concern in Malaysia due to the crippling 
medical-related complications associated with it. Studies have proven that the 
various micro- and macrovascular complications associated with T2DM are placing a 
substantial economic burden on the healthcare system, with patients requiring 
hospitalisation and ambulatory care and also suffering a premature death in many 
cases (Jönsson, 2002; Ringborg et al., 2009). Besides, recent studies indicate that a 
majority of T2DM patients in Malaysia, at both public hospitals (87.8%) and public 
health clinics (76.2%), fail to achieve optimal glycaemic control (Feisul Idzwan & 
Soraya, 2013; Mafauzy, Zanariah, Avideh, & Chan, 2016). This only serves to 
exacerbate their condition as these patients are at higher risk of developing the 
above-mentioned costly complications. Nevertheless, due to the fact that 80% of 
T2DM patients are managed in public health clinics (56%) and hospital-based clinics 
(24.6%) in the public health sector (Institute for Public Health, 2011), where almost 
95% of the cost is financed by the Malaysian Federal Government, the adoption of 
better preventive measures at this ground level may work to reduce some of the 
avoidable costs. 
 
In Malaysia, modern medicine has been practised since the colonial period. T2DM 
patients in Malaysia are managed based on the established international standard and 
evidence-based practice, which has been locally modified. However, diabetes is also 
known as ‗sweet urine‘ in Malaysia, reflecting urine that attracts ants and is 
associated with a high blood sugar level (Ariff & Beng, 2006). Additionally, 
traditional forms of medicine, including Malay medicine, Islamic medical practice, 
traditional Chinese medicine, traditional Indian medicine and homoeopathy, are still 
widely practised by Malaysians as an alternative or complement to modern medicine 
(Ariff & Beng, 2006; Othman & Farooqui, 2015). Ching, Zakaria, Paimin & Jalalian 
(2013) found that 62.5% of T2DM patients in Malaysian primary care used 
traditional medicine when managing their condition. Despite this large percentage of 
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Malaysian users of traditional medicine and the emphasis being placed on HCPs to 
better understand the practice, there is still a lack of integration into the healthcare 
service of this traditional and complementary medicine based on scientific evidence 
(Othman & Farooqui, 2015).  
 
2.4.3 T2DM management based on Malaysian Clinical Practice Guidelines 
(CPG) 
In Malaysia, it is recommended that the management of all patients with T2DM is 
based on the CPG, as issued by MOH Malaysia. This document has been repeatedly 
revised and updated in line with advancements in T2DM management and the latest 
research findings. There have so far been five editions of the guidelines since their 
introduction in 1992. The main purpose of the CPG is to facilitate HCPs in their 
ability to properly identify, diagnose and manage patients with T2DM.  
 
2.4.3.1 Assessment and treatment modalities 
The CPG contain a set of unique treatment algorithms for Malaysian T2DM patients. 
These treatment algorithms cover newly diagnosed T2DM cases, clinic follow-up 
cases and also special cases, with the aim of improving patients‘ quality of life, 
reducing complications and preventing premature deaths. They also emphasise the 
need to obtain a detailed medical history from newly diagnosed patients, in addition 
to conducting a full physical examination. This is imperative for identifying the 
presence of T2DM complications and cardiovascular risk factors in terms of 
determining the most appropriate management regimen for these patients. For other 
patients, it is recommended that therapeutic decisions are made based on a full 
clinical, physical and psychosocial assessment, with an emphasis placed on their 
HbA1c level.  
 
Diabetes education 
The CPG advocate that all T2DM patients must be periodically advised and educated 
by their HCPs. The guidelines include self-management support and 
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recommendations for patients with regard to a healthy lifestyle. These include 
changes to dietary habits, increasing levels of physical activity, smoking cessation, 
medication, self-care, self-monitoring of blood glucose (SMBG) and foot care, 
problem-solving skills, and psychosocial adaptation, which is important in patient 
empowerment. All HCPs involved are responsible for educating their patients about 
the above-mentioned areas so that the knowledge is repeatedly reinforced. This is 
important as the main objectives of T2DM education are to improve patients‘ 
understanding, alleviate their anxiety and promote their self-management and 
compliance with the treatment.  
 
Recognition of the importance of T2DM education has become more visible in 
Malaysia with the establishment of Diabetes Resource Centres (DRCs), especially in 
public hospitals. A number of certified diabetes educators are assigned to each centre 
so that as many patients as possible can be equipped with ample diabetes-related 
knowledge, awareness and skills.  
 
Pharmacological modalities 
Besides diabetes education for all patients, there are also patients who need extra 
help to achieve an optimal glycaemic level of 6.5% or below, which is the level set 
as the target for typical cases of T2DM in Malaysia. This is lower than the 
recommended 7.0% level in the USA and UK (ADA, 2017; NICE, 2015). The CPG 
contain a wide variety of pharmacological modalities, which are chosen based on 
patients‘ individual T2DM needs. In this treatment algorithm, it is suggested that 
pharmacological modalities are initiated in all T2DM patients to aid them in 
achieving the target HbA1c level.  
 
Similar to the guidelines from the UK‘s NICE (NICE, 2015), the Malaysian CPG 
also recommend Biguanides (e.g. Metformin) as the first line of medication for 
patients who are in need. There is also a recommendation for the initiation of other 
oral antidiabetic (OAD) agent/s if Metformin alone is not sufficient to achieve 
optimum blood glucose level. These include Sulphonylureas, Meglitinides, Alpha-
glucosidase Inhibitors, Thiazolidinediones (TZDs), Dipeptidyl Peptidase-4 (DPP-4) 
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Inhibitors and Sodium Glucose. It has previously been reported that almost all of the 
T2DM patients (94.1%) attending public health clinics have a prescription for at least 
one OAD agent (Feisul Idzwan & Soraya, 2013). This includes 27% of patients with 
monotherapy, 45.7% of whom are prescribed at least two OAD agents, and 16.5% of 
patients who receive a combination of OAD agents and insulin. Despite the increased 
availability of new OAD agents, including at public health facilities, Metformin 
remains the most commonly prescribed OAD, with 82.5% of the patients who 
receive this form of treatment being prescribed this sole agent of Biguanides (Feisul 
Idzwan & Soraya, 2013; Zanariah et al., 2015). This OAD agent has acquired and 
maintained its popularity due to its effectiveness not only as a monotherapy for new 
or uncomplicated cases of T2DM but also due to its low cost and low incidence of 
adverse side effects (C. J. Bailey, 2017). 
 
Injectable agents such as insulin and Glucagon-like Peptide-1 (GLP-1) Receptor 
Agonist can be used as an adjunct therapy for newly diagnosed patients with high 
glucose levels or for patients who remain hyperglycaemic despite optimal OAD 
therapy. Besides, adapted from the Practical Guideline to Insulin Therapy in Type 2 
Diabetes Mellitus (MOH Malaysia, 2010a), the Malaysian CPG recommend early 
insulin initiation among patients who struggle to optimise their glycaemic level even 
if they are prescribed with three oral agents, since a delay in insulin initiation often 
results in suboptimal glycaemic control. The use of insulin, especially human insulin, 
is dominant among injectable agents. This is more apparent within the realm of 
public health settings due to its lower cost, particularly when compared to GLP-1 
Receptor Agonists (Zanariah, Sri Wahyu, Singh & Swee, 2015). It is recommended 
that insulin is combined with Metformin since these therapies work differently to 
reduce blood glucose level. Insulin dosage is titrated based on a patient‘s glycaemic 
level. There is an increasing trend in the percentage of patients with insulin 
prescription in both public health clinics (rising from 11.7% in 2011 to 21.4% in 
2012) and public hospital clinics (rising from 54% in 2008 to 65% in 2013) (Feisul 




Self-monitoring of blood glucose (SMBG) 
The CPG also emphasise the importance of SMBG, especially among patients with 
insulin therapy, in assessing the effectiveness of their overall T2DM management 
and preventing hypoglycaemia. This is because SMBG readings are useful for 
patients when it comes to them self-managing their T2DM (Hou, Li, Qiu, & Wang, 
2014). 
 
Despite recommending that patients perform SMBG at least four times a day, the 
CPG also allow some flexibility with regard to its frequency based on patients‘ 
glycaemic status and goals, and their treatment modalities. Besides, in most 
Malaysian health facilities, patients are required to buy their own glucometer, lancet 
and strips, which, if they are required to test their blood glucose level four times per 
day, can result in significant long-term expenditure on the part of patients. Ong, 
Chua, and Ng (2014) also identified the high cost of SMBG as one of the barriers to 
SMBG practice, along with a phobia of needles and pain, patients‘ frustration of high 
blood glucose readings, and a lack of motivation, knowledge and self-efficacy. 
Although Diabcare studies found a significant improvement of SMBG practice 
among patients with pharmacological therapies in public hospital clinics, rising from 
26.8% in 2003 to 58.7% in 2008 (Mafauzy et al., 2011), patients should continuously 
be reminded of its importance so that their T2DM can be optimally managed.  
 
2.4.3.2 Team approach  
In the Malaysian healthcare system, various professional healthcare groups are 
involved in the management of patients with T2DM. These include endocrinologists, 
FMSs, internal medicine specialists, medical officers, diabetes educators, nurses, 
dietitians and pharmacists. Medical officers are responsible for managing 
uncomplicated diabetes cases in both public health clinics and hospitals. Cases that 
require more advanced management and/or that involve other body systems are 
handled by endocrinologists at the main state general hospitals, internal medicine 
specialists at smaller hospitals or by an FMS in primary health clinics. Those 
working in the primary care setting are considered to be the first point of contact for 
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T2DM patients, especially medical officers. In settings where diabetes educators and 
dietitians are not available, they are the ones responsible for orchestrating patients‘ 
overall diabetes care, which includes lifestyle modification and patient education.  
 
There is an increasing availability of diabetes educators, who are commonly nurses 
and medical assistants, in Malaysian public health facilities. This is due to the fact 
that they are currently no longer only to be found in the DRC of the main state 
general hospitals, but also in some smaller urban state hospitals and health clinics. 
The MOH has run a post-basic course in diabetes management since 2000, with 
HCPs who complete this course becoming certified diabetes educators. These 
diabetes educators are generally responsible for delivering diabetes education and 
facilitating diabetes self-management. Based on the CPG, this includes the 
promotion of healthy eating and physical activity, patients‘ self-monitoring and 
problem-solving, medication adherence, goal setting and risk reduction practices 
such as weight management, smoking cessation and adherence to medical 
appointments and follow-ups (MEMS, 2016). Despite this, there remains a lack of 
modules, outlines and regulations at the national level that can be used specifically 
by diabetes educators when undertaking their role in diabetes management. The sole 
manual specifically for diabetes educators at the national level is the Diabetes 
Education Manual 2016, which was published as recently as April 2016 by the 
Malaysian Diabetes Educators Society (Malaysian Diabetes Educators Society, 
2016). Thus, many diabetes educators may still be unfamiliar with it. As a result, 
there is a high possibility of different diabetes educators at different locations having 
different responsibilities and using different intervention tools, which are commonly 
set by the facility‘s administrators or specialists.  
 
Dietitians in Malaysia are those responsible for planning individualised dietary 
recommendations for patients with T2DM. Medical Nutrition Therapy (MNT) is 
listed in the CPG as one of the main diabetes nutrition therapies in helping patients 
modify their diet (MEMS, 2016). Based on the findings of a 2013 study by 
Barakatun Nisak, Ruzita, Norimah, and Nor Azmi, the use of MNT by dietitians in 
their individual consultations with diabetes patients is effective in reducing 
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fructosamine and HbA1c levels, especially among patients with a highly elevated 
HbA1c level. However, similar to diabetes educators, despite the rising number of 
dietitians, this is still not enough to cater for the increasing demand for their support 
in managing diabetes patients, especially in the primary healthcare setting.  
 
Diabetes Medicine Therapy Adherence Clinics (DMTACs) were introduced as a way 
of guiding pharmacists to improve patients‘ medication adherence and enable them 
to achieve better glycaemic control (MOH, 2010b). This is in line with the role of 
pharmacists as outlined in the CPG. Since its introduction in 2006, this ambulatory 
care service has been found to have significant positive impacts on the management 
of diabetes patients in Malaysia. Among DMTAC patients, there has been an 
improvement in medication understanding and adherence which has resulted in 
reduced glycaemic levels, both in health clinics and hospital-based clinics (X. Y. Lee 
et al., 2015; Lim & Lim, 2010). On the other hand, pharmacists are also responsible 
for providing education related to the prescribed medications, including their side 
effects, to all patients with a prescription (MEMS, 2016). 
 
The CPG also emphasise the importance of there being a collaborative effort among 
these different professionals in providing patients with a combination of different 
expertise and continuity of care. However, this may not be easy to achieve due to the 
multifaceted nature of the Malaysian healthcare system, which may complicate 
information sharing and responsibility, not only among HCPs in different settings but 
also within the same setting. This was proven in a study carried out at one of 
Malaysia‘s public teaching hospitals, in which a lack of continuity of care was found 
among patients with chronic disease due to a lack of communication between the 
involved HCPs, in addition to the existence of a dual medical records system 
(Sellappans, Lai, & Ng, 2015). This resulted in various problems, including 
difficulties in prescribing and managing complex medication regimens for HCPs, 
especially among primary care physicians, together with missing information in 




2.4.4 Research on patient involvement in decision-making and shared 
decision-making in the management of T2DM – Malaysian context 
The review of the existing literature focusing on patient involvement in decision-
making and shared decision-making in the management of T2DM in the Malaysian 
context found there to be only a limited body of literature, despite this having grown 
in size in recent years. A study by Hwa (2005) was one of the cornerstones of patient 
involvement in decision-making for T2DM management in Malaysia. Although the 
study did not focus on the decision-making process, it did aim to investigate the 
preferences of T2DM patients for information in the patient–physician relationship. 
The quantitative study involved 105 diabetic patients from a public hospital and 50 
diabetic patients from a private hospital. The patients stressed the importance of the 
quality over the quantity of the information provided by their HCPs. They 
appreciated clear and comprehensible information, especially in relation to their 
diagnosis and treatment. Furthermore, similar to the emphasis given by Western 
patients, the sense of being heard by their physician was also found to be important 
to the patients in Malaysia (Hwa, 2005). Thus, an assessment of patients‘ needs, 
expectations and preferences should be carried out earlier and become one of the 
fundamental objectives to ensure that the consultation session will not take too long 
and will also be worthwhile for both patients and HCPs. 
 
Nevertheless, patient involvement in decision-making and shared decision-making in 
the management of patients with T2DM is a new area in Malaysia. Only a limited 
amount of research activities have been carried out by a small group of researchers 
over recent years (Y. K. Lee, Low, & Ng, 2013; Y. K. Lee, Low, Lee, & Ng, 2014; P. 
Y. Lee et al., 2015). All of these qualitative studies have formed part of a larger drive 
to create decision aids for facilitating the implementation of shared decision-making 
in insulin initiation for T2DM patients in Malaysia. 
 
The initial study in 2013 by Y. K. Lee and colleagues involved 21 patients with 
T2DM from public and private clinics in both urban and rural areas, with the 
objective of exploring the values involved in the making of a decision for initiating 
insulin therapy. Using semi-structured in-depth interviews, the researchers identified 
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three main values that the patients considered to be important in deciding to 
commence insulin therapy. These were ‗treatment-specific values‘, ‗life-goals and 
philosophies‘ and ‗personal and social background‘. The study also revealed that 
sociocultural and family situations influenced the decision-making process. Although 
the study contributed to the area of patient involvement in decision-making, it 
focused more on the patients‘ values in relation to the treatment decision that needed 
to be made as opposed to their values with regard to their involvement in making the 
decision.  
 
The patients‘ values with regard to being involved in decision-making were 
addressed by the following study, conducted by a similar group of researchers (Y. K. 
Lee et al., 2014). Data from 22 T2DM patients were analysed qualitatively with the 
aim of identifying factors influencing decision-making role preferences during 
insulin initiation. Almost half of the patients preferred to play an active role in 
determining their insulin initiation, with only one patient preferring a collaborative 
role. The study identified five main factors: ‗trustworthiness in the patient–clinician 
relationship‘, ‗perceived responsibility‘, ‗level of knowledge‘, ‗perceived family 
involvement‘ and ‗personal characteristics‘. The sole patient who preferred 
collaborative decision-making believed that both the patient and physician make an 
important contribution in making the decision on insulin initiation. Additionally, 
various non-medical perceived barriers were also identified, including religious 
beliefs regarding blood and a fear of social stigma arising from injection scars. This 
study also confirmed that patients in Malaysia are still not familiar with the term 
shared decision-making. This may be due to the use of the term collaborative 
decision-making as opposed to shared decision-making and the fact that the 
participants in the study were not provided with any vignettes.  
 
The latest research, by P. Y. Lee and colleagues (2015), was conducted to explore 
the views of patients and HCPs on a patient decision aid for use in making a decision 
about the same topic, that of insulin initiation. The recruited HCPs were the same 
ones who were involved in training workshops on the use of a newly developed 
patient decision aid among T2DM patients requiring insulin therapy. These HCPs 
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then used the decision aid in their consultations with patients. At the end of the 
consultation, the patients and HCPs were interviewed. The study involved 13 HCPs, 
comprising two general practitioners, seven medical officers, three diabetes nurses 
and a pharmacist, along with 18 patients. The involvement of both patients and HCPs 
in this study allowed the researchers to analyse data from both groups. Discrepancies 
in the views were identified as both groups had different views on the patient 
decision aid being tested. The patients stated their preference for more detailed 
information and their appreciation for the way in which the information was given 
within the decision aid, which they described as direct and understandable, whereas 
the HCPs considered the information provided to be overly lengthy and complex for 
the patients to understand. Another important mismatch was detected in terms of the 
information that both groups considered to be important. It was found that compared 
to the HCPs, who emphasised the benefits of insulin, the patients wanted information 
related to its practicality and the impact of insulin on their day-to-day activities.  
 
The review of the empirical studies of patient involvement in decision-making in 
Malaysia also found a small number of studies looking at health problems other than 
T2DM. These studies are elaborated in this section to provide a more comprehensive 
picture of this studied area in the Malaysian context. A quantitative study by 
Ambigapathy and colleagues (2016) was conducted among 470 adult patients 
visiting an academic primary care clinic, and 47 physicians. Using the Control 
Preference Scale, their preferences on patient involvement in decision-making were 
assessed. Similar to the findings by Y. K. Lee et al. (2014), it was found that the 
majority of the patients in this study preferred to be involved in making decisions, 
with more half of them (51.9%) preferring shared decision-making and another 21.8% 
preferring an autonomous role when it came to making their treatment decision. 
Nonetheless, the data collected from the physicians revealed that they were unable to 
recognise this and underestimated their patients‘ preferences with regard to active 
involvement.  
 
Mah and colleagues (2016), in their study involving 210 hypertensive patients, also 
identified comparable findings with regard to patients‘ desire to be actively involved 
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in making a decision. In this quantitative study, the questionnaire by Bruera, 
Sweeney, Calder, Palmer and Benisch-Tolley (2001) was used to assess the 
preferences for patient involvement in decision-making. The study indicated that 
51.4% of the patients preferred shared decision-making despite the fact that fewer 
patients (1.9%) preferred an autonomous role. Additionally, this study showed that 
despite most of the patients perceiving that they were informed that a treatment 
decision needed to be made and being presented with the available options, relatively 
few of them believed their opinion and preferred option were taken into 
consideration. This finding demonstrated that the physicians continued to make 
decisions paternalistically despite their effort to share information with their patients. 
 
Y. K. Lee and colleagues (2015) conducted a study on patient involvement in 
decision-making from the perspective of HCPs managing patients with localised 
prostate cancer. Focus group discussions and interviews were conducted among 20 
physicians and government policymakers. The findings indicated that the HCPs had 
different views on the role of HCPs in determining a treatment option for prostate 
cancer patients. There were some HCPs who believed they should be the ones 
making the decision based on an assertion that this was their patients‘ preference, 
which was actually an erroneous assumption on their part, as also found in another 
study by P. Y. Lee and colleagues (2015). Nevertheless, this study showed that there 
were some HCPs who viewed themselves as a guide and facilitator for the patients 
and their families in terms of their role in determining the most suitable treatment 
option for them. 
 
2.4.5 Section summary  
Malaysia, as a developing country, has a good healthcare system and has also 
developed its own guidelines for managing T2DM. In reviewing the research 
activities, only a limited number of studies have been conducted in exploring and 
investigating patient involvement in decision-making and shared decision-making in 
Malaysia. The majority of these studies found patients who preferred to be actively 
involved in deciding their treatment option despite the complexity of the process and 
the traditional paternalism that has long been embedded within the Malaysian 
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healthcare system. Among these studies, only three looked at T2DM, with the focus 
on the development of decision aids for insulin therapy initiation. It was also found 
that despite there being two studies involving both patients and HCPs, only one of 
these included diabetes nurses and a pharmacist among its participants. Thus, a study 
that further and more deeply explores patient involvement in decision-making and 
shared decision-making in the overall management of patients with T2DM from the 
perspective of not only patients and physicians but also other HCPs will contribute 
significantly to a more comprehensive and wider context. 
 
2.5 Chapter summary and areas for further exploration 
This chapter began with an overview of the philosophical underpinning of patient 
involvement in making decisions about their T2DM treatment and management. 
Based on patient-centred care, shared decision-making has encouraged the popularity 
of patient involvement in their T2DM decisions since it was first introduced in 1997 
by Charles and colleagues, owing to its proven effectiveness. Nonetheless, due to a 
lack of consistency in its conceptual underpinning in different contexts, its 
integration into practice and the measurement of outcomes has been challenging.  
 
The second part of this chapter reviewed existing empirical studies surrounding 
patient involvement in decisions, which include shared decision-making on T2DM 
care. The review focused on the perceptions and experience of the stakeholders with 
regard to patient involvement in decision-making, including shared decision-making 
itself. This was carried out as shared decision-making is considered to be the 
narrower or arguably ideal model of patient involvement in decision-making, yet it 
may not be familiar to a wider audience, especially for those who have not yet been 
introduced to the model. Thus, a review of the studies in the wider context of patient 
involvement in decision-making was more sensible in terms of producing a more 
comprehensive explanation of this component of patient-centred care. On the other 
hand, an exploration of views and experiences is still important as the foundation of 




Overall, it is clear that the involvement of patients in decision-making remains poor 
despite the acceptance of patient-centred care and the realisation of its importance 
and benefits. The preferences of the participants with regard to the practice, as one of 
the most explored areas in shared decision-making, also vary depending on the value 
that they place on being involved in decision-making. It was also found that patient 
involvement is heavily dependent on the patient–HCP relationship and the 
characteristics of HCPs as the gatekeepers to healthcare services. Paternalism 
continues to be very apparent and most of the time still plays an important role in 
patient involvement in decision-making as patients‘ opportunity and intention for 
becoming involved still depend greatly on their HCPs. Nonetheless, this may also be 
due to the fact that there was a lack of exploration of this matter among HCPs as 
compared to patients. This is especially the case among pharmacists and dietitians 
who are considered to be the groups that are actively involved in the management of 
T2DM.  
 
Finally, despite the emphasis on the importance of stakeholders‘ understanding and 
values pertaining to patient involvement in decision-making in different cultures and 
contexts, not many studies were found exploring these elements in either Asia or in 
Malaysia specifically. This type of exploration is considered to be fundamental in 
shaping the measures and plans in the implementation of shared decision-making in 
this part of the world that has significantly different cultural and social backgrounds. 
The exploration of the same issues in the management of T2DM in Malaysia resulted 
in the discovery of three papers that mainly described one project on shared decision-
making intervention using decision aids focusing on insulin therapy initiation. 
However, there is still a lack of basic understanding of both patients‘ and HCPs‘ 
views on their experience of, and the factors related to, patient involvement in 
decision-making and shared decision-making in the overall management of T2DM.  
 
Thus, the completion of this chapter has highlighted the need for a study that 
explores the views not only of patients but also of different groups of HCPs in 
producing a more comprehensive overview of the current status of patient 
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involvement in decision-making related to T2DM in the Malaysian context. This is 
because, as a relatively new approach to fostering the involvement of patients in 
decision-making, the model or framework and measurement instruments, including 
measurement of the process, outcome and the surrounding elements of shared 
decision-making, need to be continuously developed and improved. This is in order 
to demonstrate the effectiveness of the approach, especially in the management of 
chronic diseases including T2DM among people from different sociocultural 
backgrounds. Thus, the findings of this research will help the researcher to 
understand the perspectives of patients and HCPs in the comprehensive management 
of T2DM and may also contribute to the future development of a shared decision-
making framework in the Malaysian context. With the empirically grounded findings 
of this approach, it is hoped that a better outcome may be achieved so that patients 
with T2DM will have a better quality of life and better overall health outcomes. 
 
2.6 Statement of the research problem 
Over the last three decades, patient involvement, also known as patient participation, 
has been one of the central issues of research focusing on patient autonomy in the 
healthcare system. However, due to its complexity and an overall lack of clarity, the 
concept has tended to be addressed with little more than ‗tokenism‘ by HCPs 
(Roberts, 2002). This may be partially attributable to the fact that each patient and 
HCP may have his or her own opinions or ideas about the meaning and 
implementation of patient participation in disease management (Sahlsten et al., 2008).  
 
Patients with T2DM run an elevated risk of developing dangerous complications 
such as nephropathy, neuropathy, retinopathy and other cardiovascular problems, if 
the disease is not properly managed. Patients are required to deal not only with the 
decision-making process with their HCPs but must also decide on their daily 
activities. This may seem minor, but the decisions that are made also have a greater 
effect on patients‘ overall health, including on decisions regarding the type of food 
they consume, medication adherence, physical activity, smoking or drinking habits 
and any other related behaviour (Ming et al., 2011). Thus, shared decision-making 
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may contribute significantly to a patient‘s empowerment, which in turn will lead to 
good decisions being made by the patient, even in the absence of their HCPs, 
especially with regard to decisions pertaining to their own self-care and self-
management (Bodenheimer et al., 2002). 
 
Shared decision-making, as mentioned earlier, is one of the approaches that 
encourage patient participation in the decision-making process as it relates to the 
patient‘s illness. However, the same trend of patient involvement in terms of a lack 
of clarity has also been found for this concept. Shared decision-making has been 
described, interpreted and implemented differently across the academic literature, 
especially across various cultural and social contexts (Peek et al., 2008; Mead et al., 
2013; Obeidat, Homish, & Lally, 2013; Ahmad et al., 2014; Shay & Lafata, 2014). 
This is because every person has their own views and values regarding what is 
important to them in implementing shared decision-making in practice (Goold, 
Williams & Arnold, 2000; Sahlsten et al., 2008; Y.K. Lee et al., 2014). These views 
and values are based primarily on people‘s social, cultural and religious beliefs, 
which can give rise to different views, expectations, needs and preferences regarding 
the shared decision-making approach (Thelen, 2005; van Kleffens & van Leeuwen, 
2005). Furthermore, there is evidence of incongruities between patients‘ 
understanding of the shared decision-making approach and how it is conceptualised 
by the theorists and researchers (Entwistle et al., 2008; Peek et al., 2008; Shay & 
Lafata, 2014). 
 
Besides, even though patient involvement in decision-making and shared decision-
making has been widely researched and incorporated in healthcare systems, 
particularly in Western countries, a review of the topic in Malaysia has shown that 
incorporation and research of the concept and approach are scarce (Ng et al., 2013). 
The transfer of conceptual understanding from one cultural and social context to 
another will therefore not necessarily be effective (Charles, Gafni, Whelan, Ann & 
Brien, 2006), especially when Malaysia has a distinctly different social and cultural 
background compared to Western countries. Thus, an extensive exploration of the 
understandings and views of the people involved is needed in order to investigate its 
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suitability and to ensure it can be successfully accepted and become effective in the 
long run. A deeper and more thorough understanding of this matter is crucial so that 
a comprehensive model or framework for incorporating shared decision-making into 
diabetes management in the Malaysian healthcare system can be designed and 
operationalised. 
 
2.7 Personal reflections on the research problem 
My personal interest in the area of decision-making for diabetic patients was sparked 
after I first encountered a patient with uncontrolled T2DM who, despite having had 
diabetes for more than three years, was still unclear about his own health problem 
and the treatment he was receiving. As a result, most of the time he merely attempted 
to adhere to his recommended management, and most of the time he found himself in 
a difficult situation where he did not know what to do and then chose to simply 
abandon his prescribed treatment and the advice given to him. Further conversation 
with the patient revealed that most of the decisions and related information were both 
made and given by HCPs, without any effective discussion between them. After 
some time, I realised that other patients were also experiencing the same problem as 
this particular patient. Throughout my literature search exploring these two worrying 
conditions, I came to realise that they were likely to be related. From the literature, it 
is found that involving T2DM patients in decision-making may help to improve their 
knowledge about their health condition and management, develop their self-efficacy 
in managing their illness and at the same time improve their quality of life. However, 
the amount of information in this area remains very limited, especially in the 
Malaysian context. Therefore, I developed a very strong interest in exploring shared 
decision-making as one approach to encouraging patient involvement in making their 






 CHAPTER 3: METHODOLOGICAL ISSUES AND RESEARCH DESIGN 
 
3.1 Introduction 
Chapter 1 of this thesis highlighted the worrying trends in and impact of T2DM all 
over the world, including in Malaysia. Involving the patient in decision-making has 
been encouraged as a means of both improving T2DM management and meeting the 
needs of the contemporary health landscape, where increasing value is being placed 
on patient participation in decision-making. As such, shared decision-making was 
introduced 20 years ago to facilitate this effort. Chapter 2 further demonstrated the 
lack of information on patient involvement in T2DM decision-making, in both the 
Malaysian and wider Asian contexts. This has created uncertainty as to whether the 
existing shared decision-making models and interventions, which are mostly derived 
from Western culture, are transferable to Malaysian patients. As such, the 
perspectives of the different stakeholders who are directly involved in managing the 
illness in this part of the world should be explored in order to gain a comprehensive 
understanding of their experience and understanding of patient involvement in 
T2DM decisions. To address the chronic nature of T2DM, where the patients are the 
ones that need to carry out the decisions made during the clinical encounters, this 
study focuses on T2DM management in the outpatient setting. Consequently, the 
information gathered from this study can help to develop a more appropriate policy 
and practice that is tailored to Malaysian needs. 
 
This chapter begins by outlining the research aims and questions. It then proceeds to 
discuss the philosophical basis of the qualitative research design. The data collection 
strategy is also explained, together with the data analysis process, related ethical 
considerations and questions of validity and reliability. Finally, the chapter presents 




3.2 Research aims 
This study aims to explore the perspectives and experiences of patients and HCPs 
with regard to patient involvement in decision-making in the management of T2DM 
in Malaysia.  
 
3.3 Research questions 
In the Malaysian healthcare system:  
1. How do patients and HCPs experience patient involvement in decision-
making for the management of T2DM? 
2. How do patients and HCPs view shared decision-making for the management 
of T2DM? 
3. What are the factors related to patient involvement in decision-making for the 
management of T2DM? 
4. How can shared decision-making be operationalised in the management of 
T2DM?  
 
3.4 The research paradigm 
A paradigm can be defined as “… the basic belief system or worldview that guides 
the investigator” (Guba & Lincoln, 1994: p. 105). In determining the paradigm of 
this study, thoughtful deliberation was carried out with regard to a number of critical 
considerations. This was done to ensure that the selected paradigmatic approach 
would direct the study to achieve its aims since the paradigm strongly influences the 
ontology, epistemology, theoretical perspective, methodology and methods of a 
study (Guba & Lincoln, 1994; Crotty, 1998; Lincoln & Guba, 2000).  
 
The first important consideration was that this is an exploratory study since its focus 
is on building an understanding of the meanings, along with their construction, that 
are ascribed to patient involvement in decision-making and shared decision-making, 
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which also typically further relates to the participants‘ attitude and behaviour in 
making decisions concerning the management of T2DM. Next, it is also crucial to 
acknowledge and incorporate the understandings and views of heterogeneous groups 
from different backgrounds that are directly involved in the management of T2DM 
so that the topic of interest can be explored holistically. Besides, as the act of 
decision-making in T2DM predominantly involves interaction between these groups, 
the social aspect of the meaning-making is also considered in depth.  
 
Since T2DM is a chronic health problem that requires patients to meet regularly with 
their HCPs in respect of its ongoing management and treatment, combined with the 
fact that HCPs meet different types of patients, it is common for the meanings 
ascribed by both patients and HCPs to change over time in line with new interactions 
and experiences. This forms another important consideration for this study. By 
contrast, this study also aims to identify the need for change so that 
recommendations for practice can be made accordingly. Lastly, an acknowledgement 
of my contribution to the study as the researcher is also relevant due to the fact that I 
was a nurse who previously managed inpatient T2DM patients. Despite having been 
involved in a slightly different context from that of this study, my background 
interest and position nevertheless had great potential to impact upon the study 
process. This is further explained in the Reflexivity section in 3.11.  
 
3.4.1 Paradigm, ontology and epistemology 
Based on the critical considerations presented in 3.4, the paradigm best suited to this 
study is constructivism. Constructivism is also predominantly chosen due to the 
alignment of its aims with the aims of this study. It allows the researcher to address 
the complexity of humans and their interaction with their social surroundings and 
environment (Miles & Huberman, 1994).  
 
This paradigm also acknowledges that there is no one absolute true reality, since 
reality is created through one‘s social, cultural and experiential process (Guba & 
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Lincoln, 1994). Multiple realities and meanings are put forward by the different 
individuals involved in the study with regard to certain situations, and these are 
extensively explored and valued in this paradigm (Creswell, 2008). This is also 
known as relativism, which serves as the ontology of constructivism (Patton, 2002; 
Creswell, 2008). The concept of having multiple realities fits well with this study as 
it embraces the contribution of participants from diverse groups so that a 
comprehensive understanding of how they view and understand social interaction 
and the world can be achieved. The participants in this study are not only situated at 
two different ends of the healthcare system, with patients as the receivers and HCPs 
as the providers, they also have different sociocultural backgrounds and stages of 
disease progression in the case of the former, and different roles in managing T2DM 
patients for the latter.  
 
The justification for selecting constructivism as the paradigm of this study is further 
strengthened as it supports the changes in patients‘ and HCPs‘ views on patient 
involvement in decision-making that occur over time. This is because T2DM is a 
chronic disease that requires patients to continually consult their HCPs. The 
advantage of using constructivism over other paradigms is that it enables further 
exploration of the implications of the cognitively and emotionally constructed 
meanings of the individuals with regard to their attitudes, actions and interaction 
with others and the world (Patton, 2002). This is again important in the context of 
T2DM as a chronic condition for which patients need to make decisions outside their 
consultation sessions with their HCPs.  
 
In preserving the complexity of the realities and meanings that emerge from the data 
collected, Creswell (2008) emphasised the importance of the role of the researcher in 
addressing these rich findings and not merely categorising the views into only a few 
themes. They have to go beyond this in order to gain a deeper and more extensive 
understanding of the topic being studied. This is also done to address the 
epistemological stance of the constructivist paradigm, which concerns the 




Despite the advantages it offers, constructivism has also been criticised for its 
exclusion of any critical sense of the construction of social and cultural meanings 
(Crotty, 1998), especially when compared to other research paradigms and 
epistemologies such as social constructionism and feminism. As explained earlier, 
the social and cultural element cannot be separated from this study as it is considered 
to be one of the main elements in the decision-making process due to the fact that it 
involves interaction between at least two people. Besides, critical sense in 
conducting empirical studies will guide researchers to comprehend and change the 
underlying orders of social life which commonly relate to power (Foucault, 1978). 
Thus, in addressing this issue, symbolic interactionism and the work of Bourdieu on 
practice and power relations were used to guide further exploration of these critical 
issues that were found to be greatly and inevitably related to the studied topic. 
Further explanation of these theories can be found later in this chapter.  
 
3.4.2 Theoretical perspectives: Interpretivism and symbolic interactionism 
3.4.2.1 Interpretivism  
In constructivism, people play an active role in the construction of meaning based on 
their interpretation of the social reality (Patton, 2002), and this is aligned with 
interpretivism. Based on the following description of interpretivism by Blaikie 
(2000), the adoption of this theoretical perspective assists in the building of a 
sophisticated understanding of the influence of the meaning and value attributed to 
social interaction and experience concerning patient involvement in decision-making 
and its related factors at the individual level.  
 
“Interpretivists are concerned with understanding the social world people 
have produced and which they produce through their continuing activities. 
This everyday reality consists of meaning and interpretations given by the 
social actors to their actions, other people‟s actions, social situation, and 
natural and humanly created objects. In short, in order to negotiate their way 
around their world and make sense of it, social actors have to interpret their 
activities together, and it is these meanings, embedded in language, that 




In addition, the role of the researcher in constructivism is not only as an information 
processor. As presented in the critical consideration of this study in the earlier 
subsection of 3.4.1, the researcher is acknowledged as the active generator and 
constructor of the context alongside the participants (Guba & Lincoln, 1994; 
Charmaz & Belgrave, 2014). This is similar to the roles played by researchers under 
interpretivism. Schwandt (1994) suggested that interpretivism is concerned with the 
contribution of the investigators to the process of meaning construction, in addition 
to being concerned with the method and matter of knowing and being of the people.  
 
3.4.2.2 Symbolic interactionism 
To further address the social construction of meaning, symbolic interactionism, as 
one of the primary strands of interpretivism, was chosen to further guide this study. 
The outcome of the decision to use symbolic interactionism in this study is evident 
throughout the Findings and Discussion chapters. 
 
Symbolic interactionism by Blumer (1969), which originally emerged from the work 
of George Herbert Mead (1863–1931), enunciates the close relationship that exists 
between the action of an individual towards people or situations and the meanings 
they ascribe to those particular people or situations; it cannot thus be isolated from 
the society and culture. Symbolic interactionism also focuses on language, thought, 
meaning, shared symbols and social acts (Boden, 1990). It can thus be seen that 
symbolic interactionism and constructivism complement each other as both 
emphasise the construction of the meaning and action of individuals, in addition to 
addressing the contribution of social interaction to the construction of social meaning 
(Blumer, 1969; Charmaz & Belgrave, 2014). Blumer (1969) also included words, 
gestures, rules and roles as the main symbols that are present and which play an 




The patient–HCP partnership is given as one of the most important elements in 
shared decision-making and also predominantly depends on the parties‘ engagement, 
relationship and interaction with each other during their encounters (Charles et al., 
1997; Coulter, 1997; Towle & Godolphin, 1999). In addition, the social reality and 
environment of both patients and HCPs contribute significantly to these meanings 
(Rapley & May, 2009). As quoted from Patton (2002: p. 132), the central question of 
symbolic interactionism is “… what common set of symbols and understandings has 
emerged to give meaning to people‟s interactions?” Thus, symbolic interactionism is 
particularly relevant in exploring the experience and meanings of patient 
involvement in decision-making as it allows the researcher to discover not only the 
meanings and interpretation that both patients and HCPs ascribe to their experience, 
interactions, actions and situations, but also how these meanings have developed 
differently in the Malaysian context by incorporating a different social and cultural 
background from that of the Western context, where shared decision-making has 
already been introduced to facilitate patient involvement. In addition, this theoretical 
perspective acknowledges ‗rituals in social life‘ (Crotty, 1998: p. 77), which are 
considered to be the common belief of the reality. This is especially important in this 
study as it will help me to make sense of the common belief in relation to the 
permissible acts within the study context.  
 
Decision-making in the management of T2DM as a chronic disease is an iterative 
process that involves long-term relationships and interactions between the patients 
and HCPs within the healthcare system. By using symbolic interactionism this 
phenomenon is properly addressed, as Blumer (1969) emphasises that meanings are 
moulded and modified over time by individuals‘ social interactions. One of the 
reasons that this happens is due to a change or improvement in individuals‘ capacity 
to interpret and construct social reality (Patton, 2002). Therefore, symbolic 
interactionism helps to form a deeper and more comprehensive understanding of the 
decision-making behaviour and views of both patients and HCPs, and its link with 
the above-mentioned concepts and symbols by Blumer (1969). Charmaz (1990) also 
asserts that symbolic interactionism triggers questions relating to why participants 
think, feel and act the way they do. ‗How do their constructions of the meaning 
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develop and change throughout their illness?‘ Charmaz also highlighted how 
symbolic interactionism is concerned with the contribution of one‘s beliefs, feelings 
and actions to these constructions, and the further consequences of these 
constructions. This further helps me to interpret and present arguments pertaining to 
the causal relationships among the data gathered on shared decision-making, which 
is considered to be one of the main aims of qualitative research (Mason, 2002). 
 
Nevertheless, symbolic interactionism is labelled as ‗pragmatism in social attire‘ 
(Crotty, 1998: p. 62), and this serves to further frame this study. Pragmatists believe 
that problems can usually be addressed by understanding the function of thinking in 
humanity‘s adjustment to the environment (Hammersley, 1989). It is also considered 
as ‗a tool for action‘, and from this perspective, there will always be an association 
between people‘s knowledge of the concept and its practicality in the real world 
(Cornish & Gillespie, 2009: p. 802). Thus, there should be a flow of research 
enquiries aimed at a resolution of the human problem, which in this case is the lack 
of effective management of T2DM and an understanding of the patients‘ and HCPs‘ 
perspectives of a new interventional model that may improve management of the 
disease. 
 
3.5 Research Methodology 
This study aims to explore and understand patient involvement in decision-making 
and shared decision-making since knowledge of this topic has not been extensively 
and fully developed, especially in the context of the management of diabetes in 
Malaysia. A direct adoption of the available Western model of shared decision-
making, which was introduced to facilitate the involvement of patients in decision-
making, will probably not be a good fit for the needs and situation in this study 
context.  
 
 A qualitative research method was considered to be the best design for this study as 
the objective is to explore the meanings that the participants ascribe to their 
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experience of involving patients in decision-making, their preferences, expectations 
of shared decision-making and the reasons behind these (Charles et al., 1999; Paley 
& Lilford 2011). This is also aligned with the paradigm chosen for this study. By 
using a qualitative method which is naturalistic in nature, the researcher is able to 
develop a deeper understanding of the topic of interest as it explores not only how 
the participants conceptualise patient involvement in decision-making and shared 
decision-making but also enables the researcher to identify the process and related 
factors and to discover unforeseen phenomenon (Maxwell, 1996; Patton, 2002).  
 
3.5.1 Qualitative research method 
Based on the symbolic interactionism view, in gaining an understanding of the 
meaning and experience of shared decision-making, the interpretations and meanings 
that the study participants attribute to their experience (actions and interactions) and 
the context need to be explored (Crotty, 1998). Thus, the chosen method should 
allow the researcher to hear the participants‘ points of view expressed in their natural 
context, with only minimal alteration of the study sites and no prior limitation of the 
output. The qualitative research method was thus chosen for this study as it helps to 
facilitate this kind of exploration (Lincoln & Guba, 1985; Bowling, 2009).  
 
Qualitative research has a history dating from the early twentieth century and rests 
on the epistemological bases of George Herbert Mead‘s symbolic interactionism and 
Florin Znaniecki‘s analytic induction. It became a new interest during the 1920s and 
1930s as researchers identified the need for a new method to explore human 
behaviour and thought, which are complex and irreducible to simplified and fixed 
patterns (Hammersley, 1989). These characteristics thus increase the suitability of 
the adoption of a qualitative research method in exploring the complex idea of 
patient involvement in making decisions related to the management of T2DM. In 
addition, Bowling (2009) also strongly recommends that qualitative researchers 
explore the cause-and-effect relationship of the topic of interest. This is because they 
have better access to the type of rich and in-depth information that is required, 
including people‘s experience, perceptions and opinions, feelings and understanding 
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and knowledge, despite the approach‘s lack of ability to test causal hypotheses. This 
is in parallel to the explanation of interpretivism by Bryman (2016) regarding the 
valuable contribution of the qualitative method in providing an interpretive 
understanding of causal explanations of human behaviour. 
 
Since its introduction, work has continuously been carried out on qualitative research 
methods not only to address the criticisms laid on them by other methods, but also to 
provide qualitative researchers with scientific or empirical guidelines. The basic or 
original qualitative research method itself has been labelled using other terms such as 
interpretive, basic (Merriam, 2009), generic and descriptive qualitative research 
(Sandelowski, 2000; Caelli, Ray, & Mill, 2003). This is due to the development of 
other methodological variants following the development of the original qualitative 
method throughout the years. Among the famous qualitative methodological variants 
discussed extensively by Creswell (2007) in his book Qualitative Inquiry and 
Research Design are grounded theory, narrative study, case study, ethnography and 
phenomenology. Nevertheless, due to its alignment with the main aims of this 
research and its epistemological basis, the basic or generic qualitative research 
method was chosen. However, for the purpose of this study, it is termed as an 
interpretive qualitative research method as this matches the theoretical underpinning 
of the study. The following subsections will further explain why this method was 
selected over other major qualitative research methods. 
 
3.5.2 The rationale for choosing the interpretive qualitative research method 
The interpretive qualitative research method was adopted for use in this study to 
assist me as the researcher in understanding patient involvement in decision-making 
as a whole. Supporting the epistemology and theoretical perspective of this study, the 
selection of the qualitative research method allows me to capture and interpret the 
subjective element of the participants. The overall interpretation of the data helped in 
exploring the participants‘ perspectives and practice in relation to shared decision-
making and how this is cognitively and emotionally constructed based on the 
attribute of their experiences and the world that they are in (Merriam, 2009). 
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Nevertheless, even though a range of quantitative instruments have been used to 
study patient involvement in decision-making, these instruments are likely capable of 
eliciting only limited information, and this may not be locally and culturally sensitive 
(Clayman & Makoul, 2009). The interpretive qualitative method enabled the 
researcher to hear directly from the patients and HCPs regarding their preferences 
and expectations of shared decision-making, and why these were important to them. 
 
The use of the qualitative research method, not underpinned by any specific 
philosophical framework such as grounded theory, ethnography or phenomenology, 
is also reasonable to use in exploring the topic of interest as it was proven to be 
useful in various studies with similar aims that were conducted in other contexts 
(Peek et al., 2008; Shay & Lafata, 2014; Jull, Giles, Boyer & Stacey, 2015). It has 
also proven to be valuable in exploring the possibility of different understandings of 
the concepts despite the existence of a significant number of available theories of 
shared decision-making (Lim, 2011). This is especially true where shared decision-
making has not yet been introduced, despite patients‘ involvement in deciding their 
T2DM management being encouraged and valued. This corresponds with the 
situation at all of the study sites. 
 
Nowadays, more and more research in the health and social science field employs a 
qualitative research approach that is not underpinned by any specific philosophical 
framework (Sandelowski, 2000; Caelli et al., 2003). The interpretive qualitative 
research method enabled the researcher to extract useful elements from the other 
variants that fit with this research at the same time as maintaining flexibility in 
answering the research questions in the context of the contemporary  
world (Kahlke & Hon, 2014; Bryman, 2016). However, this is opposed by Silverman 
(1994) who made the traditional assertion that different methods of qualitative 
research should not be specified as a general approach and combined freely. 
Nevertheless, according to Thorne, Kirkham and MacDonald-Emes (1997), the 
utilisation of a credible interpretive qualitative method is useful for developing 
clinical knowledge when it is combined with relevant health/nursing/medical science. 
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This clinical knowledge, which encompasses an understanding of how people view 
and experience the health problem, can be further used in the strategic development 
of measures for improvement. 
 
It is common for the interpretive qualitative method, which is also regarded as a 
basic qualitative method, to be labelled the „crudest form of inquiry‟ (Thorne et al., 
1997: p. 170) due to its lack of theoretical structure. However, according to 
Sandelowski (2000), there should not be a hierarchy when it comes to describing 
different types of methods as these methods are employed based on their potential to 
answer the research questions in hand. In dealing with this criticism, this study has 
employed elaborate theoretical foundations including constructivism and symbolic 
interactionism, as explained earlier in section 3.4. 
 
Despite grounded theory being one of the qualitative research methods that could 
have been used to address the research questions of this study since it aims to 
conceptualise social reality and its implication for human behaviour, its main focus is 
the development of a theory (Petty, Thomson, & Stew, 2012; Charmaz, 2014), which 
is not the main objective of this study. In contrast, as was laid out earlier in 
subsection 3.4.1, one of the main underpinning considerations of this study is to 
accurately represent the meaningful experiences and understanding of patients and 
HCPs. There is the potential for this not to be properly addressed using grounded 
theory as the data selected as being relevant to the development of the theory tend to 
be abstract in nature and are usually removed from the participants‘ accounts 
(Holloway, 2005). Compared to the theoretical sampling conducted in grounded 
theory with the aim of developing a theory (Glaser & Strauss, 1967), this study‘s 
purposive sampling method focuses more on the recruitment of diverse groups who 
are directly involved in the management of patients with T2DM. 
 
Nevertheless, in this study, the data were analysed concurrently during the data 
collection and constant comparison processes, a practice which is more common in 
grounded theory (Glaser & Strauss, 1967; Charmaz, 2014). This was carried out to 
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enable further exploration of the emerging themes at the same time as ensuring that 
all of the data collected were systematically compared to all of the other data in the 
data set and not overlooked (Pope, Ziebland, & Mays, 2000; O‘Connor, Netting, & 
Thomas, 2008).    
 
Another research method that is popular in qualitative studies looking at patient 
involvement in decision-making is ethnography. According to Hammersley and 
Atkinson (2007), ethnography can be described as an approach that “… involves the 
researcher participating, overtly or covertly, in people‟s daily living for an extended 
period of time, watching what happens, listening to what is said, and/or asking 
questions through informal and formal interviews, collecting documents and 
artefacts – in fact, gathering whatever data are available to throw light on the issues 
that are the emerging focus of inquiry” (p. 3). The adoption of ethnography is useful 
as it enables the observation of an interview with the participants to be conducted in 
their natural setting and the context in which the behaviours of concern are practised. 
However, the decision-making process involved in chronic health problems, 
including in T2DM, is not a one-off event but rather is distributed across people, 
places and time. This requires rigorous observation of not only multiple medical and 
health consultations but also the observation of patients‘ decision-making processes 
outside consultation times, yet this may be considered to be too intrusive to both 
patients and HCPs. Besides, the information needed to answer the research questions 
and to achieve the main objective of this study can be collected through in-depth 
qualitative interviews with heterogeneous participants, thereby avoiding any 
unnecessary disruption to the everyday lives of the participants.  
 
Case study is another qualitative research method that was reviewed for its potential 
as an approach for this study, as it aims to “… develop a complete, detailed portrayal 
of some phenomenon” in a particular context (Schwandt & Gates, 2018: p. 346). The 
researcher is required to collect data from multiple sources, including in-depth 
interviews, participant observation and document review, to achieve a 
comprehensive understanding of the participants‘ views and experiences. As 
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mentioned earlier in reference to the unsuitability of ethnography, this is not 
necessary for this study. Besides, similar to the assertion by Creswell (2007), it was 
difficult to identify the case/cases of this study, and this may have led to even more 
challenging implications in the later process of the research.  
 
3.6 Research methods 
This section describes in detail how this study was carried out. It includes the 
sampling strategy, data collection method, data analysis, ethical considerations and 
issues related to validity and reliability under the topic of rigour. 
 
3.6.1 Sites of the study 
This study was conducted at government-funded health facilities based on the fact 
that the majority of patients with T2DM in Malaysia attend these facilities for their 
T2DM management and follow-ups (Institute for Public Health, 2011). Two health 
clinics (SC and CC) and one medical specialist clinic (HC) at a hospital were 
selected. All of these health facilities are situated in the urban area of the Federal 
Territory of Kuala Lumpur and Putrajaya, which is centrally located in Peninsular 
Malaysia. These study sites were selected in order to meet the aims and objectives of 
this study within the time and resources available.  
 
Besides being located in urban areas, which are found to have a slightly higher 
prevalence of diabetes in comparison to rural areas in Malaysia (Letchuman et al., 
2010; Institute for Public Health, 2015), the sites were also selected for their ability 
to provide the maximum variation of participants. SC and CC are situated within 
high-density areas that are home to residents with a broad range of backgrounds and 
socio-economic characteristics. On the other hand, HC was chosen due to the status 
of the hospital as a tertiary endocrine referral centre, thereby enabling the 
recruitment of patients with different progressions of T2DM from those that could be 
recruited at the health clinics. Due to its status as a referral centre, HC primarily 
manages complex T2DM cases from other governmental health institutions, 
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including primary health clinics and other hospitals, private practitioners and walk-in 
patients that require more advanced and comprehensive management, in addition to 
its own T2DM patients discharged from wards. Patients with different backgrounds 
are referred from all over the area, and this makes a significant contribution to the 
study, not only by providing data for different layers of T2DM outpatient 
management but also by enabling the recruitment of patients from a wider range of 
sociodemographic backgrounds and T2DM progression and management. The 
inclusion of HC benefits this study as the outpatient management of T2DM in 
Malaysia also includes the hospital‘s medical/endocrine clinics. Its inclusion thus 
provides a greater and more comprehensive picture of the management of T2DM in 
the outpatient setting in Malaysia.  
 
There are differences in the management of T2DM across these different settings. SC 
and CC are among Malaysia‘s 1,060 public health clinics that serve as the first point 
of contact for health services in Malaysia. Both clinics are divided into two main 
divisions: an outpatient clinic (primary care service), and a maternity and child 
health clinic (maternity and child health service). Despite this, the clinics are led by 
one FMS, and both divisions share the same resources. Both SC and CC are 
equipped with basic imaging and laboratory facilities, and a pharmacy. The 
outpatient clinics receive new or walk-in cases, patients who have been discharged 
from hospitals and follow-up cases presenting with various medical problems. The 
management of T2DM at SC and CC is fairly similar and involves an FMS, medical 
officers, nurses, pharmacists and dietitians. Both of the clinics also have a diabetes 
team that is responsible for the organisation and management of any activities related 
to diabetes in the clinics. Compared to HC and CC, the management of T2DM in SC 
can be considered as basic, as it only recently moved to its current location. Despite 
having a diabetes team, it is yet to be fully functioning for the same reason. The 
diabetes-related programmes were still in the planning stage at the time the data 
collection for this study was carried out. Nonetheless, aside from a dietitian, there is 




At CC, besides having a staff nurse who is also the diabetes educator (referred to as a 
diabetes nurse educator in this current study), the clinic runs programmes aimed at 
improving the management of patients with diabetes, which is something not yet 
available at SC. These programmes include a diabetes management group 
comprising different HCPs who are responsible for the management of T2DM at the 
clinic. The group comprises an FMS, several medical officers, a diabetes nurse 
educator, a dietitian and several pharmacists. The programmes include group-based 
diabetes education and health education seminars. CC has also introduced 
personalised care to improve the management of patients with chronic disease, 
including T2DM. Under this scheme, T2DM patients see the same medical officer at 
each medical follow-up, thus ensuring continuity of care for their chronic illness.  
 
HC, as the specialist medical clinic in a hospital, sees the greatest variety of T2DM 
cases among the study sites and offers a wide range of services for these patients. 
Hence, more HCPs are involved in the management of T2DM at this site compared 
to the other study sites. These include endocrinologists, medical officers, diabetes 
educators (nurses and medical assistant), pharmacists and dietitians. In this clinic, 
endocrinologists manage diabetes patients together with medical officers. This 
hospital also provides diabetes consultation through their DRC. Four diabetes 
educators (three nurses and one medical assistant) are assigned to provide diabetes 
education and support for patients in managing their T2DM in their everyday life. 
The aim is for all new patients, especially those who are prescribed insulin, to be 
referred to this centre so that they can be equipped with the sufficient knowledge, 
skills and tools to carry out all of their T2DM self-management, especially insulin 
self-administration and self-monitoring of blood glucose. This centre receives 100 to 
200 patients each month (new and follow-up cases), 70% of whom are referred from 
the hospital‘s specialist medical clinic. Similar to SC and CC, this clinic and its DRC 
run an appointment-based system for the scheduling of patient visits. Follow-ups for 
the DRC are given to patients, ranging from every two weeks to monthly based on 
their ability to control their glycaemic level, whereas meetings with physicians take 
place ranging from every month to four to six months. Besides physicians and 
diabetes educators, patients are also referred to the dietitians, pharmacists and wound 
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management team for further diabetes counselling and consultation. Different 
activities and programmes are also organised at this site to support their diabetes 
patients, including an obesity clinic, group-based diabetes education and health 
education seminars. The variety of management of T2DM across the selected sites 
was useful for capturing a more comprehensive level of data for this study. 
 
3.6.2 Sampling strategy  
As the main aims of this study are to explore the views and experiences of T2DM 
patients and HCPs, the study used purposive sampling to recruit both patients and 
HCPs. This sampling technique is used widely in qualitative research as it enables 
the identification and selection of participants who are in a good position to provide 
rich information and in-depth insights into the area of interest and, most importantly, 
the research aims, and not merely for the purpose of generalisation.  
 
In addition, the adoption of purposive sampling enabled a diverse range of patients to 
be selected based on their social background (age group, gender, ethnicity and social 
classes) and T2DM characteristics (length of time diagnosed with T2DM, T2DM 
progression, trend of diabetes control, severity of T2DM and treatment trajectories). 
For the HCPs, this sampling method permitted different groups of HCPs within each 
facility to be recruited and represented (Bowling, 2009). Thus, the data from a 
heterogeneous sample could be explored, thereby increasing the richness of the data 
and enabling maximum variation of the participants and a comprehensive exploration 
of the topic of interest (Ritchie, Lewis, & Elam, 2003). Throughout the six months of 
data collection (November 2015–April 2016), a total of 43 participants with different 
backgrounds and roles in the management of T2DM in the study sites were 
successfully interviewed. A further breakdown of the participants is given in 




3.6.2.1 Recruitment of the patients 
The records of patients who attended their medical appointments during the data 
collection period were reviewed. Discussion was held with the HCPs, who serve as 
the immediate gatekeepers of the patients, thus ensuring the eligibility of the patients. 
Some of these gatekeepers also put forward a number of recommended patients as 
they had already been briefed on the details of the study and the inclusion and 
exclusion criteria. The patients‘ records were further reviewed to ensure their 
eligibility and fit with the needs of the research.  
 
The patients were selected based on the inclusion and exclusion criteria listed below: 
Inclusion criteria: 
 Patients with T2DM 
 Patients aged 18 years and above 
 Patients who are able to communicate in Malay or English 
 Patients who are willing and able to provide informed consent 
 Patients who are willing to discuss and share information.  
 
Exclusion criteria (determined from a patient‘s records or discussion with the 
gatekeeper): 
 Patients determined as having a cognitive impairment or learning disability 
through discussion with the HCP in charge 
 Patients with a diagnosis of depression that had a high possibility of being 
exacerbated through their participation in the interview 
 Patients with type 1 diabetes mellitus 
 Patients below 18 years of age 
 Patients not fluent in either Malay or English 
 Patients who were not willing to provide informed consent 




The selected eligible patients were subsequently approached individually, and an 
explanation of the study was provided. A participant information sheet was 
distributed during this initial briefing session. The contact details of the potential 
participants were obtained, and they were contacted within 24 hours to enquire as to 
their willingness to participate in this study. A cooling-off period of 48 hours was 
given to the potential participants to provide them with an opportunity to reflect on 
their decision. For those who agreed to participate, the interview session, date, time 
and venue were arranged based on the participants‘ availability and convenience. 
Nonetheless, almost all of the patients who agreed to participate preferred to be 
interviewed on the same day that they indicated their willingness to participate. 
Informed consent was obtained from the participants prior to the interview session. 
Figure 4 provides a summary of the recruitment strategy for the patients. At the end 
of the data collection stage, 7 patients from SC, 7 from CC and 10 from HC, thus 
making a total of 24 patients, were successfully interviewed. Further details about the 

















Figure 4: Recruitment strategy of patients 
 
Reviewing patients’ 
medical records  
Discussing patients’ eligibility 
to participate with the HCPs 
Approaching the potential 
eligible participants  
Recommendation by 
the HCPs  
Reviewing patients’ 
medical records  
Participants: 




Table 2: Characteristics of T2DM patients 
Participants‘ 
ID 















PT2 SC 61 Male Indian PhD 10 years Insulin 
Actrapid, Oral 
Metformin  
PT3 SC 70 Female Malay Standard 
4 primary 
school 
15 years Insulin 
Actrapid 
PT4 SC 62 Female Chinese Standard 
4 primary 
school 
4 years Oral 
Metformin  
PT5 SC 71 Female Indian Form 3 
secondary 
school 
6 years Oral 
Metformin  
PT6 SC 54 Female Malay Form 3 
secondary 
school 
10 years Insulin 
Actrapid 
PT7 SC 47 Female Malay Form 3 
secondary 
school 










PT9 HC 70 Male Malay Bachelor 11 years  Insulatard 








































PT15 CC 59 Male Malay Form 3 
secondary 
school 
15 years Oral 
Metformin, 
Glibenclamide 
PT16 CC 57 Male Chinese Bachelor 4 years Oral 
Metformin, 
Glibenclamide 









1 year Oral 
Metformin, 
Gliclazide 




10 years Oral 
Metformin, 
Gliclazide 








PT21 CC 66 Male Malay Standard 
3 primary 
school 

















PT22 HC 34 Female Malay Diploma 4 years Insulin 
Mixtard 



















3.6.2.2 Recruitment of the HCPs 
A series of meetings was held with the unit managers/administrators, and a list of 
recommended professionals who are actively involved in the making of decisions in 
relation to the management of T2DM patients was obtained. This list included nurses, 
who make up the majority of the diabetes educators, a medical assistant, who is also 
a diabetes educator, dietitians, a nutritionist, pharmacists, medical officers, 
consultants and a specialist. The sampling was done to ensure that each HCP group 
was represented. The potential HCPs were approached individually. Details 
regarding the study were explained and an information sheet was provided for their 
reference. Additionally, the same time frame of 24 hours was given for them to 
consider their participation, along with a 48-hour cooling-off period. Similar to the 
procedure with the patients, for HCPs who agreed to participate, the interview 
session, date, time and venue were arranged based on their availability and 
convenience. Informed consent was obtained from those who agreed to participate. 
Figure 5 contains a summary of the recruitment strategy for the HCPs, and a total of 
19 interviews were conducted with HCPs. Table 3 provides the characteristics of the 

















Meeting with the administrator:  
Presentation of topic and proposal. Obtained a 
list of recommended HCPs to be recruited 
Approaching the potential participants  
Participants: 
7 physicians (2 endocrinologist, 1 specialist 
and 4 medical officers), 
 5 nurses (1 nurse-in-charge and 4 diabetes 
educators), 
 3 dietitians,  
2 pharmacists, 





Table 3: Characteristics of HCPs 
Participants‘ 
ID 
Establishment Age Gender Ethnicity Occupation Years of 
working with 
T2DM 
HCP1 SC 55 Female Indian Staff nurse 20 years 
HCP2 SC 28 Female Malay Nutritionist 2 years 
HCP3 SC 25 Female Chinese Pharmacist 2 years 
HCP4 SC 28 Female Malay Dietitian 3 years 
HCP5 SC 33 Female Malay Medical officer 3 years 
HCP6 HC 38 Female Malay Diabetes nurse 
educator 
6 years 
HCP7 HC 35 Female Malay Diabetes nurse 
educator 
6 years 
HCP8 HC 44 Female Malay Diabetes nurse 
educator 
10 years 
HCP9 CC 31 Female Chinese Pharmacist 8 years 
HCP10 CC 29 Female Malay Dietitian 6 years 
HCP11 CC 28 Female Malay Medical officer 1 year 
HCP12 CC 39 Female Indian Medical officer 2 years 
HCP13 CC 37 Female Malay Diabetes nurse 
educator 
5 years 
HCP14 HC 30 Male Malay Medical assistant 
(Diabetes educator) 
1 year 
HCP15 CC 47 Female Indian Family medicine 
specialist 
10 years 
HCP16 HC 34 Female Malay Dietitian 10 years 
HCP17 HC 33 Male Chinese Medical officer 8 years 





Establishment Age Gender Ethnicity Occupation Years of 
working with 
T2DM 
HCP19 HC 50 Female Malay Endocrinologist 20++ years 
 
3.6.3 Data collection method 
3.6.3.1 In-depth interviews  
The main aim of the study is to gain an understanding of human beings in their social 
environment, which was achieved by exploring the views and experiences as 
perceived by the people involved in the management of T2DM. In alignment with 
this aim and the philosophical stance of this study, in-depth interviewing was 
considered to be the best method of enquiry (Mason, 2002; Brinkman, 2018).  
 
“What is distinctive about interpretive approaches, however, is that they see 
people, and their interpretations, perceptions, meanings and understandings, 
as the primary data sources. Interpretivism does not have to rely on „total 
immersion in a setting‟ therefore, and can happily support a study which uses 
interview methods for example, where the aim is to explore people‟s 
individual and collective understandings, reasoning processes, social norms, 
and so on.”  (Mason, 2002, p. 56) 
 
The in-depth interview also provided the opportunity for me to probe and question 
extensively in response to each participant and their individual experience, 
perspective, behaviour and context (Arthur & Nazroo, 2003). Based on Blumer's 
(1969) enunciation of symbolic interactionism, humans‘ perceptions and the 
meanings that they attach to their experience change over time. This is more 
significant in this study due to the fact that a decision relating to the management of 
T2DM as a chronic health condition is not a one-time event (as mentioned earlier in 
section 3.5.2). Thus, an in-depth interview was considered to be the best means of 
capturing all of the information required by this study as it enabled a comprehensive 
and detailed exploration based on not only one particular time, which would serve to 
limit the observation. Compared to a focus group discussion, the in-depth interview 
was more useful for this study as it allowed for an exploration of the key issues 
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among all of the participants in addition to a discussion of sensitive issues, which is 
very significant to the topic of decision-making (Kaplowitz, 2000).  
 
Face-to-face interviews were conducted with the patients in either a private 
room/area at the respective clinics or at another location near to the clinics, as per the 
wish of the patients. The HCP interviews were conducted either at their office or a 
private room at the respective clinics, based on availability. Prior to the interview 
and after written consent had been obtained, details about the participants were 
collected. A separate form was used to record all of the required details, which was 
important in analysing and understanding the data. Different forms (Appendix 5) 
were used for the patients and HCPs, as different details were required for each of 
these two groups. Each interview was also audio-recorded with the permission of the 
participant. Two devices were used to record each interview in the event that one did 
not work as planned. The interviews were conducted in either Malay or English 
based on the participants‘ preference and lasted for between 30 and 90 minutes. 
 
For this study, face-to-face in-depth interviews were conducted with the participants 
based on the topic guide, as given in Appendix 5, to ensure that the relevant issues in 
regard to the studied social phenomenon were covered and the research questions 
were answered (Arthur & Nazroo, 2003). The interview guide was created based on 
the key elements as listed in the integrated model of shared decision-making by 
Makoul and Clayman (2006). Basically, all of the participants were asked about their 
experience of the decision-making process, their role in determining their 
management and their views and expectations of shared decision-making. The 
interviews employed open and broad questions in relation to the overall perspectives 
of the participants from their subjective accounts. Aside from this, the interview 
sessions were conducted in a sufficiently flexible manner to allow the key topics and 
issues to be covered in the order most suited to each participant, thereby allowing the 
participants‘ responses to be fully explored and the researcher to be responsive with 
regard to unanticipated issues raised spontaneously by the participants, in addition to 
enabling any new issues to emerge (Arthur & Nazroo, 2003).  
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3.6.3.2 Interview transcriptions  
Although verbatim transcription of audio recordings can be considered as a 
straightforward task (J. Bailey, 2008), the transcribing of 43 interview recordings 
was also a time-consuming process. Thus, the process was carried out by me with the 
help of two other hired transcribers. However, to ensure accuracy and to provide 
context to the transcriptions carried out by the transcribers, I carefully listened to the 
recordings again and compared them to the transcriptions. This re-listening of all of 
the transcriptions was crucial in enabling me to become familiar with the data and to 
pick up on any details that had been missed during the transcribing process.  
 
3.6.3.3 Translation  
A total of 32 out of the 43 interviews (74.4%) were conducted in Malay, with the 
remaining 11 in English. According to Wong and Poon (2010), there has been a lack 
of debate on translation issues in cross-cultural qualitative research in general, not to 
mention, more specifically, on the appropriateness of the translating method used in 
the study. However, the decision was made to translate all of the Malay 
transcriptions into English prior to the detailed analysis process being carried out. All 
analysis was done of the English transcripts. This was primarily because it allowed 
me to share the translated interview transcriptions with my non-Malay-speaking 
supervisors. This sharing was imperative in order to increase the credibility of this 
qualitative study, as suggested by Creswell (2007). This is especially crucial given 
the fact that I am a novice qualitative researcher and have required close guidance by 
the supervisors in analysing the collected data and to assist me in not missing any 
useful details. In addition to the 11 interviews in English, the interviews conducted in 
Malay were rich in information and also worth sharing with the supervisors, thus 
reinforcing the decision to translate the Malay interviews into English. Equally, it has 
to be acknowledged that the conducting of analysis in only one language can reduce 
any risk of confusion as it results in the use of codes in only one language.   
 
In comparison with the transcribing process, I opted to translate all of the Malay 
transcriptions into English myself, as I am familiar with both of the languages. 
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Despite being as time-consuming as the transcribing process, this decision was made 
as I realised that an appointed professional translator may not be able to accurately 
capture the true meaning of the language used by the participants merely from the 
transcriptions (Harrington & Turner, 2000). In addition, having only one translator in 
a study can ensure consistency of translation, thereby ultimately increasing the 
reliability of the translated documents (Twinn, 1997). It is also believed that having 
all of the Malay transcripts translated by myself, as the person who conducted all of 
the interviews, helped to ensure better translation, especially when words or phrases 
could be translated in several different ways or where there was no direct English 
translation. The translating process also helped me to become more immersed in and 
closer to the data. Nikander (2008: p. 226) emphasised that “… practical 
compromises are typically made between the ideals of faithfulness to the original, the 
readability and accessibility of the final transcript, as well as time and space issues”. 
In addition, this study does not employ discourse analysis, where the concern is very 
much focused on the language. 
 
Nevertheless, a number of measures were taken to ensure the trustworthiness of the 
translated texts. The structure of the patients‘ speech in Malay was maintained as far 
as possible to ensure there was no alteration to the meaning. A further step taken to 
preserve the trustworthiness of the study was to maintain a fluid description of those 
words that did not have an exact equivalent in English (van Nes, Abma, Jonsson, & 
Deeg, 2010). For these words, the Malay word or phrase was included immediately 
after the translated word or phrase to enable it to be easily referred to if needed. The 
translated text was also positioned in the box next to the original Malay text up to the 
end of the analysis stage in a bid to reduce the possibility of misanalysing, following 
a recommendation by Nikander (2008). In a bid to further reduce bias, the translated 
texts were also shared and discussed with two other qualitative researchers who 





Notes detailing the session were also documented for each interview. These included 
information about the physical setting of the sessions, details of the interaction 
during the interviews and reflections on the information received in the sessions 
(Patton, 2002). However, this information was not analysed; instead, it was used as a 
reflexivity tool to assist in the data analysis as it helped to recall certain events that 
were important and was also helpful for planning the subsequent interviews (Patton, 
2002). Even though the data analysis of this study was done concurrently, the notes 
from the previous interviews helped me to plan ahead for my next interview.  
 
3.7 Data Analysis 
Qualitative data can be analysed in many ways, including thematic analysis, 
framework analysis, discourse analysis or narrative analysis. The data in this study 
were analysed using thematic analysis with the incorporation of the constant 
comparative method. The data analysis for this study was conducted while the data 
collection was still in progress. This helped my thinking process to revolve around 
the existing data and prevented me from amassing huge volumes of superficial data. 
The following data collection was carried out based on the strategies that were 
generated from the earlier data analysis, which allowed for the gaps in the data to be 
filled (Miles & Huberman, 1994). 
 
3.7.1  Thematic analysis 
Thematic analysis was used in this study as it allowed the researcher to 
systematically identify common meanings and patterns within the data collected 
from a significant number of participants, which then resulted in the emergence of 
themes (Sandelowski, 2000; Guest, Macqueen & Namey, 2012). Thematic analysis is 
an analytical approach that is commonly linked to generic qualitative study. It is 
considered to be one of the most frequently used methods of analysis in qualitative 
study as it offers wide-ranging flexibility (Braun & Clarke, 2006) despite the claim 
that it lacks ‗identifiable heritage‘ (Bryman, 2016: p. 584) and transparency (J. Smith 
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& Firth, 2011). Loffe and Yardley (2004) further highlight how the strengths of 
thematic analysis lie in its combination of the systematic treatment of data, the 
development and refinement of themes and the possibility of contextualising them. 
Besides, this type of analysis also shares the inductive qualities of grounded theory 
but does not necessarily lead to the creation of a theoretical model, which is not the 
aim of this study (Guest et al., 2012).  
 
All of the above-mentioned reasons reinforced the decision to use thematic analysis 
over other types of analysis such as phenomenological analysis, which has the aim of 
capturing the uniqueness of the participants‘ narratives as co-constructed with the 
researcher, or discourse analysis that focuses on the use and meaning of language, 
which was not congruent with the main aim of this study (Patton, 2002; J. Smith & 
Firth, 2011). 
 
The thematic analysis in this study involves six phases of analysis based on Braun 
and Clarke (2006), and these are illustrated in Table 4. A further explanation 
concerning the adoption of this method for analysing the study data is given in 3.7.3. 
 
Table 4: Flow of thematic analysis method (Adopted from Braun and Clarke, 2006) 
No Stage Description of the process 
1. Familiarisation Transcribing data, translating the Malay 
transcription, repeated reading of the data and 
identification of initial ideas 
2. Generation of initial codes The data were gathered into codes, which 
were generated systematically during this 
stage 
3. Search for themes The generated codes were then gathered to 
identify the emerging themes 
4. Reviewing the emerging 
themes 
The themes were checked to ensure their 
relation to the coded extracts and the entire 
data set to generate a thematic map 
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No Stage Description of the process 
5. Defining and naming the 
themes 
The themes and overall story that the analysis 
tells were further refined to generate clear 
definitions and names for each theme 
6. Producing the report The final stage comprising the selection of 
vivid, compelling examples relating the 
analysis back to the research question and 
literature to produce a scholarly report of the 
analysis. 
 
3.7.2 Constant comparative method 
In ensuring that all of the data were analysed and systematically compared with all of 
the data in the data set, constant comparative analysis was carried out in conjunction 
with thematic analysis (Lincoln & Guba, 1985). The use of constant comparison 
means that patterns across and variation between the participants‘ accounts can be 
determined (Glaser and Strauss, 1967). Although Glaser and Strauss (1967) describe 
the main purpose of the constant comparative method as the construction of a theory 
from the ground up, the method was employed despite this not being the main aim of 
the study as it helped to provide an explanation and perspective of the behaviour of 
the participants in their natural environment (Glaser & Strauss, 1967; Thorne, 2000). 
In addition, according to Charmaz (2014), constant comparison can help the 
researcher assess how each participant in the study understands their situation.  
 
Fram (2013: p. 20) argued that the adoption of constant comparison outside 
grounded theory is beneficial to “… maintain the emic perspective and how 
theoretical frameworks maintain the etic perspective throughout the analysis”. In-
depth interviews provide thick description from the participants, who are also known 
as insider(s). This served as the emic perspective in this study and was maintained by 
using constructivism, plus symbolic interactionism, as the foundation of the 
qualitative study. The integrated shared decision-making model by Makoul and 
Clayman (2006) was used to explore the patients‘ involvement in decision-making 
versus the existing models that are beneficial in encouraging this in practice. 
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Bourdieu‘s work on practice and power relations was used as an interpretive 
theoretical framework for exploring those factors that had a relationship with the 
related behaviours at the abstract level (Charmaz, 2006). Both of these were used to 
maintain the etic perspective in my study and enabled me as a novice researcher to 
explain and discuss the social phenomena of the study (Fram, 2013). The value and 
support of a theoretical framework and literature review to empirical qualitative 
research is also emphasised by Charmaz (2006; p. 165), outlined as helping the 
researcher to position their findings in the existing knowledge and also to determine 
how their findings can ‗extend, transcend, or challenge‘ the main ideas in the field of 
study. 
Contrary to the traditional assertion by Glaser and Strauss (1967) in terms of 
describing a constant comparison regarding literature exploration, in this study the 
literature review commenced at the beginning of the research project. The carrying 
out of a review of the literature both before and during the data analysis helped me as 
a novice qualitative researcher not only contextualise the study within the existing 
knowledge and but also to further explore the topic of interest by looking at the 
cause-and-effect relationship or ‗mutual shaping‘ of the interactions and actions 
related to patient involvement in decision-making (Lincoln & Guba, 1985; Strauss & 
Corbin, 1990; Creswell, 2007). However, in maintaining my openness to the 
emerging themes, the theoretical framework which served as the analytical tool for 
this study was determined in the middle of the data analysis, based on the findings 
that emerged from the inductive analysis of the data. According to Charmaz (2009), 
this analysis is known as abduction in the constructivist framework. 
 
This study follows Lincoln and Guba's (1985: p. 340) adoption of Glaser and 
Strauss‘s constant comparative method in the exploration and construction of 
relationships from data, a process also known as „mutual shaping‟. Lincoln and Guba 
(1985) acknowledge Glaser and Strauss‘ four steps of constant comparative analysis: 
comparing incidents applicable to each category, integrating categories and their 
properties, delimiting the theory, and writing the theory. However, similar to this 
study, their implementation of constant comparison does not include the theory 
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development steps and is limited to the data processing aspect of constant 
comparative analysis.   
 
3.7.3 Integration of thematic analysis and constant comparative analysis 
As the data collected in a qualitative study are thick and rich, I need to be familiar 
with all of the data sets. As such, data analysis commenced with me repeatedly 
listening to the audio recordings and re-reading the interview transcripts so that I 
could be immersed in all of the data that I had collected (Braun & Clarke, 2006). 
This was done for all of the data sets of both patients and HCPs concurrently. Apart 
from that, I also verbatim transcribed almost half of my interview recordings, re-
reading and comparing the transcripts against the original audio recordings, and 
translated all of my Malay transcripts into English. Despite being time-consuming 
tasks, all of these were crucial in further facilitating me to become familiar with the 
flow of the data and to identify common similarities or differences and to discover 
the potential patterns that could be generated (Bowling, 2009; Braun & Clarke, 2006). 
Thus, during this stage, notes were taken on the theoretical and methodological 
memos, and also my personal insights, so that they could be referred back to in the 
later stages of the study. As the study‘s data analysis was carried out concurrently 
with the data collection, some changes were made to the interview topic guide based 
on the analysis of data that had been carried out earlier. These included further 
explanation of the topic and inclusion of the new topics that had emerged from the 
previous interviews. 
 
Initially, I planned to analyse the data sets from the patients and HCPs differently, 
believing that the experiences discussed by the patients and HCPs would be different. 
However, as I interviewed the patients and HCPs and became familiar with the data 
from both groups, it became apparent that most of the time there was an element of 
crossover within the respective discussions. For example, the HCPs‘ experiences and 
perceptions were drawn from a wide range of experiences involving different 
patients requiring discussion about different decisions based on their T2DM problem. 
Similarly, the patients also described their experiences of dealing with different 
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HCPs in managing different problems related to their T2DM. As a result, in many 
instances, the data from both groups generated similar, if not the same, codes. In 
addition, since the interviews with both of the groups were conducted concurrently, it 
was reasonable for the data analysis that was started during data collection to be done 
concomitantly. Thus, the decision was made to merge the analysis for the patients 
and HCPs. 
 
Next, line-by-line coding was carried out for the entire data sets using NVivo 10. 
This was done with the intention of condensing and labelling the data so that they 
could be organised in a more systematic and meaningful way (Saldaña, 2010). Each 
unit of data was labelled with a unique code, with most of the codes being used 
repeatedly in the analysis of other data sets as all were found to contain common 
areas of discussion. According to Braun and Clarke, (2006: p. 88), “… coding will, 
to some extent, depend on whether the themes are more „data-driven‟ or „theory-
driven‟”. The coding began in a more data-driven manner as the entire content of the 
data sets was coded. By doing this, all of the data sets from all of the participants 
were given equal attention and repeated patterns were identified across the data. Yet, 
as Makoul and Clayman‘s (2006) integrated shared decision-making model was used 
as the base model of the shared decision-making approach in this study, some of the 
related data were coded around some of the elements that were listed in this 
integrated model. Due to this, in many instances, one unit of data was given more 
than one code, which Braun and Clarke (2006) describe as a common occurrence. 
Throughout the coding process, the data sets and codes were shared with the 
supervisors for review. This was done to support the trustworthiness of the study 
process and the emerging findings, as discussed in subsection 3.10.3. 
 
Constant comparison was carried out in all stages of the data analysis. It was done in 
a recursive manner, moving back and forth between the emerging codes and the data, 
and between the newly emerging codes and the previous codes. By doing this, 
similarities, differences and salient patterns were identified within the data. Similar 
codes addressing similar concerns were then grouped together under one category or 
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theme. The continuous comparative process further helped me to maintain my emic 
perspective of the data at the same time as triggering and guiding me to find the 
description and characteristics of the categories (Lincoln & Guba, 1985). This is 
described as the step of integrating the categories, which are referred to as themes in 
this study, with their properties.  
 
Based on the thematic analysis, the analysis of the data progressed as the themes 
were identified, reviewed and named (as described in Table 5). Table 5 provides an 
example of the themes that emerged from the codes. In this study, the properties 
were identified and their connection with the themes was explored and built based on 
the participants‘ narratives (constant comparative analysis), theoretical memos and 
also from the existing literature (Fram, 2013; Charmaz, 2014). The theoretical 
memos are the records of my analytical thinking that facilitated me in making 
connections between the abstract ideas for the gathered data and the concrete details 
of the evidence. This is in line with the assertion by Glaser and Strauss (1967) that 
memo writing is necessary in the constant comparative method in order to build a 
description and interpretation of the emerging themes. As such, the memo is crucial 
in tracking the development of the relationship between the ideas or themes and also 
to uncover the properties of the themes (Roulston, 2008). Thus, by engaging in 
theoretical memo writing during the data analysis phase of this study, an integrated 
understanding of the empirical data obtained from the interview sessions could be 
developed and the relationship between the categories could be examined. At this 
point, I attempted to generate my initial thematic maps as a visual representation of 
my interpretation of the data, with the maps being continually modified and updated 
as the data analysis progressed.  
 
However, my supervisors and I then established the need for a social theory to 
further facilitate my analysis and help me make sense of the data. This theory would 
serve as my theoretical framework and enable me to conduct deeper exploration of 
the characteristics of the emerging themes and produce a better explanation of the 
association not only between the themes and their characteristics but also between 
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the overall themes. After much consideration, Bourdieu‘s work on practice and 
power relations (further explained in section 3.7.4) was chosen for use as a 
theoretical framework to further analyse the data due to its compatibility with the 
emerging themes and also with symbolic interactionism as the theoretical perspective 
of this study. Subsequently, all of the data sets, codes and themes, and their 
properties, were again reviewed and compared in a more theory-driven approach, so 
that a cohesive explanation could be produced for the mass of data that had been 
collected.  
 
Furthermore, even though the analysis of the data from the patients and HCPs was 
conducted at the same time and not separated, any similarities and differences were 
presented and discussed in the subsequent Findings and Discussion chapters. This 
was done with a selection of quotes representing both the patients and HCPs so that 
the presentation and discussion of the data was carried out not only on an individual 
and also a larger collective basis, but also to enable opinions from both groups to be 
presented and discussed in a more meaningful way, which is parallel to the 
theoretical underpinning of this study. Despite the fact that both groups discussed 
most of the categories, occasional categories included extracts from only one group, 
as only that group had spoken about it. Subsequently, further discussion on the 
reason for this occurrence was entered into. All of this material can be found in the 
following Findings and Discussion chapters. As qualitative research is very much 
concerned with the preservation of the natural language of the participants, I tried not 








Table 5: An example of emergent themes from codes 
 
Transcripts Codes Theme 
―But sometimes…for example for SMBG, actually they have to do it 
everyday but because of the cost, every strip cost RM 2, so it depends to the 
patients. It would be enough if they can do it 3 times per week.‖ HCP8 








―Yes, maybe because they are afraid of renal failure and all. They get that 
from surrounding and not from our medical practitioner. When they tell us 
that, we‘ll try to convince them back. All the medication that been prescribed 
and provided by MOH are tested and researched ones, and it‘s already been 
approved and proven. Furthermore, we‘ll do blood test and if the medication 
is not suitable for them, we‘ll discontinue it and change to other available 
medication.‖ HCP14 
Justifying the 
recommended option by 
medical evidence 
―And what i do sometimes is the one that is 50-50 whether they   want to take 
it or not, I try to bargain with them, "okay, aunty, I'll give like 2 weeks you try 
first, and if you can't do it, it's fine I'll off it and we can again some other 
time.‖‖ HCP5 
Convincing patients to 
try the recommended 
option 
―Actually about the suggestion by the private doctor, I did ask the doctor here, 
―can I try this medication?‖ He said okay, if I am brave enough to try. Try it 
for one month, and see whether it will help or not, and if not, I should stop.‖ 
PT24 
HCPs allowing patients 







3.7.4 The background to Bourdieu’s writing on practice and power relations 
The preliminary analysis of the collected data resulted in the identification of several 
key aspects in relation to the patients‘ involvement in decision-making. These 
included the characteristics of the patients and HCPs, social and cultural aspects, and 
patient–HCP power dynamic/power relations. At this point, I began to look for 
existing literature to serve as a conceptual analytical tool in navigating the complex 
data, so that all of the key aspects could be further explored in more detail. A 
qualitative research method is a method that allows pragmatic consideration in 
addressing the issues of uncertainty in conducting research (Patton, 2002). Thus, the 
decision to adopt Bourdieu‘s work during the analysis process is acceptable in 
qualitative research as it is believed that it will generate outcomes that are more 
meaningful as it helps the researcher to “… move beyond basic description to in-
depth description, interpretation and explanation” (Kelly, 2009: p. 286). 
 
3.7.4.1 Habitus, capital and field 
Habitus 
Habitus is one of the most prominent and multi-layered concepts introduced by 
Bourdieu. In his book Outline of a Theory of Practice, habitus is defined as: 
 
“… the durably installed generative principle of regulated improvisations, 
produces practices which tend to reproduce the regularities immanent in the 
objective conditions of the production of their generative principle, while 
adjusting to the demands inscribed as objective potentialities in the situation, 
as defined by the cognitive and motivating structures making up the habitus.” 
(Bourdieu, 1977: p. 78)  
 
It can thus be summarised that an individual‘s attitude, perceptions, beliefs and 
knowledge are generated through principles or dispositions known as habitus that is 
moulded by past history and experience, thought process and motivation. This 





and durable principles, habitus can be changed or fixed, although this does not 
happen easily. Adjustment will occur as needed in a situation or over a long period of 
time as the situation or the world evolve (Navarro, 2006). Both embodiment and 
adjustment occur without being noticed by individuals, and they are often ignored. 
Habitus is also inclined to govern an unconscious practice as the objective 
potentialities subdue conscious calculation (Bourdieu, 1990). It has been used to 
form an immediate plan of action when facing a probable future. This plan will serve 
as guidance for things to either do or not do, or to say or not say, in generating the 
desired results.  
 
People as agents are also tied to their social world, as habitus is ‗the internalisation of 
externality‘ and ‗the externalisation of internality‘ (Bourdieu, 1977; Bourdieu, 1990). 
It is common for individuals from the same social class to have similar practices as 
they tend to share the same basic notions and principles (including social norms, 
rules, obligations and laws), which often serve to standardise the way they think, feel 
and respond (Von Scheve & Von Luede, 2005). A similar background history or 
objective conditions among a social class serve to form a unitary objective meaning 
among its members. The personal preference and style of each social member are 
collectively generated for these reasons. As a result, it is often the case that an 
individual‘s personal intention and practice are taken for granted (Bourdieu, 1990). 
Nevertheless, for these reasons, Bourdieu denied that homogeneity of practice is a 
product of obedience.  
 
Field 
Besides habitus, field is another concept that is taken into account as it provides a 
current context, structure and/or practical sense to habitus, which results in a more 
relevant practice (Bourdieu & Wacquant, 1992). Bourdieu‘s work on the notion of 
field began with his discussion of the social structure and class which are located in 
the field (LiPuma, 1993). The social structure in the field consists of positions 
occupied by social agents. There are internal and power dynamics within social 





positions in the field. Consequently, fields, according to Bourdieu, are hierarchical 
(Grenfell, 2014). Bourdieu also made the assertion that the members of a certain 
class often strategise in order to maintain or improve their position in the field, as a 
field is a common site of struggle and dispute (LiPuma, 1993; Collyer, 2015). 
Additionally, Bourdieu identifies social agents‘ sense of ‗feel for the game‘ that 
becomes second nature to them (Bourdieu, 1990). These may be the underlying 
reasons for the dominant role taken by some of the HCPs in making decisions 
regarding their T2DM patients‘ management.  
 
Nonetheless, Bourdieu emphasises the contribution of social agents in prescribing 
their practices even when they are within the above-described hierarchical social 
field (Bourdieu, 1977). Bourdieu also believed that habitus and field are interrelated; 
for example, not only that the rules in the field can influence social agents‘ habitus, 
but also that the ‗feel for the game‘ commonly evolves as a result of a change in the 
embodied experience of the social agents (Bourdieu, 1993). 
 
Capital  
It is often the case that the social position of the agents in the field is based on their 
possession of capital, which is something that will usually take a lot of time and 
effort to build, especially in the case of social and cultural capital. Capital has a 
direct association with power relations that will determine the practice of the agents 
together with their habitus and field. It is described by Bourdieu (1986: p. 46) as “… 
a force inscribed in objective or subjective structure” and “… the principle 
underlying the immanent regularities of the social world”. Bourdieu broadened the 
existing concept of capital at that point, which up to then had focused mainly on 
economic capital, by introducing social, cultural and symbolic capital. However, 
these resources will only become valuable if the society/group in the field value them 
collectively and they ultimately provide a significant advantage in the form of power 
and dominance to those individuals or groups who hold them (Bourdieu, 1998; 
Grenfell, 2014). Besides interacting with habitus within the field boundaries, it is 









Economic capital is the longest-standing source of power and domination. It refers to 
tangible assets, such as money and possession, and right up to the present, economic 
capital has served as a resource for the other types of capital (Bourdieu, 1977; 
Bourdieu, 1986). This is because the attainment of the agents‘ social, cultural and 
symbolic capital has been boosted by economic capital. For example, it is common 
for those who are rich to have better access to education, which is one of the main 
resources of cultural and social capital. Besides, in Malaysia, the rich will usually go 
to the private hospitals that provide them with access to a better healthcare service 
(Thomas, Beh, & Nordin, 2011). 
 
Social capital 
Bourdieu defined social capital as “… the aggregate of the actual or potential 
resources which are linked to possession of a durable network of more or less 
institutionalised relationships of mutual acquaintance and recognition” (Bourdieu, 
1986: p. 51). Individuals with a bigger and stronger network occupy a better social 
position or hierarchy in the field. The understanding of social capital is extended to 
include the groups to which the individual belongs and the difference between these 
groups in terms of their status and power (Bourdieu, 1986; Putnam, Leonardi, & 
Nanetti, 1994; Szreter & Woolcock, 2004). Putnam (2000) further emphasised the 
importance of reciprocity and trust within and between different groups when it 
comes to them obtaining their needs. In the healthcare system, HCPs are considered 
to have a higher level of social capital compared to patients as they occupy a position 








According to Bourdieu (1986), cultural capital can be categorised into three distinct 
states: embodied state, institutionalised state and objectified state. Culture is 
considered to be the most prominent form of embodied cultural capital. For this type 
of cultural capital, the process of embodiment often does not occur instantaneously 
and happens unconsciously. The acquisition of cultural capital varies depending on 
the duration and the society in the field. In addition to culture, language, skills and 
education are also listed as cultural capital by Bourdieu. The institutionalised and 
objectified states are the ways in which others are informed of one‘s acquisition of 
cultural capital. These may be in the form of educational certification, writings, 
paintings and other material objects that serve to describe cultural capital. 
 
In using the concept of cultural capital to understand patient–HCP interaction in the 
field of healthcare, cultural capital was further extended by Shim (2010) to become 
known as cultural health capital. It is defined as “… the repertoire of cultural skills, 
verbal and nonverbal competencies, attitudes and behaviours and interactional 
styles, cultivated by patients and clinicians alike, that, when deployed, may result in 
more optimal health care relationships” (Shim, 2010: p. 1). Shim‘s work on cultural 
health capital focuses on this type of capital possession among patients, covering 
their cognition (linguistic facility and ability to understand biomedical information), 
attitude (proactivity in accumulating knowledge) and behaviour (ability to use the 
biomedical information and instrumental approach to disease management). Shim 
also argues that her concept of cultural health capital is particularly helpful in 
understanding the social production of the unequal patient–HCP interactional 
dynamics between patients and HCPs. 
 
Symbolic capital  
Since power relations is one of the most prominent emerging issues in the data of this 
study, this category of capital is considered to be the most pertinent to this study. It is 
a type of capital that is formed through a legitimatisation of the other types of capital 





into an extensive discussion of this type of capital, and it has its own section in his 
books Outline of a Theory of Practice and The Logic of Practice.   
 
Bourdieu (1977: p. 76) described symbolic capital as “… conventional and 
conditional – stimulations, which act only on condition they encounter agents 
conditioned to perceive them, tend to impose themselves unconditionally and 
necessarily when inculcation of the arbitrary abolished the arbitrariness of both the 
inculcation and the significations inculcated”. Thus, the conversion of other types of 
capital to symbolic capital is deemed to be important as this is the most effective way 
for the individuals or groups with the capital to acquire an advantage or power within 
a specific context or field. Symbolic power is a more implicit form of capital, thus 
rendering it more acceptable in the social world. In this study, several symbolic 
capitals emerged as factors that have relations with the practice of shared decision-
making. These include the patients‘ socio-economic status, illness experience and 
knowledge, the HCPs‘ health and medical expertise, and both groups‘ language and 
communication skills.  
 
Symbolic power and doxa 
In discussing practice, habitus and field, Bourdieu also routinely talks about 
symbolic power. Symbolic power depends heavily on the possession of symbolic 
capital (Bourdieu, 1989) and, similar to symbolic capital, is a legitimised form of 
another type of power. Symbolic power is inseparable from language due to the fact 
that language is used as a means of transforming other types of power into symbolic 
power. Symbolic power, however, is considered to no longer exist once the 
accumulated capitals which produced the power are no longer recognised or 
considered to be collectively useful. The HCPs are considered to be the group with 
more power in the healthcare system as they possess more capitals in comparison to 
the patients. However, in the current changing world, there are changing perceptions 
of the meaning of these capitals. More often than not, this leads patients to question 
their HCPs‘ decision, with the effect that the advice and prescriptions given by HCPs 





As for doxa, this is a product of unquestioned symbolic power within the field among 
agents with similar habitus (Grenfell, 2014). There is a legitimation or recognition of 
doxa as something that should be accepted by all agents of the field as being both the 
‗rules of the game‘ and indisputable. The acceptance of doxa as a common belief is 
not due to any external force but rather results from the agents‘ internalisation of the 
forces, predisposition and/or experience which further shape the habitus and field 
(Grenfell, 2014).  
 
Modes of domination  
Power is commonly associated with actors in a higher position exerting dominance 
over those in a lower position. In his writing on ‗Modes of Domination‘, Bourdieu 
states that “… domination no longer needs to be exerted in a direct, personal way 
when it is entailed in possession of the means (economic or cultural capital) of 
appropriating the mechanisms of the field of reproduction by their very functioning, 
independently of any deliberate intervention by the agents” (Bourdieu, 1977: pp. 
183–184). It can be said that domination is not directly exerted through the 
possession of capital but that it usually occurs autonomously as the institution serves 
as an instrument to facilitate the reproduction of domination in the field. On the other 
hand, the ability of accumulated capitals to be objectified is also important in 
determining the modes of domination and ensures that the domination is reproduced 
(Bourdieu, 1977). This may serve to explain why those HCPs who prescribe or allow 
patients access to medication and wider healthcare services are always viewed as 
having more power and domination compared to HCPs who merely give advice to 
patients. In this study context, only medical officers, FMSs and endocrinologists 
have the authority to do so.  
 
3.7.4.2 Integration of Bourdieu’s work in data analysis 
 
Although there is debate as to whether Bourdieu‘s work on habitus, capital 
(economic, cultural, social and symbolic), field (the arenas of social structures and 





violence) can be considered outdated, it was nevertheless deemed to be the most 
comprehensive form of guidance available for use in making sense of the complexity 
of the gathered data. According to Collins (1993), Bourdieu's work is also relevant as 
it bridges the ‗objective‘ social structure and ‗subjective‘ human characteristics and 
practice, in addition to providing a means of understanding the power relations that 
exist among people in certain contexts and fields. These are aligned with both 
symbolic interaction, which is the theoretical underpinning, and qualitative research 
as the methodology of this study (Crotty, 1998; Patton, 2002). Furthermore, 
Bourdieu‘s social theory and the concept of power are a good fit with constructivism, 
which is the paradigm of this study, as they value the views and experiences of each 
social agent within the boundaries of a specific social field. Multiple perceptions and 
practices are anticipated as the field is heavily influenced by individual habitus and 
possession of capitals. Thus, his theoretical notions on the above-mentioned aspects 
were used extensively to guide further analysis and discussion in constructing a 
theoretical understanding and building intricate interrelationships or associations 
between the elements that emerged from the data, which are the main contributions 
of qualitative research (Patton, 2002). 
 
Besides, taking his recognition that cultural order (cultural capital) and social 
structure are parallel, the work of Bourdieu can further explain how the actions of 
both patients and HCPs are not only the result of an internal practical logic and 
individual disposition but are also moulded by the social structure (field) in the 
healthcare system and the Malaysian or Asian cultural and social backgrounds from 
which they emerge (Bourdieu, 1977; Bourdieu, 1990). These are useful when 
extensively exploring the contextual factors that influence the practice of patient 
involvement in decision-making, which is unique to this study. Table 6 contains an 
example of how Bourdieu‘s work was adopted in facilitating the emergence of 
themes in Chapter 5. The result of this adoption in analysing the data of this study is 
presented in Chapter 5. This led to further utilisation of his work in Chapter 6, 
especially in 6.4, which contains discussion about the patient–HCP interpersonal 










Table 6: An example of emergent themes from codes using Bourdieu‘s work 
Transcripts Codes Theme 
―What is the point for me to be clever? I don‘t have any expertise. You are the doctor, 
you tell me.‖ (PT2, 61-year-old Indian man, SC) 
Patients’ expertise and 












―When I was working, I got my medication from the private, I could ask for something 
more. RM1000-RM2000, they can give me, but when you come to the government 
hospital, they say, ―look, I don‘t have any other thing, this is what is available, what I 
can give to you?‖ They give, I‘ll take. Our treatment method is not right. But if you are 
the type who doesn‘t have the capability to buy, go and see the government doctor, 
they‘ll give the best treatment. Because the treatment is good, but not the medication, 
government doctors do not have it. It‘s quite expensive. If you‘re not rich and just 
average, forget about it, government servant and all that. It is for the rich so, I‘ll just go 
on with it. The medications are there, but it‘s for the rich and famous.‖ (PT17, 58-year-
old Indian man, CC)  
Patients’ acceptance of public 
facilities (habitus and field) 
―I will wait and see. I‘ll see the changes, if it is needed for me to tell them, I will tell. If 
not, I will just stop…I have taken this nerve medication for so long, I can say that I‘ve 
tried everything from A to Z, but no changes.‖ (PT8, 61-year-old, Malay man, HC) 
Patients’ belief and value in the 
treatment modalities (habitus) 
―Maybe the patients become a little bit more passive, they do it for the doctor‘s sake. 
Maybe, they want to please their doctor. Some doctors are very strict, so they do it 
because they want to make sure when they come to the check-up everything is good, so 
the doctor will be happy.‖ (HCP19, endocrinologist, HC) 





The accordance with symbolic interactionism is strengthened through this section‘s 
discussion on the adoption of Bourdieu‘s work as the analytical tool with which to 
explore the factors that influence the practice of patient involvement in decision-
making in the study context. This is because it supports the three main premises of 
symbolic interactionism by Blumer (1969): (1) human beings act towards things on 
the basis of the meaning those things have for them; (2) the meaning of things is a 
social product; (3) meanings are handled in, and modified through, an interpretive 
process used by a person when dealing with the things they encounter. 
   
3.8 Data Management 
The data relating to the participants were stored in separate folders. Each folder 
contained all of the data obtained from each participant, including an audio recording 
of the interview and its original transcript, the English translated transcript (if any) 
and related notes. The data analysis for this study was also supported by the 
qualitative data analysis software package NVivo 10. This software helped me to 
systematically manage the rich and thick data obtained during the interview sessions 
in terms of storage, coding, retrieval and making comparisons and linkages, yet the 
analysis was still done by the researcher (Patton, 2002). NVivo was chosen over 
other available computer-assisted qualitative data analysis software (CADQAS) due 
to my familiarity with the software and the fact that it is both available at and 
supported by the university. Besides, this software also functions well with different 
qualitative designs and data analysis techniques, including thematic analysis 
(Zamawe, 2015).  
 
All of the hard copies were stored in a locked cabinet, accessible only by me, while 
electronic copies were stored on my laptop and desktop with an access code. All of 
the documents, including the audio recordings, will be destroyed in accordance with 






3.9 Ethical Consideration                                                                                                                                          
3.9.1 Ethical approval, and access to sites and study participants 
Ethical approval was sought from the School of Health in Social Sciences, University 
of Edinburgh Ethics Committees prior to the commencement of the study. At the 
same time, an online application was submitted to the Malaysia Research and Ethics 
Committee (MREC) and the Malaysia National Medical Research Registry (NMRR) 
to request ethical approval to conduct the study in the selected hospitals and health 
clinic. Approval was also sought from the Economic Planning Unit, Department of 
Prime Minister as the analysis of this study was conducted outside Malaysia.  
 
The process of gaining access to the study sites only commenced once approval from 
all of the above-mentioned ethics committees and unit had been granted. This was 
done by sending an application letter to the State Health Director, District Health 
Officer, Hospital Director and the Clinical Research Centre of the hospital. Once all 
of the relevant parties had approved the study proposal, letters were sent to the 
gatekeepers at the study sites, which included the heads of department and nursing 
administrator at the hospital and the medical and nursing administrators at the health 
clinics, requesting access to the sites and study participants. Later, appointments 
were made with these gatekeepers so that the aims, objectives, purpose of the study 
and data collection activities could be thoroughly discussed. This process was very 
important for building rapport and securing the cooperation of the gatekeepers in 
order to assist the data collection process (Patton, 2002; Holloway & Wheeler, 2010). 
With their permission, a brief initial observation was carried out to gain further 
understanding of the process of T2DM management at each of the study sites.   
 
Initially, four health facilities were approached; two health clinics and two 
medical/endocrine clinics located at two different hospitals. However, data collection 
was only carried out at three of these facilities. This was because of a newly created 
regulation put in place by a head of department at one of the initially selected 





prior to the data collection. No further action was taken in respect of this site as the 
other selected hospital‘s specialist medical clinic had sufficient capacity to provide 
the required participants. Thus, data were collected from three health facilities: two 
health clinics and one hospital medical/endocrine clinic.   
 
3.9.1 Informed consent and voluntary participants 
There was no anticipated risk associated with this study. However, informed consent 
was obtained from each participant to ensure they were fully informed and willing to 
participate voluntarily in the study. In order to obtain written informed consent, the 
potential participants were thoroughly informed regarding the details of the study, 
their comprehension was checked and they were given the freedom to either 
participate or decline (Bryman, 2016). Their right to withdraw from the study at any 
time, even after they had consented, was also clearly explained in order to respect 
their rights as study participants. Additionally, the patients were given a guarantee 
that their decision to participate in this study would have no bearing on their 
treatment in the future. 
 
A participant information sheet, available in both English and Malay (refer to 
Appendices 1 and 2), was provided to each potential participant to assist them in 
their decision to become involved in the study. They were given sufficient time to 
read the sheet, ask questions, address any concerns they may have had and consider 
whether or not they wished to participate. An informed consent form was then signed 
by each participant who wished to participate prior to the interview, thus indicating 
their understanding of the study and their agreement to participate. Finally, the 
participants‘ consent to be audio-recorded was established prior to the interview.  
 
3.9.2 Anonymity and confidentiality  
Guaranteeing the anonymity of the participants in a study is paramount (Grinyer, 
2002), with the potential for a participant‘s identity to be uncovered being relatively 





documents and information obtained about the participants, which also contained the 
written consent forms with their names on, were kept confidential and separate from 
the interview data.  
 
Furthermore, the patients‘ names were removed from the transcripts and replaced 
with non-identifiable pseudonyms. Only I as the researcher am able to match the 
identity of the participants to their voice recording. Since two external transcribers 
were hired, an agreement was sought from both transcribers with respect to their 
nondisclosure and maintenance of confidentiality of the recordings, and the 
transcriptions and recordings were sent via password-protected email and disposed of 
immediately following completion of the transcriptions. All of the transcriptions 
were carried out in a private room using headphones/earphones so that the recordings 
were not heard by other people. Furthermore, the transcripts that were shared with 
the study‘s supervisors to confirm the accuracy of the analysis and interpretation 
were shared in a similar way to how the data were shared with the transcribers, 
namely via password-protected email.  
 
The possibility of anonymised verbatim interview quotes being used in reports, 
publications or presentations was explained to the study participants, and their 
consent regarding these matters was sought. No details that had the potential to lead 
to the identification of the participants were included in the shared transcriptions or 
extracts/excerpts in this thesis. Any reports or publications that arise from this study 
will also include only anonymous excerpts.  
 
3.10 Rigour of the Study 
Rigour in qualitative research is described as ‗trustworthiness‘ and relates to the 
quality of the data; it is also known as validity and reliability in quantitative research 
(Welsh, 2002 and Bryman, 2016). Trustworthiness in qualitative research is achieved 
when the researcher fulfils at least two of the eight strategies for validity and 





and persistent observation, triangulation, peer review, analysis of negative cases, 
researcher reflexivity, member checking, rich and thick description and external 
audits. In this study, more than two of these strategies were adopted to ensure its 
trustworthiness. 
 
3.10.1 Prolonged engagement  
Data were collected from the study sites during the period between November 2015 
and April 2016. Despite in-depth interviews being the only method of data collection 
used, I spent the majority of this period at the study sites. The reason for this was not 
only to build relationships and trust with the staff in order to facilitate the participant 
recruitment process, but also to learn and understand the study sites‘ environment 
and culture so that contextual understanding of the participants‘ narrative and 
meanings could be achieved (Creswell, 2007; Lundy, 2008).  
 
3.10.2 Triangulation  
Triangulation in qualitative research is vital in establishing credibility and 
confirmability (Lincoln & Guba, 1985). It can be carried out by having multiple and 
different theoretical perspectives or theories, methodologies, methods of 
investigation and/or sources of data (Denzin, 1970; Fielding & Fielding, 1986). As 
the data were collected through interviews, triangulation was carried out within the 
method in order to attain greater accuracy and credibility of the findings (Denzin, 
1978). This was done by having multiple viewpoints of the patients and HCPs from 
three different clinics, incorporating relatively different systems for managing T2DM. 
Besides, as mentioned in the recruitment of study participants section of 3.6.2, 
patients with different sociodemographic and T2DM characteristics, in addition to 
different groups of HCPs, were recruited for this study. 
 
3.10.3 Peer review 
The issue of peer review and debriefing was addressed in this study with the help of 





protocols, methodologies, interview transcripts and the analysis process were held 
between both of the supervisors and me. Both supervisors acted as what Lincoln and 
Guba (1985) describe as ‗devil‘s advocate‘, in that they prompted me to consider 
things or situations from different perspectives in order to reduce my implicit 
assumptions and bias, thereby increasing the study‘s credibility. 
 
3.10.4 Rich and thick description 
In this study, coupled with a thick description of the settings and context (including 
geographical and sociocultural characteristics), rich and long excerpts from the 
participants were also included in order to provide the reader with a detailed 
description of each finding that would enable them to make a judgement with regard 
to their transferability (Geertz, 1973b; Lincoln & Guba, 1985). According to Lincoln 
and Guba (1985), rich and thick description is important in helping readers to 
determine the potential for transferability of the findings of this research to other 
settings or contexts.  
 
3.10.5 Researcher reflexivity 
Researcher reflexivity is a description of the researcher‘s background and experience, 
which is an indispensable element of qualitative research. This act of self-reflection 
serves to provide clarification on how the researcher‘s past experience, biases and 
personal judgement may influence the way in which the study was conducted from 
the initial phase of planning right up to the end when the findings were analysed and 
presented (Creswell, 2007). Researcher reflexivity is described more fully in 3.11. 
This explanation is important not only to advise the reader on the researcher‘s 
position but also to minimise biases as I was aware of how these factors had the 
potential to affect my study. Its inclusion therefore ultimately increases the 







The issues of bias and qualitative research are inseparable as the researcher acts as an 
instrument for both the data collection and analysis. The fundamental 
recommendation is for the social researcher to keep their distance so that they can 
maintain their objectivity throughout the research process. However, according to 
Patton (2002: p. 49), in gaining a full grasp of the data, especially when it comes to 
meaning-making that is associated with participants‘ cognition and emotion, “… 
understanding comes from trying to put oneself in the other person‟s shoes, from 
trying to discern how others think, act and feel”. This shows that there is a need for 
researchers to put themselves in the participants‘ position so that they can understand 
their opinions, emotions and behaviour, empathetically.  
 
However, it is also important for researchers to be transparent and present the detail 
of the study process so that bias can be reduced. This is known as reflexivity and it 
helps the researcher to be aware of their own interpretation of the data at the same 
time as informing the reader of the researcher‘s background knowledge, values and 
beliefs that may impact upon the research (Finlay, 2002; Charmaz, 2006). In line 
with the paradigm and theoretical perspective of this study, which are constructivism 
and symbolic interactionism, the researcher‘s contribution to a research process is 
significant as their experiences, cognitive predisposition and emotions help them in 
understanding the phenomena or social reality in question. Thus, discussion on the 
researcher‘s reflexive stance is crucial as it is strongly linked to the quality and 
credibility of a qualitative study.  
 
As described earlier in section 3.6.3.4, notes were written and kept immediately after 
each interview. Despite the fact that these notes were not analysed, they served as a 
reflexive tool as they included my personal thoughts and feelings throughout the 
interview sessions. Besides, as the notes detailed the non-verbal communication cues 
such as body gestures and facial expressions that could not be captured by the audio 
recorder, they provided some profound context to the participants‘ answers and the 





of the narrative, thus hopefully ensuring the trustworthiness of the study (Bryman, 
2016).  
 
Despite the intention to comprehensively explore patient involvement in health 
decision-making and shared decision-making, I admit that my background of having 
a Master‘s in Health Education led to me having a greater interest in the information 
sharing and communication between the patients and their HCPs. This was further 
strengthened during the review of the literature, where both of these elements are 
listed as prerequisites for shared decision-making (Charles et al., 1997; Coulter, 1997; 
Elwyn et al., 2000; Makoul & Clayman, 2006). However, throughout the planning of 
the study, including setting out the research aims and questions, data collection and 
data analysis, no significant focus was given to this element. The exploration was 
also carried out based on an integrated model of shared decision-making by Makoul 
and Clayman (2006). This is a comprehensive model that integrates the extensive 
existing literature on the shared decision-making model. Aside from the shared 
decision-making model, I chose not to use any other theory in the initial stage of my 
study so that no premature focus could be accorded to any specific realm. However, 
my interest in the communication and information exchange elements was again 
reinforced as they emerged significantly from my data, thus leading me to gravitate 
further towards those elements.  
 
However, as I shared the interview transcripts and my analysis with both of my 
supervisors, my interpretations and analysis were constantly challenged, especially 
during the first half of the study process. On the other hand, the constant comparative 
method also helped me to remain objective with my data, as I constantly had to 
compare the data not only to find differences and similarities but also to make sense 
of incidents or the occurrences based on the participants‘ narratives. This is because, 
despite being one of the important elements listed in the existing shared decision-
making models, the underlying factor of power relations became the main reason for 
the current practice to revolve around patients‘ involvement in decision-making in 





Nonetheless, the benefits of my previous background and a further exploration of the 
information exchange led me to identify power relations as the main underlying 
theme that greatly influenced the extent of patient involvement in the decision-
making process. This further guided me to use Bourdieu‘s theory of practice and his 
work on power relations, both of which facilitated further exploration and 
explanation of the properties of the emerging categories and ultimately provided a 
framework for me as the researcher to produce a more relevant and concrete 
connection between the categories or themes, compared to using my implicit 
assumptions and interpretations as a base. According to Hertz (1997), this is how a 
reflexive researcher should contribute to her/his study and not merely become a 
reporter of the participants‘ narratives; as such, she/he should actively continue to 
construct and question her/his interpretation of the collected data. 
 
Constructivism greatly relates not only to the meanings that participants attach to 
their experiences and their perceptions of social reality, but also to the construction 
of understanding and interpretation of these meanings and perceptions, which is 
predominantly conducted by the qualitative researcher. This, coupled with the task of 
the researcher, as the interviewer, to gather the information from the patients meant 
that the power dynamic between the participants and myself was taken into account 
during the study‘s data collection. Power asymmetry is common in research 
interviews as the researchers hold the power in terms of scientific competency and 
they also have the power to shape the setting of the interview sessions (Brinkman & 
Kvale, 2015). Consequently, some participants may react undesirably as counter 
control measures. These may include a refusal to share the truth, changing the subject, 
questioning the intention of the researcher with regard to the asking of certain 
questions and, in the worst-case scenario, withdrawing their participation (Brinkman 
& Kvale, 2015). Power asymmetry in the research interview is not something that 
can be eliminated; however, by acknowledging and being aware of its presence, the 
hope is that it can be reduced so that any impact will be less severe or else can be 





All of the patients were informed of my position as a doctoral research student and 
that I had no affiliation with the study sites or the MOH. It was important that the 
participants did not feel threatened by me, which was again emphasised in the cases 
where I sensed that the participants were trying to conceal the truth or their real 
opinions or feelings. This also reaffirmed the need for their anonymity. Throughout 
the duration of the data collection, my background as a nurse became identifiable to 
some of my participants. Realising that this may distort their perception of me and 
result in them taking counter control measures, I reassured them by emphasising that 
my current role was that of a researcher and not of a nurse in clinical practice. 
Despite this, however, it could be sensed that some of the participants were trying to 
give a positive impression when answering the questions.  
 
Additionally, when entering the study sites, it was common for me to meet patients, 
as my participants, who did not understand about and/or adhere to their T2DM 
management. As a nurse, it was disheartening for me to discover this, but I was 
unable to consult or advise them further since my role at the time was as a researcher. 
Instead, I could only tell them to discuss their concerns and issues with their HCPs at 
the very earliest opportunity. Finally, my previous experience as a nurse who used to 
care for patients with T2DM served as both a friend and foe throughout. Being a 
novice qualitative researcher, it was hard for me to look at the data solely through a 
researcher‘s lens and put aside my nurse‘s lens. As such, in some instances, I tended 
to make premature conclusions with regard to the issues emerging from the data. 
This is where my supervisors again played a role.                
                       
3.12 Limitations 
Even though diversity among participants was kept in mind during the collection of 
data for this study, due to its purposive sampling and the small number of 
participants, who were concentrated in an urban area, the findings of this study 
cannot be generalised to the wider Malaysian population. However, similar to most 
qualitative studies, this was not the main aim of this study. Conversely, this study 





meanings and views that the study participants ascribed to their social reality and the 
world.    
 
However, as the study employed only in-depth interview as its data collection 
method, there are two major concerns regarding the data of this study. One of the 
major issues concerns the veracity of the data that were given by the participants. As 
mentioned earlier in section 3.10, there were some participants who tried to conceal 
their true feelings or behaviour and practices, or the real occurrences, and presented 
me with only the nice parts. This was especially true when it came to activities that 
could potentially leave me with a negative impression, such as non-adherence, 
dissatisfaction with the services received, limiting patients‘ opportunity to be 
involved in the discussion and others. However, as the interview progressed, and the 
more the participants felt comfortable and the more questions were asked, the more 
the realities and truths were revealed. 
 
Another disadvantage of the interview in this study was that there was a high 
probability of some details not being shared or otherwise excluded by the 
participants, and not because they wished to hide them from me (Bryman, 2016). 
Such an occurrence may instead have been because the participants had to 
retrospectively recall various events, including distressing ones, and this could be 
very demanding for the participants involved, especially the patients. Some patients 
also had difficulties in answering some of the questions due to their poor or repressed 
memories. In some cases, the participants may not have shared the important details 
as they did not consider the matters to be worth mentioning. Several measures were 
taken to address these issues.  
 
Furthermore, some of the patients in this study were identified with the help of HCPs. 
This may introduce ethical issues to the study recruitment. This potential for bias 
could be due to the patients‘ perception regarding the impact of their participation in 
the study on their relationship with their HCPs, or their concern about the treatment 





(Mason et al., 2007; Wilson, Draper & Ives, 2008). However, this concerned only a 
small number of the patients in this study and the recruitment was not carried out 
directly by the HCPs. Instead, the HCPs directed me to the patients that they 
considered suitable for the study, and I then approached and recruited them. This was 
believed to negate any feeling of obligation to participate on the part of the patients. 
 
As I can only understand and converse in English and Malay, the data were only 
collected from people who could also understand and converse in these two 
languages. As a result, only a small number of Indian and Chinese patients were 
successfully recruited in this study. Although Malay is Malaysia‘s national language, 
not many Chinese and Indian people, especially the elderly, are able to converse in 
either Malay or English, the latter of which is considered as the second language. 
Hence, the issue of a language barrier, which was mentioned by the HCPs, could not 
be explored from the perspective of the patients as it was never raised by any of 
those whom I interviewed, and I did not have access to the same patients with whom 
the HCPs had language problems.     
 
3.1 Chapter summary 
This chapter began by outlining the methodological issues and research design of this 
study. As presented, the main aim of this study is to explore the understanding and 
perceptions of patients and HCPs of patient involvement in decision-making and also 
shared decision-making in the management of T2DM in Malaysia. The justifications 
of constructivism and symbolic interactionism as the theoretical philosophy 
underpinning this study were thoroughly discussed. This then led to the identification 
of an interpretive qualitative research method as the most suitable approach for 
conducting this study. 
 
Relying on the chosen research paradigm, the methods used to conduct the study 
were presented in detail, including the sites of the study and the sampling strategy for 





to use to answer the research questions as it allowed me to gain an extensive 
understanding of the meanings that the participants ascribed to their experience of 
the involvement of patients in decision-making and their perception of shared 
decision-making. The data in this study were analysed using thematic analysis with 
the support of the constant comparative method in order to uphold the emic 
(participants‘ narratives) and etic (researcher‘s interpretation, theoretical framework) 
perspectives in this study (Fram, 2013). This chapter also contains an explanation of 
Bourdieu‘s work on practice and power relations as this was used as the theoretical 
framework to further analyse and discuss the emerging issues that were identified in 
the middle of the data analysis.  
 
Furthermore, the ethical considerations of the study were also outlined in this chapter, 
including ethical approval and access to the sites, informed consent and voluntary 
participation, and anonymity and confidentiality. As the rigour of qualitative study is 
also important, I explained the measures that were taken to ensure the trustworthiness 
or the reliability and validity of this study. Lastly, there was a discussion to present 
some of my reflexivity throughout the study process. This is to both inform the 
reader and to make myself aware of my reflexive stance in relation to conducting the 






 CHAPTER 4: PATIENT INVOLVEMENT IN DECISION-MAKING 
 
4.1 Introduction 
This chapter explores the perceptions of patients and HCPs of the current nature of 
patient involvement in the decision-making process in the management of diabetic 
patients. Decision-making is one of the main activities in the patient–HCP encounter 
(Elwyn et al., 2001). Patient involvement in the process is currently an area of focus 
within the healthcare landscape, with an emphasis being placed on the shift from 
disease-centred to patient-centred care. The following sections detail the findings 
relating to an exploration of the perceptions of patients and HCPs regarding their 
experience of patient involvement in the selection of treatment and management for 
patients with T2DM. In this chapter the emerging findings looking at how these 
different groups of individuals perceive patient involvement in decision-making are 
organised based on the essential elements of shared decision-making presented in the 
previous Literature Review chapter. These elements are (1) identification of patient 
needs; (2) information sharing and HCPs‘ recommendation; (3) discussion and 
deliberation; and (4) final decision.  
 
As this study involves patients and different groups of HCPs from different study 
settings, some additional information is included for each excerpt from the 
participants. Each excerpt from the patients is followed by their pseudonyms and the 
setting from which they were recruited. For HCPs, additional information about their 
job is also included. To enable differentiation of the accounts from patients and 
HCPs, different colours are used for each group, with blue for patient excerpts and 
purple for those from the HCPs. 
 
4.2 Identification of patient needs  
Based on the review by Makoul and Clayman (2006) on shared decision-making, 
defining patients‘ needs is one of the essential elements shared by the existing 





emerging issues related to the way patients‘ needs are identified with respect to a 
new decision. These important issues include a cursory assessment by HCPs 
focusing on clinical parameters, patients‘ dependence on the HCP, patients‘ sharing 
of their practice, concerns and problems, meeting different individuals, and the 
language barrier. 
 
4.2.1 Cursory assessment by HCPs focusing on clinical parameters 
Most of the HCPs emphasised the importance of assessments for identifying patients‘ 
problems and needs, and these were usually conducted at the start of the session. The 
results were then used to guide the later stages of their encounters with patients.  
 
 … they come, and I will check, so while checking the leg, we will be asking 
questions, such as whether there is numbness or not. Do you feel any pain, is 
there any redness? And when they walk, is it normal or not? All these 
questions will be asked first. We will check BP and dextrostix. Based on the 
result, we will talk about the medication, if they are taking insulin or Dionil; 
whatever medication they are taking we will also ask about that. And then 
while checking the leg, we‟ll look for oedematous, pulse, lateral pulse, all the 
things we have to check. Then the nails, looking for any infection, some have 
no nails. And then we will look in between the toes, checking for any infection, 
itchiness or anything. And then plantar there, we will check for corn, callus 
and heel cracking and then the leg, whether there is any hair loss or not, we 
will enquire about that. Any pigmentation, colour change, any ulcer. (HCP1, 
staff nurse, SC) 
 
…we will assess their control in terms of, specifically, like hypoglycaemia, 
blood glucose monitoring, if they are doing it at home and then any issues 
with their diet, physical activities, and then usually have a quick examination. 
Depending on whether it‟s a brief or a more complete examination, we will 
mainly have a quick look at their feet. The other things that they may have 
had done include a foot examination before, by the nurse, or an eye 
examination at the eye doctor‟s. Then, lastly, we look at their blood lab 
results, focusing on their HbA1c, lipids, kidney function and then we wrap it 
all up to assess the current status of their diabetes control, their current 






The above excerpts by HCP1 and HCP19 indicate that assessment is carried out 
based on the HCPs‘ role in managing patients with diabetes. HCP19, who is a 
specialist and is mostly responsible for the overall management of patients with 
complex diabetes problem, conducts assessments that are more inclusive yet 
superficial in comparison to those conducted by HCP1, who is a nurse responsible 
for managing diabetic foot problems. This shows that a team-care approach to 
managing patients is very beneficial as a means of ensuring that patients are managed 
comprehensively and to reduce the risk of any clinical or physical problems being 
missed, despite the added redundancy. This is because not all patients have the 
opportunity to meet HCPs other than their own physicians in relation to the 
management of their T2DM. Nonetheless, both of the above accounts reflect how the 
main focus of assessment is on the patients‘ biomedical parameters, especially their 
glycaemic level and any diabetes-related physical changes. This is aligned with the 
main clinical indicator for the effectiveness of T2DM management issued by the 
MOH Malaysia within the CPGs (MEMS, 2016) and the traditional healthcare 
paradigm that focuses on the illness.  
 
However, the IDF 2012 Clinical Guidelines Task Force (2012) also recognises 
patients‘ psychosocial status together with their knowledge and beliefs regarding 
their T2DM as the important elements to be assessed when managing patients with 
diabetes as these can negatively affecting their well-being (Grigsby et al., 2002; 
Nouwen et al., 2010) and may become a barrier to their diabetes management 
(Glasgow, Toobert, & Gillette, 2001; Fisher et al., 2010). There seems to be limited 
mention in the collected data of patients‘ psychosocial status, including their 
emotional burdens, concerns about diabetes, need for support and their thoughts on 
their disease condition and management, as an element that many HCPs will 
intentionally assess at any point in time. Analysis of the overall data has also 
revealed the limited indication of any tool for use in directly assessing patients‘ 
psychosocial and emotional status, which may be due to its recent development and 
introduction in Malaysia (Chew et al., 2015; Y.W. Chin, Siew, & Chia, 2017). 
However, it was commonly found throughout the data that the patients associate 





It just goes up. It fluctuates. Sometimes, when you are okay, then the sugar is 
okay. Sometimes, when you feel stressed, it goes up. Because as far as I can 
see, my food intake is not that much. (PT13, 48-year-old, Indian woman, HC) 
 
PT13, for example, felt that her uncontrolled diabetes may be caused by stress, 
although this had not been properly addressed since no assessment had been 
conducted in this area by any of the HCPs she met, and neither did she share her 
thoughts with them. This concern is in contrast to the following account from HCP12, 
who did not consider stress to be a factor that contributes directly to an increase in a 
patient‘s glycaemic level. 
 
Oh, yes, sometimes. They do come, they do tell other things other than 
diabetes. They are stressed because of this, sometimes their BP is high 
because of stress, or some other problem. Those kinds of things, they come 
out, we try to ... you know, do the DAS screening or things like that. So, we 
try to help them in that way, refer them to a counsellor. We do that. (HCP12, 
medical officer, CC) 
 
In the above excerpt, HCP12 admits that some patients do complain of suffering 
from stress and that this is further addressed accordingly. However, the excerpt also 
demonstrates that this medical officer considers stress to be mainly linked to patients‘ 
high blood pressure rather than diabetes, which could lead to stress levels among 
diabetic patients being overlooked. Despite the fact that a direct link between stress 
and glycaemic level remains controversial, Lloyd, Smith and Weinger (2005) argued 
that stress has a bidirectional association with patients‘ T2DM self-management and 
might negatively affect their overall well-being.  
 
In the area of patients‘ knowledge, values and belief regarding their T2DM status 
and management, an assessment was mainly carried out by those HCPs responsible 
for delivering health education and counselling to patients, comprising mainly 
diabetes educators, pharmacists and dietitians or nutritionists. Yet, based on the 





patients, patients with an uncontrolled glycaemic level or to those who have 
expressly requested to meet them. 
 
Normally in the first session we‟ll do a pre-test, patients will answer about 
their medication, everything that they know. So at least I know what they 
know. So I don‟t have to explain more on that and focus on the parts which 
they don‟t know. (HCP3, pharmacist, SC)  
 
Based on the above excerpt by HCP3, patients‘ level of knowledge, especially in 
regard to their pharmacological modalities, was extensively assessed by the 
pharmacist to identify their main needs in facilitating T2DM self-management. In 
doing so, T2DM patient education with regard to their medication therapy with a 
pharmacist in Malaysia is guided by the DMTAC protocol so that an improvement in 
patient care in terms of quality, safety and cost-effectiveness can be ensured (MOH 
Malaysia, 2014). However, only a limited number of patients are involved in a 
DMTAC programme and it tends to focus on patients who are struggling to maintain 
their glycaemic level due to non-adherence to their medication (MOH Malaysia, 
2010b).  
 
For the patients who referred by the doctor, usually the doctors have set 
target and why did they refer the patients to us. They‟ll mention the reason 
that they refer patients, whether it‟s just for injection technique only or 
SMBG only. (HCP8, diabetes nurse educator, HC) 
 
In other cases, with HCP8 as an example, the main focus in the education session is 
based on a target set by the physician. This may be useful, especially when the HCPs 
have limited time with patients, yet it may also be detrimental as it may limit the 
opportunity to explore other underlying issues, as demonstrated by HCP16 in the 
excerpt below.  
 
As we already thought that they‟re not compliant and take care of themselves. 
That‟s why we just say to them, „Okay, you have to follow, ABC, and if you‟re 





medication. Are they really taking their medication? Do they know about 
hypo? About diet? Maybe, they‟ve never had a consultation with a 
dietitian …We‟ve given the medication and if they take it the sugar will 
decrease. But we don‟t know that our patients actually go for traditional and 
all. (HC16, dietitian, HC) 
 
HCP16 also highlighted that any assumption made by HCPs concerning patients‘ 
non-compliance may further heighten the possibility of missing the main concern of 
the patients, as previously mentioned by PT3.  
 
4.2.2 Interaction during assessment 
Similar to the following account by HCP19, most of the HCPs admitted that they 
asked their patients questions with regard to gathering the necessary information, in 
contrast to working based solely on the test results and findings from the physical 
assessment. This serves as a positive indication that HCPs are acknowledging the 
importance of patients‘ contribution during their clinical encounters. Asking patients 
is one way of gathering the information needed to identify their health problems and 
needs, in addition to it facilitating interaction between both parties.  
 
…and during that time usually what we‟ll do is ask them if they have had any 
other problem between their visits that they want to discuss, usually 
medically related. (HCP19, endocrinologist, HC) 
 
Different people have different problems. Not every patient has the same 
problem. (PT13, 48-year-old, Indian woman, HC) 
 
Two-way interaction during the assessment was also seen as vital among the patients, 
as illustrated in the above account from PT13. This patient wishes to be understood 
by her HCPs as an individual who suffers from T2DM, and not merely as another 
diabetic patient, with the latter type of approach potentially leading to generalised 
management based on standard guidelines. This corresponds with the patient-centred 





holistically, with their care decisions based on their background, preferences and 
values (IOM, 2001; Royal College of General Practitioner, 2014). Besides, in 
comparison to the identification of acute health problems, which is more 
straightforward, the identification of problems faced by patients with diabetes and 
their needs is more complex as it can be influenced by many factors and involve 
multiple modalities, which may require customised management (Murrow & 
Ogiesby, 1996). Despite having the same uncontrolled glycaemic level, the reasons 
for this are not necessarily the same for every patient and may not necessarily require 
any modification to their pharmacological modalities. In terms of this study, this may 
be more apparent in HC as it receives more complex cases due to its status as a 
referral centre for diabetes in Malaysia.  
 
However, similar to findings by Witry and Doucette (2015), the HCPs in this study 
were more likely to pose additional questions to patients they considered to be 
problematic relative to those who they assumed did not have a problem. The 
determination of whether or not a patient was problematic was again made based on 
their glycaemic level, as illustrated in the following excerpt from HCP5.  
 
Usually I will ask, when I can see that the sugar is out of control and I have 
to trouble shoot, I have to ask, I have to find out why, is it because of the 
injection technique or so on and so forth. (HCP5, medical officer, SC) 
 
She didn‟t ask anything, she just asked how I was. As for my diabetes, she just 
glanced through, as my sugar level is under 10. That was it. She didn‟t ask 
anything else apart from that. (PT1, 82-year-old Malay man, SC) 
 
This lack of assessment by HCPs of patients with no apparent clinical and/or 
physical problem is supported by the above statement by PT1. The account indicates 
that the HCP enters into no further discussion, particularly if there is no significant 
abnormality in their clinical parameters or physical characteristics. This may have 
the effect of delaying the early identification and prevention of problems among 





other HCPs generally depend on medical officers (as mentioned earlier), this may 
further hinder the proper identification and addressing of patients‘ underlying non-
clinical or non-physical issues.  
 
 Okay usually all their investigation will be attached. So we have FBS, RFT, 
LFT and then HBA1C. So we will go with all the results, and then we‟ll have 
a look at it first, how‟s the reading for now. And then we‟ll look at their 
compliance. Basically, because we have a very short time only. There are a 
lot of patients, so not much time to spend, but whatever time is there we 
utilise. So we‟ll see the compliance, we‟re worried at that time, are they 
experiencing any reaction? Are they able to tolerate the medication? Are they 
compliant? And then next one, first medication and after that their lifestyle. 
What are the lifestyle changes that they‟ve done to cope with diabetes? And 
then we encourage them to join our programme as well… You know you can‟t 
talk much. Counselling will take time, so it depends. I might do it. I have to 
address today‟s problem and give the appointment. (HCP12, medical officer, 
CC) 
 
Nevertheless, HCP12, in the above account, voices her concern about not having 
enough time to go beyond what she thinks is important in managing patients with 
T2DM. This concern is also shared by many other HCPs, especially among the 
medical officers. In relation to the finding by Seale, Anderson, and Kinnersley 
(2005), in comparison with non-physician HCPs, the physicians in this study are all 
likely to have limited time to spend with each patient as a result of their heavy 
workload. This time constraint hinders them from conducting a thorough question 
and answer session with the patient, which is aligned with the assertion by Loh, Yip, 
Packer, and Quek (2005) that some Malaysian HCPs have a time-conscious attitude. 
This is more apparent among medical officers, who normally have only around five 
to ten minutes to spend per patient, thus arguably compelling them to focus on 
patients‘ glycaemic levels, verbally expressed complaints and whether or not any 
clinical examinations have been undertaken. On the other hand, although some 
patients may have more detailed assessments when meeting with other HCPs, the 
findings discussed in this subsection demonstrate that most of the HCPs concentrate 
on managing problems that are clearly manifested both clinically and physically. 





emotional, spiritual, social, cognitive and psychological challenges (Arnold, Butler, 
Anderson, Funnell & Feste, 1995).  
 
4.2.3 Patients’ sharing of their practice, concerns and problems 
Diagnosing patients‘ problems is the first step in the decision-making process for 
which the HCPs are accountable. Nevertheless, patients also play an important role 
in sharing their concerns and needs during their encounters with HCPs (Towle & 
Godolphin, 1999). In addition to the fact that most diabetic patients did not come to 
the clinic with acute health problems, based on the findings in 4.2.1, there were a 
number of occasions where the patients‘ main needs related to their psychosocial 
problems were not correctly identified as a result of the lack of comprehensive 
assessment and sharing from the patients‘ side. However, some of the patients in this 
study shared their needs and problems with their HCPs, as illustrated below: 
 
I stopped, then called and asked the doctor to change my medication. I don‟t 
wait until the next appointment as it is still a long way off. Then, the doctor 
just changed the medication. (PT22, 34-year-old Malay woman, HC) 
 
Previously, I was injecting, right. Then I stopped injecting. I told the doctor 
that I didn‟t have enough money to buy needles. The doctor said, “Okay 
aunty, I‟ll give you oral medication first”. (PT20, 54-year-old Malay woman, 
CC) 
 
PT22 and PT20 are examples of patients who took the initiative to resolve their 
issues and problems without being asked repeatedly by their HCPs. Both PT22 and 
PT20 informed their physician that they had stopped taking their medication. PT22 
was experiencing side effects, while PT20 had a financial constraint and was unable 
to buy needles for her injections. Despite their different reasons for doing so, both of 
these patients had discontinued their medication as they were under the impression 
that they needed a new prescription from the physician for their T2DM to be 
controlled. Most of the patients shared the same view, stating that they would share 





indicate their belief in the contribution of pharmacological modalities to managing 
their T2DM and the need for it to be properly managed. However, patients were 
likely to have a greater tendency to share problems related to their pharmacological 
modalities relative to those for other forms of T2DM management, since the former 
is heavily based on a prescription by the physician. This corresponds with the 
assertion by Leventhal, Phillips and Burns (2016) that the patient will play an active 
role as an act of coping when they perceive they are facing problems that require 
further intervention from the HCP. These accounts also demonstrate that these 
patients‘ autonomous actions in expressing their needs and problems facilitate shared 
decision-making and benefit both the patient and HCP. However, there were also 
other reasons that influenced the patients‘ decisions to share their concerns and 
present enquiries to the HCPs, as explained further in both this chapter and Chapter 5. 
 
The below account by HCP6 illustrates how the HCPs appreciated patients‘ initiative 
in sharing their concerns and problems, without being prompted, as it eased the 
process of identifying the problems that needed to be addressed. 
 
They did share their problems with us. So from there, we‟ll know how we can 
help them. (HCP6, diabetes nurse educator, HC) 
 
However, analysis shows that most of the patients were still fully reliant on their 
HCP to initiate and conduct the assessment. The following account by PT2 clearly 
reflects this patient‘s dependence on his HCPs to initiate the interaction between 
them so that his real problems could be identified and discussed. This reflects his 
belief that it is the HCPs‘ responsibility and he is convinced and trusts that they have 
the greater knowledge and skill to be able to do this.  
 
Definitely they would know what questions to ask. We don‟t know… Similarly, 
as the doctors, they should know what questions to ask. In this situation, this 
is the problem, how to analyse it, they should know and I trust their 






It never crosses my mind. I don‟t know why. (PT6, 54-year-old Malay woman, 
SC)  
 
In contrast, it never occurs to PT6 to talk to any of her HCPs about her struggle to 
control her diet. This may be due to her inability to identify it as a problem that can 
and should be discussed with them. It is also sensed that neither patient was aware of 
the importance of their contribution in facilitating an accurate identification of the 
problems that needed to be managed because, despite their uncontrolled glycaemic 
level, neither patient had developed any other health problems. They might therefore 
have felt comfortable with the way their T2DM was being managed by their HCPs. 
In addition, Bugge, Entwistle and Watt (2006) found that patients will not share any 
information they do not consider relevant and appropriate to the HCPs concerned. 
However, these findings also parallel with one of the unique aspects of patient 
involvement in mitigating diagnostic errors as listed by K.M. McDonald, Bryce, 
Graber and McDonald (2013). They highlighted that patients will not usually be able 
to recognise or locate information that needs to be shared with their HCPs due to a 
lack of understanding of the diagnostic process, despite the fact that they are the ones 
experiencing the symptoms. In addition, the accounts by both PT2 and PT6 may 
indicate a lower level of health literacy and a sense of disempowerment (which is 
explained in the next chapter) as the patients failed to identify and share their 
problem. This is even more common among patients in Malaysia as they tend to be 
quiet and non-assertive during encounters with their HCPs (Kennedy & Mansor, 
2000). 
 
There are patients who just come and see us, but they don‟t do anything. 
Every time they come to us, they don‟t want to be involved at all. They totally 
depend on us to help them. So, I think it‟s hard for me to handle such patient. 
(HCP7, diabetes nurse educator, HC) 
  
That would be detrimental to the patients because if they are not voicing their 
problems, or they are not telling the side effects of something which they are 
not agreeable with, it might not help them in the disease or their treatment 





For HCPs, they are aware of their patients‘ full reliance on them, and it is not 
something that they appreciate, as shown in the accounts above. HCP7 assumed that 
patients become dependent on HCPs as they are not interested in being involved 
themselves. This assumption may be true, but several studies have suggested that 
patients‘ dependency on their HCPs may be incorrectly interpreted as it was found 
that the patients did not share information as they had not been asked directly by the 
HCP and due to the fact that they worried about the HCPs labelling them as difficult 
and considering them to be non-compliant (K. M. Mcdonald et al., 2013; Snow, 
Humphrey, & Sandall, 2013). Patients‘ concern with regard to the label given to 
them by their HCPs is further discussed in 5.2.4 in the next chapter. Whatever the 
reason behind the lack of problem sharing on the part of patients, most of the HCPs 
shared the same concern as HCP7 and HCP17 in terms of believing that this non-
disclosure of important information by the patient may lead to difficulties in 
determining the direction of the discussion during the clinical encounter.  
 
Once I told them I‟m having an erection problem, but it‟s not my priority and 
they said it‟s okay… I‟m coming to 58, it‟s not really an issue but as a human 
being, you have the ego, as it is related to my manhood. (PT17, 58-year-old, 
Indian man, CC) 
 
Meanwhile, in some other cases, with PT17 as an example, patients‘ concerns and 
complaints were not given proper attention by the HCPs, thereby hindering the 
patients from further sharing their concerns. According to Hajos and colleagues 
(2011), HCPs‘ lack of attention may be due to their tendency to underestimate 
patients‘ perceived concerns. The situation faced by PT17 is also comparable to a 
finding by De Berardis and colleagues (2002), who suggested that sexual dysfunction 
goes undetected in more than half of patients due to their HCP‘s lack of attention and 
investigation. Şahin and Şahin (2015) also posited that, despite the fact that sexual 
dysfunction (which affects both male and female T2DM patients), like many other 
T2DM complications, poses no risk of becoming a life-threatening condition, it may 
nonetheless have an impact on a patient‘s overall quality of life. Issues related to 





into with a degree of apprehension by both patients and HCPs, especially when the 
patient and HCP are of different genders (W. Y. Low, Wong, Zulkifli, & Tan, 2002; 
C. C. Ho et al., 2011). Thus, given that these types of problems are unlikely to show 
up in any biomedical test or regular physical assessment, the patients‘ ability to 
express their side of the story is important when it comes to making improvements to 
their quality of life. This will help HCPs make an accurate diagnosis, which will 
further aid them in identifying suitable treatment options to offer to the patients 
(Martin, Williams, Haskard, & DiMatteo, 2005). However, HCPs‘ lack of attention 
with respect to patients‘ sharing may serve to reduce their interest in remaining 
active in discussing the problem that needs to be tackled as they feel disappointed, 
inferior, unheard and uncomfortable with the HCPs‘ feedback (Entwistle et al., 2008). 
A similar assertion was also made by PT22, as given below: 
 
…I‟ve told him that I‟m in pain, “The injection is painful, doctor”. “It is 
painful, but there‟s nothing that we can do,” he said, just like that. I‟ve 
shared with him, “doctor, I do inject but I feel pain every time I inject”. And 
he said that, I was quite shocked. (PT22, 34-year-old Malay women, HC) 
 
Maybe because she met a lot of patients who can‟t hear her very well, so she 
talked loudly. I‟m a softly spoken person, and then she talked loudly, “what‟s 
wrong with this doctor, I‟m sick here”. “Your sugar is high!” It‟s not, I just 
entered the room and she already said it was high. Maybe it‟s just her feeling. 
I just keep quiet and follow. I just smile. (PT10, 35-year-old Malay man, HC) 
 
PT10 at times felt he was being ‗ambushed‘ and not given the chance to 
communicate at all. This is more apparent during consultation with physicians as 
they tend to focus predominantly on patients‘ biomedical characteristics, often 
displaying reduced sensitivity regarding the concerns that their patients bring to the 
table (S. Collins, 2005). Thus, it is undeniable that such perception of the patients 
and conduct on the part of the HCPs may result in their patients feeling inferior, 
unhappy, unheard and uncomfortable, which further reduces their intention of 





Nonetheless, besides the time constraint that limits the HCPs‘ focus on patients‘ 
biomedical status, as discussed in 4.2.2, HCPs also have their own justification for 
the ways in which they respond to patients‘ complaints. 
 
The doctor will change the medication or start insulin on top of their current 
oral medication. The patient will say, despite the fact that they have had their 
oral medication for years, suddenly that day when we added the insulin, they 
said that their appetite increased, or they had stomach ache, even though we 
know that those are not side effects of insulin. That‟s why we‟ll be like, “eh, it 
seems to be impossible that you immediately had stomach ache right after 
insulin injection. Why aunty?” “I don‟t know, after I injected and when I 
pulled, I definitely feel pain.” “Is it stomach ache or pain at the injection 
site?” We have to ask further. (HCP13, diabetes nurse educator, CC)  
 
In the above account, HCP13 expressed her concern at the possibility of patients not 
being truthful when sharing their problems or in having their own agenda, as they 
only shared information after there had been an intensification of their management, 
which she viewed as a patient‘s way of rejecting it in a subtle way; this was 
previously identified by Joshi and Aravind (2017) as a common practice in Asian 
culture. This also reflects the HCPs‘ lack of trust in patients, which may be due to 
their past experience of dealing with similar situations in which patients attempt to 
present an excuse for rejecting the prescribed management. However, there is a 
possibility that the patients may not share their struggles and concerns in the first 
place as they perceive them as being minor and manageable and therefore not worth 
discussing with their HCPs (further explanation of this is given in the next chapter), 
or for some of the other reasons discussed in this section. It was found that any lack 
of concern for patients‘ health complaints on the part of HCPs that arises for these 
reasons can be a form of paternalism, especially when there is no further 
investigation of the matter and HCPs‘ inability to properly address patients‘ reported 
concerns results in the inadequate assessment and collection of patient data due to the 







4.2.4 Meeting different individuals 
Another important issue that emerged in describing the current practice of identifying 
patients‘ problem is the fact that most of the patients meet different HCPs during 
their follow-up and the HCPs, especially the medical officers, did not manage the 
same set of patients.  
 
So when you have different doctors seeing one patient, these different doctors 
tend to, actually, maybe want to hurry up and they don‟t know the 
background of the patients so they only focus on the problem at that current 
time that they see the patients… (HCP19, endocrinologist, HC) 
 
HCP19 is an endocrinologist who meets the same set of patients. She realised, 
however, that most medical officers did not have the same opportunity to review the 
same patients, similarly for the diabetes educators at HC who work on a rotation 
basis. In the excerpt above, she mentioned that this would most probably affect 
patient care in the sense that it would remain superficial and lack continuity, as it is 
only ever based on the issues that are presented and discussed during that particular 
visit. Due to this, she emphasised the importance of inquiring as to any concerns and 
problems that patients experienced between appointments, as has been discussed in 
the previous section of 4.2.2.  
 
I met with a different person on each visit. Sometimes, they wanted me to 
repeat the problem again, which sometimes made me fed up. I also have no 
idea what my problem is. I was like, “Read for yourself”... If we meet the 
same person, maybe we can tell her/him that, “Doctor, after I took the 
medication that you prescribed last time, I felt like this and this”. But when 
we meet with a different person, she/he will say, “You just continue the same 
medication that we prescribed”. So, we just continue. “So far I can see that 
you‟re okay and everything is normal”. So, we‟ll be like, “Okay no need for 
me to tell anything, just go back”. They don‟t provide us with any guidance. 
No guidance is given about anything. (PT12, 29-year-old, Malay woman, HC) 
 
The excerpt from PT12 serves as a further indication of the disadvantages of patients 





person on each visit, experienced frustration and confusion about her health problem, 
as she continued to be asked the same questions on each visit by different physicians 
and diabetes educators. As a result, this patient perceived there to be no visible and 
satisfying result from the management that she received. This seemed to lessen her 
interest in playing an active role in further discussing her problems with the HCPs, 
which was similarly identified by Joseph-Williams, Edwards, & Elwyn, (2014). This 
is not an isolated case, however, as, throughout the analysis, the situation faced by 
PT12 was found to be common and shared by many patients in this study when it 
came to meeting different HCPs, particularly physicians. 
 
When you see them more frequently they will treat you as a friend and they 
will tell you. Like sometimes, they inject everything okay, so I‟ll ask them, 
“How‟s your diet intake?” “Sometimes when I go out and hang out with my 
friends, I‟ll take sweetened milk tea and all that”. (HCP9, pharmacist, CC) 
 
The above excerpt by HCP9, on the other hand, demonstrates the advantage of a 
patient‘s management being handled by the same HCPs for a long period of time. 
Similar to HCP19, this DMTAC pharmacist has the luxury of meeting the same set 
of patients, which she further described as smoothing the information exchange 
between both parties, especially when it comes to identifying a problem at the 
beginning of their encounter as they are already conversant and comfortable with 
each other. This is because multiple encounters with the same HCP will facilitate a 
better, long-lasting relationship between the patient and HCP, which in turn makes a 
significant positive contribution to the development of highly trustful health 
interactions over time (Riva et al., 2014; Dardas, Stockburger, Boone, An, & Calfee, 
2016). Thus, it will further help the HCPs to gain a more comprehensive 
understanding of the patients‘ disease progression, as they have the opportunity to 
discuss the decision that was made in the previous appointment and are also able to 
further discuss any decisions that were not made. This continuity of care is very 





continuously adhere to a way of managing the condition that they are most 
comfortable with.  
 
We do, but again, that‟s a very beautiful word, but it doesn‟t work when you 
have resource constraints. So that‟s what I mean. Personalised care is when 
those with uncontrolled diabetes are supposed to go back to the same MO for 
them to follow up and all that, but we are very short of doctors at the moment. 
Only a few days ago there was an argument between an MCH doctor and 
OPD doctors. Who has to cover who? Because we have the MCH running as 
well. It‟s the same pool of doctors. We don‟t have separate pools of doctors, 
no, unfortunately we don‟t. Because of that, when there‟s so much in the way 
of resource constraints, when we are very short of doctors, sometimes even 
now the appointment rooms are also open as OPD rooms, you know. (HCP15, 
family medicine specialist, CC) 
 
However, this is not easily achieved, especially among medical officers and for 
professionals who work on a rotation basis, such as diabetes educators, pharmacists 
and dietitians, who have to cover more patients compared to other professionals. It 
becomes even trickier for medical officers who have a greater number of patients and 
who are responsible for the overall management of their patients. With this 
realisation, an approach known as personalised care was introduced at one of the 
study sites in a bid to enable diabetic patients to be seen by the same medical officer 
on each visit. However, according to HCP15, despite the usefulness of this approach 
in fostering mutual familiarity, continuity of care and more effective consultation, it 
was a challenge to continuously employ this approach due to the high 
patient/primary care physician ratio and shortages of other resources in the clinic.  
 
If they met other person, they might not feel comfortable as they‟re not used 
to it, but sometimes they don‟t want to try. The problem with the patients they 
do not want to try with other doctors and probably the doctor is better than 
me. So there are still options, but sometimes, when I look at the patients, they 
know you, they like you and then they, they don‟t want to trouble themselves 
to meet other person. But, on and off, for example my patients, sometimes, 
they need to see other doctors… not just for second opinion because the 
doctors that haven‟t seen them will look from different angles, compare to me, 
sometimes I‟ve assumed, “Oh I know this patient very well” and sometimes, 
few things seemed to not triggered you, you know. For example, I know you 





“Eh, why you look different?” Because when we see them, it‟s like when your 
parents see you every day. So, I think they should. That‟s why, if I‟m not 
around, I allow any doctors to see them because I believe that probably there 
will be extra input that will help the patients. (HCP18, endocrinologist, HC) 
 
In contrast, however, it may also be beneficial for patients to meet other HCPs, as 
this can bring new perspectives to the patients‘ T2DM management. HCP18, in her 
account above, believed that other HCPs would view a patient‘s problem and 
condition with a fresh set of eyes and a different perspective, which would result in a 
different management recommendation. A study by Frongillo, Feibelmann, Belkora, 
Lee and Sepucha (2013) further asserted that these patients tend to be more involved 
in making a decision as they have access to a more balanced discussion on the 
different options that are suitable for their health condition. However, HCP18 also 
posits that this may not be easy among patients as they tend to be reserved with 
people with whom they are not familiar, in addition to refusing to meet other HCPs, 
thus meaning more effort is required to connect and interact. 
  
4.2.5  Language barrier 
As mentioned earlier in the introduction chapter, Malay is the national language of 
Malaysia. Nevertheless, not all Malaysians are well versed in the language due to the 
country‘s multiracial society. Despite English being the national second language, 
there are Malaysians who lack proficiency in both languages and who are fluent only 
in their native language. This is especially the case among the elderly population or 
less educated non-Malays, which is mainly due to ethnic segregation in Malaysia‘s 
education system (Raman & Sua, 2010). Examples of situations where the language 
barrier was a factor can also be found in this current study. 
 
Language is very, so tired. So, I will say the words one by one and the 
simplest ones. And what they can do, and for those cases you have to do it 
one way. We can‟t discuss at all, because they can‟t, their vocabulary is very 
limited. For those cases, I‟ll ask what they eat. I will still do the diet recall 
despite the barrier… But we also know some of the food. Like oats, they call 






If they have a problem they will tell. It‟s just they can‟t really speak well in 
Malay. So, this is the main issue for the elderly and less educated. If you use 
simple Malay, still okay, but if you ask more, maybe they can‟t really give the 
answers the doctor want. Sometimes the doctors ask questions, I‟m not sure 
how the doctors ask, but sometimes maybe they can‟t understand. Sometimes, 
some doctors are quite good, they‟ll write down language barrier with 
patients and certain thing doctors ask patients, they don‟t understand they 
will write down there, “Please confirm these with this patient” and then the 
doctor will write language barrier. So, we‟ll ask back, “How you take this 
medication? Doctor wants to know whether you take correctly or not.” Quite 
a few numbers. Because we have a lot of elderly. If the children come 
together with them, okay. But those who come alone, or both also very elderly 
ones, husband and wife, a bit difficult. (HCP9, pharmacist, CC) 
 
As a multi-ethnic country, the different languages spoken and different levels of 
proficiency between patients and HCPs were found in this study to constitute a 
prominent barrier to fostering shared decision-making as they complicated 
information exchange. Despite there being an intention to communicate and discuss 
patients‘ concerns and problems, the information exchange seemed to be extremely 
challenging and impaired, especially in cases when the patient and HCP were from 
different ethnic backgrounds. Comparable with the findings of previous studies 
involving multi-ethnic participants, the descriptions by HCP10 and HCP9 
demonstrate their difficulty in exploring patients‘ problems and in having a more in-
depth discussion on their condition due to the language barrier (Patel, Stone, 
Chauhan, Davies, & Khunti, 2012; Renfrew et al., 2013).  
 
Nonetheless, realising the negative impact of the language barrier, these HCPs 
attempt different methods to overcome the problem, including learning important 
words and phrases that may encourage further information exchange and patient 
participation, referring the patients to another HCP from a similar ethnic background 
and encouraging a family member who is proficient in either Malay or English to 
join the consultation. These efforts may thus reflect an improvement in terms of 
Malaysian HCPs‘ reception and their embracing of their patients‘ contribution to the 






However, there is no evidence of this in the patients‘ data; this may be due to the fact 
that patients who are not proficient in either Malay or English are excluded from this 
study. Haron and Ibrahim (2012) found that almost half of the patients in their study 
preferred to be seen by HCPs of the same ethnicity and with a similar linguistic 
proficiency as this eased communication and understanding (Kim et al., 2000; 
O‘Daniel & Rosenstein, 2008). Yet again, it would be difficult to assign patients to 
HCPs from the same background and this approach is deemed to be ineffective in the 
following account by HCP5 due to a lack of manpower. A similar concern was also 
raised by the participants in another Malaysian study by Y.K. Lee et al. (2012), 
where it was reported that they did not have enough Indian staff to cater for their 
Indian patients. 
 
It‟s hard to imagine what will happen if we do that. I can‟t imagine. Because, 
we only have one Chinese doctor here, so we can‟t expect her to see all 
Chinese patients. (HCP5, medical officer, SC) 
 
4.2.6 Section summary 
The findings and discussion in this section demonstrate a mismatch of expectations 
between patients and HCPs with respect to the assessment aimed at identifying the 
problems to be addressed. Despite being emphasised as an element in the 
management of patients with T2DM (Chew, Vos, Mohd Sidik, & Rutten, 2016) and 
supported by the assertions of the patients in this study, patients‘ psychosocial 
problems are clearly not one of the main agendas that HCPs have in mind in 
managing their patients with T2DM. The HCPs‘ lack of concern in this matter might 
be because patients with T2DM will be provided with on-going care, thus ‗non-
urgent‘ and ‗non-clinical‘ problems can be dealt with later as they face time pressure 
in terms of managing all of the patients who come to their facility. Besides, the focus 
given by most of the HCPs to patients‘ biomedical status seems to prevent them from 
further exploring the roots of the patients‘ problems, which were commonly related 
to psychosocial factors and required active engagement on the part of the patients. 





barrier, which can be related to the patient–HCP interpersonal relationship and 
communication. 
 
4.3 Information and recommendation 
This section discusses the findings that relate to two essential elements in a shared 
decision-making model – presenting options and HCPs‘ recommendations. The 
following four important issues emerged for these two elements: (1) The role of 
HCPs: giving options, recommendation or instructions?; (2) Sequence of options; (3) 
Missing information by the HCPs; (4) Patients perceive they have no other options. 
 
4.3.1 HCPs’ role: giving options, recommendations or instructions? 
If we feel that a particular treatment is suitable for patients, but if we have 
limits based on our quota or budget, we still offer them alternatives. They can 
purchase the medication outside. It‟s not to say, “No, we don‟t have the stock, 
you cannot continue”... Because now, as of now, diabetic medication is so 
advanced, there are so many ways of treating it, if there is a new drug out 
there that is suitable for them and might help achieve very good control, we 
will advocate it and if we don‟t have the facility, we‟ll offer them an 
alternative or an option to purchase on their own. (HCP17, medical officer, 
HC) 
 
HCP17 is among the HCPs who mentioned that, apart from offering options that can 
be provided in the facility, patients also have the choice to opt for a medication that 
they can obtain outside the facility. However, this may not suit every patient, as not 
all patients will be able to afford outside treatment or medication, which is mainly 
provided by the private sector. This will cost them more compared to treatments that 
they can access from government-funded facilities, for which there is usually only a 
minimal charge. Nevertheless, this also illuminates the complexity of the healthcare 
system in Malaysia, which can be both advantageous and detrimental to the 
management of T2DM in general and to the implementation of shared decision-
making specifically as it involves both the private and public sectors. Although a 
wider range of T2DM treatment and management is offered by private health 





government. As such, the much more comprehensive T2DM management at private 
facilities can only be accessed by patients who can afford out-of-pocket payment 
(Thomas et al., 2011). 
 
We‟ll provide them with alternatives. Okay, even though we know that the 
food is not healthy, but I know, we want them to be functional, and a little bit 
happy. (HCP13, dietitian, CC) 
 
The claim resonates in the account from HCP13. In helping patients to adapt and 
adhere to their lifestyle modification, especially a healthy diet, HCP13, as a dietitian, 
presents what she considers to be acceptable choices, which, although they may not 
always be considered the healthiest, are nevertheless acceptable for the patients. This 
provides patients with a greater array of choices and enables them to make an 
informed decision when they are at home and have no immediate access to their 
HCPs. Yet, similar to most of the cases, HCP13 is more likely to present these 
options to her patients if the option that they recommend is more expensive. 
However, she still considered that her recommended option is the best option for the 
patients and viewed other options as inferior to the recommended one.  
 
…in certain conditions, for example, we say, “Okay, I‟ve increased your 
dosage”. So, they have to follow, they must follow that. But in terms of sugar 
monitoring, I‟m more flexible. So, I will not say, “You do this, you follow 
this”. It is not necessary for that. I‟ll ask, “Are you okay with this? Do you 
agree to do it like this?” But in terms of insulin dosage, adjustment, we want 
them to follow us. So, it depends, it depends on what the decision is and it 
depends on the condition. (HCP7, diabetes nurse educator, HC) 
 
The above account by HCP7 is one of the examples of common practice found in this 
study. Similar to many HCPs, HCP7 tends not to provide patients with an option or 
even ask for their agreement when it comes to their medication, especially when it 
comes to the option that the HCP considers to be the best fit for the patient. HCP7 
also clearly prefers to take a paternalistic approach, with her interactions with 





instructions to adhere to, as opposed to information being provided and then 
discussed, which will be further explained in section 4.3.2 of this chapter. On the 
other hand, HCP7 did consider patient involvement when it came to determining the 
frequency with which they performed SMBG and enquiring as to their opinion and 
agreement. This corresponds with the previously discussed practice by HCP13 and in 
the study by Wens, Vermeire, Royen, Sabbe and Denekens (2005), where it was 
found that different options were more commonly discussed when deciding on non-
pharmacological management relating to the patients‘ environment, cultural and 
social status. In this case, the recommended practice of SMBG requires patients to 
buy their own glucometer, strips and lancets, which contrasts with those 
pharmacological modalities in which most of the medications and related equipment 
are provided by the public health facilities in Malaysia.  
 
The presenting of options to patients is considered to be important as it is believed to 
boost equity in the use of and efficiency of the healthcare services (Fotaki, 2014). 
However, Dixon and colleagues (2010) suggested that patients who are offered too 
many options may experience dissatisfaction with the one they are forced to choose, 
arising from their limited access to the other options. This limited access may stem 
from many factors, including their inability to afford any of the alternatives. This was 
referred to by Schwartz (2000) as the ‗tyranny of choice‘ and it may further diminish 
the power or capacity of patients to act (Bourdieu, 1977). Being presented with 
different options may actually benefit neither patients nor HCPs, especially when the 
patients are not fully equipped with the requisite support and information to enable 
them to weigh the ‗pros and the cons‘ of each option that is presented to them (Boyle, 
2013).  
 
A lack of different options being offered by HCPs was also found in the data 
collected from the patients. Most of the patients admitted that there were no, or very 
few, occasions when options other than the recommended or prescribed one had ever 






Look at this, she added another 2, it becomes 20… Injection. That‟s what I 
said just now, when I see them, the injections will increase. They will add… 
It‟s just my diabetes, 10.7. It can be considered borderline, 10. I don‟t know 
how they calculate it….But, actually, I thought to myself, I‟m not, I hope that 
the doctor‟s medication will be good, but I used to stay at the night market, I 
sat there and I saw a lot of traditional medication, I also take it, but I take the 
ones with, not the ones without, I take the certified ones. (PT15, 59-year-old 
Malay man, CC) 
 
Then, he even added the frequency. Haaa, can you see? He‟s adding my 
problem. I‟ll feel even more pain. Then, I asked for other oral medication but 
I saw that he didn‟t really check. There must be other medications that I 
haven‟t tried yet. There must be a lot, right? For me, there must be a lot. But 
it might be limited and my condition is not that bad. So, they prioritise people 
with worse conditions. (PT22, 34-year-old, Malay woman, HC) 
 
PT15 and PT22, besides having their medication added paternalistically, believe 
there was a lack of discussion regarding their condition and that insufficient 
information was given to them regarding the change of their prescription. Despite 
having a positive perception of the reason for the aforementioned practices of his 
physician, PT15 also seemed to have a lack of understanding of his current T2DM 
management. This may be among the reasons why he considered traditional 
medicine, which is popular among Malaysians as an alternative means for treating 
their health problems (Siti et al., 2009). Besides, Malaysians are more exposed to this 
type of medication due to the ease with which it can be accessed and the widespread 
direct-to-consumer advertising in comparison to that for conventional medication 
(Chin, 2005). 
 
If we can share the information with them and they can understand you, 
actually they can follow. Maybe they didn‟t agree with the recommendation 
because they don‟t give the information or they listen to their friends. This is 
the main problem. A lot of patients said, “my friend said…”. (HCP9, 
pharmacist, CC) 
Furthermore, based on health-seeking behaviour, if T2DM patients are deprived of 
the opportunity to seek alternative options and related information, this can often 
lead to a greater tendency for them to seek it from other sources, such as from their 





easily attracted and persuaded by this information compared to the information that 
they receive during encounters with their HCPs, as was evident in the above accounts 
by PT15 and HCP9. This is more apparent in the collectivist Malaysian culture and 
in situations where long-term trustful relationships cannot be formed for reasons such 
as those previously discussed in this chapter. This lends support to the importance of 
discussion being held with patients, which has also been further found to be strongly 
associated with patients‘ non-adherence (Chao, Nau, & Aikens, 2007). 
 
Similar to the finding by Hajos and colleagues (2011), PT22 would appreciate being 
offered different options and related information to consider. However, due to the 
lack of options presented to her, she began to question her physician‘s paternalistic 
decision to increase the medication dosages, which may indicate her lack of trust and 
confidence in the physician‘s professional judgement. This tendency was also 
evidenced in the findings of Price, Bereknyei, Kuby, Levinson, and Braddock (2012). 
Added to this was her physician‘s refusal to enter into a further discussion regarding 
her query about other oral medications and the physician‘s ignorance towards the 
reported effect of her current medication, which further fuelled her scepticism 
regarding the physician‘s intention to provide treatment that best suited her condition. 
Yet she also understood that there may be only limited availability of other options in 
the public health facilities and that there are also other patients whose need for these 
options is greater. 
 
4.3.2 Sequence of options 
The management of T2DM involves complex interactions between biological, 
psychological and behavioural factors of care. Additionally, advances in medical 
technology have led to a wider range of pharmacological modalities for diabetes 
(Tahrani, Bailey, Del Prato, & Barnett, 2011). However, as mentioned in 4.3.1, the 
analysis has shown that it is unusual for options other than the recommended one to 
be presented to the patients in this study. It is also found to be common for the HCPs 






Usually I will ask them first, “Can you do this every day?” If they can‟t, we‟ll 
make a deal. If they can‟t do it, they can do it on alternate days or every 3 
days… There are a lot of options, which means we don‟t force our patients to 
do exactly what we say. They do have other options. (HCP8, diabetes nurse 
educator, HC) 
 
In the above account, HCP8 states that options will be presented if a patient is 
considered to lack the ability to carry out the suggested or prescribed management. 
Such patients will not be forced to carry out their SMBG every day as recommended 
by the Malaysian CPGs (MEMS, 2016) but will instead be presented with other 
options that may suit them better. Yet the practice of such options being presented 
only after patients are deemed unable to perform the recommended option, or they 
disagree with it, may reduce the possibility of all available options being given to all 
patients in the first instance for them to thoroughly consider and evaluate. According 
to Beauchamp and Childress (2013), this is another form of paternalism as it may 
introduce bias since patients might form the impression that they have no option 
other than the recommended one, as further explained in 4.3.4.  
 
In other cases, alternative options will be given to patients who face problems with 
treatment that has previously been prescribed paternalistically by their HCP.  
  
Sometimes, there are complaints, “it‟s hard for me to take it twice”. They‟ll 
tell us. And we‟ll try to adjust it. Usually it depends on the patient‟s condition. 
(HCP11, medical officer, CC) 
 
Based on the above account by HCP11, an adjustment is made for patients who are 
struggling with their current treatment. Most of the time, and similar to the previous 
account by HCP8, only one option will be presented initially, meaning this cycle will 
continue. Some patients will never be aware of or have access to these other options 
as they have not shared their problems based on a belief that there are no better 
alternatives for managing their T2DM. For others, as mentioned in the previous 
section, their problems and needs are not thoroughly assessed. This may pose a 





and evaluate each available option prior to agreeing with the HCPs‘ recommended 
treatment or opting for something else (Elwyn et al., 2012). Besides, presenting only 
the recommended option may serve as a good but subtle indication that the HCPs 
still maintain the belief that their recommended option is the best for patients. This is 
discussed further in section 5.3.1.2 of the next chapter. 
 
4.3.3 Missing information by the HCPs 
At times, whether the patients were presented only with the recommended option or 
different available options, the gathered data revealed that HCPs were generally not 
fully transparent and unbiased with their patients in terms of the information they 
shared. 
 
 Okay by right, CPG HBA1C more than 8 they are supposed to be on insulin. 
But doesn't work that real. Not everybody is going to do that. So over here in 
this setup, we have only 2 types of medication. Metformin and Gliclazide. 
Once they‟re at maximum dose, we really don‟t have other grousp high tech 
medication. So, we have to go with this. We use our resources. So, the next 
option will be insulin. So, we have to convince them…‟ HCP12, medical 
officer, CC  
 
One more thing is, insulin is adjustable. If they take oral medication, they 
can‟t adjust the dosage, but they can do this if they‟re on insulin. So, their 
sugar will decrease and their sugar level can be controlled in the normal 
range. Usually we‟ll make that sort of comparison. When we tell the patients 
that they can adjust the insulin dosage, they will like it. As compared to oral 
medications, if the prescription is one tablet, they can only take one tablet 
and they can‟t adjust it by themselves, whatever happens. For insulin, they 
can adjust it based on their diet. So, patients will be more open. (HCP6, 
diabetes nurse educator, HC)  
 
Based on HCP12‘s account, the HCPs‘ recommended option is usually made based 
on the Malaysian CPGs for T2DM. To reiterate, the CPGs promote the early 
optimisation of diabetes medications in an effort to achieve glycaemic control and 
prevent complications (MEMS, 2016). This includes the early initiation of insulin 





glycaemic level. However, similar to patients in other parts of the world, Malaysian 
T2DM patients often have a negative perception of insulin and prefer to manage their 
T2DM using all other available means, including complementary therapies, prior to 
starting insulin therapy (Peyrot et al., 2005; Y.K. Lee et al., 2012). Between this and 
the lack of treatment options available at the study sites, the information presented 
with regard to deciding upon insulin initiation is often geared towards convincing 
patients to agree, as illustrated in the above accounts by HCP12 and HCP6. The 
account from HCP6 further shows that even though this nurse stated that she made a 
comparison between the oral medications and insulin, she made a point of only 
emphasising the advantages of insulin injections, with no mention of the advantages 
of oral medication. This may serve as an indication that the options were not 
presented equally, as suggested by the shared decision-making model (Makoul & 
Clayman, 2006). Comparable to this is a study by Guerrier, Légaré, Turcotte, 
Labrecque, and Rivest (2013) which found that among HCPs with prior training on 
shared decision-making, their intention to follow the CPGs often reduced their 
intention to engage patients in shared decision-making.  
  
…we‟ll tell them about the medication and all but we‟re lacking in terms of 
side effects of the medications. We don‟t have enough time to explain in detail 
and we‟ll hand it over to the pharmacist. Usually, we‟ll explain about the 
medication that we have prescribed and why they have to take it and all, but 
not so much information about the drug itself. Because the pharmacists are 
the experts on that. (HCP11, medical officer, CC)  
 
Actually, all of that should be told, but I‟m not sure, and I don‟t want to 
blame anyone. But then we also don‟t know whether our patients are having 
side effects after the prescription or not… Maybe that‟s why sometimes when 
the patients have no courage to tell. They stopped the medication by 
themselves. They stopped and then we ask whether they take their medication 
or not and we‟ll ask in detail. If they tell us, “I stopped taking it a long time 
ago”, then we‟ll ask them “Why?” They‟ll tell us, “Abdominal discomfort”. 
So, that‟s one of the side effects of the prescribed medication. So, we‟ll say, 
“Actually that medication is good but if the patient is experiencing any side 
effects from it, we‟ll recommend other medication but from the same group”. 






The analysis of the data in this study also demonstrates that it is common for patients 
to not be fully informed about the possible side effects of the recommended 
medications, as illustrated in the above accounts by HCP11 and HCP14. A study by 
Sibley and colleagues (2011) had similar findings in that concerns about medication, 
including side effects, was one of the elements least frequently discussed during 
prescription despite it being the issue most commonly raised by the patients. 
According to Latter, Maben, Myall & Young (2007), this is frequently associated 
with a covert effort by HCPs to obtain the agreement of patients. Furthermore, a lack 
of discussion on the negative effects of the recommended option may be a way in 
which HCPs seek to maintain control over both the ability of their patients to choose 
and their behaviour, as asserted by Lanceley (1985) and Laverack (2005). In this 
study, although it may appear that they are providing their patients with a range of 
options for consideration, the way in which the information relating to these options 
is presented is often subtly shaped by the HCPs so that patients will tend to agree 
with their recommendations as opposed to using their own free choice based on the 
presentation of unbiased information from their HCPs.  
 
However, the above accounts by HCP11 and HCP14 also demonstrate 
misunderstanding between different groups of HCPs in terms of the responsibility for 
providing such information to patients. Based on HCP11‘s account, information on 
the prescribed medication may not be fully discussed by physicians as they believe 
that further discussion will take place between the patient and the pharmacist. Yet 
many non-physician HCPs, including the pharmacists, perceived this to be the 
responsibility of the physicians as part of issuing the prescription, as asserted by 
HCP14. This confusion with regard to the responsibility for informing patients about 
one of the most important aspects of the medication serves as evidence of the 
complexity of involving different groups of HCPs and points to the need for 







In addition, the lack of attention to information on the side effects of treatment serves 
as a possible indication of HCPs‘ belief that medication-related side effects are often 
exaggerated (Williams, Manias, & Walker, 2008). As a result, much important 
information regarding the chosen treatment fails to reach patients, along with a lack 
of presentation of other available options. HCP14 also mentioned that most patients 
were reluctant to or did not share problems they faced with their medication, which 
may be due to the way information about it was communicated to them (as explained 
in 4.1.2), or because the information was never presented to them in the first place. 
Typical consequences of this are prolonged self-modification or discontinuation of a 
course of medication, as illustrated in the above account by HCP14 and the below 
account by PT12. 
 
PT12: She just asked me to try the medication. She said because my sugar is 
high, „So you try this medication.‟ Then I took it once, but I wasn‟t feeling 
very well, so I stopped. 
R: How long have you stop the medication? 
PT12: Quite long as I only took it once. That‟s why I needed to admit to the 
hospital as I wasn‟t feeling very well. (PT12, 29-year-old, Malay woman, HC) 
 
PT12 is one of many cases in which medication was prescribed paternalistically with 
neither a presentation of the other available options nor any discussion on the 
prescribed medication. This is in contrast to the assertion by Heisler and colleagues 
(2003) that patients who agree with the recommended management receive better 
information as that form of management is thoroughly discussed by the HCPs. Due 
to a lack of information, PT12 ceased taking her medication after only one dose. She 
then sought no further help despite finding information on the Internet that the 
symptoms she was experiencing were consistent with those of the side effects of her 
medication. This account is comparable with previous studies in which patients who 
were found to lack knowledge about their management, including their medication, 
displayed a greater tendency for non-adherence (Chao et al., 2007; Nair, Levine, 
Lohfeld, & Gerstein, 2007; Aiken & Piette, 2009; Gimenes, Zanetti, & Haas, 2009; 





patient was admitted to hospital with pneumonia, which is a common complication in 
uncontrolled diabetes (Torres, Blasi, Dartois, & Akova, 2015).  
 
No, no one has ever mentioned about the side effects of my medication. But 
we know, there are chemicals or substances that enter our body which can 
cause our kidneys to work harder I understand that and that‟s why, in the 
beginning, I just couldn‟t accept that I had diabetes, as I couldn‟t accept that 
I had to take medication. (PT11, 36-year-old Malay woman, HC) 
 
I have to eat brown rice, right. As for wholemeal bread, sometimes I can‟t 
take eat it anymore, as I‟m eating it too often. Sometimes, I just can‟t 
control…I don‟t know how to ask. Don‟t know what to ask. (PT7, 47-year-old, 
female, SC) 
 
In the case of PT11, the lack of information from HCPs led to her generalising her 
existing knowledge of the side effects of her previous medication and subsequently 
applying this knowledge to her newly prescribed medication. This further 
underscores both her need and right to receive unbiased, sufficient information, 
including the potential side effects, of all suitable management options. The findings 
by Mann and colleagues (2009), supported by DiMatteo, Haskard-Zolnierek, & 
Martin (2012), demonstrate that a failure to fulfil patients‘ need for information is 
likely to encourage their non-adherence. Such non-adherence can also be sensed in 
the above account by PT7, which may be due to her lack of understanding regarding 
the advice given by her HCPs. Besides, similar to many of the patients in this study, 
PT7 admitted that she did not enquire further as she was unaware with respect to 
what to ask for and how to ask for it. 
  
Like just now, he only said, “Liver okay, sugar high”. He only said that. I 
said, “What is the (sugar) reading doctor?” Then he opened back, “For the 3 
months test is 11, and the fasting sugar today is 13”. “How about my liver?” 
“Liver is okay, in the normal range”. Then I asked, “What is the value where 
the liver no longer okay, doctor?”  So, I‟m the one who asked a lot of 
questions. If not he only said to me like that, “Liver is okay, sugar for 3 
months is high”. Then I wasn‟t satisfied, he opened back because I asked him. 






However, there are also patients who will ask for the information they need, as 
illustrated above in PT22‘s account. PT22‘s enquiries were made with the intention 
of obtaining a better understanding of the T2DM condition and its management. This 
is aligned with the evolving culture in Malaysia in which Malaysian people are no 
longer comfortable with ambiguity and are becoming increasingly concerned about 
their future (Hofstede, 1984; Ken & Ying, 2013). Thus, in this study, the increased 
Malaysian score for uncertainty avoidance can be translated into patients wanting 
more knowledge and information to help them navigate their T2DM management 
and avoid both its side effects and complications. Supporting the importance of this, 
previous studies have also found that most of the patients involved believed that they 
needed this information and that their HCPs should not withhold it (Ziegler, Mosier, 
Buenaver, & Okuyemi, 2001; O‘Brien et al., 2013). 
 
4.3.4 Patients perceive they have no other options 
The analysis further reveals that due to the way information on different options is 
delivered, as explained in 4.3.1, 4.3.2 and 4.3.3, some patients feel they do not have 
any option other than to acquiesce to their physician‘s recommendation, even in 
situations where they have been presented with other options.  
 
R: So the doctor did give you choices? The other choice is another oral 
medication? 
PT2: Add another oral medication, but it is not advisable because it will damage 
the kidneys. Actually, the medicine that I‟m currently on is also bad for the 
kidneys, but if I add another one, it will become worse. So, she advised me not to 
do it. So, the doctor suggested that I go for insulin, and though I really don‟t like 
it, I have no choice... 
R: So you have to take the oral medication together with insulin? Or just the 
insulin? 
PT2: No no no. They are giving me the medication and also insulin. So, I wonder, 
why they are giving insulin and the medication. 





PT2: No, I will ask her after this. That thought just came to me only. I didn‟t, but 
they are giving me both? The doctor also wrote it. (PT2, 61-year-old Indian man, 
SC) 
 
PT2 did not consider any options other than the one that was recommended. For PT2, 
this perception may have developed due to a combination of the aforementioned 
reasons and his trust and high regard for the physician‘s expertise, a factor that is 
also mentioned in 4.3.1. This led to the patient choosing to agree with the HCP‘s 
recommendation to start on insulin, which he actually rated as his least preferred 
option despite also being presented with his preferred option of adding another oral 
medication. Similar to the recommendation of the existing model of shared decision-
making, a degree of tolerance needs to be shown by both sides when seeking to 
determine the best option for the patient, which also means there is always the 
possibility of either side‘s preference not being fulfilled (Makoul & Clayman, 2006). 
Yet, as asserted previously, sufficient information needs to be given to patients in 
order for them to have the comprehensive understanding needed to reach this kind of 
decision, which could be described as less preferred and difficult yet necessary 
(Elwyn et al., 2012). In this case, the information shared by the physician may be 
considered as deficient and biased, with the previous excerpt revealing that PT2 had 
a misunderstanding concerning his pharmacological modalities. He was under the 
impression that he would no longer need to take his oral medication if he started on 
insulin. However, this was not the case as he was still required to take his previous 
dosage of oral medication in addition to the newly prescribed insulin.  
 
 … they did tell me what food I should avoid. There‟s a lot. Even the rice, I 
only can take one-quarter of the plate. It‟s too little. Sometimes I just eat one 
whole plate and I even add some more. They also advise me not to take curry, 
rendang, coconut milk, sweet sour and all. They asked me to only take broth. 
That‟s it. But I don‟t follow. They even ask me to avoid paratha. They said 
only once a week. But I just ate everything. (PT21, 66-year-old, Malay man, 
CC) 
PT21, on the other hand, as outlined above, considered that he had no choice but to 
strictly follow the advice given by his HCPs due to the lack of explicit food options 





to completely disregard the advice as he felt it was too difficult to follow. These two 
accounts serve to strongly indicate that neither patient was fully informed of the 
treatment options or able to thoroughly discuss them with the HCPs. This finding 
also supports the suggestion that it is important for all of the available options to be 
fully discussed and for patients‘ preferences and values to be thoroughly explored 
prior to HCPs giving their recommendation (Robinson, Callister, Berry & Dearing, 
2008; Sandman et al., 2012). 
 
4.3.5 Section summary  
Overall, the findings discussed in this section indicate that the practice of information 
provision is lacking among the HCPs. The findings from this study are similar to 
those of Aasen, Kvangarsnes, and Heggen (2012), whereby the HCPs often shaped 
the information given to the patients so that they would agree with their 
recommendation or prescription, instead of facilitating discussion on the most 
suitable option for the different patients. HCPs will do this by presenting the 
recommended option prior to other options and by providing insufficient and biased 
information regarding the options. This is especially the case in relation to decisions 
on patients‘ pharmacological modalities compared to other forms of T2DM 
management. Due to the way in which the options, related information and 
recommended choice was presented, most patients felt compelled to agree and then 
encountered difficulties in carrying out the chosen T2DM management on a daily 
basis. Besides, the patients in this study appeared to want more information about 
their management and the other options available for their own T2DM case. 
However, due to a lack of skill and knowledge, their need for information was not 
typically shared with their HCPs. Finally, when it comes to the presentation of the 
available options, risks and likely benefits in terms of the heightened opportunity for 
patients to be involved, there are some dissimilarities and inconsistencies in the 
overall data.  
4.4 Discussion and deliberation 
Charles and colleagues (1997) asserted that the presentation of all of the suitable 





crucial to allow patients to evaluate and deliberate, in addition to enabling them to 
develop their ability to self-manage their T2DM. Following the findings presented in 
the previous section 4.3 on the lack of presentation of options and related 
information, the analysis also found that there was a lack of discussion and 
deliberation in making decisions for T2DM patients at the study sites. Besides, only a 
small handful of the HCPs elicited and discussed their patients‘ preferences and 
values in an effort to ensure that the chosen option matched their preferences and 
values. This section presents and discusses the following two important HCP 
practices pertaining to discussion and deliberation: (1) deliberating or persuading 
patients to agree?; and (2) flexibility and compromise with patients.  
 
4.4.1 Deliberating or persuading patients to agree? 
The data in this study reveals that most of the HCPs‘ deliberations with their patients 
were geared more towards seeking patients‘ agreement with their recommendation, 
as shown in the accounts from HCP12 and HCP5 below: 
 
Usually you have to ask them why, we‟ll explore why and then I‟ll try to re-
counsel them. Try to reason with them, try to show them, “you see all of this 
is happening, your sugar is just going up, you‟re gonna get complications 
soon”. Usually I will count the risk score in front of them and say, “Okay 
madam you see you are at so-and-so risk of having a heart attack”. So, once 
they understand they become receptive, but some still don‟t want to. We have 
to persuade them repeatedly because, as I say, we don‟t really have many 
treatment options. Reasoned with them. (HCP5, medical officer, SC) 
 
…but the most important thing is we have to get their agreement. (HCP13, 
diabetes nurse educator, CC) 
 
Similar to the findings discussed in section 4.3.2, HCPs evidently often persuaded 
and convinced patients to agree with their recommended treatment, especially with 
regard to starting on insulin therapy. This is more aligned with obtaining patients‘ 
consent (General Medical Council, 2008; Malaysian Medical Council, 2016) than it 





preferences and values so that these could be taken into account when making the 
decision (Makoul & Clayman, 2006; Elwyn et al., 2012). This is further discussed in 
section 5.3.1.1. 
 
HCP5 continued to discuss the reasons for patients‘ refusal of the recommended 
treatment, in this case commencing insulin therapy, and emphasised the benefits it 
would bring in terms of controlling their glycaemic level and preventing 
complications. Rather than being overly concerned with ensuring patients truly 
understood insulin as a form of treatment, most of the HCPs were more concerned 
with ensuring patients agreed to begin using it, which often resulted in the sharing of 
biased information. Loewenstein, Brennan and Volpp (2007) termed this practice 
asymmetric paternalism, whereby discussion of the available options was shaped by 
the HCPs in order to direct patients to the recommended option while at the same 
time not depriving them of their right to other suitable options and the related 
information. Politi, Lewis, and Frosch (2013) suggested that this practice is common 
when there is little in the way of clinical evidence as to the effectiveness of other 
options. As such, a similar practice of persuading and convincing patients was found 
across the data, even with the non-physician HCPs. The excerpt from HCP9 below is 
one such example. 
 
I can‟t say we can make together, but sometimes we can ask patients‟ opinion. 
But making the decision together I think we must convince the patients to 
follow the treatment the doctor wants to give. If we can share the information 
with them and they can understand you, actually they can follow. (HCP9, 
pharmacist, CC) 
 
4.4.1.1 Perceived intimidating messages 
On many occasions, some of the patients believed that as well as not having enough 
discussion on the decision to be made, they mostly felt pressurised or even 






Sometimes when we have to say, “If your sugar is continuously like this, the 
doctor said to me that she wants to discharge you from this hospital. We are 
the specialist hospital here and if your sugar is still not controlled it means 
that we‟ve failed in managing your diabetes. So, you can go back to the 
health clinic, we discharge you. Do you want that?” We say it like that and 
only they‟ll be like, “Oh okay”. (HCP7, diabetes nurse educator, HC) 
 
 She threatened me. I‟m not really keen on the way she delivers the message, 
“If you feel that you that you want to pregnant, you have to reduce your 
weight”. It‟s like she threatened me. But the message didn‟t come across. I 
don‟t really pay much attention to her after that. (PT12, 29-year-old, Malay 
woman, HC)  
 
The above accounts reveal that these intimidating messages were not only in the 
form of the most serious and feared complications but also included the 
consequences that the patients may have faced if they did not agree with what the 
HCPs perceived to be the best option for them. The excerpt by HCP7 provides an 
example of the way in which the HCPs communicated this information. This will 
most probably further reduce patients‘ intention to become involved in a discussion 
about their health decision in addition to them being intimidated by the complexity of 
the decision-making process (Frosch & Kaplan, 1999). The perception of these 
messages as threatening can be detrimental for some patients, with PT12 as an 
example. PT12 admitted to being likely to disregard such emotionally charged 
messages despite being aware of their significance (Lawson, Bundy, & Harvey, 2007; 
Matthews, Peden, & Rowles, 2009). 
 
Their high voice is one thing. It‟s the tone of their voice. The doctors should 
be more prudent. They should not intimidate people. Cut their legs, insulin 
and all. (PT18, 55-year-old Malay woman, CC)  
 
Additionally, as mentioned in subsection 1.5.1, Malaysia is a society with high-
context communication in which implicit communication, which includes tone of 
voice, facial reaction and body gesture, is as important as direct communication (Hall, 
2000). Thus, the complaint from PT18 is not unusual and is actually one that is 





barrier to patient involvement in decision-making for their T2DM management. It 
would also appear from PT18‘s excerpt that insulin initiation is used by HCPs as a 
way of intimidating patients. This may lead to patients developing bad 
misconceptions with regard to this pharmacological modality and may also influence 
their preference and practice of it in the future (Brod, Alolga, & Meneghini, 2014). 
 
Usually, we‟ll re-counsel them. We have to explain why we want to start 
insulin. We have to draw the picture of pancreas and everything. There is 
impairment here, you might have to do dialysis and all. We threaten them a 
little bit. For some patients, it has been so long since the first time it was 
suggested for them to start on insulin. They‟ve been talked about this by the 
staff for quite sometimes and they keep on rejecting. (HCP11, medical officer, 
CC)  
 
Nonetheless, in further investigating this approach from the HCPs‘ perspective, it 
was found that they tended to use it owing to a frustration with their patients‘ 
stubbornness. They may therefore have felt the need to be a little more aggressive 
with their patients in order to get them to agree with their recommended management, 
as was also identified by Wens and colleagues (2005). Similar to the study by Wens 
and colleagues, the accounts from HCP7 and HCP11 in this subsection reflect the 
HCPs‘ belief in the effectiveness of this approach as one that would put pressure on 
the patients to agree and comply with the suggested option despite the potential for a 
fall in both their satisfaction and perception of self and identity (Hornsten et al., 
2005). However, C. Price (2009) argues that this pressure is necessary if there is no 
option left to offer to the patient. There may be many reasons for this, including a 
lack of resources or the treatment option in question being the only one that will suit 
the patient‘s condition. 
 
4.4.2 Flexibility and compromise with patients 
On the other hand, the analysis has also shed light on the fact that some of the HCPs 
are eliciting patients‘ needs, preferences and values, in addition to being flexible with 





For the active ones, I like to know what their preferred choice is first. What is 
it that they want, we jot it down and what are the choices that I can give to 
them? Because for these active patients, they have a lot of ideas but we can‟t 
take all. Okay, after they gave their ideas, and I gave mine, we‟ll discuss. If 
let‟s say I can accept their idea, we can include it in their management but 
let‟s say, if I think the second part is not that suitable for them, and I have a 
better option, “If you think that you can follow my plan, we merge it. It is not 
necessarily all of these plans of yours we‟ll accept. Just the plan A. We might 
combine plan A and plan B, but we will discard those that we think are not 
suitable.” So, usually they‟ll try to say, “eh, but I am”… even though they 
have a lot of ideas but they feel that, it‟s not really confirmed. So we‟ll say to 
them, we can discuss what‟s the best. (HCP13, diabetes nurse educator, HC)  
  
There are patients who want to do the monitoring every other day, then we‟ll 
see which time in course of the day that they want to do it. Is the time suitable 
with their method, insulin and all? If it is not suitable, we‟ll change it again. 
Let‟s say they want their insulin need to be injected 2 times a day, morning 
and evening, but they want to check their sugar in the afternoon which is not 
practical to their condition, so we say, “Okay, it‟s okay if you want to do that 
but I would prefer if you do like this”, and then we explain to them why. So 
they‟ll understand. All of these things depend on the suitability. (HCP7, 
diabetes nurse educator, HC) 
 
Some of the HCPs in this study understand the importance of being flexible with 
patients. For these HCPs, even though they believe that the available guidelines are 
beneficial in terms of helping them in the management of patients with T2DM, it is 
also important for them to consider their patients, as every patient is a different 
individual with different preferences and backgrounds, and the guidelines may not 
suit their particular condition and needs. This is termed by both Charles and 
colleagues (1997) and Makoul and Clayman (2006) as negotiation and usually occurs 
when the patients have verbalised a preference for doing something other than the 
recommended option, thus potentially generating conflict. Usually, the HCPs will 
negotiate in a bid to find some middle ground between the recommended option and 
the patient‘s request. For these HCPs, both their recommended option and the 
patient‘s preferred option will be fully explored and they will endeavour to identify 
something that both sides can work with. Nonetheless, both HCP13 and HCP7 





as maintaining their position as the health expert and that they can still help patients 
to understand why their preferred option might not be good for them.  
 
However, aside from their intention to ensure that the chosen and planned 
management can be better carried out by the patients, it can be argued that another 
reason for HCPs to enter into discussion is to find a better way to convince patients 
to accept their recommendation, based on the premise that the patients can be 
persuaded that the recommended option is better than their preferred one. Sandman 
(2009: p. 238) makes the assertion that “... if the conflict is resolved or disappears as 
a result of rational deliberation, this cannot be characterised as a compromise or as 
not as optimally satisfying the interest of the parties”. This effort should not be 
viewed lightly, however, as it is an indication that the HCPs are beginning to open up 
to the idea of taking patients‘ opinions into consideration in the decision-making 
process, to ensure that the planned management will suit patients‘ individual 
conditions, needs and values. Brown and colleagues (2002) found the early 
acknowledgement of a patient‘s preference by HCPs to be the most useful way of 
encouraging their involvement in decision-making. This is very similar to the 
practice by HCP13, as illustrated in her excerpt above. This finding also reflects how 
the HCPs listen to their patients‘ needs and concerns, which is vital in therapeutic 
communication not only from the western perspective, as asserted by Saba 
colleagues (2006) and Entwistle and colleagues (2008), but also from the Asian 
perspective in particular (Claramita, Nugraheni, van Dalen, & van der Vleuten 2013).  
 
4.4.2.1 Patients trying different options 
In this study, some patients were allowed by their HCPs to try their preferred choice, 
while other patients were asked to try their HCPs‘ suggested option, in order to help 
them identify the option that they were most comfortable with. Giving patients the 
opportunity to choose their preferred option themselves is a good indication of 






Actually about the suggestion by the private doctor, I did ask the doctor here, 
“Can I try this medication?” He said okay, if I am brave enough to try. Try it 
for one month, and see whether it will help or not, and if not, I should stop. 
(PT24, 44-year-old, Malay woman, HC) 
 
According to PT24, she was allowed by her doctor to try her preferred medication, 
but the above account also illustrates that the physician was not overly optimistic 
with regard to its effectiveness over that of the recommended treatment. It seems that 
the physician was allowing PT24 to try her preferred option as a way of proving to 
her that it would be neither effective nor suitable, meaning the patient would 
eventually agree to the recommended option. This is one way in which HCPs can try 
to convince patients that their recommended treatment method is the best and works 
as a subtle way of them avoiding any conflicts in their effort „to right the wrong‟ 
(Shea, 2016: p. e249).  
 
…and what I do sometimes is the ones that are 50-50, whether they want to 
take it or not, I try to bargain with them, “Okay, aunty, I‟ll give like 2 weeks 
for you to try first, and if you can‟t do it, it‟s fine I‟ll remove it and we can try 
again some other time”. (HCP5, medical officer, SC)  
 
In other cases, HCPs tried to bargain so that their patients would agree to try the 
suggested treatment. By extending an offer for a patient to carry out their own 
experiment with the suggested treatment, HCP5 hopes that her patients will be 
persuaded that it is not as bad as they think and will agree to continue with it. 
Whether allowing patients to try their preferred option or asking them to try the 
recommended option, it would appear that both approaches have the same objective 
on the part of the HCPs; that is, to persuade their patients to ultimately provide their 
implicit agreement for the recommended treatment. Even though persuasion in this 
context is deemed acceptable by Shaw and Elger (2013), it does deviate from the 
main objective of the shared decision-making approach, which is to ensure that the 
most suitable option for each patient is identified and selected. However, in the 
defence of the HCPs, patients may not be able to correctly identify which option suits 





aligned with the assertion by Montori and colleagues (2006) that shared decision-
making in T2DM allows patients to try different options due to the chronic nature of 
the condition.   
 
4.4.3 Section summary 
Following on from the previous section of 4.3, where the presentation of options and 
their related information was seen to be routinely biased, scarce or even non-existent, 
a similar finding has also been shown for when there was discussion involved in 
making the decision. There was only limited investigation of patients‘ preferences, 
and discussion or negotiation was generally shaped to influence these preferences so 
that the patients would agree with the HCPs‘ recommendation. The latter was 
routinely carried out using persuasion and intimidation, which is akin to the finding 
by Greenfield, Kaplan, Ware, Yano and Frank (1988) and further supported by 
Upton and colleagues (2011). These findings highlight the lack of deliberation 
practice among HCPs in the study context. Nonetheless, most of the HCPs in this 
study use this technique of persuasion and intimidation as they believe it to be 
effective in protecting their patients from options that they believe may be harmful to 
them, while at the same time trying to respect their autonomy.  
 
On the other hand, some of the HCPs aimed to elicit their patients‘ preferences and 
engage in a discussion about the ‗pro and cons‘ of each available option so that a 
middle ground could be found. In some cases, HCPs also suggested that patients then 
try to change the management so that the best option may be identified to fit each 
individual patient. Both of these are examples of patients being offered an element of 
flexibility and are parallel to the recommendation within many of the existing shared 
decision-making models (Charles et al., 1997; Makoul & Clayman, 2006; Elwyn et 






4.5 Final decision 
Politi (2013) asserts that shared decision-making does not include an obligation for 
the final decision to be made equally by patients and HCPs. Street, Makoul, Arora 
and Epstein (2009), on the other hand, highlight the importance of a mutual 
agreement by both sides on the decision that is made. In making the final decision, 
the data from the participants in this study reveal the following three main 
approaches: 1) HCPs making the final decision; 2) patients and HCPs deciding 
together, and 3) patients making the final decision.  
 
4.5.1 HCPs making the final decision  
The most common situation to have emerged from the data is that the HCPs play a 
greater role and have more responsibility in making the final decision. Through their 
personal accounts and from the further analysis, most of the HCP participants are 
seen to believe in the benefit of involving patients in discussions about their 
condition, preferences and values, although it is the HCPs who make the final 
decision and this is then agreed by the patients. 
 
So I tell them, “This decision, I can make this decision very easily, but this 
medicine is going into your body, so yes we have to have the discussion, you 
and I will discuss the pros and cons, but the final decision, you have to allow 
that to be mine… You have to trust that I‟m giving you this medicine to help 
you.” Because if I left the decision to them, they would say, “no, I don‟t want 
the medicine”. They don‟t want any medicine. They want their diabetes to be 
magically managed. I guess it makes sense, nobody wants to take medication. 
So I explain that to them. I explain, “This is the discussion because you need 
to be aware and you have to share the decision-making, but you need to 
understand the final decision should be the doctor‟s. You know, because if 
you tell me, “no, I don‟t want this”, I can‟t just write there, the patient 
doesn‟t want this medication. (HCP15, FMS, CC) 
 
From this account, HCP15, as the FMS, clearly demonstrated her perspective on the 
HCP being the decision maker, recognising that they are the experts in the medical 
field and not their patients. This was despite her awareness of the benefits of shared 





opt for any medication as they ideally want their T2DM to be miraculously cured. 
This suggests that she most probably lacks trust in a situation where her patients are 
involved in the decision-making process, believing they would not actively 
contribute to the selection of what she considered to be the best treatment; this is 
again despite her recognition of the importance of holding a discussion with her 
patients as part of the process. This is supported by Saba and colleagues (2006), who 
mention that trust in shared decision-making is bidirectional.  
 
HCP15 also believes that decision-making is shared with her patients as she 
encourages discussion in the earlier stages of the process, which differs from the 
assertion by Politi (2013) regarding shared decision-making. Nevertheless, as the 
objective of the discussion is mainly to instil a better understanding in patients of 
their condition and the prescribed treatment, with a view to them being more 
accepting of and adhering to it, this may lead to a lack of the exploration and 
consideration of patients‘ preferences and values that is deemed to be the essential 
basis for shared decision-making. HCP15 also appeared to detest the idea that she 
needed to report patients‘ rejection of her recommendation. Among the cases 
referred to her were patients that her subordinates were unable to manage; as such, 
her failure to make the patients agree could be perceived as an inability to fulfil her 
expected role as an FMS. 
 
Patient involvement, well, for me, I always practise shared decision-making 
for my patients. I do not force patients. To me, I always have an open kind of 
discussion regarding options for therapy. But the typical patients may feel a 
bit more comfortable when the doctor decides for them to do next because of 
their background knowledge and awareness is less. (HCP19, endocrinologist, 
HC) 
 
So, they come they look at you in a very blank way, you know, you have to 
push them to get interested, when we are talking about management, they say, 
“You‟re the doctor, you decide”. The problem is I don‟t think that we want to 
make the decision for the patients, the reason we decide because they don't 






I don‟t really mind, as long as they take good care of me. (PT6, 54-year old 
Malay woman, SC) 
 
On the other hand, some of the HCPs, HCP19 and HCP15 for example, outlined how 
patients often give them the final decision-making power despite being encouraging 
to become involved in making a decision. This is comparable to Levinson and 
colleagues (2005) who revealed that, despite the patients in their study appreciating 
shared decision-making, half of them preferred for the final decision to be made by 
HCPs. It is presumed that this preference will be more apparent among Malaysian 
patients who come from a collectivist and high power distance culture where HCPs 
are often viewed and respected as people who are wiser, as is apparent in PT6‘s 
account. In Malaysia, HCPs are seen as benevolent authority figures in the health and 
medical fields, and it is common for patients to make every effort to avoid the 
uncertain consequences of disagreeing with them or requesting other options 
(Kennedy & Mansor, 2000; Khairullah & Khairullah, 2013). PT6‘s account is also 
comparable with a study by Peek and colleagues (2008); here, the study‘s patients 
did not mind how the decision was made, including paternalistically, as long as the 
HCPs took good care of them and provided them with sufficient information.   
 
4.5.2 Deciding together 
I believe from the beginning of their diagnosis till the point of continuation of 
care with them, they‟re always needed, it‟s almost necessary that they are 
involved in the decision-making process of what sort of treatment they are to 
receive. It is not gonna be a one-sided, or only physician directed decision-
making for the patients, cause at the end of the day, the patients are the one 
who received the care and they would benefit most in treatment or 
modification which is suitable for them. (HCP17, medical officer, HC) 
 
Some of the HCPs openly stated that they involve the patient in making the decision. 
HCP17, for example, prefers for the final decision to be made together and she 
usually tries to find an option on which both parties agree. This aligns with the 
recommendation by Charles and colleagues (1997) that shared decision-making is a 





preferences will be fully satisfied. HCP6‘s preference for deciding together was due 
to her belief in the greater benefit that this approach would bring for the patients, 
which is akin to the findings by Desroches, Lapointe, Deschênes, Gagnon, and 
Légaré (2011). 
 
I think it should be okay, because sometimes we don‟t understand which 
medication will suit our condition. But for me, even though the doctor knows 
about medications but have they ever taken those medications? So, we‟re the 
one who takes it and experience the effect. So, the doctor, for example, they 
may advise us and for us we have to tell what our problem is too. So, from 
there, maybe they could combine all of the information gathered and try the 
most suitable one. We‟ll continue taking the medication if we don‟t have a 
problem or side effect from it. If I experience any of it, I might discuss back 
with them, to see what else that we can do. (PT12, 29-year-old, Malay woman, 
HC)  
 
PT12 expressed her preference for a decision to be made together as the input of both 
patients and HCPs is important to ensure that the best option is chosen. The fact is 
that it is the patients who have to carry out the management and experience the effect, 
whether this is positive or negative, and PT12 believes it is crucial for patients‘ views 
to be taken into account when determining the treatment. Being involved in making 
the decision in the first place would mean she also felt more comfortable to share, 
further discuss and perhaps find a better way if it was felt that the current 
management was not suitable. Moreau and colleagues (2012) found that the patients 
in their study viewed shared decision-making as this type of interactive process, 
whereby most of the young and middle-aged patients preferred for the decision to be 
made together. The account from PT12 also clearly indicates that she feels 
responsible for her own management since the decision was made by her and her 
physician and, due to shared deliberations, she understands that there are also other 
options if the current agreed management does not work for her. This suggests a 
strengthening of patients‘ sense of empowerment through the bidirectional transfer of 
knowledge and therapeutic alliance between patients and their HCPs (Moreau et al., 
2012). Further explanation and discussion on patients‘ sense of empowerment is 





4.5.3 Patients decide  
In rare situations, certain HCPs state that they would let patients make the decision 
after having given them all of the available options and related information, which is 
termed informed choice or autonomous decision in some of the literature. 
 
…we must give them two options, you know. If you want to do the dressing 
with dermacyn, you also can. The healing process will still take place, but 
more slowly. So, we will leave her on that, but we will ask them to put a little 
bit of cream and all, so that the puss from deep inside will come out. (HCP1, 
staff nurse, SC) 
 
From the data gathered, this permission is more apparent in non-pharmacological 
management, with patients usually being able to modify their treatment based on 
their judgement, preferences and values at different times and conditions throughout 
their disease process. For this type of management, patients will usually have the 
opportunity to test and modify the management in order to find the method that suits 
them best. The account by HCP1 is an example; here, the patient has to attend the 
clinic at least once every three days for the purpose of diabetic wound dressing, with 
the method recommended by their HCP incurring an extra cost that would have to be 
borne by the patient. In this case, the patient has more opportunity to be autonomous 
and try different options compared to trying out different medications that can only 
be changed when they meet with the physician, usually at intervals of at least two 
months. This may also be the reason why the HCPs are more open to their patients 
being involved in the making of non-pharmacological decisions compared to the 
more authoritative decisions related to their medication.  
  
Because I‟ve tried all oral medication and it caused diarrhoea. So, I wasn‟t 
comfortable, as I had to run to the toilet every day. Then, I asked for it 
(insulin). Actually, at first the doctor seemed reluctant to prescribe me the 
insulin as I was at the early stage, but then he just gave it to me and since 
then, I haven‟t any symptoms like diarrhoea anymore… that‟s why I asked 
just now, because, they told me to take it 30 minutes before a meal. But I 
wasn‟t told what would happen once I took it. So, I don‟t know. (PT22, 34-






Analysis of the data from the patients highlights the HCPs‘ lack of preference for and 
practice of autonomous decision-making. However, a few patients did describe 
experiences of making their own decisions during the encounter. PT22, for example, 
decided to begin insulin therapy despite it not being the recommendation of her 
physician. Despite her physician‘s agreement after she had insisted on it, it appeared 
that she was not fully informed about her chosen treatment. The patient was then left 
with the thought of being abandoned by the HCP after she had selected an option 
other than the recommended one, something which would most probably make her 
feel uncomfortable with both her involvement in the decision-making process and the 
option that she had decided upon. This echoes the assertion by Davies and Elwyn 
(2008) who emphasised the importance of support for patients who may potentially 
develop a sense of abandonment as they have made their own health decision. As 
such, these patients usually feel compelled to agree with the recommended treatment 
in their next consultation and this is just their way of pleasing and gaining 
reassurance that their HCP will not abandon them, even though they may not truly 
feel that the option is the best one for them. 
 
4.5.4 Section summary 
The examples in this section have provided insight into how the final decision is 
made in a variety of ways. Nonetheless, the HCPs are the main decision makers for 
reasons including their lack of trust in their patients‘ ability and motives, patients‘ 
preference for the HCPs to make the decision for them, and patients‘ lack of 
understanding and awareness of their right to be involved right up to the end of the 
decision-making process. It is also explicit in the examples that the decisions that are 
made paternalistically are those relating to patients‘ pharmacological modalities. The 
paternalistic way of making the final decision is predictable as it is parallel with the 
previous findings that have been presented in the earlier sections of this chapter. 
Nonetheless, in some instances, the final decision is made via a process of discussion 
and mutual agreement by patients and HCPs. This happens when both sides realise 





improvement in the patient‘s overall condition. Finally, autonomous decisions in this 
study took place only rarely. 
 
4.6 Chapter summary 
This chapter has explained the current practice of decision-making in the study 
context from the participants‘ perspective. The HCPs were found to focus on patients‘ 
biomedical and physical status when seeking to identify the patient‘ problems and 
throughout the decision-making process. In addition, patient involvement in this 
phase was often limited to queries posed to them by the HCPs, as not many of the 
patients would actively share their problems and concerns without first being asked 
by the HCPs. Consequently, it was common for the patients to feel that the root of 
their problems was not being fully addressed, which they also perceived was a 
situation that could be improved through a process of shared decision-making. 
Nonetheless, it is also shown that interaction between HCPs and patients does take 
place during the initial phase of decision-making, despite there being a lack of this 
overall. The patient–HCP interpersonal relationship and communication was found 
to play an important role from this initial phase since the lack of a prolonged 
relationship, combined with the language barrier, was identified as hindering the 
involvement of patients in identifying the problem to be addressed.  
 
Following the identification of the problem to be addressed, the examples given in 
sections 4.3 and 4.4 demonstrate that the HCPs took different approaches to making 
the decision. In some cases, the decision was made paternalistically, with limited or 
no information provided to the patient. However, in most cases, the patients were 
presented only with the HCPs‘ recommended choice, with any subsequent 
information provided and discussed by the HCPs with the aim of persuading the 
patients to agree and adhere to this option. Other options may or may not be 
presented based on feedback from the patients. Despite the high likelihood of the 
best option for patients being the one that is recommended to them since it is made 
by HCPs based on the established guidelines, the way in which information is 





discussion, which is important in terms of improving patients‘ understanding and 
also to address their dissatisfaction and any future non-adherence. In other cases, 
meanwhile, various options were given to patients, taking into account their 
preferences and values, and a discussion was held to ensure that they were given 
sufficient information to enable the best option to be chosen that best suited their 
needs. 
 
Similarly, based on the descriptions by the participants, it was common for the final 
decision to be made paternalistically, either with or without an explicit agreement 
from the patients. This is aligned with their preferences, the belief of HCPs as the 
experts and the patients‘ lack of awareness. Some of the participants preferred to try 
and find a middle ground and decide together as they believed this would yield the 
most benefits in the future. Occasionally, the patients were described as making their 
decision with or without sufficient knowledge and support from the HCPs. This led 
to further consequences for not only their management but also for their future 
encounters with the HCPs.  
 
In conclusion, as the participants in this study, patients with different levels of 
involvement in decisions regarding their management have different views about the 
practice. However, HCPs still play an important role in the decision-making process, 
whereas patients play a more passive role. This is comparable to the findings of 
studies conducted all over the world (Bugge et al., 2006; Hajos et al., 2011; Pellerin 
et al., 2011; J., McDonald et al., 2012). Furthermore, this study finds that patient 
involvement remains limited in terms of the extent to which HCPs grant patients the 
opportunity to be involved in making decisions. The next chapter contains a further 
exploration of the factors associated with patients‘ understanding of the practice of 






 CHAPTER 5: EXPLORING PATIENT INVOLVEMENT IN 
DECISION-MAKING: BOURDIEUSIAN PERSPECTIVE 
 
5.1 Introduction 
Most of the participants‘ descriptions of their experiences with T2DM treatment and 
management decisions have at some point featured patient involvement and shared 
decision-making, as presented and discussed in Chapter 4. Moreover, it can be 
sensed from the previous chapter that most of the participants employ different 
approaches of decision-making, ranging from HCP-driven outcomes approach, to 
patient-driven outcomes. However, HCP-deriven outcomes approach or paternalism 
remains dominant. 
 
Aligned with symbolic interactionism as the theoretical perspective underpinning this 
study, perceptions of the practice according to both patients and HCPs were 
thoroughly explored and found to greatly influence the current practice of patient 
involvement in decision-making in the study context. Furthermore, as mentioned in 
Chapter 3, Bourdieu‘s thinking tools on the concepts of habitus, field, capital and 
power have been used as an interpretive lens through which to illuminate the factors 
that shape the participants‘ understanding and practice of patient involvement in 
decisions, as presented in Chapter 4. In applying these concepts to the data analysis, 
this chapter presents patient involvement in decisions as being heavily reliant on 
patients‘ and HCPs‘ past experience and motivation, in addition to their perceptions, 
values and beliefs in relation not only to their individual characteristics but also to 
the characteristics of each other and their embodiment of the norms of the healthcare 
system and culture. In addition, aligned with Bourdieu‘s work, the discussion of the 
characteristics of patients and HCPs in this chapter covers not only their 
sociodemographic characteristics but also their habitus (including the patients‘ sense 
of empowerment and embodiment of the sick role, the HCPs‘ embodiment of their 
professional roles and their permissive and dismissive characters) and capitals 





5.2 Patients’ characteristics, values and beliefs  
This section will discuss the findings of further exploration regarding the influence 
of patients‘ characteristics, values and beliefs on their involvement in decision-
making. These include patients‘ expertise and contribution, their beliefs and values in 
the decision and treatment modalities, acceptance of public facilities, and their sense 
of being good patients. 
 
5.2.1 Patients’ expertise and contribution  
Chapter 4 highlighted how the treatment decided upon during the encounter was 
based more on HCPs‘ technical expertise, with the decision being made by the HCP. 
It was also demonstrated in 4.5.1 that this occurs not only because the HCPs prefer to 
make the decision for the patient but also as patients refuse to make it, preferring 
instead for the HCPs to make it on their behalf. One of the principal factors 
appearing to give rise to this preference among patients and HCPs is the lack of 
appreciation and value placed on the lay expertise of patients by both themselves and 
HCPs.      
 
What is the point for me to be clever? I don‟t have any expertise. You are the 
doctor, you tell me. (PT2, 61-year-old Indian man, SC) 
 
PT2 is one of many patients who consider their contribution to be less necessary 
compared to that of physicians, who are considered to be the experts. Owing to the 
low value placed by this patient on his experiential knowledge in comparison to the 
technical knowledge of the HCPs, he prefers to take a passive role in decision-
making, anticipating that the physicians will provide the information relevant to the 
decision. This corresponds to the findings from a study by Protheroe, Brooks, Chew-
Graham, Gardner & Rogers (2013), where the patients felt they were not expected to 
take an active role in making the decision. Instead, they considered it to be the role of 






It depends on the doctors too. If she forces me to take Gliclazide, I might stop the 
insulin injection. But, as she gave me the opportunity to make the decision, so I 
decided to continue. If there are options given, I‟ll choose. But, if there is none, 
I‟ll not make it. Because they know better, they are wiser. Who are we to 
compare as I also don‟t have any medical knowledge? (PT11, 36-year-old, 
Malay woman, HC) 
 
Contrary to PT2, PT11 wanted to be actively involved in choosing her T2DM 
management. Again, however, due to her concern about not having the requisite 
technical knowledge, she had a reservation over whether or not to become involved 
and made no request to be involved after the opportunity was not presented by the 
HCPs. This finding is supported by HCP3 in the following account, in addition to the 
findings of a study by Fraenkel and McGraw (2007). The latter also demonstrated 
that dependency commonly occurred among the patients in the study when they 
failed to recognise and understand that their contribution to the discussion on their 
management decision was based more on the non-medical part and their personal 
preference, thus leading to their more meaningful involvement in making the 
decision. The point illustrated in the following account by HCP3 was also outlined 
by Hartzler and Pratt (2011), namely that this non-medical expertise of the patient is 
focused on their strategies of coping with the daily health challenges they face, 
which they develop through their own experiments with their management. 
 
Sometimes there are side effects from the medication, so they don‟t take the 
medication. If I pick up on that, I will go and ask the doctor if it can be changed 
to something else. For example, Metformin, a lot of them have diarrhoea and 
others, because of that they don‟t take, but they never tell the doctor. But during 
these sessions, I‟ll ask them, and then I‟ll found out… (HCP3, pharmacist, CC) 
 
However, the sentiment expressed by PT2 and PT11 is shared by most of the patients, 
in that they fail to acknowledge that their experiential knowledge in dealing with 
their diabetes management places them on a par with their HCPs in terms of 
contributing to the discussion on the selection of treatment modalities. Larsson, 
Sahlsten, Segesten, and Plos (2011) linked this to patients‘ low self-esteem as they 





challenges in managing it, therefore leading to their non-involvement. We can add to 
this the Malaysian culture with its great emphasis on hierarchy. The placing of 
greater value on the technical knowledge of HCPs bestows on them a higher position 
in the health and medical field, where power is unequally distributed between the 
different levels, although some improvement in this has been evident over time 
(Hofstede, 1980; Ken & Ying, 2013). Consequently, many of the patients believe 
that their T2DM management should be decided by the HCPs during the consultation 
and that their participation is limited to what is allowed by their HCPs. 
 
I don‟t know. Maybe they don‟t have the knowledge or it‟s easier for them, 
they just have to follow whatever we told them, “It‟s okay, you just tell me, 
and I‟ll do it”. Most of the patients are like that, they don‟t mind. (HCP7, 
diabetes nurse educator, HC) 
 
However, besides a lack of recognition of their own contribution in deciding their 
diabetes modalities, the reasons for patients‘ preference to hand the responsibility for 
making decisions to their HCPs and for not entering into a discussion with them are 
debatable. As demonstrated in HCP7‘s account, it can be argued that patients prefer 
to play a passive role since this requires less effort compared to being an active 
patient, which was also asserted by Solomon (1948). Diabetic patients need to make 
considerable effort if they are to remain an active partner in the discussions with their 
HCPs, reflecting the chronic nature of diabetes as a disease. They have to 
continuously learn about their condition since most cases of diabetes progress and 
require concomitant changes in management. Over time, some patients may become 
tired or frustrated as they perceive no point in becoming involved, as illustrated in 
the following account by PT2. 
 
No. Long time ago. Now I have no time. I have better things to do. (PT2, 61-
year-old Indian man, SC) 
 
…I feel it is better if discuss, discuss together. Because like me, I don‟t really 
have high knowledge in the medical field so it‟s better for us to discuss. Listen 





Because they can evaluate whether I am suit or not with the medication… 
Because in my opinion, sometimes, certain medication doesn‟t suit us. Because 
from my experience, high blood pressure medication, when I took it, my leg 
swelled. Another one is cholesterol medication, when I took it, my whole body 
ache… (PT24, 44-year-old, Malay woman, HC) 
 
Nevertheless, PT24 perceives her non-scientific contribution to the making of 
decisions to be as important as the medical and health expertise of the HCPs. A 
similar type of appreciation was evident among the patients in a prior study by 
Fraenkel and McGraw (2007), triggered by the patients‘ realisation that they would 
be the ones left to deal with the outcome of the chosen treatment. This realisation 
was prompted mainly by their experience of managing their health condition and 
empowered them to take an active role in making decisions. PT24‘s desire for 
decisions to take into account the input of both patients and HCPs aligns with the 
concept of shared decision-making. Further description of patients who believe their 
input is important in making the decision is presented in 5.2.1.1. 
 
Sometimes, patients are more aware of their ability, their restriction, better 
than us and they just about to start. We don‟t target too high, as we don‟t 
want the patients to feel disappointed. When they feel disappointed, they will 
not be able to reduce the weight and later on they don‟t want to do it 
anymore. (HCP4, dietitian, SC) 
 
Entwistle and colleagues (2008), meanwhile, emphasised the importance of the value 
placed by HCPs on the contribution of patients to decision-making in the context of 
encouraging patient involvement. In their study, some of the HCPs acknowledged the 
patients‘ diabetes experience, values and preferences as their expertise. Such HCPs 
felt that these elements should not be taken lightly in order that the option and goal 
established would be aligned with the patient‘s individual condition and also as a 
means of avoiding frustration, as illustrated by HCP4 in the above account. 
 
Of course, I prefer those who are involved, because the selections might be 
more practical to them…For me it‟s important for them to be involved, means 





discuss especially for the obese ones. Why? Are they having trouble at their 
office? Are their friends offering food? or they are the ones that can‟t control? 
What are their problems? Easier for us to discuss and as for me, I‟ll see the 
results as they‟re improving and better. So next time they come, at least they 
can change 1 thing. As for me, no need for too many changes at one time. 
(HCP4, dietitian, SC) 
 
HCP4‘s account above further demonstrates that she, by valuing her patients‘ 
expertise, prefers for them to be involved and tends to take into account the 
information that they share when it comes to identifying the different options that are 
suited to them and eliciting their preferences when deciding on their management. 
Due to this, it also appears that HCP4 attempts to set realistic goals, which Baillie 
(2016) identifies as being more patient-centred goals. This will make the long-term 
achievement of the goals by the patients both more likely and more sustainable.  
 
However, many of the HCPs in this study do not share this opinion with regard to the 
importance of patients‘ non-technical expertise in deciding their management.  
 
No, no. They‟re just being given the opportunity to listen and accept only. 
There‟s no way that the information goes to us. They are not allowed to tell 
the HCP. Maybe because we think that we know better than the patients. 
(HCP16, dietitian, HC)  
 
HCP16‘s account above conveys the value and practice found more commonly in 
this study, whereby HCPs place only limited value on the experiential knowledge of 
patients. Consequently, the HCPs effectively put a limit on the amount of patient 
involvement they allow in decision-making.  
 
They actually can decide, it just that they don‟t want to. Maybe they don‟t 
know as they are not the experts. So, they are not aware that they can 
actually decide. Medication, for example, what kind of medications that are 
not suitable and everything. Actually, they can be involved but they don‟t 
have the knowledge, so it‟s a little bit hard for them to be involved in the 





choose this medication, doctor?” Not like that, just yes and no. In terms of 
medication, we are the ones who manage. (HCP11, medical officer, CC) 
 
Furthermore, other HCPs shared the same view as HCP11, that their patients refuse 
to be involved in the decision-making process due to a lack of the higher cognitive 
ability needed to be involved in a more complex discussion about their diabetes. This 
usually resulted in only the most basic level of patient involvement in the selection of 
their management. Patient responses to queries from HCPs tend to be limited only to 
agreement or disagreement with the HCPs‘ recommendation, thus frequently 
preventing them from becoming involved in further information exchange in a 
manner that is more empowered and useful. This highlights HCPs‘ view of patients‘ 
technical knowledge as being their expertise, instead of their experiential knowledge. 
 
Consequently, owing to HCP11‘s perception that patients do not have the requisite 
technical knowledge, it is also perceived that they do not have the capability to be 
effectively involved in making the decision. Therefore, the HCP prefers to be the 
decision maker, especially with regard to decisions on pharmacological modalities. 
This is despite HCP11‘s claim that she encourages patient involvement. However, 
Wagner (2000), together with Kambhampati, Ashvetiya, Stone, Blumenthal and 
Martin (2016), argued that this preference of HCPs may limit the acquisition by 
patients of the information and skills they need to help build their confidence and 
cognitive ability to contribute to making the decision, thus resulting in a vicious 
circle of a lack of patient involvement in decision-making and limited technical 
knowledge about their T2DM. 
 
In addition, the accounts by PT11, HCP4, HCP16 and HCP11 strongly illustrate that 
HCPs‘ appreciation of patients‘ expertise is vital, with it being evident that it is the 
HCPs who continue to steer the decision-making process at these study sites, 
including the extent to which the patient‘s contribution is taken into account. 
According to Dubbin and colleagues (2013), patients‘ appreciation of their own 





accorded to it by their HCPs. This will further shape patients‘ involvement in 
decisions during their future encounters with HCPs.  
  
5.2.1.1 Empowered patients 
The discussion on patients‘ expertise in the previous subsection of 5.2.1 leads to yet 
another important theme, that of patient empowerment. Patients‘ sense of 
empowerment has been recognised as one of the important elements in shaping their 
attitude and practice with regard to their involvement in choosing their own 
management or treatment. 
 
Like just now, I told her everything… I wrote everything including what I eat. 
Sometimes, some people are afraid to reveal about their diet, as their sugar is 
high. I just admit what I eat because it‟s like a self-reminder to me. I‟ll note 
the food that I take if my sugar is high, so next time I will not take that food 
again. Coconut rice, for example, we know that not only does the rice contain 
sugar, but also the sambal. So, if I‟m craving it, I‟ll just take some of the rice 
and some of the sambal only… Because I‟m worried. I want to share I went 
through it already. It can happen very fast. I think I‟ve done it wrongly. 
(PT11, 36-year-old Malay woman, HC) 
 
With regard to the few patients found to be taking charge of their diabetes 
management and playing an active role in managing their condition, they shared their 
practice and concern with their HCPs. This was combined with an intention to 
further educate and take better care of themselves. Taking PT11 as an example, her 
active involvement during the encounter was prompted mainly by the concern that 
her T2DM would worsen without good management. This concern was based on her 
past experience of having an uncontrolled glycaemic level due to her incorrect self-
management. Her effort to share information with her HCPs as she wanted to 
improve her diet served as a good indicator that she is empowered since she is 
evaluating her diet and examining it in the context of relating her food intake to her 
blood sugar level. This account is consistent with the definition of empowerment by 
Funnell and colleagues (1991), who defined empowerment as a patient‘s own ability 






We can also see that PT11 had no concern with regard to informing her HCPs that 
she had consumed foods that were considered unhealthy as she needed their help to 
better plan her diet in the future. This supports the assertion by Weiss (2006) that 
empowered patients will usually be more open with their HCPs as they value their 
expertise in helping them to identify what is best for them as a way of helping them 
adjust their current diabetes self-management. This can be seen in the below account 
by PT8, where the patient is empowered and actively puts forward his preferences as 
a result of his experience of dealing with T2DM over the years. These findings 
correspond with the concept of empowerment that Lather (1991: p. 4) defines as “… 
a process one undertakes for oneself; it is not something done „to‟ or „for‟ someone”. 
 
No, I don‟t want. I will tell. Previously, I just followed. My panel doctor 
prescribed me with the best medication, when I was still working, Avandia. If 
you remember, if you Google Avandia, it was claimed to be the best for 
diabetes, to cure diabetes. But, when it was confirmed to cause kidney 
problem, so when I heard that, I was like, “I was one of the guinea pigs, I 
became the victim”. (PT8, 61-year-old, Malay man, HC) 
 
On the other hand, the above account by PT8 illuminates a different aspect of the 
trust in the patient–HCP relationship. The existing literature commonly describes a 
high-trust patient–HCP relationship to be one of the cardinal elements of patient 
empowerment (Mechanic, 1996; Nygårdh, Malm, Wikby, & Ahlström, 2012). 
Instead, PT8 became more empowered only after his health status had worsened, 
which resulted from the ‗bad‘ decision made by his previous physician. He thus felt 
cheated as he put his full trust in the HCPs to decide for him. He perceived that he 
had to take an active role so that the HCPs would not take advantage of him by easily 
making a decision and not being careful and thorough about it. Aligned with 
symbolic interactionism, which addresses the fact that meanings can change over 
time (Blumer, 1969), this patient‘s perception, altered by his bad experience, 
empowered him to both share his problem with his physician so that it could be 
properly managed and to alert his HCPs to matters that were concerning him. This 





with his HCPs. In addition, the previous account from PT11 demonstrates how she 
used the individualised information gathered from her enquires when carrying out 
her self-management. These findings support the existing literature in which it is 
suggested that patients‘ sense of empowerment has a positive impact on their 
adherence to their diabetes management and improves their overall well-being 
(Sigurdardottir & Jonsdottir, 2008; Hernandez-Tejada et al., 2012).  
 
Haa, they don‟t want to add their medication. Even the doctor at the primary 
clinic said, “I‟m having a headache. Patients themselves told me not to 
simply add any medication”. Patients said they know their body. So, they 
want to control their diet first. That‟s why we have a high number of 
references to a dietitian. Patients asked the doctors to refer them to us. It is 
the current trend. Previously, they were more like, “no need for this”. This is 
the comparison with 5 years ago, there were a lot of defaulters, we know. As 
for now, the number of defaulted cases is decreasing. (HCP16, dietitian, HC) 
 
 …If they want to add my medications I will ask. I don‟t want to take these 
medications as people say it can cause kidney problem, right? I‟m afraid that 
I‟ve taken too many medications, especially these diabetes medications. 
(PT18, 55-year-old Malay woman, CC)  
 
Despite the fact that there seemed to be a lack of patients in this study with a good 
sense of self-empowerment, the account by HCP16 indicates that their number is 
increasing. As such, more and more patients are expressing concern regarding the 
amount of medication that they have to take as they believe it gives rise to long-term 
adverse effects, as also featured in PT18‘s account. This in turn leads to them 
rejecting the idea of a higher dosage or of adding to their existing medication. Instead, 
they raise the possibility of their T2DM being better controlled through dietary 
modification and request further support to improve their diet. As a dietitian, HCP16 
welcomes these requests despite the potential difficulty they may cause for 
physicians. These active and empowered patients no longer simply agree to abide by 
their physicians‘ instructions or suggestions since they consider that their experience 
and how they feel their bodies have reacted to their current and previous diabetic 
management must be taken into account when making any decision on new changes 





based on the fact that they are the ones that have to be responsible and bear the 
consequences if the chosen management does not suit their overall needs. HCP16‘s 
account also demonstrates that patients are more likely to adhere to management that 
is in line with their preferences as she mentions that more and more patients attend 
appointments with a dietitian compared to a higher number of non-attendees in the 
past.  
 
Nonetheless, it can be sensed from HCP16‘s account that some physicians would not 
especially welcome patients‘ determination to stand by their preference and not 
merely agree with the physician‘s recommendation; indeed, further exploration 
indicates that this is despite their openness to the idea of patient empowerment, as 
asserted in the below account by HCP17.   
 
He asked me to reduce my weight. I told him, “Doctor, I‟m on a lot of 
psychiatric drugs, that‟s why I gain weight”. “Don‟t give excuses.” He said 
that to me. I was shocked. I was really shocked. “Don‟t give excuses, madam.” 
He shouldn‟t say that, right? So rough. “Don‟t give excuses, madam.” 
Steroid, right. You know what the effects are. Weight gain is for sure. What 
can I do? I have to take the medication to live, to survive. I have to go to 
work, raise my children. (PT22, 34-year-old Malay woman, HC)  
 
However, it appears that these empowered patients‘ efforts to be involved in 
decisions are routinely being challenged by their HCPs. Similar to the findings by 
Frosch, May, Rendle, Tietbohl and Elwyn (2012), PT22‘s account illustrates her 
difficulty in being an empowered patient and in being involved in the discussion 
about her management. In addition, her physician adopted a narrow focus on only her 
diabetic status, which may be considered normal in diabetes management in 
Malaysia. PT22 gave a reason for her weight gain which was then questioned and 
eventually deemed by the HCP to be an excuse to justify her non-adherence to her 
T2DM management. This is comparable with a study by Snow and colleagues (2013) 
in which it was found that some HCPs were not very comfortable having patients 
who were confident in being involved in their own disease management, aside from 





 You don‟t get a patient that comes and say, “hey, you forgot to refer me for 
my eye check-up. When did you last see my feet?” No. So, if they know better 
that they should be having their eye check-up, that the doctor hasn‟t ordered 
it, that they haven‟t had their ECG for 4 to 5 years, so maybe the level of 
awareness, knowledge of the patients… (HCP19, endocrinologist, HC) 
 
Nevertheless, a lack of patients‘ sense of empowerment was evident in most of the 
interviews, and in most of the accounts it is possible to relate this to the patients‘ 
level of technical knowledge in the first place. HCP19, for example, stated that she 
had not met any patients who were sufficiently knowledgeable and empowered to 
ask her about any related medical procedures that they believed they needed based on 
their prior knowledge of diabetes and awareness. 
 
This is the way Malaysians are brought up, from young. We do, you follow, 
we do, you follow. Nobody is taught to learn, to understand. We are so into 
the textbook and read, which is going on, even now. So, these are the 
youngsters who will grow up as a very ignorant adult. So, they want to 
continue asking people do for them, instead of thinking themselves and taking 
responsibility. (HCP15, FMS, CC) 
 
Our education system could be a factor where everybody is waiting for help, 
waiting for education and the way that the education is transmitted to us is 
always one direction, it‟s never two-directional. They are waiting for help. 
They are not empowered, “doctor, you tell me what to do”. (HCP17, medical 
officer, HC) 
 
Another important issue mentioned by some of the participants, especially the HCPs, 
is how patients‘ sense of empowerment, preferences and characteristics in managing 
their T2DM are shaped by Malaysian culture and its interrelated social and education 
system. The Malaysian education system can be described as one that relies on a 
conventional teacher-centred approach and where there is a mostly one-directional 
transfer of knowledge. In this type of system, information and instruction are usually 
conveyed by the teachers, with the students listening passively, following the 
instruction and making occasional enquiries during the learning session. Furthermore, 





their teachers despite them having disagreements or when teachers make errors as, 
culturally, teachers must be revered at all times. Similar to the style of education in 
most other Asian countries, Malaysian students are required to memorise the content 
of lessons due to the system‘s focus on examinations, with less emphasis placed on 
them developing a deeper understanding and less innovation in terms of how the 
lesson relates to real-life situations (W. K. Lim, 2010a, 2010b). Despite the fact that 
the Malaysian education system is continuously progressing and teachers are more 
open to the idea of it being bidirectional and making the effort to ask their students 
questions, it has been found that these questions are typically not sufficiently 
challenging to encourage critical thinking on the part of students (Yin Peen & Yusof 
Arshad, 2014). 
 
The above accounts by HCP15 and HCP17 indicate that the Malaysian education 
system is capable of exerting a great impact on patients‘ behaviour during their 
patient–HCP encounters. This corresponds with Bourdieu‘s (1990) assertion that 
educational experience is one of the elements that substantially structures the habitus 
and practice of the social agent. The educational system in Malaysia has in effect 
moulded them to be ignorant, passive, dependent, excessively receptive and 
unquestioning, which in turn can be viewed as being closely linked to their lack of 
self-empowerment. When the patients carry this passivity into the management of 
their health, it may lead to them feeling sicker since they have been treated only 
clinically and physically and not as a whole being (P. W. Chen, 2009). Nevertheless, 
patients‘ lack of awareness in this regard, due to them being accustomed to it, results 
in them not applying their efforts to acquire a deeper understanding with regard to 
either their diabetes or its management and treatment, thereby posing a significant 
barrier to them becoming involved in the decision-making process. 
 
5.2.2 Patients’ belief and values in the decision and treatment modalities 
Another apparent issue found to influence patient involvement in decisions involves 





not interested in discussing their concerns and self-management if they felt there was 
nothing wrong with them, even if they had a problem with their current management.  
 
I have 12, 8 for diabetes and 4 for high blood pressure. So I take 
2…3….(counting the pills), I only take 4 for diabetes and left the other 4 
because my friends said that I mustn‟t take too much, it will ruin by kidney, so 
I follow them. So, I take 4 of diabetic medication and 3 of high blood pressure 
medication. I don‟t take the other 5….No, I never tell anyone. The doctors 
will get angry if I don‟t want to take, they are fierce. But last time I checked 
my sugar, on the 21
st
 it was good, only 6. On the 22
nd
, I ate a lot of variety of 
food, so it increased. When I checked it was 15. I ate mango, paratha, fried 
noodle, fried rice and iced tea. That‟s why it increased. In 1 day it increased, 
from 1 to 7. In just 1 night, I ate a lot and it increased to 7. But it can be 
reduced very fast. It can be reduced to 5.7 if I control a bit in 2 days. (PT21, 
66-year-old, Malay man, CC) 
 
I will wait and see. I‟ll see the changes, if it is needed for me to tell them, I 
will tell. If not, I will just stop…I have taken this nerve medication for so long, 
I can say that I‟ve tried everything from A to Z, but no changes. (PT8, 61-
year-old, Malay man, HC) 
 
PT21 disclosed how he did not adhere to his abundant medication based on a concern 
about adverse effects. However, the patient shared neither his decision to skip the 
medication nor his concern, which was founded on information obtained from his 
friends, with his HCPs. This came despite an increase in his glycaemic level and his 
prior acceptance of his increased range and dosage of medication. The patient did not 
perceive any of these things to be worthy of disclosure as they were not serious 
matters and could be managed easily without being shared with his HCPs. This 
action can be seen in parallel to prior research that has cited the seriousness 
perceived by patients and the threat of the problem as important determinants in 
whether or not a patient takes action; in this context, this means whether or not they 
become actively involved in discussing their diabetes management decision (Stein, 






On the other hand, based on his nine years of dealing with HCPs in managing his 
T2DM, PT21 had come to anticipate a negative response from physicians when 
dealing with the sharing of his practices (especially with regard to the undesired 
ones), which may have been a further reason for him to avoid sharing this concern 
and practice (Rosenstock, 1974). The construction of patients‘ anticipation regarding 
their HCPs‘ response based on past experience is aligned with Bourdieu's (1990) 
description of habitus. Consequently, it is often the case in this present study that the 
patients endeavour to resolve their own problems to the maximum extent possible, 
without discussing them with their HCPs, as demonstrated in the above account by 
PT21. 
 
Besides, as shown in the above account from PT8, these patients shared information 
based on a consideration of how their body reacted to the medication. They will only 
share and consult with their HCPs once the matter is ‗out of their hands‘ and they 
require action in the form of an HCP intervention. This action that entails selecting 
the kind of information to put forward during their encounter with HCPs, as shown 
by PT21 and PT8, is also considered by Bachrach and Baratz (1970) as patients‘ way 
of exerting covert power.  
 
Despite T2DM involving patient self-management since most of its related decisions 
and management are carried out at home, any situation in which patients are not in 
possession of sufficient knowledge may result in mismanagement on their part. This 
is evident in PT21‘s admission that he has covertly modified and reduced the dosage 
of his medication in an effort to address his concern regarding the greater negative 
effects that he may develop due to his multiple pharmacological prescriptions, in 
contrast to discussing the matter. This may also be the reason for his inconsistent 
glycaemic reading with his HCPs. This can commonly lead to mismanagement by 
HCPs and to a dissipation of resources as a patient‘s medication dosage will be 






Some, you have to force them to start insulin, because they‟ll always tell you 
that they don‟t want, don‟t want until their HbA1c more than 10%. From 8-7, 
maybe they‟ll just need Insulatard. But if they keep telling you, “I don't 
want...I don‟t want” until HbA1c 13, 14, 16. We force them to start… If not, 
they‟ll be getting complications or maybe their eyes start to have a problem, 
and the HbA1c more than 10, the doctors have to start insulin also or the 
HbA1c more than 8, the doctors have to start also because it can cause 
cataract and other things. So, if we follow patients, none of them are willing 
to start injection, actually. Unless they‟re educated, they know what is insulin, 
that one is a different thing. So 50-50. I can‟t say we can make together, but 
sometimes we can ask patients‟ opinion. (HC9, pharmacist, CC) 
 
However, the above account by HCP9 provides a different perspective on the 
relationship between the seriousness of the problems and patient involvement in 
decision-making. According to HCP9, the bigger a patient‘s problem, the less chance 
there is of them being involved in making the decision. This pharmacist prefers to 
make decisions herself out of concern regarding patients with serious and difficult 
problems developing complications. This is also due to her experience of dealing 
with these kinds of patients, in that she believes they will become worse yet will also 
never agree with the HCP‘s recommended option, especially with regard to the 
initiation of insulin. This may also indicate that HCP9 lacks trust in her patients‘ 
ability to make the right decision, which was also discussed by Miller (2007). Thus, 
it can be argued that most patients‘ practice of not sharing their concerns, combined 
with their lack of ability to identify the information considered relevant to be shared, 
may lead to a worsening of their condition. In such an event, the likelihood of them 
becoming actively involved in making a decision becomes even slimmer as their 
HCP may not permit them to do so (S. N. Whitney & McCullough, 2007).  
 
5.2.3 Patients’ acceptance of public facilities 
The other matter that emerges concerning patient involvement in decision-making is 
their sense of acceptance of the services provided at the study sites, which are public 
health facilities. This refers to how patients believe they have to agree with and not 
question the services they receive based on the fact that they pay only small amounts 






When I was working, I got my medication from the private, I could ask for 
something more. RM1000-RM2000, they can give me, but when you come to 
the government hospital, they say, “look, I don‟t have any other thing, this is 
what is available, what I can give to you?” They give, I‟ll take. Our treatment 
method is not right. But if you are the type who doesn‟t have the capability to 
buy, go and see the government doctor, they‟ll give the best treatment. Because 
the treatment is good, but not the medication, government doctors do not have 
it. It‟s quite expensive. If you‟re not rich and just average, forget about it, 
government servant and all that. It is for the rich so, I‟ll just go on with it. The 
medications are there, but it‟s for the rich and famous. (PT17, 58-year-old 
Indian man, CC)  
 
PT17, who no longer has the financial means to access what he perceives to be a 
better service at private facilities, believes he is obliged to accept the HCP‘s 
recommendation. This belief will serve to not only limit patients‘ involvement in 
making the final decision but will also limit their desire to enquire about related 
information or other available options, as was evidenced in a study by Fraenkel and 
McGraw (2007). Similar to the findings of this present study, the participants in 
Fraenkel and McGraw‘s study also did not believe they had any right to be involved 
in selecting their treatment due to the fact they did not have to pay for it.  
 
Actually, there‟s a difference between private and government [facilities]. I 
know that I can‟t afford to go to the private. So, whatever they give me at the 
government, I have to accept as I don‟t have a lot of money to spend. We only 
have to pay for registration, which is so much less than in private. As you know, 
currently, health, education and everything has become so expensive. I don‟t 
have insurance to cover my medical expenses. So now, when I‟m here at the 
government hospital, I have to accept it. I‟m lucky as I was referred here, 
where they have all the facilities. If, let‟s say, I go to the hospital near my 
hometown, the facilities will most probably not be as complete as what they 
have here. Here, if you need a CT scan, they will do it immediately. As for 
other hospitals, they have to wait for an appointment to do it and you have to 
go there to do it, which might far from their home. But, here, we have to come 
2 to 3 weeks before our appointment for a blood test, as compared to the 
private, where we can go immediately or only have to wait half an hour for the 
results. But we understand. They have a lot of patients here and we only pay a 
small amount of money. Even the medication is subsidised by the government, 







PT11 shared the same value as PT17 in 4.5.1 in the previous chapter when she 
mentioned that she accepted the recommended management since she did not 
consider there to be any other option available at the public facility aside from the 
one being recommended or prescribed by the HCPs. Despite her understanding of the 
limited options available at these facilities, PT11 implied a sense of lacking power 
when she said “I don‟t have any insurance to cover my medical expenses. So now, 
when I‟m here at the government hospital, I have to accept it”, pointing to a sense of 
powerlessness. She expressed her lack of control over the decisions made at the 
public facility in comparison to those made at a private facility, which she may 
perceive as being able to offer her better options despite the fact that these would 
cost more. It seems plausible to relate this sense of powerlessness to her inability to 
spend more on her medical expenses. This is in accordance with the findings of a 
study by E. S. Rogers and colleagues (1997), also supported by Bourdieu (1977), in 
which patients‘ economic background was found to be closely related to their sense 
of having power.  
 
Here, it‟s quite slow. They check the sugar (level) after 4 months and if we 
suddenly have a problem, we don‟t know how to ask. We can‟t call them, as 
we don‟t know them. Don‟t know at all, right. For this hospital, I only use 
their insulin. The rest of the medication, I get from outside. (PT24, 44-year-
old Malay woman, HC) 
 
The relationship between patients‘ earning potential and their sense of power is 
further described by PT24. Assuming that PT24 is able to allocate more money to her 
medical expenses, she went for her preferred option that she obtained from outside 
the public facility, believing she was being offered a better quality of service and 
more treatment options. This indicates that she perceived herself as having greater 
control over her decision compared to PT11, who did not have the capacity not only 
to access treatment apart from that provided in public facilities but also to be 
involved in choosing her T2DM treatment. PT24‘s possession of economic capital 
clearly affords her greater opportunity to assess healthcare services, in addition to the 





The above accounts further highlight the health inequalities among patients. Baum 
(1998), together with Lynch, Due, Muntaner, & Davey Smith (2000), discussed the 
shifting causes of health inequalities since the late 1990s and early 2000s, from 
economic to psychological factors. This recent focus on patients‘ social and cultural 
capital may demonstrate a lack of appreciation of the power of economic capital in 
terms of its contribution to health disparities. Despite this, the health inequalities 
between the patients in this study were found to be linked to their economic status. 
This is especially the case in countries in which the healthcare system consists of 
both public and private services. This includes Malaysia, in which private healthcare 
is more accessible to people in the higher socio-economic groups (Hassan, 2007; 
Collyer, 2015). 
 
Like just now, actually I‟m supposed to be with a specialist, then they put me 
with the “normal” doctor. “Doc, no offence, I have to see my specialist 
because she has my records.” Then they checked and said that she‟s seeing 
the HIV patients today, that‟s why I can‟t see her. See, because I asked, what 
if I didn‟t? I told her, “doctor, please don‟t get angry, the specialist has my 
record and I‟m comfortable [with her]”. She said, “Can I give you another 
appointment?” Because I asked and she explained. (PT17, 58-year-old 
Indian man, CC)  
 
Nevertheless, there were some patients who felt empowered despite them attending a 
public facility. PT17 argued that it was important for him to verbalise his preference 
to be treated by an FMS, believing this still gave him a chance to see her compared 
to if he did not ask at all. Even though he had to make a compromise in the form of 
accepting an alternative appointment, his request to see his usual doctor was fulfilled. 
This scenario serves as a good indication that despite the limited resources available 
at public facilities, they still attempt to support and fulfil their patients‘ preferred 
options so long as the patients put them forward. As such, this renders patient 
empowerment even more important in the context of public facilities, as all of the 






5.2.3.1 Cheap to be sick 
Nonetheless, a concern was raised by the HCPs regarding patients‘ passivity during 
decision-making based on the perception that it is cheap for them to be sick and 
obtain treatment from public health facilities.  
 
…you know, sometimes when you provide for everything, sometimes it‟s taken 
for granted. “I actually come, I waited for so long, so as long as I get my 
medication it‟s okay.” Whatever we discuss may go in and out, in and out, in 
and out, in and out. “But I just want my medication”… They hardly pay 
anything actually for their medication. It‟s sad, I think the healthcare system 
may be, to some extent, it‟s my personal opinion, has promoted to the public 
who are unaware of healthcare cost. And if you don‟t know healthcare cost, 
then you don‟t prioritise health as healthcare is so cheap and it‟s quite cheap 
to be sick. (HCP19, endocrinologist, HC) 
 
Further exploration of the nominal cost charged to patients in return for access to the 
public healthcare system shows that their lack of involvement during encounters and 
discussion about their health decision is not merely due to their acceptance of the 
limited resources in the public healthcare facilities (as previously explained in this 
subsection) but is also due to the lack of value that they place on the service they 
receive. This is apparent in the above account by HCP19 in which she described her 
encounter with these passive patients whose only concern during their appointment is 
about receiving medication. It can also be sensed from HCP19‘s account that the 
patients‘ lack of involvement and non-adherence stems not only from the fact that 
they do not have to pay much for the management of their current health problem but 
that they also have the perception that it would not cost them much if their condition 
were to worsen or if they were to develop complications.  
 
…They only pay RM1 to see the doctor and all are free until they see their 
doctor next time. A lot of patients return Metformin, actually. I don‟t know. 
Maybe they have follow-up at other places. So, they collect all of their 
medicine and we can‟t use it. Same with Insulin we have to dispose it, 






Similar to HCP19‘s assertion, HCP3 also spoke of multiple instances of patients 
returning the medication they should have been taking. According to the guidelines, 
these medications are not supposed to be used for other patients and thus need to be 
disposed of (Pharmaceutical Services Programme MOH Malaysia, 2016; WHO, 
2011). This can be detrimental as it can lead to an unnecessary wastage of medical 
resources that might otherwise have been avoided if the prescription had been 
developed through a process of active discussion between patients and HCPs. 
However, as asserted by HCP19, not many patients are aware of the increased cost of 
medical services and supplies. This is because they are not directly bearing the cost, 
with this instead being met by the government (Thomas et al., 2011). 
  
…I have a lot of medication. But I‟ll take whatever they give. I‟ll look at the 
effects as I‟m already afraid. Because I knew that if we take so too many 
medications, it will affect our kidney, so I try to not take too much of it. So, if 
they give, the ones that they prescribed, I‟ll take it first, then I‟ll stop. (PT8, 
61-year-old, Malay man, HC) 
 
…But I didn‟t tell her I didn‟t take five of my medication. (PT21, 66-year-old 
Malay male, CC) 
 
In examining this matter based on the patient data, the above account from PT8 
seems to support the concerns raised by HCP19 and HCP3. In receiving the 
prescription for his medication, PT8 tended to agree with all of the medications 
suggested for him prior to subsequently considering, outside the consultation time, 
whether or not to continue taking them. In addition, as is the case in the above 
account from PT21, some of the patients did not share their self-discontinuation or 
non-compliance with their medication with their HCPs, thus contributing to a waste 






5.2.4 Being a good patient 
Throughout the data, it appears that the patients routinely elected not to share their 
disagreement with or non-adherence to the recommended or prescribed management 
with their HCPs.  
 
It‟s hard to say, because we just listen, okay, it‟s increased. They add, add 
and add. But we will not add, no. We can‟t just say, “I eat a lot”. We can‟t 
say that. If we say that the doctor will respond, “Your sugar has increased, 
why you didn‟t control”. So, we will be like, “okay, okay”. I couldn‟t say 
anything else. I just accept it. But, let say I think I eat less, those that they add, 
I will not take. (PT16, 57-year-old Chinese man, CC) 
 
They give us medication and we take it, but I didn‟t tell them that I don‟t take 
all of it. They might get mad if I tell them. But my friend said, “if you take a 
lot of medication, it might damage your kidney, it might rupture”. But when I 
asked the doctor just now, she said, “No, it‟s not. Don‟t listen to others. 
Don‟t listen when they said that medication will damage the kidney as it has 
to work harder to crush the medication”. (PT21, 66-year-old Malay male, 
CC)  
 
It‟s like they fight back, right. We have to stand with our way too. We also 
have to fight on what best for them.‟ (HCP14, medical assistant (diabetes 
educator), HC) 
 
Maybe the patients become a little bit more passive, they do it for the doctor‟s 
sake. Maybe, they want to please their doctor. Some doctors are very strict, 
so they do it because they want to make sure when they come to the check-up 
everything is good, so the doctor will be happy. They didn‟t realise it‟s about 
them actually being having the good outcome. It‟s not actually to please the 
doctor but actually, it‟s for themselves. (HCP19, endocrinologist, HC) 
 
In the case of PT21, despite him expressing his concern to his physician about the 
side effects of his oral hypoglycaemic agents, he shared neither his reluctance to 
proceed with the recommended option nor his non-adherence. It could be argued that, 
based on the authoritative style of feedback that he received following his prior 





agreeing and as fighting back, this patient chose not to share his concern further, 
which resulted in his current intention of not adhering to his medication. The patient 
may not want to irritate his physician, as also demonstrated in HCP19‘s account, 
which may then further upset the patient–HCP relationship or lead to abandonment 
by the HCPs, as presented in 4.5.3. As such, the patients concerned with this matter 
are commonly more comfortable agreeing with their HCP and would prefer to 
remain passive during their encounter in order to not be viewed as a ‗difficult‘ or 
stubborn patient. Frosch and colleagues (2012: p. 1032) reported a similar practice 
among patients in the US, which they describe as „conforming to socially sanctioned 
roles‟. However, as seen in the account by PT16, patients tend to only play this 
subservient role during the patient–HCP encounter as it is common for them to have 
no intention of carrying out the prescribed or advised management as they do not 
consider it to suit their needs, thereby ultimately leading to their non-adherence. 
  
Sometimes they think that when they meet with the dietitian, we would not 
check their dextrostic, so they drink milk tea before they came. That‟s why 
when they come to me most of their sugar level is high, because they already 
know that the doctor will check their sugar and if it‟s high, the doctor will be 
angry. So they‟ll fast or take any herbal medicine. But when they come to see 
me, they‟ll be like, “I rarely drink milk tea, but I drank it today as I‟m very 
happy that I can go out this afternoon. Usually, I just stay at home and I 
don‟t drink such drinks. I thought that you‟ll not check my sugar so that‟s 
why I drank milk tea and ate paratha”. That‟s why their sugar reached 20. 
(HCP10, dietitian, CC) 
 
…like previously I went to the clinic, “Don‟t you love your eyes? Do you 
want to go blind?” They should‟ve said, “You may lose your eyesight if you 
are not taking care of your eyes”. They have to find ways to deliver the 
information. Same like elderly, long time ago, when my mom was about to go 
to the clinic in the certain months, she started to fast, to control her diet. The 
results were around 6. She‟ll bring her grandchild‟s urine for testing. Then, 
when the doctors reviewed the results, they were happy, no medication was 
required. The doctors were also happy as their patient was good, her sugar 
was 6. (PT8, 61-year-old, Malay man, HC) 
 
Additionally, in this study, the matter seems to be more worrying since a majority of 





becoming firmer and more paternalistic towards those whom they perceive to be 
difficult, stubborn or non-adherent, as seen in PT8‘s account above. This will be 
discussed further in section 5.3. This account also serves as strong evidence of the 
negative effect of poor communication skills by the HCPs in addressing patients‘ 
concerns, which in this case impeded PT8‘s intention to share and discuss his 
concern despite him claiming that he was not intimidated by HCPs.  
 
This is because, in some instances, instead of being compliant with their HCPs, the 
accounts in this section demonstrate that the patients make an effort to appear as a 
‗good‘ patient. In addition to the non-sharing of their disagreement with the 
recommended management as seen from PT16 and PT21, the accounts from HCP10 
and PT8 highlight how they also attempt to do things which they believe will conceal 
the effects of their non-adherence, especially with regard to their glycaemic level. 
Such measures include fasting, taking traditional medicine and, to some extent, 
cheating in their urine test. Patients usually resort to these types of measures in the 
hope of conveying the impression that they are managing their T2DM well in the 
eyes of their HCPs, thereby avoiding any further problems in the form of being 
questioned by the HCPs or an intensification of their diabetes management. It may 
also indicate that the patients are attempting to control the course of their session 
with their HCPs and thus using their covert power to prevent conflicts with their 
HCPs (Bachrach & Baratz, 1970). The account by HCP10 also suggests that the 
HCPs are starting to become aware of patients‘ efforts to hide the outcome of their 
non-adherence. 
 
Nonetheless, patients‘ wariness of their non-adherence being resented by HCPs is 
understandable and was addressed by Parsons (1951b) in his book The Social System. 
Here, a situation was described in which patients who fail to conform to their 
sanctioned roles will face the possibility of social exclusion by their HCPs. Thus, it is 
common for the patient, as the person who seeks help, to be more subservient to 
whomever he/she is seeking the help from, which in this case is the HCPs, as 





Frosch and colleagues (2012), there were patients who were apologetic about taking 
up their HCPs‘ time as they discussed their challenges in managing their T2DM, as 
illustrated below: 
 
Few of them actually when you spend more time, I mean you spend more time 
because the glycaemic control is not good and the control is not in the target, 
but they actually appreciated that. They will actually look at that like a 
scenario where you have a lot of patients outside but you still have time to 
talk to me and make my diabetes control better. Things like that. So, they 
mentioned that there were few patients that mentioned that, “I‟m sorry, that 
you have to spend more time for me”. (HCP18, endocrinologist, HC) 
 
5.2.5 Section summary  
In summary, it is apparent in this section that a patient‘s characteristics as the social 
agent of the decision-making heavily influence their involvement in making the 
decision. These factors include the value that both patients and HCPs place on the 
patients‘ experience as their expertise, the patients‘ own sense of empowerment, 
patients‘ belief in the importance of their involvement, the value that patients put on 
the service they receive from the public health facilities, and their expected role. 
These give rise to the various practices of patient involvement in the decision and 
also to the power dynamic between patients and HCPs. It can be concluded from the 
findings presented in this section that the patients had only limited involvement in 
decisions and that power was asymmetric since it is the HCPs who determine the 
extent of the patients‘ involvement in the clinical encounters. Consequently, it was 
common for patients to exercise their power outside the clinical encounter.   
 
5.3 HCPs’ characteristics, values, beliefs and practice 
Similar to patients, the analysis has also shown that HCPs‘ characteristics, values, 
beliefs and practice influence the overall experience of patient involvement in 
decision-making, as presented in Chapter 4. These matters are discussed in this 
section by dividing HCPs into the two categories of dismissive and permissive. From 
the exploration, dismissive HCPs are often associated with a lack of patient 





agreement with and adherence to the recommended option, a belief in the superiority 
of their recommended options and their paternalistic style of communicating with 
patients. These dismissive HCPs found to be paternalistic in making the decision, 
which as presented in Chapter 4 as giving instruction rather than options and 
recommendation, sharing lack of information and options, persuading patients to 
agree, using intimidating messages and making decision for patients.  
 
Permissive HCPs, in contrast, hold positive views and beliefs about their patients‘ 
characteristics, in addition to displaying empathy and compassion towards their 
patients that typically manifest in their facilitative behaviours and communication 
style, which ultimately facilitate patient involvement in decision-making. Permissive 
HCPs tend to give options and recommendations, encourage information sharing, 
deliberation and compromising, and make decision with their patient or give their 
patients the opportunity to make decision, as presented in Chapter 4. Finally, this 
section highlights the difference in engagement between patients and their physicians 
compared to their non-physician HCPs.  
 
5.3.1 Dismissive HCPs 
5.3.1.1 HCPs’ conceptualisation of patient involvement in decision-making; 
patients’ agreement and adherence to the recommended treatment 
Based on the findings discussed in Chapter 4, the general aim of information sharing 
and discussion about the decision by the HCPs is to secure the agreement and 
adherence of patients to the option that the HCPs consider to be the best for the 
patients. Further exploration indicates that this may be due to how HCPs 
conceptualise patient involvement in decision-making. The analysis found that most 
of the HCPs tend to equate it with patients‘ agreement with and/or adherence to the 
HCPs‘ recommended management. 
Their agreement, that‟s what important. Rapport, of course, is also important. 
That‟s why we need to communicate with them. But, the most important thing 
is for us to get their agreement. If they are the one that says it is hard and 





managed to convince them, they usually have the desire to improve 
themselves. (HCP13, diabetes nurse educator, CC) 
 
As shared by many of the other HCPs in this study, HCP13 believes that the main 
aim of involving the patient in decision-making is to secure their agreement with her 
recommendation. This understanding is much more akin to obtaining consent, which 
is widely used in the current Malaysian healthcare system, compared to shared 
decision-making (Ng et al., 2013). However, according to S. N. Whitney, McGuire, 
and McCullough (2003), despite sharing the similarity of respecting patient 
autonomy in making a decision about their treatment, shared decision-making is 
more preference-sensitive in comparison to informed or simple consent. Thus, due to 
HCPs‘ equating of shared decision-making with the obtaining of patient consent, 
HCPs‘ efforts, which include building a good interpersonal relationship and fostering 
patients‘ sense of comfort and trust, as asserted in the above account by HCP14, are 
usually geared towards ensuring that the patients agree to the recommended 
management (as explained in Chapter 4) as opposed to encouraging them to share 
their preferences, values and beliefs about the management decision under discussion.  
 
On the other hand, shared decision-making is important when determining patients‘ 
lifestyle modification as their preferences and values are greatly related to the 
suitable option (S. N. Whitney et al., 2003). Compared to medication or other 
medical procedures, lifestyle modification mainly involves behavioural change on 
the part of patients, for which HCPs can only provide ‗prescription‘ and 
recommendations in the form of advice. Thus, it makes sense when HCP6 mentions 
below that it is not something they can force and that patients need to be totally 
convinced in order to agree it is something they need to do in order to maintain their 
glycaemic level. 
 
 One more important element is cooperation. Which means the patients give 
their cooperation, they‟ll do what we ask them to do. It shouldn‟t be only one 
way. It‟s like we are forcing them to do, but they didn‟t do… As for me, I 
hope that patients will follow. If we ask them to check their sugar, they will 





normalise. So that the patients will not develop complication too soon. That‟s 
what we hope for. We want them to have a high quality of life. (HCP6, 
diabetes nurse educator, HC)  
 
If the patients don‟t want to discuss with us, we have to ask ourselves as a DE 
(diabetes educator), maybe we‟re lacking, in communication, as maybe we do 
not really connect with them. Soft skills, how is our soft skills. If we think that 
we already have tried our best, but still the patient is not involved, we can‟t 
do anything, really. But, if possible, those patients should come with their 
relatives. We‟ll convince the relative and maybe the patients will hear from 
them. If their relatives also present, usually they will also brainwash the 
patients. (HCP14, medical assistant (diabetes educator), HC) 
 
In describing the main elements of shared decision-making, HCP6 emphasises the 
importance of patient cooperation, which she describes as patients‘ compliance with 
the prescribed treatment. Similarly, HCP14‘s explanation of patient involvement in 
decision-making represents self-management support focused on improving the self-
efficacy of patients to manage their chronic illness. As such, he describes 
psychological influence and support so that the patients will carry out their self-
management. Ahmad and colleagues (2014) found it was common for these two 
approaches to be perceived as similar since both are used to promote patient-centred 
care; indeed, both approaches encourage individuals to be involved in managing their 
own illness and are commonly intertwined with patient management. Ahmad and 
colleagues (2014) further highlight that even though these approaches (shared 
decision-making, obtaining consent and support for patient self-management) are 
commonly intertwined and employed in conjunction with one another in an effort to 
operationalise patient-centred care in the practice, the way in which the approaches 
are understood has implications for their implementation. This is because each 
approach has different objectives, meaning they each require different measures.  
 
5.3.1.2 Superiority of the recommended option 
Apart from HCPs‘ conception of the term shared decision-making as the obtaining of 
consent and self-management support, the other important reason why HCPs focused 





identifying an option aligned with the preferences and values of the patients, is their 
belief in the superiority of their recommended option versus other options.  
  
…,but the final decision, you have to allow that to be mine, because you may 
not want to make that decision, but you have to trust me to know that this 
medicine is good for you, because you didn‟t go to medical college. So you 
may never understand the concept of diabetic retinopathy, nephropathy, you 
can say, “yes I know it does this to my kidney” but you don‟t know the fine 
things about it…. (HCP15, FMS, CC) 
 
Despite realising the advantages of patient involvement in their health decisions and 
allowing them to be involved in the discussion, HCP15 believes that her 
recommended option will be more effective compared to others due to her 
credentials as a specialist. This is in accordance with the assertion by Bourdieu 
(1986), together with Fredericks and colleagues (2012), that HCPs‘ expertise acts as 
a cultural capital that contributes greatly to their higher position and discursive 
power over the patients in the medical and health field.  
  
Based on the guidelines, Metformin is the first choice treatment for newly 
diagnosed patients. Other medications also have side effects. So usually, the 
doctor will start Metformin for new patients at the minimal dosage. If patients 
still can‟t tolerate, then only the doctors change to other medication. (HCP8, 
diabetes nurse educator, HC) 
I‟m a disciplined person. If there is a guideline, I will follow. I will not follow 
if the resources are not accredited. But if it can be proven as good, 
scientifically, I will follow. (PT10, 35-year-old Malay man, HC) 
 
Besides, HCPs make recommendations based not only on their medical and health 
knowledge but also on guidelines employed at the national level, mainly the 
Malaysian CPGs, as demonstrated in the above account from HCP8. It was also 
mentioned in Chapter 1 that Malaysians are increasingly seeking more information 
and evidence as they are no longer comfortable with ambiguity (Ken & Ying, 2013). 
Thus, the establishment and usage of the Malaysian CPGs in making management 





renowned international medical and health bodies such as the IDF, ADA, Trafford 
NHS Healthcare Trust and others, which are taken into account by the MEMS (2016). 
This approach is also aligned with the Malaysian need for rules, protocols, guidelines 
and schedules as a means of providing more assurance in relation to the prevention 
of unwanted effects (Hofstede, 1980).  
 
However, the belief of both patients and HCPs in the superiority of HCPs‘ 
recommended option due to their technical expertise and based on the scientific 
guidelines may serve only to strengthen the disparity between patients and their 
HCPs in the hierarchical structure of healthcare (Bourdieu, 1977). This reinforces not 
only the paternalistic manner and content of the interactions of HCPs with their 
patients (as explained in Chapter 4 and the following subsection 5.3.1.3), but also the 
way in which patients interact with them, whether or not this is intentional (Bourdieu, 
1986; Shim, 2010), as illustrated in the above account from PT10. 
 
5.3.1.3 HCPs’ paternalistic style of communicating (verbal and non-verbal) 
The previous subsections of 5.3.1.1 and 5.3.1.2 described the increased possibility of 
HCPs‘ misconception of different approaches to patient-centred care and their belief 
in the superiority of their recommended option, thus leading to a more paternalistic 
style of communication among them. Chapter 4 mentioned some of the 
communication styles that can be considered to be aligned with paternalism, 
including biased information that leans towards the recommended option and HCPs‘ 
use of threatening messages. This chapter further presents and discusses the other 
styles found in this study that hinder patient involvement in decision-making. 
 
Sometimes we have to be stern. Slow talk doesn‟t work. We have to “up” it a 
little bit. If slow talk does not work, we have to be a little bit firmer. It‟s always 
been like that. But they‟ll surrender. I think, they‟ll surrender. Because I have 
the facts in front of my eyes. I can‟t simply say it. When we‟re in the first 
appointment, they were not convinced, they don‟t want. Still, they win. But, one 
or two visits later it‟s like they lose and say “I will”. Still, we manage to 





HCP12, for example, believes that HCPs must be strict in order to ensure that 
patients who continually refuse the option they consider to be the best are eventually 
convinced and agree to it.  
 
Certain things, which relate to wrong decisions made by the patients, so I 
can‟t agree with them. For example, if their sugar level is high, then I will be 
strict to them and I would not let them make their own decision...I‟ll be strict 
in term if sugar control, I‟ll tell them they can‟t take it anymore, especially if 
their sugar level is consistently high, 11, 11, 11. So, if he still drinks sweet 
drinks, of course, it will stay high. So when they see the doctor and the sugar 
is high, it means the dietitian is not effective. (HCP4, dietitian, SC) 
 
HCP12‘s persistence in having her patients agree with her recommendation and 
using an authoritative approach to obtain their agreement is shared by many, 
including HCP4. Indeed, HCP4 is one of many HCPs concerned with the potentially 
graver consequences of patients‘ chosen management option over their 
recommended one, as it is their duty to be “… responsible for whatever form of 
therapy is given to patients” (Code of Medical Ethics, 2002: 8). As accountable 
HCPs, it is also their duty to protect their patients from any harm they foresee that 
the patients themselves may not yet understand. Thus, as a good advocator for their 
patients, these HCPs feel compelled to get their patients to agree and carry out the 
recommended treatment. Nonetheless, in the event that complications begin to 
emerge in the future, there is also the possibility of their patients and colleagues 
claiming they are not good at doing their job of managing their diabetes patients, as 
can be seen in the above account from HCP4. These findings epitomise the dilemma 
faced by HCPs with regard to the extent to which patients should be involved in 
making decisions about their diabetes management.  
Furthermore, the data collected from the patients clearly illustrate the impact of 
HCPs‘ strict communication style on patients‘ intention, attitude and practice of 
becoming involved in making the decision. 
 
The doctor just now seemed to be serious. So I‟m scared to ask. It depends on 





now, he seemed to be a little bit firmer, so I‟m afraid to ask. Despite having 
questions, I will not ask. … When the doctor is firm with us, we will become 
scared and only then we realise. (PT22, 34-year-old Malay woman, HC) 
 
The description by PT22 is comparable with the findings by Eldh, Ekman, and 
Ehnfors (2006), and also Frosch and colleagues (2012), which suggest that it is 
common for patients to feel uncomfortable in having a discussion with HCPs who 
portray themselves as superior and who fail to create a sense of partnership in their 
relationship with their patients.  
 
Dr K is really fierce. She‟s not really fierce, more too strict. The other patients 
in my obesity group also complain if they get Dr K. But actually, there is a 
benefit when we meet her. Sometimes, we‟ll be closer to her as she‟s straight to 
the point. She said, “You have this problem. So, you have to do this, this and 
this. If not, this, this and this will happen”. There‟s no hidden information. 
She‟ll tell us it all... it depends. Surrounding factors and emotional factors. 
We‟ve waited for a long time to see the doctor and sometimes we can even lose 
our temper just by waiting. And when we meet with the doctor, he/she scolds us, 
which make thing even worse and we become even more sensitive. So we just 
ignore them. (PT12, 29-year-old Malay woman, HC)  
 
Furthermore, the above account from PT12 contends the assertion by Laverack (2009) 
as to the usefulness of HCPs‘ domination in ensuring patients‘ adherence to the 
agreed course of management. Again, even though this patient believes that her 
physician uses her power for her benefit and appreciates her transparency in 
conveying the information, the physician‘s fierceness has nevertheless had a negative 
effect on her. This patient not only expressed her emotional distress but also admitted 
that she would ignore the instruction and advice given by physicians, which could be 
termed intentional non-adherence. Despite Laverack's (2009) claim that HCPs‘ 
dominance can be beneficial and may be considered a ‗healthy‘ power in certain 
situations, the above finding indicates that it may also lead to a patient‘s dependence 
on their physician, which not only reduces that patient‘s cognitive ability and self-
efficacy but also affects their emotional status, something which was also suggested 






They might not tell their doctors, they‟re afraid, they cry. If they meet with 
their doctors, they cry. When the doctor informs them of complications, they 
cry. There are some doctors who take a safe side and who don‟t want to talk 
about complications. They want to please their patients, so they just keep quiet 
and the patient wouldn‟t know. Fierceness is needed nowadays, in my opinion, 
because I noticed that when they come and see me, they complain that the 
doctor in this room was fierce, but they are the ones who comply. That‟s what I 
noticed. But we have to look at what kind of fierce, because patients like some 
types of fierceness, as they think that the doctor actually gives them reminders. 
We have to look at each doctor‟s approach. But, actually, it‟s good for the 
doctors to be fierce, as the patients are the ones who will control. Most of the 
time. (HCP4, dietitian, SC)  
 
In contrast, for HCP4, despite her realisation of the negative effects of physicians‘ 
fierceness towards patients, she believes that the benefits of this approach outweigh 
any negative effects. She emphasises how a physician‘s fierceness will serve as an 
impactful reminder for patients regarding the severity of their problem and that it will 
encourage them to follow the recommended management. She thus perceived it to be 
the best option for patients. This claim was made by HCP4 based on her experience 
of working with cases of controlled diabetes; indeed, she had witnessed patient 
impacts that she believed could be attributed to physicians‘ fierceness.  
 
5.3.2 Permissive HCPs  
Despite the findings in Chapter 4 and previous sections of this chapter identifying 
paternalism as the prevailing approach in the current management of patients with 
diabetes in Malaysia, with shared decision-making remaining largely unfamiliar, it 
can also be sensed that most of the HCPs have started to embrace certain elements of 
shared decision-making and are permitting patients to become involved in choosing 
their own management since they have started to value the involvement of patients in 
managing their own chronic illness. The below accounts by HCP5 and HCP4 suggest 
some level of acceptance and adoption of shared decision-making among HCPs as 
they believe it may empower patients to better manage their T2DM. HCP4 has also 







Because I think it should be a two-way process, not just the doctor saying, 
“You have to do this or that”. I think they should understand the disease and 
then they should be empowered, they should have the power to change the 
disease itself. (HCP5, medical officer, SC) 
 
For example, if we suggest something to them, and they ask whether they can 
do this, this and this, we can see the compliance of the patients. Because they 
feel that those things are more practical to them. As compared to when we 
are the ones that suggest, they may feel like, I didn‟t do all of these things at 
home. So if it‟s like that, we can see that the patients who didn‟t involve, they 
may not turn up for their follow-up, because we can see that their sugar is not 
controlled or the sugar level is still high when they come for the second time. 
So, for those who are involved, we can see more (improvement), because we 
discuss with them what they can do at home. (HCP4, dietitian, SC) 
 
5.3.2.1 HCPs’ views and beliefs about their patients’ characteristics 
The permissive attitude and behaviour of HCPs with regard to shared decision-
making is found to be influenced by their views of their patients‘ characteristics. 
Based on their judgement of patients‘ characteristics that they gather from the 
patients‘ records, their initial interactions with them and a brief observation of the 
patients‘ behaviour, these HCPs will usually determine the extent to which patients 
can be involved in making their management decision.  
 
We will discuss about their treatment if they seem to be educated. For those 
educated patients, mostly we‟ll discuss with them. For those who are not 
highly educated like old ladies or old men, yet they have the initiative to 
improve their health, like security guard, low-income people, I will not 
instruct them to buy expensive things, I‟ll adjust it, for example, cream 
cracker, cheaper options. As for the milk, I don‟t mind whatever brand, as 
long as it written low-fat milk. (HCP10, dietitian, CC) 
 
The above account by HCP10 clearly reflects how her behaviour in terms of 
involving her patients in discussing their dietary plans is heavily dependent on the 
patients‘ characteristics. For those whom she perceives to be highly educated, the 
interaction will be two-way and discussion will be more extensive, which is a good 





dietary plans. This compares to patients whom she regards as being less educated and 
who are older, where there is more limited opportunity for discussion. The advice on 
dietary plan adjustment is given based on her judgement of patients‘ difficulty and 
limitations and in the absence of a thorough discussion with them. This style was 
commonly detected throughout this study and may indicate the disadvantage at 
which less educated patients are placed and the difficulty they have in attempting to 
be more involved in the discussion.  
 
Most of our patients, some are very good, some are, when we do get the ones 
that transferred in from private, I find the ones that transferred from private 
are more educated and those are English speaking are more educated so they 
have access to Google but the elderly, majority when they are don‟t 
understand and it‟s hard for us to discuss treatment with them. (HCP5, 
medical officer, SC) 
 
HCP5‘s account emphasises the regularity of HCPs‘ behaviour towards shared 
decision-making based on patients‘ level of education. Through her experience of 
dealing with different types of diabetes patients, this physician concludes that 
patients who come from private institutions and who are more proficient in English 
are better educated and are usually more active when it comes to discussing their 
management. She also associated these patient characteristics with the individuals 
having greater access to information on the Internet. Such patients usually come from 
more affluent communities (Thomas et al., 2011) and have better economic and 
cultural capital (Bourdieu, 1986; Shim, 2010). Based on her experience, these 
patients were also described as having a higher capacity to share the responsibility 
for making decisions about their diabetes compared to less privileged and older 
patients. Thus, she seemed to be more open to the idea of having a discussion with 
these types of patients. Based on an assertion by Bourdieu (1984), this is common as 
it is easier for the power and responsibility for making a decision to be shared among 
people who come from the same social class as they tend to have a similar level of 






HCP10, in addition to several other HCPs in this study, also mentioned and shared 
the patients‘ socio-economic status and age. Despite attempting to ensure that the 
advice given suited the patients‘ preference, needs and values, it can nevertheless be 
seen from her account that advice was given as an instruction. There also appeared to 
be only limited involvement of elderly and/or lower-income patients, as HCP10‘s 
advice was made based on her assumption that these patients would not be able to 
afford or not be willing to buy certain types of food. Nonetheless, the findings of 
previous studies have indicated that patients with lower levels of education, the 
elderly and patients with more serious illnesses tend to prefer decisions to be made 
by HCPs, which can in turn justify their limited involvement in making the decision 
in this study (Auerbach, 2001; Cole, Wellard, & Mummery, 2014). Besides, the 
HCPs‘ assertion of their greater tendency to allow the involvement of patients who 
can converse in English and who have attained a higher level of education can also 
be seen in various patients‘ accounts, with that of PT16 below as an example.   
 
They will listen because they know that we are educated. When I speak in 
English, they will listen. If they are not, I will be a little bit firm. I will say, “I 
am the patient, why you do not listen to me?” Because I‟m not type of person, 
“Okay, never mind doctor”. We need to know our condition. (PT16, 57-year-
old Chinese man, CC) 
  
5.3.2.2 HCPs’ empathy and compassionate care 
Aside from HCPs allowing patients to contribute significantly based on their positive 
perception of patients‘ characteristics, it is also found that the HCPs‘ sense of 
empathy and respect for their patients further encourages them to be compassionate 
towards them.  
 
 Putting themselves in the patients’ shoes 
… It‟s quite difficult sometimes to have this shared decision in the patients‟ 
management, initially. But I suppose you cannot give up. You cannot say, “oh 
my God, this patient”. You have to make sure that the patient likes you. First, 
you have to treat them nicely. I always believe that. Of course when I was 





understand as if we ourselves are diabetes patients. It‟s very difficult, it‟s not 
easy. (HCP18, endocrinologist, HC) 
 
The above account demonstrates HCP18‘s tenacity to involve the patient in decisions 
despite her understanding the challenging nature of this task. This is mainly due to 
her recognition of her patients‘ difficulties in managing their lifelong T2DM and can 
be seen in parallel to the definition of clinical empathy by Mercer and Reynolds 
(2002; p. S9) as an HCP‘s ability to “… understand the patient‟s situation, 
perspective and feelings (and their attached meaning)”. The account also 
demonstrates how this understanding altered the way in which she treated her 
patients in terms of building a good relationship with them and in facilitating shared 
decision-making as she became more compassionate. Compassion is one of the 
fundamental virtues of HCPs, along with discernment, trustworthiness, integrity and 
conscientiousness (Beauchamp & Childress, 2013; Papadopoulos & Ali, 2016). 
HCP18‘s sense of empathy further guided her compassionate approach to her 
patients as human beings and not merely as T2DM cases.  
 
Yes, for example, if we are talking about diabetes, most people will tell the 
patients to eat oats. It shouldn‟t be like that. Not all, even if you ask me, I 
don‟t like to eat oats, but we have options…We can‟t just simply say, 
“Diabetic patients must eat brown rice”. No, it will be beneficial for them if 
they can eat it. If not, there are other ways. Maybe they can eat a lot of 
vegetables, high fibre food. There are ways. We can‟t just simply ask each 
diabetic patient to eat brown rice as not everybody can afford it. Because 
there was a patient who said to me that she can‟t afford to buy brown rice as 
she just lost her husband. It‟s not a big problem, as she still can eat white 
rice. The food combination is more important than the type of rice. The sugar 
will still not reduce even if they eat good type of rice, but they take it (sugar) 
a lot without rice. Actually, the options are very important nowadays. It‟s not 
like, “if according to this cross book, the diabetic patients should only eat 
oats, or brown rice or all sort of that food”. We have to look at the needs of 
each patient, and these days options are very important for the patients. 
(HCP16, dietitian, HC) 
 
The above account by HCP16 demonstrates her efforts to plan her patients‘ T2DM 
management based on their involvement, which arose as a result of her attempting to 





patients‘ sharing of their daily difficulties in dealing with their diabetes shaped her 
understanding of the different preferences and values of different patients, including 
the types of food they do not like to eat, their financial problems and others, thus 
enabling her to consider the different aspects related to the options presented to 
patients. This sits in parallel to the extension of social capital by Putnam and 
colleagues (1994), who add trust and cooperation to the elements of this capital 
previously included by Bourdieu. Putnam further explains that the basis of trust and 
cooperation between heterogeneous groups lies in their different roles during the 
interaction. It is the connections between these different roles that enable them to 
trust and cooperate with each other. A study by Shultz, Sprague, Branen, & Lambeth 
(2001) also highlights the importance of patient–HCP deliberation. They identified a 
mismatched view between patients and HCPs relating to the barriers that influence 
patients‘ adherence to their recommended diet plan. As such, HCP16‘s efforts to 
offer as many dietary options as possible, and to provide patients with relevant 
information that enables them to evaluate each option fairly and make a decision 
accordingly, become even more valuable.  
 
No point in forcing the patients 
Apparent throughout both of the Findings chapters has been the emphasis by many 
HCPs that the patients cannot be forced to accept a decision that has been made 
paternalistically. Although it was discussed in 5.3.1.3 that this may result in HCPs 
taking other authoritarian measures, in other instances this belief has been shown to 
open their minds to the importance of taking their patients‘ goals, preferences and 
values into account when making decisions.  
 
Usually I will ask them first, “Can you do this every day?” If they can‟t, we‟ll 
make a deal. There are a lot of options, which means we don‟t force our 
patient to do exactly what we say. They have other options. Because one, we 
don‟t want the patients to default from the treatment and second, we want 
them to be more comfortable, “oh, this means it is not a coercion”. We give 
options so when they have to come here again, they will feel comfortable. We 
don‟t want them to default if we force them to do it. It will be harder. (HCP8, 





From the above account, HCP8‘s permissive behaviour towards shared decision-
making was due to her realisation regarding patients‘ role and power in managing 
their diabetes, as they are the ones who hold the ultimate power in deciding whether 
or not they wish to carry out their management at home. Whether or not this role and 
power is acknowledged by HCPs, she was aware of the greater potential for T2DM 
patients to reclaim and exercise their power through non-compliance due to the high 
level of their own self-management at home, which was also demonstrated in a study 
by Bauer and colleagues (2014). Thus, she prefers to discuss different options with 
her patients in respect of them performing their SMBG despite the recommendation 
in the CPGs for diabetes patients, especially those who receive multiple insulin 
injections, to carry out SMBG at least three or four times daily (MEMS, 2016). 
Nevertheless, the CPGs also permit, indeed recommend, an element of modification 
to suit each patient individually. Realising this room for modification, HCP8 tried to 
accommodate each patients‘ preference, belief and values along with the 
recommendation from the CPGs.  
 
The accounts by HCP18, HCP16 and HCP8 in this subsection demonstrate how their 
belief in the importance of patient involvement in decision-making has led to their 
caring attitudes and behaviours, which are recognised in the existing research as 
facilitating shared decision-making (Eldh et al., 2006; Entwistle et al., 2008; Lown et 
al., 2009). These behaviours include a willingness to listen to and trust their patients, 
an effort to understand and respect their patients‘ concerns and needs, discussing the 
different options available and making decisions with their patients. Similar methods 
are also given as components of compassionate practice by Papadopoulos and Ali 
(2016), based on their review of the topic. These compassionate practices by HCPs 
contribute positively to shared decision-making as they make the patients feel 
respected and treated as human beings, which is also asserted in the following 
account from PT10. This patient further admits that these positive behaviours by 
HCPs have fostered his sense of comfort with them, thus ultimately creating a sense 
of partnership and good relationships between patients and their HCPs (Fraenkel & 






…I am more comfortable here, they listen more. We respect each other, we 
are also human. We know our history, we know what happened… (PT10, 35-
year-old Malay man, HC) 
 
5.3.2.3 HCPs’ facilitative behaviours and communication style in educating 
patients 
Some of the facilitative attitudes and behaviours towards shared decision-making 
adopted by the HCPs have been explained in both Chapter 4 and the previous section 
of this chapter. In accordance with symbolic interactionism that emphasises the 
contribution made by social interaction to the construction of meaning and the action 
of human beings, this subsection highlights further descriptions and discussion to 
explicate those behaviours and communication styles adopted by HCPs that are 
found to empower patients to be involved in the decision-making process. This is in 
contrast to 5.3.1.3, where the HCPs‘ paternalistic approach was seen to hinder the 
practice. Although section 5.2.1 of this chapter has already mentioned patients‘ 
contribution in terms of their life experience when dealing with their diabetes, the 
participants in this study emphasised the importance of them having sufficient 
knowledge to build a comprehensive understanding of their medical condition and to 
make sense of the relations between their T2DM and their concerns or any problems 
that they are facing. 
 
So, what I can tell them is, “For as long as you don‟t understand this, we will 
continuously be having this issue with your sugar control”. And I actually tell 
them because some of them, wandering already, within 2 minutes. So, they 
are not listening to you. They go off on a tangent, you know. So, I have to pull 
them back, ask them back questions like in a quiz, ask them back to see 
whether they are listening to me or not…So I keep telling them, “This is your 
disease, you should be the one talking now, not me. You should be asking me 
a million questions, you should be scolding me, why is my sugar like this, you 
cannot be just sitting and staring at me.” I try to empower them to get their 






With this in mind, this FMS is attempting to empower patients, not only by providing 
them with information but also to ensure their understanding so that they can apply 
this to improving their health, including by playing an active role in managing their 
T2DM. This is aligned with the notion of health literacy as described by Rowlands, 
Protheroe, Price, Gann, & Rafi, (2014). They assert that health literacy is the “… key 
to more effective use of resources, through increased understanding of how best to 
access and use health services, through confidence and skills to enable decision-
making that is shared between doctors and patients, through to ensuring that patients 
take a full role in developing services that fit with the needs of local populations” 
(Rowlands, Protheroe, Price, Gann & Rafi, 2014: p. v).  
 
Despite the previous discussion in section 5.2 highlighting that knowledge alone is 
insufficient to facilitate shared decision-making, previous studies have highlighted 
that knowledge about health, including diabetes, is very much related to health 
literacy. The studies indicated that it is important for patients to have this type of 
knowledge in order to be able to enter into fulfilling discussions with their HCPs for 
the purpose of deciding their own management (Coulter & Collins, 2011; Azreena, 
Suriani, Juni, & Fuziah, 2016). However, the majority of diabetic patients in 
Malaysia have a limited level of health literacy and a low level of diabetes 
knowledge (Azreena et al., 2016), which was also found among the patients in this 
present study. Ishikawa and colleagues (2009) together with Moulton and King 
(2010) found this to affect their ability to participate. These researchers also made 
the assertion that patients with a high level of health literacy have a higher 
motivation to seek information from their HCPs, which encourages them to 
communicate more during the consultation. Thus, these studies attest to the 
usefulness of HCP15‘s efforts to educate her patients, encourage their participation 
in the management of their diabetes and improve their health condition.  
  
Firstly, we ask. The second one, we tell them, the thing that I noticed is, when 
we told them, “This food contains a lot of sugar”, for example, on what he 
usually eat, we told him, “Sir, you ate this together with hot chocolate just 





this? Is it okay”? There are patients like that. Through questions, through 
what we show to them, they will discuss more and more they can remember. 
(HCP4, dietitian, SC) 
 
Several empowering interactions can be found within the above account. HCP4 is not 
only assessing patients‘ current practice by asking them questions and attentively 
listening to them, thereby allowing her to focus on the root problem, but she is also 
educating and providing information based on the accurate identification of the 
problem, thereby tailoring the approach to each patient. These behaviours will also 
be beneficial in rectifying the patients‘ misunderstanding that led to their 
mismanagement as the information is given in a manner that they can relate to. On 
the other hand, HCP4‘s encouraging way of asking and responding might also be 
why patients are more open to interacting with her. By doing this, patients are given 
the opportunity to explore themselves in relation to their health condition. This 
positively impacts on their sense of encouragement and confidence which in turn will 
facilitate a continuous and self-involving relationship (Aujoulat, d‘Hoore, & 
Deccache, 2007; Maggie, 2015). This is proven by PT11 below, who admits that she 
is more comfortable and can better engage with HCPs that are more skilled in 
communicating with her. 
 
If the person is as friendly as me, it‟ll be different. There will be nothing to 
hide as I wrote everything… Maybe I‟ll be more comfortable if I meet with 
the same person and that person is concerned about me. Asking more 
questions and all. (PT11, 36-year-old, Malay woman, HC) 
The HCPs‘ acts of enquiring about her condition and responding positively to her 
concerns have encouraged PT11 to be more active in discussing her diabetes, 
especially if she meets with the same HCPs. Similar to the HCPs that were included 
in the previous subsection of 5.3.2.2, the HCP accounts in this subsection identify the 
essence of good communication skills among HCPs, which can be described as 
approachable and compassionate (Papadopoulos & Ali, 2016).  
 
This account from PT11 also illuminates the importance of HCPs‘ communication 





that was carried out in China (Ting, Yong, Yin, & Mi, 2016). As mentioned in 
Chapter 1, Malaysia, as an Asian country, has a high-context culture in which 
implicit communication is more valued than direct communication (Hall, 2000). 
Thus, besides the verbal information that HCPs try to convey during their encounters 
with patients, most patients also evaluate their HCPs‘ non-verbal styles (including 
their tone of voice, body language, eye contact and facial expressions) in determining 
their level of approachability and tolerance, which was described as friendliness by 
PT11. This will further influence patients‘ level of involvement in the discussion 
about their diabetes condition.  
 
Some people google nowadays, and everything is there, so some people do 
come out with their own, “Can I take this? Can I do this? Can I do this?” We 
have to listen too, we cannot be authoritative and say, “you this, this and this”. 
No. It has to be two-way, but again, coming back to resources. So, there are 
not many options at this place. At this level, at my level. So, we have to use the 
resources which are available. Unless they are willing to buy those drugs 
outside like other good ones, they‟re welcome to. There are one or two who are 
willing to buy. So, we just, we do welcome them. Most of the patients cannot. 
So, they go with what is available here. (HCP12, medical officer, CC) 
 
HCP12, realising the importance of shared decision-making despite the limited 
options available at public facilities, stated that her patients were given the 
opportunity to enquire about options that they perceived would suit them better and 
to seek these away from the facility, if, after having discussed the matter, they chose 
to pursue them. However, relatively few patients were able to seek their preferred 
options outside the facility due to the increased cost involved. In spite of this, HCP12 
tried to ensure patients were given a sense of being heard and tried to address their 
concerns accordingly. This may not only increase their feeling of comfort as 
previously mentioned in 5.3.2.2 but also may improve their sense of empowerment to 
express their opinion and be involved in a discussion about their diabetes 
management (E.S. Rogers et al., 1997; European Commission, 2012).  
 
Usually I will ask, when I can see that the sugar is out of control and I have 





injection technique or so on and so forth. So, some of them, actually not many 
people told me that the needles are expensive. They don‟t come out with that. 
Maybe 1 or 2. But, a lot of people when I asked to do the SMBG, the strips, 
that‟s the one that they said are expensive. But not needles, even when I 
asked why they used too long, they said “Oh, I didn‟t know about it”…Some 
will open up when we ask them why this is happening, then they will open up. 
They will be like sobbing here. I find that if you are softer with them then they 
will open up they will tell you why. (HCP5, medical officer, SC) 
 
Furthermore, by means of a thorough assessment, HCP5 is able to detect her patients‘ 
non-compliance, which provides her with the opportunity to properly address their 
main problem. By asking her patients questions and taking into account their 
experience in managing their T2DM, this HCP has the opportunity to investigate the 
non-medical reason behind her patients‘ uncontrolled glycaemic levels. Besides, 
HCP5‘s account also indicates that some HCPs realise that a friendlier approach will 
facilitate their patients‘ willingness to share their problem, as previously asserted by 
PT11 in this subsection.  
 
That is quite common, the ones who didn‟t ask much, we‟ll push them slowly. 
Ask, what, why they don‟t want to comply with medication. Actually for those 
who are less educated, it‟s not that they don‟t want to ask, sometimes they‟re 
shy, as they don‟t know what to ask. So, from there we‟ll tell them. (HCP14, 
medical assistant (diabetes educator), HC) 
 
A handful of the HCPs in this study encourage patients to ask them questions in an 
effort to make the patients feel comfortable with them, which then encourages further 
discussion. This is comparable with findings by Abdulhadi, Al Shafaee, Freudenthal, 
Östenson, and Wahlström (2007) highlighting the difficulty experienced by patients 
in communicating with their HCPs as they are not encouraged to ask questions, thus 






5.4 Physicians versus non-physicians 
Most of the HCPs also valued patients‘ sharing of information as it made their 
encounters easier. Throughout both of the Findings chapters, it was described how 
patients‘ involvement in decisions is affected by the different responses or treatment 
offered to them by their HCPs. The findings also indicate that there were noteworthy 
differences in terms of patients‘ engagement with their physician compared to their 
non-physician HCPs.  
 
The doctor‟s explanation just now was not as detailed as this diabetic nurse. 
With the diagram, it became very clear to me how to take it 
No, and I also didn‟t ask him. I only said to him, “sometimes I forgot, 
doctor”. That‟s why I asked the diabetic nurse. I felt more comfortable with 
them, because the way they interact is different. The doctor was way too 
serious. Actually, I would talk to him if only his face was more relaxed. If he 
was friendlier, maybe I would not be too afraid to ask. (PT22, 34-year-old 
Malay woman, HC) 
 
Patients are more open here compared to when they meet with physicians, 
specialists. Sometimes, I don‟t know who the management is over there, but 
here we try to be their family member. We‟ll try to be close to them. There 
are ways in which patients will be more open to telling their main problems. 
So, actually, the patients will tell us A-Z when they come here, as compared 
to the medical clinic. (HCP14, medical assistant (diabetes educator), HC) 
 
The account from PT22 illustrates that some patients are more comfortable with non-
physicians than they are with their physicians. As indicated by PT22, patients react to 
the way they are treated by different HCPs. This might suggest that some patients are 
more comfortable sharing their problems with their non-physician HCPs as these 
individuals tend to be more welcoming and have better communication skills. This 
was also supported by HCP14, who verbalised his willingness to spend extra time 
connecting with and building a better rapport with his patients. 
 
DRC is okay. There are some doctors who look friendly, I will ask them more. 
But if I get the serious one or doctors who seem to want to hurry, I will not 





There were also a few cases in which patients perceived that their physician would 
not be able to attend to their concerns due to them not deeming them to be important 
and the fact that they had other patients to see, thus creating another barrier to 
patients verbalising their concerns to their physician. Instead, patients with access to 
other HCPs, PT11 for example, preferred to share their concerns or doubts with these 
HCPs.  
 
If that happens, we‟ll consult with the doctor. Sometimes, some patients have 
side effects from Metformin, so we‟ll consult with the doctors so that they can 
prescribe them another type of Metformin. (HCP6, diabetes nurse educator, 
HC) 
 
HCP6‘s account corresponds to one of the attributes listed by Bu and Jezewski (2007) 
which emphasises that as advocates acting on behalf of their patients, HCPs, 
particularly nurses, play an important role in maintaining their patients‘ rights and 
values, especially when the patients themselves are unwilling to do so. In these cases, 
non-physician HCPs, including nurses, appear to play the role of patient advocates, 
providing further support to patients so that their verbal complaints can be better 
managed, as reflected in the following account. However, as previously mentioned, 
not all patients have access to HCPs other than their physicians, especially patients in 
primary health clinics whose interactions with pharmacists, dietitians or even nurses 
tend to be brief, one-off or based on a referral from physicians.  
 
I don‟t know about other people. I see that there are some doctors that we 
can discuss, there are some who don‟t even want to talk. (PT24, 44-year-old, 
Malay woman, HC) 
 
 
Nonetheless, similar to the accounts by other patients in this section, PT24 also 
highlights that patients‘ lack of engagement during their encounters with physicians 
is not merely because of the physicians‘ higher status but is also due to their personal 






5.4.1 Section summary 
This section further presents the understanding, beliefs, values and characteristics of 
the HCPs that are found to shape the different practices of involving the patient in 
making the decision. These include their conceptualisation of shared decision-
making and the higher value placed on their own expertise and recommendations 
compared to those of the patients, which substantially hindered the practice. On the 
other hand, those HCPs who facilitate patient involvement usually have a stronger 
belief in the benefit of their patients‘ involvement and that the patients have what it 
takes to be involved, in addition to their empathy in understanding the patients‘ 
difficulty in managing their T2DM as a lifelong illness.      
   
5.5 Chapter summary 
Through the adoption of Bourdieu‘s work in exploring the elements related to the 
practice and understanding of patient involvement in decision-making, this chapter 
relates the practice to the patients‘ and HCPs‘ character or habitus and capitals that 
have been structured by their past experience, motivation, thought process and 
embodiment of social expectation. Following the exploration, the views, values and 
beliefs that are commonly shaped by their habitus and capitals are found to further 
influence their practice of patient involvement in decision-making. 
 
One of the factors found to be most apparent in terms of influencing the practice of 
patient involvement in the decision is the value placed by the participants on both 
their own and their counterpart‘s expertise. Generally, the technical knowledge of 
HCPs is found to be valued more highly than patients‘ experiential knowledge, 
thereby hindering patients from becoming involved in their decisions. This is also 
aligned with the lack of recognition of patients‘ experiential knowledge as their 
cultural capital in comparison to HCPs‘ technical knowledge, which is accumulated 
through the formal education system (Bourdieu, 1986; Shim, 2010). As such, the 





patients should agree to it. This chapter also further highlights how the HCPs 
described shared decision-making similarly as obtaining a patient‘s consent for their 
recommendation and support for self-management. In turn, the HCPs‘ effort is often 
geared towards the securing of their patients‘ agreement and adherence. 
  
For the patients, it has been demonstrated that their sense of self-empowerment 
drives their proactive behaviour in ensuring that their concerns, preferences and 
values are taken into account in the decisions. However, it also appeared that some of 
the patients struggled in their effort to do so due to being faced with authoritative 
HCPs. Besides, patients‘ involvement is also heavily dependent on the degree of 
importance they perceive regarding the involvement and/or the decision. The patients 
were found to be more active if they perceived that their concern or problem posed a 
risk to their overall well-being or if they required an intervention from their HCPs. In 
contrast, they tended to be more passive if they believed they had no right to choose 
based on the nominal amount they paid for the service they received from public 
facilities. In addition, patient involvement in decision-making was found to be 
limited if the patients wanted to be perceived as good, particularly by their HCPs, in 
order to preserve their relationship. The following Discussion chapter further 
synthesises the findings of the current study by placing it within the existing body of 





 CHAPTER 6: DISCUSSION 
 
6.1 Introduction 
This study has aimed to address the lack of research on patient involvement in 
T2DM decision-making in the Malaysian context by understanding patients‘ and 
HCPs‘ experiences and perspectives on the matter. Patient involvement in decision-
making is considered to be one of the main components of patient-centred care as the 
ubiquitous approach promoted by the WHO in its effort to improve the quality of 
care and appropriate use of services (WHO, 2007; Stacey et al., 2014; McCormack & 
McCance, 2017). Based on the data presented in Chapters 4 and 5, awareness of and 
support for the involvement of patients in their own T2DM management has 
generally been demonstrated by both the patients and different groups of HCPs. 
However, further descriptions of their understanding and experience of it indicate 
that the matter is being viewed and practised differently, with biomedical care and 
paternalism being the main approaches. In Chapter 5 the factors that influenced the 
views and practice were further explored and explained.  
 
This chapter further elaborates the key points from both of the Findings chapters by 
linking them back to the existing literature, related models and theories, together 
with the Malaysian social and cultural background. The discussion in 6.2 and 6.3 
relates to the findings from Chapter 4 and highlights the issues considered to be 
important regarding the current practice of patient involvement in decision-making at 
the study sites. Section 6.2 contains further discussion of the key elements that 
further reflect the lack of patient involvement in decision-making, notably the 
patients having only limited involvement at the beginning, when the agenda of the 
consultation is set; the lack of information exchange by both sides; and the emphasis 
on the HCPs‘ recommendation and patients‘ agreement with that recommendation. In 
discussing these key findings the existing shared decision-making models are 
extensively referred to as ideal models for patient involvement in decision-making. 





patient involvement in decision-making as identified from both of the Findings 
chapters, namely the disassociation between patients‘ agreement and their adherence.  
 
This is followed by sections 6.4, 6.5 and 6.6. Based on symbolic interactionism as 
the theoretical underpinning of the study, together with Bourdieu‘s social theory and 
work on power, these sections discuss three key factors that were found to influence 
the practice: (1) the patient–HCP interpersonal relationship and communication; (2) 
the perceived roles of HCPs and patients; and (3) patient–HCP power relations in 
decision-making. The discussion in 6.6 draws on the work of Bourdieu on power 
relations and the power dynamic between the patient and HCP in making the 
decision. Finally, based on the discussion of the key findings of the study, this 
chapter brings forward the contribution of this study to the existing shared decision-
making concept in terms of facilitating its effective implementation in the study 
context. 
 
6.2 Patient involvement in decision-making  
To reiterate, the findings of this study suggest that patient involvement in decision-
making in this study context ranges from HCPs‘ paternalistic decision-making, 
shared decision-making, through to patients‘ informed decision-making. 
Nevertheless, further comparison of the participants‘ descriptions of their decision-
making experience with the existing decision-making models, which were previously 
presented in Chapter 2, indicate that HCPs‘ paternalistic decision-making appears to 
dominate the way in which decisions are made, with only limited active involvement 
and contribution from the patients themselves. 
 
6.2.1 Patient involvement in agenda setting 
Significant mention was made during the interviews of patients‘ involvement in 
identifying the problems. Comparable to the assertion by Entwistle and Watt (2006), 
it was apparent in the patients‘ descriptions of their experience relating to this 





shown by the fact that the patients were actively involved in responding to their 
HCPs‘ enquiries about their concerns and identified problems. This was done with 
the main aim of assessing signs and symptoms and/or complications related to their 
T2DM, along with any T2DM-related problems they encountered between their 
follow-up visits. However, the patients‘ accounts illustrate a perception that the 
concerns they shared, relating mainly to side effects, pain, stress and sexual 
dysfunction, in addition to their needs and preferences, were often not properly 
addressed or given sufficient attention by their HCPs. Similarly, a superficial 
exploration of patients‘ concerns, problems and needs, together with a lack of 
consideration of the above-mentioned verbalised psychosocial concerns from 
patients, is also apparent in the HCPs‘ accounts.  
 
The extra attention paid by HCPs to their patients‘ biomedical status and the lack of 
consideration of their psychosocial problems when setting the agenda for 
consultation can be linked to both the traditional biomedical model and modern 
evidence-based medicine. Here, the main aim is to treat the disease by restoring 
patients‘ physical function, which appears in their biomedical results or during a 
physical assessment (Szasz & Hollender, 1956; Bensing, 2000). Since the HCPs‘ 
encounters with the patients in this study context were usually brief and there was 
only a slim chance of them meeting the patients again at their next follow-up, some 
of the HCPs (e.g. HCP12, subsection 4.2.2; HCP19 in 4.2.4) felt the need to offer a 
quick fix capable of producing an improvement in their patients‘ biomedical status. 
As previously discussed in section 4.2, this was more apparent among the medical 
officers who work on a rotation basis and who typically have only around five to ten 
minutes to spend with each patient. However, further exploration revealed patient 
involvement in identifying the problems and greater consideration of patients‘ non-
biomedical problems to be crucial since the majority of them attended clinics for 
follow-up appointments. As such, most of the patients did not have any major health 
problems but they did have a range of concerns that did not appear in their test 
results and/or were not physically visible and thus could not be considered as 





vary and may not be as apparent as for patients with an acute condition since each 
individual faces different challenges in their day-to-day T2DM management. 
 
Similarly, the existing shared decision-making model lacks any description of patient 
involvement in determining their problems. This may be due to an existing 
understanding that shared decision-making between patients and their HCPs begins 
after the agenda for the consultation has successfully been determined (Charles et al., 
1997; Elwyn et al., 1999). Nonetheless, the findings of this study suggest that a lack 
of exploration and consideration of patients‘ concerns and needs at this stage tends to 
adversely affect the overall process of decision-making and patients‘ adherence to 
any decisions that are made within this encounter. This is because, similar to the 
findings by R. O‘Brien, Wyke, Guthrie, Watt and Mercern (2011), there is a disparity 
in the nature of patients‘ and HCPs‘ concerns and their agenda for the encounter. 
Besides, the findings of this study also support the assertion by Bugge and colleagues 
(2006) that the lack of an information exchange on patients‘ problems may lead to 
patients worrying unnecessarily that the severity of their problem is not being 
adequately explored. There is also the possibility that inadequate patient involvement 
at this initial stage may complicate the effort to develop a comprehensive shared 
understanding and good patient–HCP relationship. Consequently, many of the 
patients in this study reported a diminished intention to discuss their problems and 
concerns not only in that specific encounter with their HCPs but also in their 
subsequent clinical encounters, despite them continuing to be very concerned about 
the problems.  
 
These findings accentuate the need for the shared decision-making model to also 
focus on involving patients in the identification of problems and concerns that may 
give rise to the need to make new decisions, as suggested by Murray and colleagues 
(2006). By examining the original work of Charles and colleagues‘ (1997) shared 
decision-making model in general practice, Murray and colleagues (2006) noted that 
the ‗additional task of deciding an agenda for a consultation‘ should be included as 





defining or explaining the problem, as listed by Makoul and Clayman (2006) as one 
of the essential elements in their integrative model of shared decision-making in 
medical encounters.  
 
6.2.2 Information exchange  
Another critical element of the involvement of the patients in this study in their 
decisions involves the exchange of information between the patients and HCPs, 
where there appeared to be a lack of information sharing by both sides. This serves 
as another indication that shared decision-making is not fully practised in the current 
management of T2DM at the study sites, despite it being highlighted as one of the 
important components within many of the shared decision-making models (Charles 
et al., 1997; Makoul & Clayman, 2006; Elwyn et al., 2012). 
 
6.2.2.1 Information from HCPs 
The findings of this study indicate that on most occasions, the patients were neither 
presented with other options nor were they given sufficient information. As such, it is 
debatable as to whether any decision made on the basis of such a lack of information 
from the HCPs can be considered as a shared decision; indeed, Zanini and Rubinelli 
(2012) asserted that for patients to be truly involved in and to benefit from discussion 
about the different options available for their individual condition, the information 
provided should be sufficient and unbiased. This is crucial in allowing patients to 
have the correct understanding of all of the available options and for them to 
construct their own point of view, thereby enabling them to effectively choose their 
preferred option and to then discuss this further with the HCPs. Thus, in the absence 
of sufficient unbiased information being provided by HCPs, patients, including a 
large proportion of the patients in this study, are unable to discuss the decision, 
vocalise their doubts, arrive at their own preferred option or reach any justification 
for it. As a result, a common situation is for discussions relating to decisions to be 
based on HCPs expressing their point of view, with patients not being able to raise 
any doubts in relation to this viewpoint. This was demonstrated in the previous 





than to take the recommended option, despite having sensed an element of 
disconnect between the recommended treatment and their everyday life. Similar to 
the outcome of patients‘ lack of involvement, this can lead to a greater potential for 
patients‘ non-adherence, whether or not they had willingly decided to agree in the 
first place. These accounts can therefore serve as the basis for stating that the 
information is provided mainly to inform the patients about the treatment option/s 
and not really to enable them to participate in making a decision. Slovic (1995) 
suggests that to facilitate patient involvement in decision-making, the information 
provided to patients should enable them to construct their own view and preference 
based on their values and beliefs and should not merely guide their expectations with 
regard to their illness and its treatment.  
 
On the other hand, the findings in sections 4.3, 4.5 and 5.2 revealed the likelihood of 
patients experiencing frustration as they were not able to pick their preferred option 
out of a variety of options that either were or were not presented by their HCPs for a 
variety of reasons, despite their acceptance of the condition. This corresponds to the 
assertion by Peters, Dixon, and Hibbard (2007) that too much information may lead 
to worse decisions being made due to patients‘ cognitive and emotional overload. 
They may feel overwhelmed and anxious by the sheer amount of information 
received from the HCPs. Nonetheless, Rosenbaum (2015) argues that this should not 
be a reason for patients to be uninformed. Instead, she suggests that HCPs should 
seek to manage their patients‘ cognitive and emotional struggle in addition to 
providing sufficiently transparent information. In doing so, it is important for HCPs 
to take into account the patients‘ concerns and needs, level of health literacy and 
ability to comprehend and apply the information to their own clinical issues (Epstein, 
Fiscella, Lesser, & Stange, 2010).  
 
The importance of information provision by HCPs can be identified in this study. 
The patients appeared to have access to other options and information about their 
T2DM management from resources other than the HCPs, including from family and 





may or may not be shared with their HCPs for further deliberation. In this study 
context, besides other conventional treatment options, the patients appeared to also 
consider traditional medicine as a viable option for managing their T2DM. In 
comparison to the West, traditional medicine is both widely used and easily 
accessible in Malaysia, regardless of whether or not it is combined with the patients‘ 
conventional medicine (Othman & Farooqui, 2015). The use of this type of medicine 
by T2DM patients in Malaysia is widely known and has been addressed in the recent 
CPGs by MOH Malaysia. However, due to a lack of solid evidence as to its effects, 
the CPGs do not recommend traditional medicine as an option for managing patients. 
Nonetheless, the guidelines do recommend that HCPs assess their patients‘ usage of 
traditional medicine. The excerpt from PT15 in subsection 4.3.1 is one example of 
where the patient found out about traditional medicine from his workplace. For this 
patient, it seemed that the combination of the lack of information from the HCPs and 
the information about traditional medicine that he had gathered on his own initiative 
from outside the healthcare system had increased his potential for non-adherence. It 
had also led to him developing an undesirable impression of his HCPs as he raised 
the question during the interview of how the decision had been arrived at to increase 
his insulin dosage. Subsection 6.3.1 contains further discussion on the impact of this 
lack of information sharing on the patients‘ views of their HCPs.  
 
Furthermore, on the rare occasions when options other than the HCPs‘ 
recommendation were presented, they were generally introduced after the 
recommended option. In many cases, other options were considered only after the 
patients had been deemed unable to perform or accomplish the first option, or when 
further assessment or evaluation revealed that the option recommended initially was 
not suitable for the patient. Overall, it was also detected that other options were not 
routinely presented, especially when it came to the intensification of pharmacological 
modalities, including the increased dosage of medications and the addition of oral 
medication. The other most common areas in which inadequate provision and 
discussion of information by the HCPs were found centred on the unwanted risks or 
side effects of their recommended option, as presented in section 4.3. In some of 





favouring their recommended option, might relate to their effort to obtain patients‘ 
agreement and adherence to the recommended option.  
 
Nonetheless, obtaining the agreement of patients might not have been the only reason 
that the HCPs in this study did not share and discuss the options and related 
information with their patients. It may also have been due to the HCPs considering 
the information to be unimportant or inappropriate, their belief that the information 
they provide to patients should be based on their own professional expertise and 
responsibilities, or otherwise due to time constraints. These potential reasons are in 
line with those found in a study by Bugge and colleagues (2006). Claramita and 
colleagues (2013) also suggested that a lack of information and options being 
presented by HCPs is associated with their lack of awareness of unusual conditions 
or problems. However, this study further found that some of the HCPs refrained from 
disclosing information that they did not consider the patient would understand. Aside 
from the potential impact on the patients‘ experience of healthcare and their 
perceptions of their treatment decisions, Entwistle and Watt (2006) and Frandsen and 
Kristensen (2002), along with Claramita and colleagues (2013), suggested that a lack 
of or ambiguous information may frustrate patients‘ efforts to carry out their 
management. This in turn can result in a lack of adherence among patients, which 
has also been demonstrated in this study. All of the above discussion in this 
subsection is aligned with the description of the paternalistic approach by Emanuel 
and Emanuel (1992), whereby HCPs share the information that they select in such a 
way that reassures the patient and leads to them agreeing with the treatment that they 
consider to be the best. Hence, it can be concluded that the HCPs hold the power to 
control the provision of medical information and the discussion that ensues with their 
patients.  
 
Besides, it was found that the patients in this study wanted more information about 
options and their management. Comparable with the findings of the existing research 
presented in subsection 2.3.3.2, it was common for the patients in this study to ask 





not fully answer their patients‘ questions (Peek et al., 2008; Corser et al., 2010; 
Hajos et al., 2011). Besides the aforementioned problems that arise as a result of 
HCPs‘ non-disclosure of information, similar to the findings by Bugge and 
colleagues (2006), some patients did not appear to mind that they had not received all 
of the related information so long as they were taken care of by their HCPs. Varul 
(2010) suggested that this might be due to the lack of any incentive for normalisation 
among patients with a chronic illness, which may then be followed by a feeling that 
the way in which the decision is made is insignificant. However, due to the severity 
of the potential ramifications of a lack of information sharing, it is suggested that 
HCPs ask their patients if there is anything else they may wish to know or discuss 
(Bugge et al., 2006), which was actually seen to be practised already by some of the 
HCPs in this study.  
 
Thus, tailored decisional aids are found to be widely developed and used in the 
making of decisions for T2DM patients, especially in Western literature, thereby 
facilitating the HCPs to provide sufficient and transparent information while 
restricting their own domination and enabling them to elicit questions from patients 
on the information they want from the HCPs (Weymiller et al., 2007; Mullan et al., 
2009; Drewelow et al., 2012; Branda et al., 2013; McBride et al., 2016). In Malaysia, 
as presented in Chapter 2, a decision aid focused on insulin initiation was developed 
and tested by P. Y. Lee and colleagues (2015). In this study context, no specific 
decision aids were used and on the occasions that a tool was used to help explain the 
options, the HCPs used tools that had been developed mainly for the purposes of 
patient education and self-management support.  
 
6.2.2.2 Information from patients 
In the shared decision-making approach, the emphasis is on information being 
exchanged in a two-way direction, as the information shared by the patients is 
considered to be equally as valuable as that provided by the HCPs (Charles et al., 
1997). The information considered vital to be shared by the patients includes their 





of this information was clearly lacking throughout the decision-making process, with 
the interaction remaining one-sided when information from the patients was shared 
less than that from the HCPs. Aligned with the recommendations in the existing 
shared decision-making models (Elwyn et al., 2000; Elwyn et al., 2012), most of the 
sharing by the patients in this study was heavily dependent on the HCPs‘ attempts to 
elicit the requisite information from them. Besides, it was common for the patients to 
refain from relaying the information to the HCPs unless they were asked to do so. As 
a result, the only information asked of the patients and subsequently discussed was 
that considered by the HCPs to be important. This may indicate the existence of 
power asymmetries in the exchange of information between patients and HCPs. This 
is where the use of a decision aid, which was previously explained in Chapter 2, is 
extended to help HCPs ensure that patients‘ views are elicited and considered when 
making the decision (Weymiller et al., 2007; Mullan et al., 2009; Drewelow et al., 
2012; Branda et al., 2013; P. Y. Lee et al., 2015; McBride et al., 2016). 
 
In some other cases, the patients did not share any information regardless of whether 
or not their HCPs asked them to do so. The following factors are some of those found 
to be associated with the lack of information sharing by the patients in this study: (1) 
patients‘ perception that the information is not important or does not need to be 
shared with their HCPs, in addition to being asked superficial questions such as ‗do 
you have any problem?‘; (2) a lack of value being accorded to their information 
(further discussed in 6.2.2.2); (3) their HCPs‘ negative responses from their previous 
sharing or not feeling comfortable to share with certain HCPs; (4) time constraints; 
(5) their forgetfulness, as they had faced the problem long before their follow-up 
appointment; and (6) intentional non-disclosure of information with their HCPs to 
serve a certain purpose (further discussed in 6.3.3). These factors indicate that 
sharing by patients is not determined solely by direct elicitation by HCPs but is also 
influenced by the implicit effort of some patients to shape the decision to suit their 
preferences and needs. This covert effort by patients is considered by Gaventa (1980) 
as their way of reclaiming power. This is further discussed in the following sections 





This discussion on the other factors linked to patients‘ lack of information sharing 
can form the basis of an argument that it is not only HCPs that have a responsibility 
to elicit information from the patients; rather, the findings of this study highlight that 
the competency and responsibility of both patients and HCPs are equally important 
so that information from the patients can be adequately shared, discussed and 
integrated into the decisions that are made. This is in accordance with another shared 
decision-making model suggested by Towle and Godolphin (1999). They also 
emphasised that although the patient can be taught and trained to become actively 
involved in the information exchange and decision-making, it is a significant 
challenge to refine the implementation as there is a lack of good literature on it. This 
is because, as presented in 2.3.3.2, the majority of the existing literature on patient 
involvement in decision-making discusses the information that is shared by HCPs. 
This is parallel to the previously developed shared decision-making interventions 
that mainly involved HCPs, with patients having limited to no involvement (Coulter 
et al., 2015). However, one intervention developed by Corser and colleagues (2007) 
was found to include a patient education session, which was found to facilitate 
patient involvement in their decisions, while the intervention itself was generally 
well accepted by both patients and HCPs. 
 
6.2.3 HCPs’ recommendation and patients’ agreement 
Many of the HCPs in this study believed that the decisions they made were shared 
with their patients by virtue of the fact that they had informed the patients and 
obtained their agreement with their recommended option, with the decisions being 
made based on a prior information exchange between them. Although this belief sits 
in contrast to the paternalism outlined by Dworkin (1972), who asserts that it occurs 
whenever a decision is made or a treatment is carried out without the consent of the 
individual, the descriptions in Chapter 4 as to how the agreement was obtained better 
accords with Emanuel and Emanuel's (1992) elucidation of paternalism. These 
descriptions include how the options and information were either presented or not 
presented by the HCPs, the limited elicitation of patients‘ concerns, needs, 





being persuaded or threatened to agree with the HCPs‘ recommended option. Similar 
to the intention displayed among the HCPs in this study, the approach that they use 
to obtain their patients‘ agreement or consent is termed ‗soft paternalism‘ (Nys, 
2008). Dworkin (1972) and Cohen (2013) further argue that some form of 
paternalism is needed, as sometimes individuals need to be nudged to act in a certain 
way in order for their condition to improve, notwithstanding that it may involve them 
doing something they do not wish to do. The above argument is also frequently used 
to justify paternalism or the effort expended by the HCPs in this study to secure the 
patients‘ agreement as it is being done for the patients‘ sake.  
  
 However, paternalism is often rejected due to its negative connotation, with it often 
being linked to the dominance of HCPs over their patients and a failure to respect 
patients‘ autonomy (J. J. Chin, 2002; Entwistle, Carter, Cribb, & McCaffery, 2010). 
In this context, it is linked to patients‘ freedom to make a decision about their T2DM 
management. However, Nys (2008: p. 67) states that autonomy is a very broad area, 
referring to respecting autonomy as “… that one is allowed to make important life 
choices…”. Yet, patients‘ autonomy with regard to a decision to commence insulin 
or a decision regarding the frequency of their SMBG differs greatly from a decision 
to increase a patient‘s dosage of oral medications, or a decision on the topic or 
agenda of health education during the clinical encounter. On the one hand, it is 
crucial for there to be a sharing of decisional authority; on the other hand, however, 
shared decision-making is considered to not make sense in certain situations (S. N. 
Whitney et al., 2003). Nys (2008) also argues that paternalism does not damage the 
value of autonomy; rather, paternalism safeguards patients‘ ability to use their 
autonomy at a later stage, when it may be needed for a bigger or more life-changing 
decision.  
 
Besides, the effort of HCPs to attain patients‘ agreement with their recommendation, 
as opposed to deliberating with a patient to decide upon the most suitable option, 
may relate back to the way they conceptualise patient involvement in decision-





decision-making, which was shared by many of the HCPs in this study, leans more 
towards the practice of obtaining informed consent than it does towards shared 
decision-making, despite the patients‘ belief that their recommended treatment is the 
best compared to other suitable options, as presented in 5.3.1.2. It appeared in 4.3 
that this is more common when it comes to insulin initiation, where the patients‘ 
agreement is considered to be essential as it requires their full commitment.  
  
However, Ahmad and colleagues (2014: p. 13) emphasise that shared decision-
making is dissimilar to informed consent in the way that the former refers to the “… 
process by which a decision is reached”, whereas informed consent refers to the 
decision itself as a legal construct where patient involvement is limited to whether or 
not they agree with the HCPs‘ recommendation (Kunneman & Montori, 2016). 
Similarly, Rosenbaum (2015) emphasises that agreement by T2DM patients is not 
only about their consent or permission; it also relates to the decision to choose 
different options for different conditions. Besides, in this study context, where the 
focus is on chronic illness, the effect of the paternalistic approaches taken by HCPs 
to obtaining patient agreement with the recommended option moves beyond 
respecting the autonomy of patients to choose, with its ramifications actually 
extending to when a patient is outside of the clinical encounter. The sharing of 
information between both sides is crucial in helping the patient to decide upon and 
then perform their self-management when their HCPs are not present. On the other 
hand, the coercive and persuasive methods used by many of the HCPs also conflicted 
with the shared decision-making model, which emphasises the obtaining of 
agreement through unbiased deliberation between patients and HCPs (Charles et al., 
1997; Towle & Godolphin, 1999; Elwyn et al., 2012).  
 
Furthermore, as discussed earlier throughout Chapter 4 and subsection 6.2.2.1, the 
recommended option was often presented in such a way that the patients would 
favour it compared to the other suitable options. This practice is contrary to the 
strategy proposed by most shared decision-making models that each option should be 





doing nothing or not deciding anything are also viable options (Elwyn et al., 2000; 
Makoul & Clayman, 2006; Towle et al., 2006; Elwyn et al., 2012). Furthermore, 
Mendel and colleagues (2012) emphasised that not only could the HCPs‘ 
recommendations lead the patients in their study away from their preferred option, 
but also that these patients were less satisfied with the decision compared to those 
who had not been diverted from their preferred option, primarily when the 
recommended option was not the one they had initially preferred. Similarly, one of 
the most recent shared decision-making models, by Elwyn and colleagues (2012), no 
longer includes HCPs‘ recommendation as one of its elements.  
 
In Chapter 4, it was also presented that limited assessment, elicitation of patients‘ 
concerns, preferences and values, and deliberation with patients led to the 
identification of a recommended option and prescription by the HCPs that may not 
ultimately have been the optimal one for the patients‘ need and condition. This may 
contribute to a perceived disconnect between the prescribed or recommended 
treatment and management and patients‘ everyday life, thus resulting in intentional 
or unintentional non-adherence, as reported in previous studies (Vinter-Repalust, 
Petricek, & Katić, 2004; Nair et al., 2007). However, as described in the previous 
Findings chapters and the previous sections in this chapter, it is seldom the case that 
patients share these perceived disconnects and non-adherence with their HCPs. The 
reasons for this lack of sharing by patients, including any perceived disconnect, have 
been discussed previously in 6.2.2.2. They include patients‘ effort to maintain a good 
relationship with their HCPs, previous bad experiences of sharing, patients‘ lack of 
cognitive understanding regarding what to share and what not to share, and patients‘ 
embarrassment at not being able to understand or afford the suggested treatment.  
 
Stevenson (2003) also raises the issue of making incorrect assumptions with regard 
to patients‘ agreement, which was also identified in 5.2.4. This resonates with the 
argument by Charles and colleagues (2006) on the importance of cultural influences 
in the clinical encounter, whereby agreement is commonly given by the patients in 





relationship with them, especially if the recommended option is forced on them or 
they are subjected to persuasion. Additionally, the fact that Malaysia has a high-
context culture increases the potential for patients‘ non-disclosure of their 
disagreement with their HCPs‘ recommended option. This is because, as mentioned 
previously in Chapter 1, a ‗yes‘ given by patients‘ may not be a true ‗yes‘ or a 
reliable indication of their agreement as it may serve only to signal their 
understanding of the suggestion (Raelin, 2000; Hooker, 2012). Raelin (2000), 
together with Say, Murtagh, and Thomson (2006), further emphasise that HCPs need 
to use their discretion as it is common in this culture for patients to agree as an 
automatic response that is considered to be socially correct, polite and respectful to 
those who are deemed to be superior, given with the intention of saving face for both 
sides. Disagreement or dissatisfaction is more likely to be communicated indirectly 
and non-verbally and through a failure to pursue the matter (Hooker, 2012), as 
demonstrated in 5.2.4. 
 
6.3 Disassociation between agreement and adherence among patients 
Adherence has been defined as “… the extent to which a person‟s behaviour – taking 
medication, following a diet, and/or executing lifestyle change, corresponds with 
agreed recommendations from a health care provider” (Sabate, 2003: p. 3). This 
accords with the emphasis given earlier in Chapter 5, whereby adherence differs 
from compliance in the sense that the former relates to a patient‘s decision to agree 
with the option that has been chosen and recommended by the HCPs. Adherence is 
one of the topics that is widely discussed in the medical and health field in general 
and also in medical and health decision-making practice specifically, not only as a 
measure of the outcomes but also due to the potential burden it can exert on patients 
and the healthcare system as it relates to morbidity and mortality, quality of life and 
healthcare costs (Sabate, 2003; Joosten et al., 2008).  
 
Similarly, in this study, adherence was a topic that was frequently mentioned by both 
the patients and HCPs. As explained in Chapter 4 and subsection 5.3.1, due to the 





were made in the study context, decisions were made mainly by the HCPs, with 
limited deliberation with the patients. Nonetheless, the findings of this study have 
also demonstrated that some decisions were made with agreement from the patients. 
Yet this agreement was often found to be insufficient to ensure the patients‘ 
adherence, despite previous studies indicating that patients‘ agreement with a 
decision might improve their adherence (Schoenthaler et al., 2012; Stacey et al., 
2014). It was pointed out in 6.2.2.2 that patients‘ non-adherence and their non-
disclosure of this is their way of claiming ownership and control over their care. 
However, other factors were also found to contribute to this non-adherence and non-
disclosure. This section contains greater discussion aimed at further exploring this 
matter in the study context. 
 
6.3.1 Patients’ non-adherence to the recommended option 
As discussed earlier in 0 of this chapter, it was often the case that the HCPs used a 
paternalistic approach as a way of securing patients‘ agreement, including by 
providing insufficient and/or biased (i.e. manipulated or misleading) information to 
the patients, and by using threatening messages, coercion and/or persuasion to 
encourage their patients to accept their recommendation. These paternalistic methods 
of delivering information often led to patients agreeing to the recommended option 
without them having the sufficient understanding, knowledge and skill to 
consistently carry out their management. Additionally, since many of the patients in 
this study have a low educational background, they may not have been able to 
understand the non-individualised information with which they were being presented 
and to then apply this as knowledge and skills in facilitating them to carry out their 
management. This is one of the main reasons for the poor adherence among patients 
in this current study and aligns with the findings of previous studies (Jeavons, 
Hungin, & Cornford, 2006; Williams et al., 2008). However, it was commonly found 
in previous studies and this study that the blame is put on the patients‘ inability to 
understand and retain the information provided, instead of the HCPs considering that 






Previous studies have also reported that patients‘ adherence often depends on how 
they feel physically, which may relate to their lack of understanding with regard to 
how their treatment and management work (Lawton, Parry, Peel, & Douglas, 2005; 
Williams et al., 2008). These studies further described that patients tend to stop their 
medication or neglect other areas of their management if they feel better or 
asymptomatic. Bhattacharya (2012), on the other hand, found that patients tend to 
neglect or ignore medically recommended lifestyle changes as they do not consider 
they will yield any positive outcomes with regard to their health conditions. This 
indicates that any decision as to whether or not to adhere to them (i.e. to stop or to 
self-adjust) was made based on the patients‘ beliefs and attitudes towards health and 
the healthcare system, along with their perceived benefits and risks, which were 
often conceptualised very broadly and were difficult for the patients themselves to 
verbally articulate (Nair et al., 2007; Williams et al., 2008; Mishra et al., 2011).  
 
Similar practices and reasons were identified among the patients in this study, with 
the practice having been previously termed intentional non-adherence. PT8 (section 
5.2), PT21 (subsection 5.2.2) and PT16 (subsection 5.2.4) were among the patients 
that either intentionally stopped taking or otherwise modified their medication when 
they did not consider it to be providing any significant benefit in terms of their 
current health condition and out of a concern about possible adverse side effects. 
This practice is in accordance with the concept of intentional non-adherence that was 
conceptualised by (Stack et al., 2010, p. 149) as “… behaviour driven by a decision 
not to take medicine”, whereas Brundisini, Vanstone, Hulan, DeJean and Giacomini 
(2015: p. 14) define it as “… the patients‟ deliberate refusal to adhere to a specific 
medication regimen”. In this study, these definitions of intentional non-adherence 
that refer to pharmacological modalities are extended to other forms of T2DM 
management, including non-pharmacological modalities.  
 
Furthermore, as is illustrated in the accounts by HCP14 and PT12 in 4.3.3, the 
patients often opted to discontinue the medication without any other follow-up 





As a result, some of the patients were unable to control their glycaemic levels and 
began to develop complications, as demonstrated by PT12 in 4.2.4. Comparable with 
findings by Gimenes and colleagues (2009), the patients in this study were seldom 
explicitly asked about their experience of medication side effects by the HCPs, in 
contrast to being asked about their adherence. This was found to be the case 
especially with regard to patients‘ oral medications as opposed to their insulin. The 
latter was usually enquired about by the diabetes educators at the hospital clinic, as 
they are the ones responsible for educating patients about insulin adjustment. This 
may be due to the serious side effects of insulin, especially hypoglycaemia, 
compared to other medications, with the latter not commonly leading to such life-
threatening effects. 
 
It also appeared in this current study that the HCPs were failing to pay sufficient 
attention to patients‘ concerns about developing side effects from their medication as 
they may have considered the potential to be exaggerated (Williams et al., 2008). In 
addition, Brundisini and colleagues (2015) reported a tendency for patients to take a 
trial-and-error approach to adjusting their medication as a result of this concern. 
They perceived patients‘ non-adherence to be related more to a lack of understanding, 
financial constraint or another motive, such as a preference for traditional medication. 
This current study suggests a slightly different finding, as the HCPs have begun to 
realise and address their patients‘ concerns regarding the impacts of the medication 
on their kidneys. Yet some of the patients still perceived that the issues were not 
being properly addressed, thus resulting in the same non-adherence. Nair and 
colleagues (2007) also found a lack of information received by patients on the 
benefits and risks of treatment or management to be another of the main reasons for 
patients‘ self-adjustment. A similar reason may also be the main factor for this 
practice among the patients in this study, especially given the nature of the 






6.3.2 Patients holding the ultimate power through intentional non-compliance  
As has been discussed previously, there are patients who nevertheless fail to adhere 
to their diabetes management despite having initially agreed to do so or not refusing 
the option that was identified. They may do this if they feel that it does not suit their 
needs and diabetic condition, or if they are concerned about the adverse effects of the 
management, especially with regard to taking their medication. However, patients 
were also found who intentionally did not comply with their management due to a 
perception that it had been paternalistically prescribed without their agreement 
and/or any further discussion. For this reason, the term non-compliance is used in 
this section in place of non-adherence, reflecting that the patients did not proceed 
with their prescribed treatment regimen as they perceived both a lack of discussion 
about it and that the decision had been made paternalistically (Horne, Weinman, 
Barber, & Elliott, 2005). 
  
It can be argued that patients‘ intentional non-compliance is their way of exerting 
power, as asserted by Bradbury-Jones, Sambrook and Irvine (2008) and supported by 
Laverack (2005; p. 34), who stated “… to exercise choice is the simplest form of 
power”. Thus, some patients intentionally chose not to comply with the prescribed 
therapy as they perceived that a decision had been made without any prior discussion 
and consensus from their side. This demonstrates that they are attempting to reclaim 
the power to determine their own management that they had either been denied or 
did not exert during the time when the decision was made. Instead of voicing their 
disagreement with the prescription or advice of their HCPs, most of the patients 
preferred to express it through their own non-compliance. This is in accordance with 
an assertion made by Freire in his book Pedagogy of the Oppressed (1970). He stated 
that in some situations, the oppressed people (patients) tend to be the oppressors 
instead of finding ways to liberate themselves from their oppressed state. He added 
that this may happen as they view their oppressor (in this context HCPs) as their 
model of ‗manhood‘. However, there are certainly other factors associated with 
patients‘ intentional non-adherence/non-compliance, including their lack of 





of the previous chapter, and their misconceptions concerning diabetes and the 
medication (Mann et al., 2009). 
  
6.3.3 Patients’ non-disclosure of their non-adherence and concern 
Parallel to the report by Horne and colleagues (2005), non-adherence among the 
patients in this study remained relatively undisclosed. In the case of non-adherence, a 
similar hesitance and the reasons for patients‘ disclosure of any other information 
with their HCPs were found, as discussed throughout this chapter. Besides, it can be 
sensed that some patients did not share their non-adherence because they were 
embarrassed by their inability to comply or adhere to their management, whether or 
not this was intentional on their part. However, previous researchers have suggested 
that this may refer more to unintentional non-adherence and thus reflect the patients‘ 
inability to adhere to their management, with the potential reasons including 
forgetfulness, carelessness, poor manual dexterity, losing their medication, running 
out of supplies or an inability to afford the treatment (Horne, Mailey, Frost, & Lea, 
2001; Gadkari & McHorney, 2012).  
 
This embarrassment, which can also exist as shame and self-consciousness, may 
develop into frustration or anger when patients are confronted about their non-
adherence or uncontrolled glycaemic level, since, aside from indicating their poor 
health, it can also point to moral failing and render them vulnerable to stigmatisation 
by their HCPs, friends and families (Broom & Whittaker, 2004; Archer, 2014). 
These emotions can be identified in PT22‘s account as presented in 5.2.1. The 
embarrassment and frustration can be sensed in her account when she was asked by 
her HCP to manage her weight better. In addition, Archer (2014) noted that for 
patients who shared a non-adherence that could be linked to their uncontrolled 
glycaemic level, their embarrassment could be identified in their expression of a 
sense of inadequacy, self-deprecating tones and their body language. Fink and 
Walker (1977), on the other hand, suggested that humorous responses are commonly 
used in an embarrassing interaction, especially among individuals of relatively equal 





culture where non-verbal communication commonly carries more meaning compared 
to verbal communication. This may not be explicit in any of the participants‘ 
accounts presented in the previous Findings chapter, but my notes gathered during 
the data collection period do convey this sense among the patients as they often 
described their non-adherence humorously during the interview.  
 
Patients‘ embarrassment at their non-adherence to their T2DM management comes 
in addition to their embarrassment at their diagnosis of the T2DM itself (Archer, 
2014). Both of these can be detrimental to the effort to preserve their quality of life. 
In dealing with patients‘ embarrassment during their clinical encounter, the HCPs in 
a study by Zoffmann and colleagues (2008) were found to frequently reflect on the 
issues they perceived as contributing to the embarrassment felt by patients when 
sharing by themselves without being directly asked to do so. This was done by 
gathering indirect information related to the issue so that they could make their own 
deduction, which was also identified in the present study where certain HCPs made 
assumptions with regard to their patients‘ non-compliance or non-adherence. 
However, Zoffmann and colleagues (2008) questioned the reliability of this practice 
as no confirmation or verification of the deductions was sought from the patients by 
the HCPs; there may thus have been misassumptions made by the HCPs. 
Furthermore, Archer (2014) suggests that HCPs must remain professional in 
communicating with their patients, including in investigating their non-adherence 
and other issues that patients may find embarrassing. In order to achieve this, HCPs 
should avoid sarcasm, teasing, pity and condescension, all of which can aggravate a 
patient‘s sense of shame. Archer also emphasises that the body language used by 
HCPs is imperative as self-conscious patients are usually sensitive to things such as a 
frown, stare or glance away, which they often associate with contempt. Besides, 
HCPs are also advised to be authentic, including about have feelings of shame, and 
to ensure that patients feel safe, secure and confident to share any embarrassing 
issues (Archer, 2014). This can be achieved if patients are aware that a certain degree 
of flexibility is common in managing chronic illnesses and they know it is possible to 
take a more realistic goal that may better suit their needs (C. R. Rogers, 2004). As 





make the patients feel more respected and comfortable in sharing their side of the 
story. 
 
Conversely, the finding presented in 5.2.4 reveals that some of the patients tried to 
conceal their prolonged between-appointment non-adherence from their HCPs by 
only adhering to the medication and then fasting during the run-up to their follow-up 
appointment or blood test. These practices were usually carried out not only to hide 
their embarrassment at not being able to adhere to the T2DM management but also 
for them to be viewed as a good patient, which they believed would help to maintain 
their good relationship with their HCPs. A similar reason may also account for their 
hesitance to share their disagreement with the HCPs‘ recommended option. Archer 
(2014) suggests that this non-sharing by patients in order to be viewed as a good 
patient may result from HCPs‘ common practice of tending to praise patients with 
good glycaemic levels as doing a good job of controlling their T2DM, which also 
commonly appeared in Chapters 4 and 5. Archer refers to such practice as ‗benign 
paternalistic statements‘, which can also serve as an expression of HCPs‘ enjoyment 
at having patients who are able to fulfil the notion of the ‗ideal diabetic‘. A study by 
Renfrew and colleagues (2013) among Cambodian patients reported that the patients 
wished to please their HCPs and not disappoint them. Some of the patients in this 
present study also described the practice of concealing their non-adherence as it was 
expected that the HCPs, especially the physicians, would be angry if they knew the 
actual situation. This resonates with the assertion by Raven (2008) that patients tend 
to hide their non-adherence if they feel they have been forced to agree to and carry 
out the treatment, and they expect some form of punishment further down the line. 
As a result, misinformation or a lack of shared information during the clinical 
encounter is inevitable and may become a major barrier to care (Renfrew et al., 
2013).  
 
In addition, extending from the previous discussion on patients‘ tendency to not 
adhere to their newly prescribed treatment or management as they did not believe it 





adherence for the same reason. This may relate to a denial of the severity of their 
T2DM on their part, or to their inability to appreciate it as something that they 
needed to discuss with their HCPs. However, at the point at which they begin to 
realise that it is important and try to share it with the HCPs, the HCPs most probably 
treat it as an excuse by the patients to refuse the new prescription or advice, as was 
identified in the account by HCP13 in subsections 4.2.3 and 5.2.1. 
 
All of the findings discussed in relation to patients‘ non-adherence are comparable 
with those from the study by Nair and colleagues (2007) in the sense that the 
decision-making among some of the patients in this present study continued even 
after their clinical encounter, via their own experimenting with and testing the 
prescribed or recommended treatment and management. Overall, the discussion in 
this section illustrates the shortcomings of HCPs‘ paternalistic approaches and the 
lack of patient involvement in T2DM management decisions. This reflects the 
importance of a collaborative effort between patients and HCPs as the management 
of T2DM among the patients in this study involves self-management. In improving 
adherence among patients, DiMatteo and colleagues (2012) suggest three important 
clinical actions, as follows: (1) ensuring that patients have the right information and 
understand how to adhere – including listening to their concerns and encouraging 
their participation in decision-making; (2) helping patients to believe in their 
treatment and motivating them to carry it out by addressing the cognitive, social, 
cultural, normative and contextual factors which are known to have an effect on their 
beliefs, attitudes and motivation, and (3) assisting patients to overcome practical 
barriers to treatment adherence and develop a workable strategy for long-term 
disease management. All of these suggestions can be related to the shared decision-
making approach. 
 
6.4 Interpersonal relationship and communication 
In comparison to decision-making for acute conditions, previous scholars have 
suggested that patient involvement in decision-making for a chronic condition should 





patient (Montori et al., 2006; Sepucha & Mully Jr, 2009). Instead, in this study 
context, parallel with symbolic interactionism that highlights how the meaning of the 
practice is socially constructed (Blumer, 1969), the main challenge lies in its 
implementation, where integral roles are played by both the patient–HCP 
interpersonal relationship and communication.  
 
 In this study, the communication skills deemed important for HCPs to have include 
providing information, facilitating two-way interaction with patients by asking them 
questions to elicit information, and listening attentively and responding to patients‘ 
complaints and answers. The findings presented and earlier discussions have 
indicated that these skills cover both verbal and non-verbal communication, which is 
consistent with the Malaysian high-context culture. Furthermore, similar to an 
assertion by Larson and Xin Yao (2005), the participants in this study also emphasise 
the importance of HCPs‘ personal engagement and empathy with patients, which 
seemed to be lacking among the HCPs in this present study. The patients in this 
current study were often hesitant to become involved in the encounter as they were 
worried about being reprimanded by their HCPs. This perception most likely derived 
from previous negative experiences in their efforts to engage with HCPs. Besides, 
HCPs‘ threatening way of communicating the information acted to further hinder 
patient involvement. In accordance with this, Larson and Xin Yao (2005) posit that 
the development of HCPs‘ emotional and cognitive empathic skills in 
communicating with their patients may improve two-way interaction in discussing 
the decisions. Nonetheless, the findings presented in Chapter 4 and section 5.2, 
together with the discussion in 6.2.2.2 on HCPs‘ lack of consideration of the 
information shared by patients, may indicate the importance of patients‘ own 
communication skills when it comes to them presenting their problems, needs, 
preferences and values.  
 
In addition, it was found that other factors influenced both the interpersonal 
communication and relationship between patients and HCPs, including the continuity 





were demonstrated by the hesitance among many of the patients to answer HCPs‘ 
questions and to be open to sharing their preferences or concerns with HCPs whom 
they had just met or with whom they were not comfortable. Similarly, despite 
patients‘ willingness to communicate with their HCPs, some of the HCPs ignored the 
patients‘ efforts as they did not trust them, which was especially the case for patients 
who they were meeting for the first time. As presented in Chapter 5, many of the 
participants perceived continuous and ongoing patient–HCP engagement as being 
necessary for the development of a good interpersonal relationship, which they 
referred to as good rapport between them that tended to enhance the trust that they 
placed in each other. However, in this study context, the patients attend public health 
facilities where there is only a very slim chance of them meeting the same HCPs 
repeatedly, especially the same medical officers. Besides, similar to the findings of a 
study in Australia by Smith, Dixon, Trevena, Nutbeam and McCaffery (2009), the 
patients in this study also emphasised that an ongoing relationship would not 
ameliorate their involvement during the clinical encounter if they did not perceive 
the HCPs‘ approaches as suiting their involvement or if they did not feel comfortable 
with their HCPs, as was seen in section 5.3.  
 
All of the findings discussed in this section support the broader conceptualisation of 
shared decision-making as it is emphasised by Entwistle and Watt (2006). They 
highlight the incorporation of the relational aspect of patient involvement. 
Comparable with the findings of this present study, Entwistle and Watt (2006) 
acknowledge the patients‘ and HCPs‘ subjective experience of involvement in terms 
of their feelings and views about each other as a crucial variable, regardless of what 
they say and do during the actual decision-making. In addition, the overall findings 
of this present study indicate that the interpersonal relationship is linked bi-
directionally with how the parties communicate with each other during the decision-







Besides, the findings of this present study are consistent with the theory of 
interpersonal relations by Peplau (1997) that describes the relationships between 
patients and their HCPs as being dynamic, interactive and a relational process that 
develops over time. This theory has recently gained in popularity following its use by 
a number of other scholars in exploring and explaining patient involvement in 
decision-making practice (D‘Antonio, Beeber, Sills, & Naegle, 2014; Mahone, 
Maphis, & Snow, 2016; Hochberger & Lingham, 2017). Generally speaking, the 
interpersonal relationship between patients and their HCPs influences the quality of 
the care provided that is intended to improve patients‘ well-being and reduce their 
dependency. However, in accordance with Morgan and Yoder's (2012) argument, the 
findings of this present study also indicate that the patient–HCP interpersonal 
relationship may not necessarily indicate that the patient is involved in the decision 
as the relationship may be asymmetrical. This is because the traditional descriptions 
of the interpersonal relationship often refer to it as one in which HCPs hold the 
authority, power and control over their patients (Peplau, 1997; Leplege et al., 2007). 
Thus, similar to the findings of this present study, Van Der Cingel and colleagues 
(2016) emphasise that patient involvement in their own care can only occur if HCPs 
adopt facilitative values such as empathy, trust and respect for the balance of power 
within the relationship.   
 
6.4.1 Trust  
The previous discussion about this interpersonal relationship corresponds to the 
assertion by Mechanic and Schlesinger (1996) as both the patients and HCPs in this 
study admitted that long-term engagement, together with having a trusting 
therapeutic relationship, tended to facilitate the decision to be shared. Trust is one of 
the central attributes of the interpersonal relationship that is found to enable patient 
involvement throughout the decision-making process in this study as it facilitates 
honest conversation between patients and HCPs. A similar assertion was made by 
Pellegrini (2017) that trust is the keystone which can make or break a patient–HCP 
relationship. However, the findings of this study also demonstrate that the association 





6.4.1.1 Patients’ trust 
Even though a good long-term relationship may increase the level of trust on both 
sides, other factors also seem to have an influence on the degree of trust that the 
parties place in each other. Aligned with Bourdieu‘s assertion, patients carrying bad 
experiences from a past encounter with their HCPs were found to lack trust in their 
HCPs, which then shapes their involvement in the decisions. Such experiences 
include being ignored or not being heard or treated well by the HCPs, a lack of 
consideration of their preferences and/or a feeling of being cheated by the HCPs and 
feeling that the decision taken was not suitable for their needs and condition. All of 
these experiences are associated with HCPs‘ verbal and non-verbal communication 
skills, which Pellegrini (2017: p. 96) cites as being “… a vehicle to build trust”. 
Riva and colleagues (2014) also found HCPs‘ communication skills to be among the 
most important features affecting patients‘ trust. The above discussion provides 
further illustration of the complex, nonlinear and multidirectional linkages between 
the patient–HCP relationship, communication and trust in patient involvement in 
decisions.  
 
A review by H.H. Choy and Aniza (2017) on the aspect of trust in the healthcare 
field suggests a diminishing level of trust among patients towards their HCPs in both 
the Western and Eastern worlds. Similarly, in this study, there were patients who did 
not fully trust their HCPs, which subsequently influenced their level of involvement 
in decisions. Interestingly, a lack of patient trust can lead to patients playing two 
different roles, namely those of active and passive. Some patients felt compelled and 
empowered to take the responsibility to decide for themselves as they did not trust 
their HCPs to make a decision that best suited them or otherwise considered that they 
themselves were better educated about their condition. On the other hand, some 
patients‘ lack of trust in their HCPs made them more passive as they did not see the 
benefit of becoming involved. However, these patients would usually go on to make 
their own decisions based on their concerns, preferences and values that were not 





can serve as an indicator of patients‘ implicit way of reclaiming the power to decide 
as they had not been able to exercise this power during their clinical encounter.  
 
Discussion was held with regard to how patients‘ limited scope for meeting with the 
same HCPs, especially the same physician, served to inhibit the development of a 
trusting interpersonal relationship. However, Pearson and Raeke (2000) suggest there 
is another type of trust, aside from interpersonal trust, that exists in patient–HCP 
relationships, namely that of social trust. This can be defined as trust in collective 
healthcare institutions and is closely related to general social confidence in the 
institutions themselves (Pearson & Raeke, 2000). The level of social trust that 
patients place in healthcare institutions usually extends to HCPs as the members of 
those institutions. Thus, some of the patients in this study who did not meet the same 
HCPs put their social trust in their HCPs based on the notion that as experts in the 
institution, they would do their best to make them feel better. According to research 
by Riva and colleagues (2014), patients, seeing HCPs as the experts, trust their 
knowledge, expertise and ability to identify their problems and provide treatment. 
Added to this, HCPs‘ positive attitudes in showing empathy and interest with regard 
to patients‘ sharing meant there were also some patients who responded positively to 
their HCPs‘ enquiry and became actively involved in making a decision during their 
encounter, as they believed that their input mattered.  
 
On the other hand, there were also patients in this current study who trusted their 
HCPs and who preferred for them to make the decision on their behalf. This was 
similar to the patients in a study in Australia by D. Y. L. Lee, Armour and Krass 
(2007), where, despite a few of the patients being concerned that they were not 
receiving enough information, they mainly relied on their HCPs to make a decision 
and accepted that decision without question due to the trust and respect that they 
placed in them as experts in the healthcare system. Thom and Campbell (1997) 
further suggested that patients‘ adherence to their trusted HCPs‘ recommended 
treatment was usually facilitated by the HCPs‘ personal traits of being compassionate, 





Quan, Stern, & Jacobs (2012) found this facilitation to be associated with an increase 
in patients‘ ability to achieve better glycaemic control. 
 
However, patients‘ unquestioning trust in their HCPs had led to them experiencing 
feelings of distrust. This has been commonly identified among patients who have felt 
cheated after discovering that the decision made for them by the HCPs had actually 
led to a worsening of their condition, or if they had later found out about another 
option that they felt would better suit their condition but about which they had not 
been informed by the HCPs. Patients place their trust in their HCPs from the outset 
in the belief or expectation that the HCPs will behave in such a way that will benefit 
them, or at least not cause them harm, and this includes deciding what is best for 
them (W A Rogers, 2002; Thom et al., 2011). W. A. Rogers (2002) further explains 
that this belief and expectation comprises both emotional and cognitive elements, 
with power also often involved. Power is usually accorded to the trusted side, which 
in this context involves the power to decide for the patients. As such, this finding is 
understandable as the patients come to feel that their trust has been violated. The 
consequences of this loss of belief in HCPs with regard to their involvement in the 
decision were similar, if not worse, to those seen in the aforementioned patients who 
lacked trust in their HCPs from the outset. Despite the fact that some patients‘ 
distrust and lack of trust actually had a positive effect in terms of it increasing their 
sense of empowerment to be involved in decisions regarding their care, such 
situations of distrust should be managed or prevented due to their potentially greater 
negative impacts, including non-adherence, dissatisfaction and impaired general 
well-being among patients (Bauer et al., 2014).  
 
As such, Pellegrini (2017) advises that HCPs make efforts to build trusting 
relationships with their patients and to not exploit patients‘ trust and vulnerability in 
order to avoid such negative repercussions. In doing so, patients should be treated as 
people, and their expertise in terms of their needs, preferences and values should be 
both elicited and respected (Peek et al., 2013). Despite being entrusted with the 





related information honestly and ensure patients understand the information being 
presented and any decision that is made.  
 
6.4.1.2 HCPs’ trust 
Besides patients‘ trust in their HCPs, the findings of this study have also highlighted 
the noteworthy relationship between HCPs‘ trust in their patients and patient 
involvement in decisions. It appears in this study that HCPs‘ trust in patients is 
reciprocated with the disclosure of information by patients due to the trust that they 
place in their HCPs and the patients‘ sense of empowerment to be involved in the 
decisions. Supporting the assertion of W. A. Rogers (2002), this finding comes 
despite the fact that patients sit on the more vulnerable side within a patient–HCP 
relationship in the healthcare field. W. A. Rogers (1999) also argues that HCPs‘ trust 
in their patients enriches the concept of beneficence rather than diminishes it as it 
combines patients‘ expertise with that of HCPs, which further leads to HCPs having 
greater therapeutic power as the chosen treatment is the best fit for the patients. 
Besides, as presented in both of the Findings chapters, those HCPs who trusted their 
patients were found to be more encouraging and to welcome their patients‘ 
involvement and thus were more likely to share the responsibility and power for 
deciding with them. This constitutes a significant contribution to the limited existing 
literature on HCPs‘ trust in the area of patient involvement in T2DM decisions, as 
presented in Chapter 2. It was highlighted there that most studies have tended to 
focus more on patients‘ trust in their HCPs despite the fact that the patient–HCP 
relationship is bi-directional in nature.  
 
In an ideal patient–HCP relationship, the HCP trusts a patient‘s motive, testimony 
and competency to decide (W. A. Rogers, 2002). The lack of HCPs‘ trust in this 
study was often due to their perception of being deceived by the patients as they were 
deemed to not be telling the truth and/or withholding information, which was also 
demonstrated in the review by Wilk and Platt (2016) on this matter. Even though this 
might be true, as previously discussed in 6.4.1, some patients chose not to share 





forgetfulness, not knowing which pieces of information were important to be shared, 
or due to not wanting to be considered as difficult; as such, the lack of sharing was 
not merely because the patients wanted to conceal the information.  
 
Besides, in this study, the HCPs‘ trust in the patients was further compromised by the 
patients‘ poor glycaemic control and progress with their T2DM. This is in line with 
the assertion that HCPs place their trust appropriately in their patients if the patients 
themselves fulfil their obligation to adhere to their management, which is usually 
demonstrated in an improvement of their T2DM status (Hawley, 2015). A lack of 
HCPs‘ trust in their patients was found to damage patients‘ opportunity to be 
involved in the discussion about decisions on their care. This is because the lack of 
trust is usually translated in the HCPs‘ paternalistic practice, including deciding for 
patients, withholding options and information and ignoring patients‘ concerns, 
preferences and values. This will most likely further affect patients‘ trust in them, 
which then leads to patients becoming reluctant to disclose important information 
and ultimately to further non-adherence.  
 
The findings on HCPs‘ trust in the patient extend the understanding of the dynamic 
of trust within a patient–HCP relationship. This discussion on its effects on the 
practice of both HCPs and patients addresses the concern raised by Wilk and Platt 
(2016) regarding the lack of exploration in this matter. It is also aligned with shared 
decision-making as the discussion on trust in this study deviates from the previous 
main focus on patients as being passive receivers who are situated on the less 
powerful side within the relationship. The findings of this study further indicate that 
in enabling patient involvement in decision-making, not only do HCPs need to gain 
and maintain patients‘ trust, but patients are also equally responsible for doing the 






6.5 Perceived role of HCPs and patients  
The findings of this study highlight the participants‘ perception of the roles of the 
patient and HCP as being one of the main factors that hinder patient involvement in 
decision-making.  
 
6.5.1 The role of the HCPs 
The decisions on patients‘ T2DM care in this study were generally made based on 
the traditional biomedical model, with this being demonstrated in two main ways. 
Firstly, the main focus in deciding patient care is to achieve a better clinical outcome. 
In doing so, it was illustrated in Chapter 4 that the HCPs commonly make the 
recommendations and, on some occasions, make the decision for patients based on 
the Malaysian CPGs for managing T2DM. However, based on the discussion of the 
CPGs, despite mentioning patients‘ input and involvement in certain areas of T2DM 
management, it appeared that there is still a lack of emphasis on patient involvement 
in the decisions and on ways in which to involve patients. This can serve as one of 
the reasons for HCPs‘ adoption of the biomedical model instead of patient-centred 
care in managing their T2DM patients. A study by Guerrier and colleagues (2013) 
lends support to this assertion as they found that HCPs‘ intention to engage their 
patients in shared decision-making was negatively influenced by their intention to 
follow the CPGs. Secondly, the findings suggest that limited patient involvement in 
the process is due to the paternalistic belief, value and attitude. These include beliefs 
that the HCPs are the main decision makers, a lack of value accorded to patients‘ 
disease experience, and patients‘ dependence on their HCPs, including in 
determining the issues that need to be addressed at each follow-up appointment.   
 
All of the above discussions of the findings are in accordance with the traditional 
descriptions of professionalism or the profession of the HCPs. In addition to 
Freidson's (1971) description of HCPs‘ authority in the clinical encounter that was 
presented in Chapter 2 (section 2.2), Parsons (1954) defines a profession as “… a 
cluster of occupational roles, that is, roles in which the incumbents perform certain 





the general role of HCPs is to improve the quality of health of the population by 
delivering important services or information in order to promote health, prevent 
diseases and their complications and provide healthcare services (WHO, n.d.). If the 
ethical principles of beneficence and non-maleficence of HCPs are added to this, 
HCPs are considered to be the guardians of patients, responsible for ensuring their 
safety and that they are provided with the best care, as determined by the HCPs 
based on their knowledge, values and expertise (Emanuel & Emanuel, 1992; 
Stubblefield & Mutha, 2002). The dominant role of HCPs in clinical encounters, 
particularly that of physicians, is also supported by the sick role concept by Parsons 
(1951b), which is discussed next in subsection 6.5.2. The relief of patients from both 
their normal everyday roles and subsequently from their sick roles so that they can 
return to their normal everyday roles usually requires legitimation from physicians. 
Thus, the power and paternalistic approaches of the HCPs which are aligned with the 
biomedical model, especially those of the physicians, are unquestionably accepted 
and considered to be common by the society (Freidson, 1971).  
 
However, as discussed previously in both Chapter 2 (section 2.2) and in this chapter 
(section 6.4), the dominance of HCPs over patients is no longer accepted without 
question. Consequently, the traditional descriptions of professionalism in medicine 
and healthcare have started to be challenged. Alongside the old, yet still relevant, 
components related to HCPs‘ altruism, technical expertise and competency, more 
recent descriptions of professionalism have started to include elements such as 
respecting patients‘ autonomy, good interpersonal relationships and communication 
skills (Irvine, 2001; Priest, 2011). These extra elements have been incorporated into 
The Code of Conduct among HCPs in Malaysia, as presented in Chapter 1. 
Ultimately, a more contemporary style of patient-centred care, particularly shared 
decision-making, may better suit the changing healthcare landscape in order that 
patients can actively contribute to their health management, combined with guidance 






6.5.1.1 HCPs’ dilemma 
In accordance with the changing healthcare landscape, a large proportion of the 
participants in this study, including the HCPs, believed it was important for decisions 
regarding patients‘ management to be shared among HCPs and patients. The HCPs 
had a more realistic as opposed to idealistic standpoint in terms of realising that the 
most suitable option for the patient may not necessarily be the one that comes out on 
top based on the CPGs. However, a belief in the importance of shared decisions, 
combined with their preconceived ideas regarding their expected professional roles, 
seemed to leave most of these HCPs in an ethical dilemma as to the extent to which 
the patient should be involved in decision-making, which is similar to the findings of 
a study by Shortus and colleagues (2011) and a more recent study by Entwistle and 
colleagues (2018). Comparable with the findings by Shortus and colleagues (2011), 
the HCPs in this present study showed a range of practices in terms of facing the 
conflict of balancing these two competing professional responsibilities. As suggested 
by Shortus and colleagues (2011), the HCPs who placed a higher value on patient 
involvement tended to be more receptive to the patients‘ complaints, preferences and 
values compared to those HCPs who were strongly motivated by the principle of 
beneficence over patient autonomy. The latter type of HCPs tended to be more 
assertive and persuasive in ensuring that their patients received the best possible care, 
according to their consideration. 
 
 Cohen (2013) further suggested that persuasion, which he referred to as nudging, is 
especially common among HCPs who have limited knowledge and skills in relation 
to involving their patients in making a decision. Similarly, the limited knowledge and 
skills among some of the HCPs in this current study also resulted in their 
unintentional paternalistic attitude. These HCPs admitted that they preferred for 
decisions to be made together with their patients, while some were of the belief that 
they already practised shared decision-making. However, other descriptions of how 
decisions were made during their encounters with patients were a better fit with the 
paternalistic and biomedical model of care. This is similar to the findings of a study 





among HCPs were due to a lack of time and HCPs‘ belief that patients were 
unprepared for a more participatory style. These reasons can also be identified in this 
current study.  
 
The HCPs‘ dilemma in considering patient involvement when making decisions in 
this study was further magnified by restrictions on the resources available in their 
publicly funded healthcare system, as argued by Sculpher, Gafni, and Watt (2002). 
HCPs must balance the need of one individual patient for a type of treatment 
available in only limited supply against the needs of all other potential patients who 
urgently require the same treatment. Besides, it is common for effective treatments 
that fail to meet the requirement of being cost-effective to not be available in these 
facilities, thereby further limiting the treatment options. However, realising the great 
benefits of involving patients in making decisions, Sculpher and colleagues (2002) 
suggest some further potential solutions to help HCPs practise shared decision-
making in public healthcare facilities. These include 1) informing patients only about 
the cost-effective options that are available in their facilities; 2) using the shared 
decision-making process to determine whether a treatment is cost-effective, and 3) 
distinguishing ‗clinical‘ from ‗system‘ guidelines (Sculpher et al., 2002). The 
findings of this study demonstrate that some of the HCPs already practise the first 
two of these suggestions, although not without issues. Informing patients only of the 
options that are available at the facilities may reduce their trust as they may have 
separate access to information about other, less cost-effective options from other 
sources, thus leading to a situation in which patients‘ agreement is less likely to be 
obtained (Sculpher et al., 2002), which was also found in this present study.   
 
6.5.2 The role of the patients 
In the previous subsection 6.4.1.1, it was mentioned that the belief in HCPs having 
greater responsibility for reaching medical and health decisions in comparison to that 
of patients often resulted in the patients taking a more subservient role. This is 
further strengthened by the traditional belief regarding the patients‘ role in making a 





seeking help, the patient has always been viewed as the one who should cooperate 
and comply with the HCP; as such, the patient will tend not to share their concerns 
without explicit invitation or encouragement from the HCPs. Patients are typically 
reluctant to ask questions or share preferences based on their experience, and they 
would probably hesitate to express disagreement during the decision-making process. 
These findings can be associated with the sick role theory by Parsons (1951b), where 
being sick is considered to be a role. As such, various expectations are placed on 
patients. According to Parsons (1951b), as a sick person, the patient is entitled to be 
relieved of their normal everyday role and needs to seek medical help to enable their 
recovery, which will usually require them to comply with the medical prescriptions 
and management as laid out by their HCP. The applicability of this concept to 
understanding the passive role played by patients due to the social forces that shape 
paternalistic medical and health encounters in this study is similar to the findings of a 
study by Fahy and Smith (1999).  
 
However, the sick role in chronic illnesses, including in T2DM, is more complex 
than that described by Parsons (Varul, 2010). Parsons‘ description of the obligation 
of patients to not perform any other roles in fulfilling their sick role, including 
making a decision, along with HCPs‘ medical authority due to their exclusive expert 
knowledge, seems to fit with the descriptions given by some of the participants in 
this study, despite their belief that T2DM patients are responsible for carrying out 
their own self-management when they are out of the healthcare system. However, 
Varul (2010) further suggests that the lack of patient involvement in decision-making 
tends to negatively impact patients‘ self-esteem in general. This may further 
complicate the management of T2DM patients, with Swendeman, Ingram, and 
Rotheram-Borus (2009) having found that low self-esteem may reduce patients‘ 
ability to self-manage. (Charmaz, 2000) also emphasised that one of the ways to 
improve patients‘ self-esteem is through participation in any activities that involve 






On the other hand, compared to the temporary sick role in acute illness where a 
patient will recover and no longer have to fulfil the role of a sick person, T2DM is a 
chronic, lifelong illness. Thus, T2DM patients are compelled to fulfil both their 
normal everyday role and their sick role. In fulfilling their normal role, it is common 
for such patients to accumulate T2DM-related medical knowledge, skills and 
experiences which serve to erode the aforementioned HCPs‘ medical expertise and 
authority (Varul, 2010). This may result in resistance and dissatisfaction among 
patients, especially in settings where belief in the sick role concept remains strong, 
including in the settings of this study (Claramita et al., 2013). Nevertheless, as 
discussed previously, the majority of the patients in this study did not explicitly 
indicate their dissatisfaction and disagreement and behaved in a subserviently 
passive manner during clinical encounters. These passive behaviours commonly 
resulted from the feeling among some patients that their active involvement in 
decision-making may irritate their HCPs, in addition to such behaviour having been 
previously ignored by their HCPs. This was considered by Claramita and colleagues 
(2013) to fit the Asian cultural pattern in which HCPs are located higher up in, and 
thus dominate, the healthcare system. However, Claramita and colleagues (2013) 
also found that patients‘ implicit dissatisfaction and disagreement were rarely 
adequately recognised by HCPs. This can further complicate efforts to identify the 
most suitable option that can be carried out by patients and often results in 
dissatisfaction and non-adherence among patients, which was clearly demonstrated 
in this study. 
 
6.5.2.1 Patients’ preferred role in being involved 
When discussing the separate roles in shared decision-making, Chapter 2 presented 
the patients‘ preferred role as one of the more popular areas for research. Based on 
this study, besides patients‘ trust in their HCPs and their ignorance of their health 
condition, their perception of their sick role appeared to also be a reason for their 
preferred passive role in making the decision. This is comparable with previous 
studies in the area which also found that sicker patients prefer to take a more passive 





to the debate around whether or not the patient‘s preference to remain inactive in 
decision-making is followed (Davies & Elwyn, 2008; Stiggelbout et al., 2012; Kehl 
et al., 2015). Most of the above-mentioned scholars highlight the importance of 
respecting patients‘ preference to play a passive role. However, the link found in this 
study between patients‘ preferred and actual roles of not being active in making the 
decision and their perception of the sick role supports a suggestion by Stiggelbout 
and colleagues (2012). The latter authors suggest that the genuine preference of 
patients with respect to their role in decision-making should be respected. However, 
they also highlight that all patients should be empathically invited and sufficiently 
supported by their HCPs in order to be actively involved. This is in addition to their 
other suggestion that patients‘ preferred role should be explored once all of the 
relevant information has been provided. 
 
6.6 Power relations in decision-making  
6.6.1 Power dynamic between patients and HCPs  
The findings of this study demonstrate that patient involvement in decision-making 
revolves around the power dynamic between the patient and HCP, and that the 
Malaysian culture and social system also extend to the country‘s healthcare system. 
Involving patients in their T2DM management decisions requires a sharing of power 
and responsibility between HCPs and patients (Hook, 2006). However, from the 
discussion of the findings, it can be established that the patient–HCP power dynamic 
in decision-making in this study currently leans towards the HCPs, despite both 
parties being open to the idea of patient-centred care and patient involvement in 
decision-making. This is generally shown by the authority of the HCPs in decision-
making on behalf of their patients during the clinical encounters. Based on Lukes' 
(2005) book Power: A Radical View, in which he draws upon Dahl (1957) and 
Bachrach and Baratz (1970), power can be present in three ways: overt, covert and 
latent power. The HCPs in this study were found to exercise all three forms of power 
in ensuring that their patients received what they considered to be the best treatment 
or management, and this extended throughout the clinical encounter, from agenda 





Chapter 4, there were instances where HCPs decided for their patients without 
discussion, with or agreement from their patients, and also examples of HCPs using 
intimidating messages to coerce or persuade the patients to accept their 
recommendations. These approaches by HCPs are identified as overt power 
according to Lukes (2005). In this present study, patients‘ perception of the use of 
overt power by HCPs was often found to lead to their ignorance as to the decisions 
being made, greater passivity and undisclosed disagreement, dissatisfaction and non-
compliance. Realising this, there were instances in which the HCPs did not share 
certain information in order to shape their patients‘ perception, cognition and 
preference. This indicates that HCPs covertly use their power so that patients will 
voluntarily agree with their recommended care and thus avoid conflict. Nonetheless, 
the findings of this study have also demonstrated that this might raise doubts among 
patients towards their HCPs, especially when they have acquired the information 
from elsewhere, as previously mentioned in section 6.2.2.1. Both of these types of 
power occur at the individual level; that is, they are exerted by the HCPs towards the 
patients (Lorenzi & Lukes, 2006). 
 
In addition, however, a more insidious form of power is identified in this study. This 
type of power is what Lorenzi and Lukes (2006: p. 91) consider as the “outcome of 
socially structured and culturally patterned collective behaviour” and is known as 
latent power. It may also be referred to as Pierre Bourdieu's (1991: p. 23) symbolic 
power, where “… the power is seldom exercised as overt physical force: instead, it is 
transmuted into a symbolic form, and thereby „recognized‟ as legitimate”. The 
findings that are particularly relevant to this form of power are the dominance of the 
HCPs‘ focus according to the biomedical model when determining the problems that 
need to be addressed, the accordance of a higher value to HCPs‘ technical knowledge 
over patients‘ experiential knowledge, HCPs‘ higher positioning within the 
healthcare system hierarchy and the embodiment of the traditional patient sick role 
by patients and HCPs in making health decisions. All of these perceptions, beliefs 
and values in the healthcare field are found to hinder the patients‘ intention and 
opportunity to be involved in decisions as they serve to strengthen the idea that the 





merely accept and carry out the decisions. This also indicates the relationship 
between Lukes‘ formulation of power and Bourdieu‘s conception of habitus, field 
and capital, which considerably shape the practice of patient involvement in 
decision-making. Since latent power is socially and culturally constructed, it is 
something that is already there, and it exists whether or not the HCPs wish to use it, 
or even if they did not intentionally want to use it. Further discussion on power based 
on Bourdieu‘s work can be found in the following subsections.  
 
On the other hand, power has also been found to be used by the patients in this study, 
whether intentionally or unintentionally. This may be in the form of overt power, 
whereby some of the patients verbalise their disagreement with their HCPs‘ 
recommendation or else enquire about other options. However, this usually led to the 
HCPs‘ further use of overt and/or covert power to ensure the patients agreed with 
and followed their recommendations, especially in cases that featured a worsening of 
the patients‘ biomedical status. From Bourdieu‘s sociological stance, this finding can 
serve as an indicator that the patients‘ cultural health capital was undermined by that 
of the HCPs, which is generally due to the latter‘s higher position in the healthcare 
field (Bourdieu, 1986, Shim et al., 2010).  
 
However, covert power was more commonly detected among the patients as they did 
not always carry out or modify their HCPs‘ prescribed or advised management, with 
this not being commonly disclosed to their HCPs. In accordance with Foucault's 
(1978) assertion, these findings indicate that the exertion of power among patients 
and HCPs in this study is intentional and calculated as it is done with an aim, 
compared to the latent or symbolic power that is already possessed by the HCP in a 
patient–HCP relationship (Bourdieu, 1991; Lukes, 2005). However, based on 
Bourdieu‘s (1998: p. 80) assertion, it could also be argued that the patient is being 
strategic in terms of them having their care matched with their needs, preferences 
and values, but this may be done without conscious calculation as they might be 






Finally, it can be concluded that the ultimate power for making the decision in this 
study lies in the hands of the patients due to the fact that the management of T2DM 
extends beyond the patient–HCP encounter. However, the findings of this present 
study indicate that such an exertion of power by patients is not merely because they 
wish to seize the power to decide from the HCPs but rather in order to use it as a way 
of making their concerns and preferences heard by the HCPs, in addition to ensuring 
that their management suits their needs and values. The discussion on the power that 
exists in this study is related to decision-making activities and indicates that it is fluid 
and dynamic. Parallel to a proposition by Foucault (1978), patients‘ resistance to 
HCPs‘ power is found to be common. Power can also shift from one side to the other, 
with or without either party noticing that a shift has taken place. However, as the 
power possessed by the patients was not generally acknowledged as being 
comparable to the power held by the HCPs, their involvement in making the 
decisions during the clinical encounter was generally hindered. 
 
6.6.2 Patient power and empowerment and HCPs’ support  
Patient involvement in making the decisions in this study has been found to be bi-
directionally associated with patient empowerment in the sense that it does not only 
facilitate or hinder their involvement, but their experience of involvement in their 
decision and care can also strengthen or weaken their sense of empowerment. This 
association accords with Paulo Freire's (1970) view on empowerment as being both a 
process and an outcome. In the context of the current study, this is demonstrated by 
the way in which patients‘ sense of empowerment is one of the main drivers for them 
to become involved in decision-making and how this involvement can further 
develop patient empowerment.  
 
The findings in Chapter 5 indicate that whether the patients‘ sense of empowerment 
stemmed from within themselves or from their HCPs‘ facilitating attitude and 
practice, it was developed based on a realisation of the importance of their role in 
managing their own T2DM. However, the discussion in 5.2.1 showed that the 





their own acceptance of their HCPs. This dependency may complicate the effort of 
both empowered patients and HCPs to further empower the patients to be involved. 
One of the main reasons for this may relate back to how the HCPs understand patient 
empowerment in decision-making. According to most of the HCPs in this study, 
empowerment is limited to patients‘ adherence to their self-management. However, 
this understanding does not necessarily fully represent the concept of patient 
empowerment in shared decision-making as it only partially covers the description 
by Anderson and Funnell (2010: p. 277) of patient empowerment in diabetes care as 
“… a process designed to facilitate self-directed behaviour change”. This definition 
outlines the responsibility of HCPs to ensure patients understand their diabetes self-
management and are aware of the aspects of their personal lives. The HCPs in this 
study have been shown to realise this, with many of them indicating that they try to 
impart as much information as their patients can handle, especially with regard to the 
information they consider to be essential to the facilitating of patient self-
management.  
 
Furthermore, Anderson and Funnell (2010) include patients‘ skill to think critically 
and make the decision about their management, especially in their day-to-day life, as 
the other half of patient empowerment. Nevertheless, they do not include it as one of 
the skills to be facilitated by HCPs, which resonates with the fact that only a few of 
the HCPs in this study mentioned this. Aside from the possibility of them not seeing 
this as a skill needed by patients, it may also have been the case that the HCPs 
considered the decisions taken by patients outside the clinical encounter to be out of 
their control, thereby making them the patients‘ responsibility and not theirs. This is 
contrary to the assertion by Ocloo and Matthews (2016) that HCPs could actually 
help their patients to develop their critical thinking, reasoning and decision-making 
skills by actively involving and discussing the options and decisions during the 
clinical encounter. Besides, the benefit of patients‘ critical thinking may go beyond 
the decisions to be made during the clinical encounter by, for example, helping 
patients to identify the information that needs to be shared. Besides, despite 
knowledge and awareness being crucial to the development of these skills, they both 





discussion on critical thinking among patients found in the current literature on 
shared decision-making, thereby supporting Ocloo and Matthews‘ (2016) point that 
the current models of patient-centred care are too narrow and require broadening. 
 
The excerpt by PT22 in 5.2.1 also illustrated the struggle experienced by empowered 
patients to be involved in their decision. The patient verbalised her struggle in 
discussing the problems that she considered as reasons for her failure to reduce her 
weight since the HCP had reacted negatively to her sharing. Aside from HCPs‘ lack 
of understanding of the concept of patient empowerment, Skelton (1994) and 
Laverack (2009) argue that negative reactions by HCPs to patients‘ efforts to discuss 
their problems and to have some control over their treatment decision may be due to 
their hesitation to hand power to the patients. This was especially the case in this 
present study when the patients described their experiences of refusing to agree with 
or doubting the HCPs‘ recommendations, or when the patients insisted on their 
preferred choice. Hamann and colleagues (2011) reported similar findings in their 
study among HCPs in Germany. Aside from the lack of trust discussed earlier in 
6.4.1.2, the HCPs‘ hesitation to allow the patients to be actively involved was also 
commonly due to their perception of the primacy of their recommended option and 
their lack of confidence in the patients‘ knowledge and ability that would enable 
them to effectively discuss and make the decision. Consequently, it was often the 
case that patients perceived their verbalising of their concerns, preferences and 
values as not being given enough attention, which was described by the patients as 
not being heard, being treated like a child or not being valued. For some patients, this 
left them feeling disempowered or powerless during the encounter, which then 
resulted in them being passive in their subsequent clinical encounters.  
 
Overall, the discussion in this section shows that even though the patients feel 
empowered, the translation of this into active involvement in decisions is heavily 
influenced by the support of HCPs, thus further illuminating the power imbalance 
within the patient–HCP relationship. All of these findings support the assertion of 





decision-making power so that patients‘ sense of empowerment and their 
involvement in decisions can be supported (Kuokkanen & Leino-Kilpi, 2000; 
Hamann et al., 2011; Fredericks et al., 2012). Nonetheless, there is a lack of detail 
within the existing shared decision-making models in terms of addressing these 
situations where there are decision conflicts or power imbalances, including for times 
when the patient disagrees with the HCP‘s recommendation (Dewey, 2013). 
  
6.6.3 Power, empowerment, habitus and capitals  
Extensive discussion has already been presented on how patients and HCPs 
understand and practise shared decision-making and on how the shifting nature of the 
power to decide is heavily influenced by their respective beliefs, values and past 
experiences. This relationship resonates with Bourdieu‘s concept of habitus and its 
influence on individual practice (Bourdieu, 1977). Overall, habitus, as discussed in 
this study, depicts the essence of being and the whole gestalt of patients and HCPs. 
Their habitus is practically and socially constituted before proceeding to 
continuously shape their perceptions and actions. In addition, in accordance with 
Bourdieu's (1990) description of habitus, the past experiences of both patients and 
HCPs become embodied. Through these experiences, they learn the rules pertaining 
to the patient–HCP interaction and develop their ‗feel for the game‘ of the healthcare 
field. This further supports Bourdieu‘s explanation of the link between individual 
practices and the field in which the practice has taken place.  
 
Aside from habitus and field, the factors found to be related to patient involvement in 
decision-making in the context of this current study are in accordance with the 
concept of capital as it is described by Bourdieu (1986). The different capitals 
specified by Bourdieu were identified in this study as shaping the power relation 
between the patients and HCPs during decision-making as a social activity. The 
influences of all three concepts were found to not only strengthen each other but in 
certain circumstances to also be in competition with each other. In addition, in 
accordance with Bourdieu‘s assertion in his book Distinction (1984), where he 





Malaysian culture, which is deeply rooted among the people, can also be added to the 
complex background of factors determining the practice of patient involvement in 
this study context. Thus, as explained in Chapter 3, Bourdieu‘s work on the practice 
of an individual is found to be helpful in explaining the power relations between 
patients and HCPs that exist in this study. 
 
Economic capital, which Bourdieu (1986) describes as the basis of the other capitals, 
is found to be associated with patients‘ perception of their right to be involved in 
decisions. They were accepting of the fact that it may not be possible for their 
management to be tailored to their preferences, needs and values since they attend 
publicly funded healthcare facilities and pay only a minimal rate. The limited time 
that can be spent with each patient and the options that can be offered to them by the 
HCPs in these facilities act as barriers to further involving patients in decisions and 
serve to accentuate the disadvantages of the patients in this study context, the 
majority of whom are from the low and middle socio-economic groups. The time 
constraint and limited number of options that can be offered to patients also highlight 
how HCPs tend to have only limited capacity for sharing the power to choose the 
best option. 
 
Furthermore, the discussion on the findings related to HCPs‘ professionalism and its 
link to their expected roles and power was identified as according with Schinkel and 
Noordegraaf's (2011) description of professionalism as a form of symbolic capital. 
The HCPs‘ practice of empowering patients or allowing them to be actively involved 
in decisions was found to be linked to the need for HCPs to relinquish their 
traditional role and power of making decisions, instructing and directing their 
patients in the healthcare field, which has become firmly engrained among healthcare 
professionals. Besides, this study highlights the importance of HCPs‘ trust in the 
patients‘ ability to be involved in making the decision, with this being listed by 
Putnam and colleagues (1993) as social capital that influences the power dynamic 






Among all of the capitals described by Bourdieu, the most noteworthy form in this 
present study was found to be the cultural capital of both patients and HCPs that 
shaped the practice and power dynamic in making T2DM decisions. As an example 
of how cultural capital influences patient involvement in decision-making, both the 
patients and HCPs admitted that patients whom the HCPs believed to be better 
educated were granted more in the way of opportunity to become involved. This 
included patients with a higher level of education or those who were able to converse 
in English, thus reflecting the commonly held view among Malaysians that people 
who are proficient in English tend to be more educated (S. C. Choy & Troudi, 2006). 
The concept of cultural capital in the healthcare field was then further extended as 
cultural health capital. Cultural health capital was introduced to fulfil Bourdieu‘s 
assertion that cultural capital is heavily dependent on the ‗field‘ (Shim, 2010). The 
field in this study refers mainly to the healthcare field as the social space where 
decisions on patients‘ T2DM management are made. Cultural health capital is 
defined as “… the particular repertoire of cultural skills, verbal and non-verbal 
competencies, and interactional styles that can influence health care interactions at 
a given historical moment” (Shim, 2010: p. 2). Drawing on the work of other 
scholars, Shim (2010) specified elements of Bourdieu‘s cultural capital as 
conforming to the healthcare field, which can then serve as a linkage between habitus 
and the social structure in the healthcare field. This will contribute to the placement 
of the person in the healthcare social hierarchy, similar to cultural capital.  
 
Among the listed elements of cultural health capital are interactional styles (verbal 
and non-verbal competencies), a proactive attitude to the accumulation of knowledge, 
the ability to understand and use biomedical information, and an instrumental 
approach to disease management (Shim, 2010). The findings of this study indicate 
that HCPs, especially physicians, possess these elements more strongly than patients. 
Following Bourdieu‘s assertion, this results in a power imbalance between the 
patients and HCPs with regard to making a decision during the clinical encounter 
(Bourdieu & Wacquant, 1992). It is also often the case that the HCPs‘ 
recommendations and perspectives are considered to be both the best and the truth, 





A similar trend with regard to its effect can also be identified when exploring this 
matter among the patients. For example, patients who are able to understand their 
T2DM biomedical information tend to be more empowered and involved in making 
the decision if they are proactive in terms of effectively communicating with their 
HCPs to acquire as much information as possible about the options and decision, 
compared to patients who do not engage in any of these other elements despite being 
able to understand. Different degrees of cultural health capital possession among the 
patients gave rise to them being involved in decisions in different ways. However, 
comparable with the discussion about patients‘ sense of empowerment despite 
possessing cultural health capital, patient involvement remains dependent on their 
HCPs. A similar concern was raised by Dubbin and colleagues (2013), who found 
that the HCPs in their study held the power to decide upon the kinds of resources, 
behaviours and skills that mattered, in addition to their value, which was then used to 
determine how deeply the patients could be involved in the clinical encounter. 
Additionally, some of the HCPs who shared their power to decide with their patients 
recaptured that power if they believed that the patients could not be trusted or were 
not capable of adhering to a decision that they had made together. This was usually 
done more explicitly in comparison to the aforementioned patients‘ implicit way of 
reclaiming the power to determine their own care via non-adherence, as seen in 
6.4.1.1.  
 
The act of domination, which includes paternalism in the healthcare system, is 
considered to be a manifestation of power and often leads to inferior agents or groups 
being involved in acts of submission. However, it will only occur if such agents or 
groups appreciate the durable effects of their act of submission (Bourdieu, 1998). In 
this study, this can be identified as the belief by patients and HCPs that if the patients 
always listen to and carry out the instructions of their HCPs, this will ensure they 
have good access to the healthcare system, are perceived as good patients or have 
better control of their glycaemic level since a decision that is made by an HCP is 
regarded as being the best. Thus, this study may benefit from Shim‘s suggestion of 
focusing on the elements of cultural health capital as leverage to improve the 





improving HCPs‘ understanding of the concept of shared decision-making and 
patient-centred care. 
 
Moreover, running in parallel to Bourdieu‘s claim of culture as being a form of 
capital, the influences of Malaysia‘s culture of high context, hierarchy, high power 
distance and saving face are evident in the level of patient involvement in decisions 
throughout this study. These cultural characteristics can also be identified as 
counteracting the patients‘ cultural health capital as they reinforce the boundaries 
between patients and HCPs in the healthcare social hierarchy that further strengthens 
the decisional power of the HCPs, especially that of the physicians, in this study 
context. Additionally, Islamic, Buddhist and Hindu teachings, which Frith (2000) 
states as being among the elements that make up the Malaysian habitus as a majority 
of Malaysians maintain a strong adherence to their faith, emphasise authority as 
being directed from the top of the hierarchical structure and that it should be 
respected, despite such teachings encouraging equality. All of these matters further 
complicate the effort to encourage shared decision-making in the study context. 
 
However, as mentioned earlier, both the healthcare system and Malaysian society are 
changing. Consequently, what worked 10 to 20 years ago is no longer applicable and 
accepted without question today. This was clearly visible in the findings of this study, 
where the patients began to question things, either overtly or covertly, and were 
starting to become non-adherent or non-compliant with any treatment that they did 
not consider as fitting with their needs, preferences and values. Bourdieu referred to 
this as an indication of their cognitive struggle in adapting to the current needs and 
context (Bourdieu, 1998). This is where the shared decision-making model can be 
useful in terms of balancing the power between patients and HCPs in deciding their 
T2DM management. 
 
6.6.4 HCPs’ decisional power 
In discussing HCPs‘ power to decide, among all of the HCPs, it was the physicians 





HCPs are also actively involved in managing patients with T2DM in this present 
study context and have also been described as playing a significant role in the 
development of shared decision-making (Holmes-Rovner et al., 2000), the 
discussions that they had with the patients in this study mainly revolved around the 
decisions made by the physicians. Besides, most of the decisions that were made in 
the encounters between other HCPs and the patients were more intangible in nature, 
such as target setting, types of advice or information that the patients needed or 
decisions about patients‘ self-management. Although the patients in this present 
study were more comfortable sharing with other HCPs, the decision-making power 
of such other HCPs was perceived to be limited compared to that of the physicians as 
they did not have the authority to prescribe medication and undertake biomedical 
testing or referrals to other HCPs, which are commonly viewed as being more 
meaningful and complex. This raises the issue of their struggle to share the power 
and responsibility to decide with the patients, as they are also perceived by both 
themselves and others to have limited power to decide for the patients.  
 
In bridging this perceived power gap between physicians and other HCPs, McKay 
and Narasimhan (2012) suggested that these HCPs attend inter-professional 
education so that their perceptions of each other and their own contribution in 
empowering the patients to be involved in decision-making can be improved. 
Nonetheless, a focused review of this power struggle by Paradis and Whitehead 
(2015) identified only a limited addressing of this matter in the existing literature on 
inter-professional education. 
 
6.7 Contribution to the existing shared decision-making approach and its 
implementation 
 
It can be concluded that decision-making for T2DM management in the study 
context is dominated by the biomedical model, patients‘ sick role and paternalism, 
thus posing a great challenge in the context of decisions being truly shared. 





patients‘ needs, preferences and values was found to motivate both the patients and 
HCPs to adopt the encouraging behaviours of shared decision-making, particularly in 
this study context that involves patients with T2DM as a chronic illness in an 
outpatient setting. 
 
Based on the findings, shared decision-making may improve the experience of both 
patients and HCPs in making T2DM management decisions, with several emphases. 
Aside from proposing better information sharing and communication between HCPs 
and patients, and better acknowledgement of patients‘ experiential knowledge, which 
is commonly included in the existing shared decision-making models, this study also 
brings forward the potential benefit of a number of other elements that are found to 
be rarely discussed. These include (1) the active involvement of patients in setting 
the agenda of their clinical encounters and overall T2DM management; (2) the 
delaying of an HCP‘s recommendation; (3) allowing patients to evaluate the 
available options on a trial-and-error basis; and (4) actively involving patients in 
programmes, interventions or training related to shared decision-making.  
 
This study further contributes to the existing shared decision-making model by 
supporting the importance of a good patient–HCP interpersonal relationship in 
T2DM management, as previously proposed by Entwistle and Watt (2006) together 
with Montori and colleagues (2006). Additionally, this study highlights that the 
therapeutic relationship is fundamental due to the potential advantage it offers in 
terms of enabling bi-directional trust and honest, two-way interaction among HCPs 
and their T2DM patients, so that the decision can be shared more effectively. 
 
The application of Bourdieu‘s work in further investigating the emerging 
surrounding issues has highlighted the power issues together with the underlying 
Malaysian culture and social background that are present within the study context. 
These issues are found to further reinforce the existing gap between patients and 
HCPs that generally places patients in a disadvantaged position in the healthcare 





not only be bound within the clinical encounter but to also extend outside the 
healthcare setting, where patients undertake their management in the absence of their 
HCPs. It has also emphasised the power struggle of the HCPs in the current study. 
Patients and HCPs battle to strike a balance between fulfilling the social and cultural 
expectation placed on them and the intention for patients to receive the care that is 
best suited to them. Therefore, this study makes a significant contribution to the 
conceptual development of shared decision-making by highlighting the need for it to 
be addressed, thus reflecting the lack of discussion on the patient–HCP power 
dynamic in the existing literature. The issue of power requires an explicit and distinct 
approach so that the highlighted issues can be successfully addressed within the 
shared decision-making framework. This is an addition to the detailed description of 
deliberation methods in order to guide HCPs in facing their dilemma and conflict 
regarding the making of decisions with their patients. In conclusion, this study 
supports a broader, more detailed and patient-centred conceptualisation of the shared 
decision-making framework that is relevant in terms of facilitating its effectiveness 



















 CHAPTER 7: CONCLUSION 
 
7.1 Introduction 
The research aim of this study was established based on the issues highlighted in the 
first two chapters. Chapters 1 and 2 identified the need to understand the 
involvement of T2DM patients in decision-making in Malaysia. As such, this 
empirical study has explored the subjective accounts of different groups of 
stakeholders who are directly involved in the management of patients with T2DM. 
These stakeholders were interviewed with the aim of gaining a comprehensive 
understanding of patient involvement in decision-making practice and its related 
factors, the key findings of which are summarised in this final chapter. The 
implications and recommendations for healthcare policy, practice and education are 
presented next. This is done to answer the research question of this study on how 
shared decision-making can be operationalised as an approach to facilitating patient 
involvement in decision-making in this study context. Finally, recommendations for 
future research are outlined.  
 
7.2 Summary of the research findings 
Overall, several key findings have emerged from this study. The findings in Chapter 
4 highlight the gap between the participants‘ conceptualisation of patient 
involvement in decision-making and shared decision-making as the ideal approach, 
which is also found to further shape the variety of patient involvement in decision-
making practice. Shared decision-making is described by HCPs as the securing of 
patients‘ agreement and compliance with their recommendation, which is mainly 
achieved through HCPs‘ technical knowledge and medical expertise. Consequently, 
the information provided by the HCPs was found to be geared towards the 
achievement of this aim compared to the main aim of shared decision-making, that of 
putting patients‘ needs, preferences, beliefs and values at the centre, together with 
HCPs‘ medical expertise, when making the decision (de Silva, 2012). However, the 
patients‘ descriptions of shared decision-making were more aligned to the approach 





information they share concerning their day-to-day T2DM management can be 
properly addressed and taken into consideration when a decision is made. These 
findings further highlight the discordance between patients and HCPs in terms of the 
focus in clinical encounters.  
 
Besides highlighting the recurrent issues related to the lack of shared decision-
making practice, including the lack of information provision by HCPs, notably in 
relation to the other available options and side effects, and the lack of any 
deliberation of the options against patients‘ needs, preferences and values, the 
findings of this study bring forward the issue of patients‘ lack of information sharing 
and the disassociation of patients‘ agreement and adherence that is barely touched 
upon in the current literature. As such, it can be concluded that the decisions on the 
management of T2DM in the study context are not truly shared, thereby resulting in 
patients‘ non-adherence and dissatisfaction. 
 
Further exploration revealed the lack of patient involvement in the current decision-
making process to be linked to the lack of a good patient–HCP interpersonal 
relationship, a lack of communication skills on both sides, the participants‘ 
conforming to the social expectations of their own and each other‘s roles, and the 
issue of power that exists in the context of making health decisions. Bourdieu‘s work 
was utilised in the attempts in this study to make sense of the power issues involved 
in the practice of patient involvement in decision-making. Through its application, 
there appears to be a power dynamic within decision-making that currently leans 
towards the HCPs. This is because of the dominance of the biomedical model over 
the patient-centred model, in addition to the fact that the involvement of patients in 
decisions continues to be heavily dependent on the allowance and facilitation 
afforded by their HCPs. The embodied habitus and capitals among the patients and 
HCPs in this study place the HCPs higher in the social hierarchy of the healthcare 
field. Therefore, it can be said that the patients face challenges in terms of being 
involved in making the decision during the clinical encounter. Nonetheless, the 





decision as the management of T2DM in the outpatient setting is mostly performed 
by the patient outside of the healthcare facilities and entails a high degree of patient 
self-management. As such, the ultimate power to decide lies in the patients‘ hands. 
 
Moreover, since different groups of HCPs were involved in this study, the power 
struggle could also be sensed among them; in other words, it occurs not only between 
themselves and their patients but also among them. The challenges faced by the 
HCPs pertaining to the issue of power include the dilemma they face in balancing 
their ethical foundation of beneficence and respecting patients‘ autonomy, their 
limited opportunity for involving patients due to the constraints on the resources 
available at their facilities, the language barrier and they themselves having limited 
power to decide. 
 
In summary, this study contributes to the current body of knowledge in terms of 
understanding the involvement in decision-making among T2DM patients, who in 
Malaysia mostly attend appointments in an outpatient setting. This is in addition to 
its valuable contribution of using Bourdieu‘s social theory in exploring the matter 
and highlighting the Malaysian social and cultural dimensions (hierarchical structure, 
high power distance, high context culture and the culture of saving face) that further 
reinforce the factors and elements that serve to maintain the gap between the practice 
and ideal aspiration of shared decision-making. As a result, this study appears to 
support the implementation of a broader conceptualised shared decision-making 
approach. 
 
7.3 Implications and recommendations 
The findings of this study highlight the differences between ethical and theoretical 
ideals and the actual practice of involving the patient in their decisions. This section 
therefore addresses the final research question of this study on how shared decision-
making can be operationalised in the management of T2DM in this study context. In 





practice and education are presented along with recommendations that can address 
the differences and facilitate the adoption of the shared decision-making model as 
one approach to patient-centred care in the Malaysian healthcare system.  
 
7.3.1 Healthcare policy 
The government healthcare policy and guidelines in Malaysia have been found to 
adopt a patient-centred care approach to managing patients in the context of the 
growing issue of patient autonomy and in the realisation of its benefits with regard to 
the health management of patients. However, its illustration is generally based on 
patients‘ involvement in their care and is lacking in terms of patient involvement in 
the decisions about the care itself, with this often being limited to informed consent. 
This is supported by the findings of this study whereby the HCPs‘ descriptions of 
patient involvement in decision-making were found to accord more with the 
obtaining of patients‘ consent to their recommended treatment choice. However, as 
previously discussed in the Findings and Discussion chapters, patient involvement in 
decisions relating to T2DM as a chronic illness may require more than this. The 
findings of this study appear to highlight the need for a broader conceptualisation of 
the shared decision-making approach in terms of facilitating its effectiveness in the 
study context. This includes the following three elements: the potential benefit of 
continuity of care among T2DM in fostering the patient–HCP therapeutic 
relationship; the integration of problem identification into shared decision-making; 
and the integration of shared decision-making with other patient-centred approaches, 
including motivational interviewing and self-management support. 
 
Also evident in this study is the potentially large contribution to be made by non-
physician HCPs, including nurses, in facilitating shared decision-making. Thus, it 
seems relevant to suggest that access to this group of HCPs is improved, in addition 
to a better acknowledgement of their roles in managing T2DM patients. This is in 
addition to the need for a policy analysis to explore HCPs‘ practice of handling 
health resources and empowering patients. Finally, this study highlights the need for 





can be achieved through the support lent by government policies and documents on 
the equality of patients‘ and HCPs‘ respective contributions in the healthcare system.  
 
7.3.2 Healthcare practice 
The findings have clearly illustrated that there continues to be a lack of patient 
involvement in decision-making in the study context and that paternalistic 
approaches are used when making most of the decisions. The first measure that can 
be taken to enable and encourage patient involvement in decision-making is to 
introduce and integrate a programme based on this model into the management of 
T2DM in the study context. Shared decision-making may facilitate the involvement 
of patients from the very beginning and throughout the decision-making process, 
which would subsequently facilitate their further involvement and management. 
However, the model should be adopted carefully and may require a degree of 
alteration in order for it to fit the needs of the study context.  
 
Since the findings of the study point to the significant dominance of the role and 
power imbalance of HCPs during the clinical encounter, an awareness of the 
importance of their partnership and equipoise of power with patients when making 
decisions should be instilled among HCPs. This becomes more significant in this 
study context where there is a much more robust hierarchical culture than is found in 
Western culture, and where the equipoise of power between patients and HCPs in 
making decisions is missing from the norms, beliefs and values (Geertz, 1973a; 
Thomas et al., 2011). Understanding among HCPs of the importance of patient 
involvement in their own care also needs to be extended to cover the decision-
making process. The HCPs in this study may also benefit from undertaking courses 
and training in shared decision-making in order to develop a better understanding of 
the approach and its related skills and to then incorporate these into their practice. 
Such training may lead to a change in HCPs‘ perception of patient involvement in 
decision-making, from one based merely on providing information and obtaining 
patients‘ agreement to a two-way interaction that involves unbiased deliberation with 





In this present study, HCPs‘ communication skills were found to greatly influence 
patient involvement in decision-making. Based on the findings, training in 
communication skills that is able to encourage transparent two-way interaction when 
deciding upon patients‘ care should focus on the following four important skills 
among HCPs: (1) the skill of sharing unbiased and adequate information; (2) the skill 
of eliciting patients‘ concerns, preferences, beliefs and values; (3) the skill of 
negotiating, and (4) the skill of attentive listening and empathetic responding. 
According to a study by Bylund and colleagues (2010), communication skills 
training for HCPs that covers these aspects can increase the potential for agendas and 
goals to be articulated, for patients‘ understanding to be confirmed and for patients to 
ask questions. Based on this study, good communication skills can also facilitate a 
good interpersonal relationship, which in turn improves patients‘ honest sharing and 
trust in HCPs.  
 
Further communication training tailored to the study context is also needed since 
nonverbal cues from both patients and HCPs have been shown to play a major role 
during their interaction when making the decision. Reflecting Malaysia‘s high-
context culture, the patients in this study appeared to be highly sensitive to their 
HCPs‘ body language, facial expressions and tone of voice during their encounters 
with them. The HCPs, on the other hand, seemed to be insensitive to their patients‘ 
verbal cues and to the possibility of there being different meanings behind the 
patients‘ verbalised responses or information. If HCPs master good communication 
skills and are able to better tailor their responses to the needs of their patients, then 
the patients may feel more comfortable disclosing important information and actively 
contribute to the deliberation on their T2DM decisions.  
 
Despite the lack of patient involvement in existing shared decision-making 
interventions as identified in a review by Coulter and colleagues (2015), patient 
involvement in such an intervention in this study context may facilitate its 
effectiveness. From the findings of this study, an awareness campaign among 





as it may increase the value that patients place on their everyday experience of 
dealing with T2DM, which may then motivate them to become actively involved. 
The involvement of patients in any shared decision-making programme may also 
further educate those who are not interested in playing an active role and who prefer 
for the HCPs to decide for them. Nonetheless, the effort to educate them is suggested 
in this study not with the intention of disrespecting their preferred role or to force 
them to participate but rather to make them aware of the benefit of their involvement 
in terms of helping them to carry out their T2DM management in a way that takes 
into account the input that they share. 
 
The discussion of the findings also highlights the need for patients‘ cultural health 
capital to be strengthened so that the gap between patients and HCPs can be 
narrowed and to further ease patient involvement in the decision. In this study, the 
patients were perceived to be lacking in health literacy, which then limits their 
involvement in decision-making. Thus, shared decision-making in this study context 
may benefit from an improvement in the health literacy of patients. As a measure, 
this could help patients to acquire further understanding of the medical information 
related to their T2DM and to improve their ability to identify the problems that need 
to be shared with their HCPs. This in turn may further ease their involvement and 
enable them to gain the attention of their HCPs. When taken in isolation, however, 
measures to improve patients‘ health literacy and their ability to identify problems 
appeared to be insufficient in relation to promoting their involvement. Patients also 
need to be equipped with good skills in critical thinking and communicating their 
problems, preferences, values and beliefs, both effectively and in a medically 
intelligible manner. Shepherd and colleagues (2011) suggested using lists of 
questions that patients can ask their HCPs as a way of promoting their active 
involvement in decisions.    
7.3.3 Education 
It is evident from the findings of this study that the way decisions were made focused 
mainly on the patients‘ clinical status and outcomes and did not give sufficient 





biomedical model. Hence, a revision of the HCPs‘ curriculum to further emphasise 
patient-centred care, especially shared decision-making, would seem to be beneficial 
in this study context. This will facilitate the HCPs‘ embodiment of this approach 
over the traditional biomedical approach, which is no longer suited to the current 
healthcare landscape. The incorporation of patient-centred care from the beginning of 
the HCPs‘ education and career has the potential to promote the required changes 
within the healthcare system so that patients‘ autonomy can be respected and a more 
holistic type of consideration can be given to their overall well-being. 
 
In addition, since the management of T2DM in the study context involved different 
groups of HCPs, the effort to improve patient involvement in decision-making may 
benefit from the integration of shared decision-making into the existing inter-
professional education, as suggested by Col and colleagues (2011). In addition to 
understanding the concept of shared decision-making and acquiring relevant skills, 
which were previously mentioned in 7.3.1, they proposed that inter-professional 
education on shared decision-making should include an understanding of inter-
professional sensitivities and the roles played by different professions in the 
management of T2DM. 
 
7.4 Recommendations for future research 
The findings of this study contribute to the understanding of the experiences and 
views of both T2DM patients and the HCPs who are responsible for managing this 
health problem. Nonetheless, as discussed in the limitations section of Chapter 3, the 
language barrier between the researcher and participants may have served to limit the 
level of exploration among those patients who were unable to converse in either 
English or Malay. Having a translator could have helped with both the recruitment of 
patients who were unable to converse in either of these languages and in assisting 
those Chinese and Indian participants with neither Malay nor English as their native 
language to more freely describe their experiences and views in their mother tongue. 





Malaysian cultural backgrounds that could not be achieved in this study due to the 
limited numbers of Chinese and Indian participants.  
 
On the other hand, as the findings of this study cannot be generalised to a larger 
population due to its qualitative nature, the scope remains for future quantitative 
research to further expand these findings as part of a more extensive yet context-
specific study. Further exploration can also be carried out to identify the strategies 
that patients and HCPs perceive would be needed to further involve patients in their 
decisions. 
 
This study also highlights a number of essential matters concerning shared decision-
making that have not previously been the subject of extensive discussion in the 
existing literature. These include the identification of patients‘ problems that need to 
be addressed during their encounter and their need for a decision to be made, the 
information sharing by patients during the decision-making and the HCPs‘ trust in 
their patients to be involved in making the decisions. Further exploration of these 
issues may contribute to the establishment of a more comprehensive understanding 
of patient involvement in the decision. Furthermore, the role expectation of both 
patients and HCPs as one of the reasons for the power imbalance between both 
groups, with the latter having been identified as the main barrier to patient 
involvement in decisions, could be explored further. The extent of the exploration 
and discussion of this important barrier was limited in this study since it was 
identified after the data collection had ended.  
 
Finally, with a passion for encouraging Malaysian T2DM patients to be actively 
involved with and responsible for their health and related decisions, the findings of 
this study could be integrated with those of potential future studies to achieve the 
ultimate aim of developing a shared decision-making programme capable of 
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INFORMATION SHEET (PATIENT) 
 
Title: Shared Decision-Making in the Management of Type 2 Diabetes Mellitus in 
Malaysia: The Perspectives of Patients and Healthcare Professionals (HCPs) 
 
You are being invited to participate in a research study.  However, before you decide 
whether to accept this invitation it is important that you know what this study is about, why 
it is being undertaken and what it will involve.  Please take the time to read this information 
and feel free to discuss this with other people. Please do not hesitate to contact one of the 
researchers if there is anything that is not clear or if you would like more information. Our 
contact details are given at the end of this sheet.  Please take time to decide whether or not 
you would like to take part in this study. 
 
Study title:  
Shared Decision-Making in the Management of Type 2 Diabetes Mellitus in Malaysia: The 
Perspectives of Patients and HCPs 
 
What is this study about? 
This study is to explore the perspectives of the type 2 diabetic patients and their HCPs 
regarding patient involvement in decision-making and also shared decision-making. 
 
Why is this study being carried out? 
Patient involvement in their healthcare management has been widely encouraged around the 
world. Shared decision-making is an approach in decision-making in which the patients and 
their HCPs collaboratively make the best treatment choice. This study will provide 
information on the perspectives of patients and HCPs regarding this approach in the 
management of type 2 diabetes mellitus to facilitate its adoption in the Malaysian healthcare 
system. 
 
Do I have to take part? 
It is entirely up to you whether you take part in this study and your participation is voluntary. 
 





If you decide to take part it would involve taking part in an individual interview with one 
researcher (Ashikin Atan, Principle Investigator).  The interview will last approximately 60 
minutes and will take place at a time and location convenient for participants. It is important 
that you answer all of the questions asked by the researcher honestly and completely. With 
your permission, we would like to record the interview for later data analysis. The recording 
will be used for research purposes only, anonymised and will be stored securely until it is 
destroyed approximately after 10 years.  
 
Confidentiality 
Everything you or any other participants will say will be kept confidential between you and 
the researcher. Your name will not be attached to any documents nor will you be identified 
as a participant in this study or in any subsequent publications of study results.    
 
What will the study result be used for? 
The study will contribute to an understanding of how the participants perceived shared 
decision-making in the management of type 2 diabetes mellitus in Malaysia. With the result 
obtained, it is hoped that this study will be able to suggest ways of facilitating the adoption 
of this concept in the Malaysian healthcare system.   
 
Who is funding the study? 
The study is funded by the Ministry of Education, Malaysia.  
 
Are there possible benefits or risks in taking part? 
In taking part you ensure that your voice is heard on the issue but apart from that there are no 
benefits or risks in taking part.   
 
Can I change my mind? 
Should you change our mind and no longer wish to take part in the study just let us know.  
You do not need to give us any reason for this change. Withdrawal from this study will not 
affect the treatment you receive for your condition. 
 
How can I contact the researchers to take part in this study or to get further 
information? 
Please contact us if you want to take part in the study or have any further questions: 
 Ashikin Atan at ashikinatan08@gmail.com or phone +6013-7411395 (Malaysia) 
 Dr Sarah Rhynas at Sarah.Rhynas@ed.ac.uk or phone +44 (0)131 650 3882 (United 
Kingdom)  
 Professor Tonks Fawcett at t.fawcett@ed.ac.uk or phone +44(0)1316503883 (United 
Kingdom)  
All at:  School of Health in Social Science 
            The University of Edinburgh 
            Medical School, Doorway 6 
            Teviot Place 
            Edinburgh EH8 9AG, United Kingdom 
 
And finally….Thank you for taking the time reading this information leaflet!  We hope to 
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Door Way 6 
Medical Quad 
Teviot Place 
Edinburgh Eh8 9ag 
No. Tel: +6013-7411395  
Email: ashikinatan08@gmail.com  
 
 
RISALAH MAKLUMAT PESERTA (PESAKIT) 
 
Tajuk: Membuat Keputusan Bersama dalam Pengurusan Diabetes Mellitus Jenis 2 di 
Malaysia: Perspektif Pesakit dan Profesional Kesihatan 
 
Anda dijemput untuk mengambil bahagian dalam penyelidikan ini. Namun, sebelum anda 
membuat keputusan untuk menerima jemputan ini, anda perlu ketahui serba sedikit 
mengenai penyelidikan ini. Sila baca maklumat berikut dengan teliti dan sebarang 
perbincangan adalah digalakkan. Sekiranya terdapat keraguan terhadap maklumat yang 
diberi atau memerlukan maklumat tambahan, anda boleh menghubungi mana-mana 
penyelidik yang terlibat. Nombor telefon dan alamat email penyelidik-penyelidik yang 
terlibat adalah seperti yang tertera di penghujung risalah maklumat peserta ini.  
 
Tajuk penyelidikan:  
Membuat Keputusan Bersama dalam Pengurusan Diabetes Mellitus Jenis 2 di Malaysia: 
Perspektif Pesakit dan Profesional Kesihatan 
 
Apakah tujuan penyelidikan ini dijalankan?  
Penyelidikan ini bertujuan untuk meneroka perspektif pesakit diabetes mellitus jenis 2 dan 
ahli profesional kesihatan mengenai penyertaan pesakit dalam proses membuat keputusan 
dan juga membuat keputusan bersama. 
 
Mengapa penyelidikan ini dijalankan?  
Penglibatan pesakit di dalam pengurusan penjagaan kesihatan adalah digalakkan di serata 
dunia. Membuat keputusan bersama adalah salah satu pendekatan dalam proses membuat 
keputusan dimana pesakit dan ahli profesional kesihatan bekerjasama dalam memilih 
rawatan yang terbaik. Penyelidikan ini akan memberikan maklumat mengenai perspektif 
pesakit dan ahli profesional kesihatan berkenaan pendekatan ini dalam pengurusan diabetes 
mellitus jenis 2 agar ia boleh diintegrasikan ke dalam sistem penjagaan kesihatan Malaysia  
 
Adakah saya perlu menyertai penyelidikan ini? 









Apa yang perlu saya lakukan?  
Sekiranya anda bersetuju untuk menyertai penyelidikan ini, satu sesi temubual akan 
dilakukan bersama salah seorang penyelidik (Ashikin Atan, Penyelidik Utama). Sesi tersebut 
akan berlangsung selama lebih kurang 60 minit, pada masa dan di lokasi mengikut 
kemudahan anda. Adalah amat penting untuk ada menjawab kesemua soalan yang 
ditanyakan oleh penyelidik dengan jujur dan lengkap. Dengan izin anda, sesi temubual 
tersebut akan direkodkan untuk dianalisa. Rekod temubual hanya akan digunakan untuk 
tujuan penyelidikan sahaja, maklumat peribadi anda akan dirahsiakan dan segala rekod akan 
dilupuskan selepas 10 tahun.  
 
Kerahsiaan  
Segala maklumat yang anda dan peserta lain berikan akan dirahsiakan antara anda dan 
penyelidik. Nama anda tidak akan disertakan dalam mana-mana dokumen dan mana-mana 
penerbitan keputusan penyelidikan. 
 
Apakah kegunaan keputusan penyelidikan?  
Penyelidikan ini akan menyumbang kepada kefahaman terhadap perspektif pesakit dan ahli 
profesional kesihatan mengenai membuat keputusan bersama dalam pengurusan diabetes 
mellitus jenis 2 di Malaysia. Daripada keputusan penyelidikan, cadangan mengenai langkah-




Penyelidikan ini ditaja oleh Kementerian Pendidikan, Malaysia. 
 
Apakah manfaat atau risiko penglibatan di dalam penyelidikan? 
Penyertaan anda akan membolehkan pandangan dan suara anda mengenai isu yang diselidik 
didengari. Selain daripada itu, tiada sebarang manfaat ataupun risiko dalam menyertai 
penyelidikan ini.  
 
Bolehkah saya bertukar fikiran?  
Sekiranya anda bertukar fikiran dan tidak lagi mahu menyertai penyelidikan ini, anda hanya 
perlu maklumkan kepada kami. Anda tidak perlu memberi sebarang sebab. Penarikan diri 
daripada penyelidikan ini tidak akan menpengaruhi rawatan yang anda terima. 
 
Bagaimana saya boleh menghubungi penyelidik-penyelidik yang terlibat dalam 
penyelidikan ini ataupun untuk mendapatkan maklumat lanjut?  
Sila hubungi kami sekiranya anda bersetuju untuk mengambil bahagian dalam penyelidikan 
ini ataupun mempunyai sebarang soalan berkenaan penyelidikan ini, anda boleh 
menghubungi: 
 Ashikin Atan di ashikinatan08@gmail.com atau telefon +6013-7411395 (Malaysia) 
 Dr Sarah Rhynas di Sarah.Rhynas@ed.ac.uk atau telefon +44 (0)131 650 3882 (United 
Kingdom) 
 Professor Tonks Fawcett di t.fawcett@ed.ac.uk atau telefon +44(0)1316503883 (United 
Kingdom)  
 
Beralamat di:   School of Health in Social Science 
              The University of Edinburgh 
              Medical School, Doorway 6 
            Teviot Place 






Dan akhir sekali….. 
Terima kasih kerana meluangkan masa membaca risalah maklumat ini. Kami berharap akan 
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Telephone: +6013-7411395  
Email: ashikinatan08@gmail.com  
 
 
INFORMATION SHEET (HEALTHCARE PROFESSIONAL) 
 
Title: Shared Decision-Making in the Management of Type 2 Diabetes Mellitus 
in Malaysia: The Perspectives of Patients and Healthcare Professionals (HCPs) 
 
You are being invited to participate in a research study.  However, before you decide 
whether to accept this invitation it is important that you know what this study is about, why 
it is being undertaken and what it will involve.  Please take the time to read this information 
and feel free to discuss this with other people. Please do not hesitate to contact one of the 
researchers if there is anything that is not clear or if you would like more information. Our 
contact details are given at the end of this sheet.  Please take time to decide whether or not 
you would like to take part in this study. 
 
Study title:  
Shared Decision-Making in the Management of Type 2 Diabetes Mellitus in Malaysia: The 
Perspectives of Patients and HCPs. 
 
What is this study about? 
This study is to explore the perspectives of the type 2 diabetic patients and their HCPs 
regarding patient involvement in decision-making and also shared decision-making. 
 
Why is this study being carried out? 
Patient involvement in their healthcare management has been widely encouraged around the 
world. Shared decision-making is an approach in decision-making in which the patients and 
their HCPs collaboratively make the best treatment choice. This study will provide 
information on the perspectives of patients and HCPs regarding patient this approach in the 
management of type 2 diabetes mellitus to facilitate its adoption in the Malaysian healthcare 
system.  
 
Do I have to take part? 
It is entirely up to you whether you take part in this study and your participation is voluntary. 





If you decide to take part it would involve taking part in an individual interview with one 
researcher (Ashikin Atan, Principle Investigator).  The interview will last approximately 60 
minutes and will take place at a time and location convenient for participants. It is important 
that you answer all of the questions asked by the researcher honestly and completely. With 
your permission, we would like to record the interview for later data analysis. The recording 
will be used for research purposes only, anonymised and will be stored securely until it is 
destroyed approximately after 10 years.  
 
Confidentiality 
Everything you or any other participants will say will be kept confidential between you and 
the researcher. Your name will not be attached to any documents nor will you be identified 
as a participant in this study or in any subsequent publications of study results.    
 
What will the study result be used for? 
The study will contribute to an understanding of how the participants perceived shared 
decision-making in the management of type 2 diabetes mellitus in Malaysia. With the result 
obtained, it is hoped that this study will be able to suggest ways of facilitating the adoption 
of this concept in the Malaysian healthcare system.   
 
Who is funding the study? 
The study is funded by the Ministry of Higher Education, Malaysia.  
 
Are there possible benefits or risks in taking part? 
In taking part you ensure that your voice is heard on the issue but apart from that there are no 
benefits or risks in taking part.   
 
Can I change my mind? 
Should you change our mind and no longer wish to take part in the study just let us know.  
You do not need to give us any reason for this change.  
 
How can I contact the researchers to take part in this study or to get further 
information? 
Please contact us if you want to take part in the study or have any further questions: 
 Ashikin Atan at ashikinatan08@gmail.com or phone +6013-7411395 (Malaysia) 
 Dr Sarah Rhynas at Sarah.Rhynas@ed.ac.uk or phone +44 (0)131 650 3882 (United 
Kingdom)  




All at:  School of Health in Social Science 
            The University of Edinburgh 
            Medical School, Doorway 6 
            Teviot Place 
            Edinburgh EH8 9AG, United Kingdom 
 
And finally…. 
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RISALAH MAKLUMAT PESERTA (PROFESIONAL KESIHATAN) 
 
Tajuk: Membuat Keputusan Bersama dalam Pengurusan Diabetes Mellitus 
Jenis 2 di Malaysia: Perspektif Pesakit dan Profesional Kesihatan 
 
Anda dijemput untuk mengambil bahagian dalam penyelidikan ini. Namun, sebelum anda 
membuat keputusan untuk menerima jemputan ini, anda perlu ketahui serba sedikit 
mengenai penyelidikan ini. Sila baca maklumat berikut dengan teliti dan sebarang 
perbincangan adalah digalakkan. Sekiranya terdapat keraguan terhadap maklumat yang 
diberi atau memerlukan maklumat tambahan, anda boleh menghubungi mana-mana 
penyelidik yang terlibat. Nombor telefon dan alamat email penyelidik-penyelidik yang 
terlibat adalah seperti yang tertera di penghujung risalah maklumat peserta ini.  
 
Tajuk penyelidikan:  
Membuat Keputusan Bersama dalam Pengurusan Diabetes Mellitus Jenis 2 di Malaysia: 
Perspektif Pesakit dan Profesional Kesihatan 
 
Apakah tujuan penyelidikan ini dijalankan?  
Penyelidikan ini bertujuan untuk meneroka perspektif pesakit diabetes mellitus jenis 2 dan 
ahli profesional kesihatan mengenai penyertaan pesakit dalam proses membuat keputusan 
dan juga membuat keputusan bersama. 
 
Mengapa penyelidikan ini dijalankan?  
Penglibatan pesakit di dalam pengurusan penjagaan kesihatan adalah digalakkan di serata 
dunia. Membuat keputusan bersama adalah salah satu pendekatan dalam proses membuat 
keputusan dimana pesakit dan ahli profesional kesihatan bekerjasama dalam memilih 
rawatan yang terbaik. Penyelidikan ini akan memberikan maklumat mengenai perspektif 
pesakit dan ahli profesional kesihatan berkenaan pendekatan ini dalam pengurusan diabetes 
mellitus jenis 2 agar ia boleh diintegrasikan ke dalam sistem penjagaan kesihatan Malaysia  
 
Adakah saya perlu menyertai penyelidikan ini? 
Penyertaan anda adalah bergantung sepenuhnya kepada persetujuan anda dan secara 
sukarela. 
 
Apa yang perlu saya lakukan?  
Sekiranya anda bersetuju untuk menyertai penyelidikan ini, satu sesi temubual akan 





akan berlangsung selama lebih kurang 60 minit, pada masa dan di lokasi mengikut 
kemudahan anda. Adalah amat penting untuk ada menjawab kesemua soalan yang 
ditanyakan oleh penyelidik dengan jujur dan lengkap. Dengan izin anda, sesi temubual 
tersebut akan direkodkan untuk dianalisa. Rekod temubual hanya akan digunakan untuk 
tujuan penyelidikan sahaja, maklumat peribadi anda akan dirahsiakan dan segala rekod akan 
dilupuskan selepas 10 tahun.  
 
Kerahsiaan  
Segala maklumat yang anda dan peserta lain berikan akan dirahsiakan antara anda dan 
penyelidik. Nama anda tidak akan disertakan dalam mana-mana dokumen dan mana-mana 
penerbitan keputusan penyelidikan. 
 
Apakah kegunaan keputusan penyelidikan?  
Penyelidikan ini akan menyumbang kepada kefahaman terhadap perspektif pesakit dan ahli 
profesional kesihatan mengenai membuat keputusan bersama dalam pengurusan diabetes 
mellitus jenis 2 di Malaysia. Daripada keputusan penyelidikan, cadangan mengenai langkah-




Penyelidikan ini ditaja oleh Kementerian Pendidikan, Malaysia. 
 
Apakah manfaat atau risiko penglibatan di dalam penyelidikan? 
Penyertaan anda akan membolehkan pandangan dan suara anda mengenai isu yang diselidik 
didengari. Selain daripada itu, tiada sebarang manfaat ataupun risiko dalam menyertai 
penyelidikan ini.  
 
Bolehkah saya bertukar fikiran?  
Sekiranya anda bertukar fikiran dan tidak lagi mahu menyertai pemyelidikan ini, anda hanya 
perlu maklumkan kepada kami. Anda tidak perlu memberi sebarang sebab.  
 
Bagaimana saya boleh menghubungi penyelidik-penyelidik yang terlibat dalam 
penyelidikan ini ataupun untuk mendapatkan maklumat lanjut?  
Sila hubungi kami sekiranya anda bersetuju untuk mengambil bahagian dalam penyelidikan 
ini ataupun mempunyai sebarang soalan berkenaan penyelidikan ini, anda boleh 
menghubungi: 
 Ashikin Atan di ashikinatan08@gmail.com atau telefon +6013-7411395 (Malaysia) 
 Dr Sarah Rhynas di Sarah.Rhynas@ed.ac.uk  atau telefon +44 (0)131 650 3882 (United 
Kingdom)  




Beralamat di:   School of Health in Social Science 
              The University of Edinburgh 
              Medical School, Doorway 6 
            Teviot Place 
              Edinburgh EH8 9AG, United Kingdom 
 
Dan akhir sekali….. 
Terima kasih kerana meluangkan masa membaca risalah maklumat ini. Kami berharap akan 










THE UNIVERSITY OF EDINBURGH 
SCHOOL OF HEALTH IN SOCIAL SCIENCE 
DOOR WAY 6 
MEDICAL QUAD 
TEVIOT PLACE 
EDINBURGH EH8 9AG 
Telephone: +6013-7411395  
Email: ashikinatan08@gmail.com  
 
INFORMED CONSENT FORM (PATIENT) 
 
 
Title of Study: Shared Decision-Making in the Management of Type 2 Diabetes 




By signing below, I confirm the following:    Please initial each 
boxes 
 
- I have been given oral and written information for the above study  
and have read and understood the information given. 
 
- I have had sufficient time to consider participation in the study and 
have had the opportunity to ask questions and all my questions have  
been answered satisfactorily. 
 
- I understand that my participation is voluntary and I can at anytime  
free withdraw from the study without giving a reason and this will  
in no way affect my future treatment. 
 
- I understand the risks and benefits, and I freely give my informed  
consent to participate under the conditions stated. I understand that I 
must follow the researcher‘s instructions related to my participation 
             in the study.  
 
- I understand that study staff, qualified reviewers and auditors, the sponsor  
or its affiliates, and governmental or regulatory authorities, have direct  
access to my medical record in order to make sure that the study is  
conducted correctly and the data are recorded correctly. All personal details  






- I understand that anonymised extracts of interviews may be used in  
any reports, publications or presentations emerging from this project. 
 
- I will receive a copy of this subject information/informed consent form  
signed and dated to bring home. 
 
 
















 Date:  
 







I/C number:  










THE UNIVERSITY OF EDINBURGH 
SCHOOL OF HEALTH IN SOCIAL SCIENCE 
DOOR WAY 6 
MEDICAL QUAD 
TEVIOT PLACE 
EDINBURGH EH8 9AG 
No. Tel: +6013-7411395  
Email: ashikinatan08@gmail.com  
 
 
BORANG PERSETUJUAN PESERTA (PESAKIT) 
 
 
Tajuk: Membuat Keputusan Bersama dalam Pengurusan Diabetes Mellitus 
Jenis 2 di Malaysia: Perspektif Pesakit dan Profesional Kesihatan 
 
        
Dengan menandatangani di bawah, saya mengesahkan bahawa: Sila 
tandatangan ringkas di setiap kotak 
 
- Saya telah diberi maklumat tentang penyelidikan di atas secara lisan  
dan bertulis dan saya telah membaca dan memahami segala maklumat  
yang diberikan dalam risalah ini.  
 
- Saya telah diberikan masa yang secukupnya untuk mempertimbangkan  
penyertaan saya dalam penyelidikan ini dan telah diberi peluang  
untuk bertanyakan soalan dan semua persoalan saya telah dijawab  
dengan sempurna dan memuaskan.  
 
- Saya juga faham bahawa penyertaan saya adalah secara sukarela dan  
pada bila-bila masa saya bebas menarik diri daripada penyelidikan ini  
tanpa harus memberi sebarang alasan dan ianya sama sekali tidak akan  
menjejaskan rawatan perubatan saya pada masa akan datang.  
 
- Saya juga memahami tentang risiko dan manfaat penyelidikan ini dan  
saya secara sukarela  memberi persetujuan  untuk menyertai penyelidikan  
ini di bawah syarat-syarat yang telah dinyatakan di atas. Saya faham  
saya harus mematuhi nasihat dan arahan yang berkaitan dengan  
penyertaan saya dalam  penyelidikan ini daripada penyelidik.  
 





terlatih , pihak penaja atau gabungannya, dan pihak berkuasa kerajaan  
atau undang-undang, mempunyai akses langsung dan boleh menyemak  
laporan perubatan saya bagi memastikan penyelidikan ini dijalankan  
dengan betul dan data direkodkan dengan betul. Segala maklumat dan  
data peribadi akan dianggap sebagai SULIT.  
 
- Saya faham bahawa petikan tidak bernama daripada temubual mungkin  
akan digunakan di dalam mana-mana laporan, penerbitan, atau  
pembentangan hasil daripada projek ini. 
  
 
- Saya akan menerima satu salinan ‗Risalah Maklumat Peserta dan  
Borang Persetujuan Peserta‘ yang telah lengkap dengan tarikh dan  
tandatangan untuk dibawa pulang ke rumah.  
 
 











Nama:  Tarikh :  
 
 





















THE UNIVERSITY OF EDINBURGH 
SCHOOL OF HEALTH IN SOCIAL SCIENCE 
DOOR WAY 6 
MEDICAL QUAD 
TEVIOT PLACE 
EDINBURGH EH8 9AG 
Telephone: +6013-7411395  
Email: ashikinatan08@gmail.com  
 
INFORMED CONSENT FORM (HEALTHCARE PROFESSIONAL) 
 
 
Title of Study: Shared Decision-Making in the Management of Type 2 Diabetes 





By signing below, I confirm the following:    Please initial each 
boxes 
 
- I have been given oral and written information for the above study  
and have read and understood the information given. 
 
- I have had sufficient time to consider participation in the study and 
have had the opportunity to ask questions and all my questions have  
been answered satisfactorily. 
 
- I understand the risks and benefits, and I freely give my informed  
consent to participate under the conditions stated. I understand that I 
must follow the researcher‘s instructions related to my participation 
             in the study.  
 
- All personal details will be treated as STRICTLY CONFIDENTIAL.  
 
 
- I understand that the researchers, reviewers and trained auditor, the  
sponsor, and the government or law authorities have direct access to  
my medical record to ensure this study is  
 
- I understand that study staff, qualified reviewers and auditors, the sponsor  





access to the data in order to make sure that the study is  
conducted correctly and the data are recorded correctly. All personal details  




- I understand that anonymised extracts of interviews may be used in  
any reports, publications or presentations emerging from this project.  
 
- I will receive a copy of this subject information/informed consent form  
signed and dated to bring home. 
  
 
















 Date:  
 







I/C number:  













THE UNIVERSITY OF EDINBURGH 
SCHOOL OF HEALTH IN SOCIAL SCIENCE 
DOOR WAY 6 
MEDICAL QUAD 
TEVIOT PLACE 
EDINBURGH EH8 9AG 
No. Tel: +6013-7411395  
Email: ashikinatan08@gmail.com  
 
 
BORANG PERSETUJUAN PESERTA (PROFESIONAL KESIHATAN) 
 
 
Tajuk: Membuat Keputusan Bersama dalam Pengurusan Diabetes Mellitus 
Jenis 2 di Malaysia: Perspektif Pesakit dan Profesional Kesihatan 
 
        
Dengan menandatangani di bawah, saya mengesahkan bahawa: Sila 
tandatangan ringkas di setiap kotak 
 
- Saya telah diberi maklumat tentang penyelidikan di atas secara lisan  
dan bertulis dan saya telah membaca dan memahami segala maklumat  
yang diberikan dalam risalah ini.  
 
- Saya telah diberikan masa yang secukupnya untuk mempertimbangkan  
penyertaan saya dalam penyelidikan ini dan telah diberi peluang  
untuk bertanyakan soalan dan semua persoalan saya telah dijawab  
dengan sempurna dan memuaskan.  
 
- Saya juga faham bahawa penyertaan saya adalah secara sukarela dan  
pada bila-bila masa saya bebas menarik diri daripada penyelidikan ini  
tanpa harus memberi sebarang alas an. 
 
- Saya juga memahami tentang risiko dan manfaat penyelidikan ini dan  
saya secara sukarela  memberi persetujuan  untuk menyertai penyelidikan  
ini di bawah syarat-syarat yang telah dinyatakan di atas. Saya faham  
saya harus mematuhi nasihat dan arahan yang berkaitan dengan  
penyertaan saya dalam  penyelidikan ini daripada penyelidik.  
 
- Saya faham bahawa kakitangan penyelidikan, pemantau dan juruaudit  





atau undang-undang, mempunyai akses langsung kepada data bagi  
memastikan penyelidikan ini dijalankan dengan betul dan data  
direkodkan dengan betul. Segala maklumat dan data peribadi akan dianggap  
sebagai SULIT.  
 
- Saya faham bahawa petikan tidak bernama daripada temubual mungkin  
akan digunakan di dalam mana-mana laporan, penerbitan, atau  
pembentangan hasil daripada projek ini. 
  
 
- Saya akan menerima satu salinan ‗Risalah Maklumat Peserta dan  
Borang Persetujuan Peserta‘ yang telah lengkap dengan tarikh dan  
tandatangan untuk dibawa pulang ke rumah.  
 
 











Nama:  Tarikh :  
 
 




















I would like to thank you for giving me chance to talk to you. My name is Ashikin 
Atan, and currently I am a PhD in Nursing Studies candidate from the University 
of Edinburgh. I am also a sponsored student from Ministry of Education, 
Malaysia. The interview should take less than one hour. Our conversation will 
be audiotaped so that I will not miss any of provided information. You may also 
see me taking note during the interview, but that does not mean I am not 
listening to you as I am writing down some points that require further 
exploration.  
 
Nobody will be listening to the tapes except for people on the project. I will be 
reading the transcripts of your interview and transcript of interviews with other 
people that I have interviewed. I will compare the interviews, make summaries 
and say this as what goes on. I might quote people, but if I do, I will drop out any 
of your identifying information. 
 
If at any time during the interview you wish to discontinue the use of the 
recorder of the interview itself, please feel free to let me know. You may 
withdraw from this study at any time without any penalty. 
 
I am your responsible researcher, and my research is supervised by two 
supervisors from The University of Edinburgh, Dr Sarah Rhynas and Professor 
Tonks Fawcett. You and I both signed and dated each copy of consent form, 
confirming that we agree to continue this interview. You will receive one copy 
and I will keep the other under lock and key. 
 
Just to make sure you have understood all information given in the information 
sheet and your consent to this study is voluntary. If at any time you need to stop, 
take a break, and please let me know. 
 






Interview guide for T2DM patient 
 
PART A: SOCIODEMOGRAPHIC CHARACTERISTICS 
 
1. Age: _________ year-old  
 
2. Gender:  
a. Male         
 [     ] 
b. Female        
 [     ] 
 
3. Race: 
a. Malay         
 [     ] 
b. Chinese        
 [     ] 
c. India         
 [     ] 
d. Others        
 [     ]  
Please specify: _____________________________ 
 
4. Religion: 
a. Islam         
 [     ] 
b. Hindu         
 [     ] 
c. Buddha        
 [     ] 
d. Christian        
 [     ] 
e. Others        
 [     ] 
Please specify: _____________________________ 
 











1. Duration having diabetes: 
 __________  months/years 
 
2. Having any other health problems: 
a. Yes         
 [     ] 
Please specify: 
____________________________________________________ 
b. No         
 [     ] 
 
3. Having any diabetes complication 
a. Yes          
 [     ]  
Please specify: 
______________________________________________________ 
b. No         
 [     ] 







PART C: INTERVIEW GUIDE 
 
1. Exploring patients‘ experience of involvement in the decision-making 
process 
a. How health decisions on your T2DM were made in the past? 
i. How involved were you? 
ii. How was your feeling/acceptance 
iii. Are you satisfied with the way that the decisions were made?  
iv. Anything that you want to change in the decision-making process 
or in the overall illness management? 
 
2. Explore the patients‘ perspectives on patient involvement in decision making 
in the management of their‘ illness  
a. What can you understand about patient involvement in decision-making 
b. Do you know about shared decision-making?(if the participant is not 
familiar with the term – to provide general definition of it) 
i. What is your view about this approach? 
ii. What do you think its‘ benefits or drawbacks? Why? 
iii. What do you think can be the barriers and facilitators? Why?  
c. Any other concerns 
 
3. Explore patients‘ preferences of shared decision-making 
a. In your opinion, what is the best way of making management decision for 
you T2DM? 
i. “I prefer to make the final decision selection about which 
treatment I received” – autonomous 
ii. “I prefer that my healthcare professionals and I share 
responsibility for deciding which treatment is best for me” – 
shared 
iii. “I prefer to leave all decisions regarding my treatment to my 
healthcare professionals” – paternalistic 
b. Reason for the choice? 
 
4. Explore the patients‘ expectations of the shared decision-making concept 













Interview guide for HCP 
 
PART A: SOCIODEMOGRAPHIC CHARACTERISTICS 
 
7. Age: _________ year-old 
 
8. Gender:  
a. Male         
 [     ] 
b. Female       
 [     ] 
 
9. Race: 
a. Malay         
 [     ] 
b. Chinese        
 [     ] 
c. India         
 [     ] 
d. Others        
 [     ]  
Please specify: _____________________________ 
 
10. Religion: 
a. Islam        
 [     ] 
b. Hindu         
 [     ] 
c. Buddha        
 [     ] 
d. Christian        
 [     ] 
e. Others        
 [     ] 
Please specify: _____________________________ 
 
11. Occupation:  _________________ 
 
12. Establishment: _______________ 
 





PART B: INTERVIEW GUIDE  
 
1. Exploring HCPs‘ experience of involvement in the decision-making process 
a. How health decisions on your T2DM patients were made in the past? 
i. How involved were they? 
ii. How was your feeling? 
iii. Are you satisfied with the way that the decisions were made?  
iv. Anything that you want to change in the decision-making process 
or in the overall illness management? 
 
2. Exploring HCPs‘ role in the overall management and decision-making in 
managing T2DM patients 
a. What is your role in the overall management and decision-making in 
managing T2DM patients? 
 
3. Explore the HCPs‘ perspectives on patient involvement in decision making in 
the management of their‘ illness  
a. What can you understand about patient involvement in decision-making 
b. Do you know about shared decision-making?(if the participant is not 
familiar with the term – to provide general definition of it) 
i. What is your view about this approach? 
ii. What do you think its‘ benefits or drawbacks? Why? 
iii. What do you think can be the barriers and facilitators? Why?  
c. Any other concerns? 
 
4. Explore HCPs‘ preferences of shared decision-making 
a. In your opinion, what is the best way of making management decision for 
your T2DM patients? 
i. “I prefer to make the final decision selection about which 
treatment they receive” – paternalistic 
ii. “I prefer that my patients and I share responsibility for 
deciding which treatment is best for me” – shared 
iii. “I prefer to leave all decisions regarding the patients’ 
treatment to them” – autonomous 






5. Explore the HCPs‘ expectations of the shared decision-making concept 
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